data_2m5x_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m5x _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.7 t70 . . . . . 0 C--O 1.243 0.714 0 N-CA-C 106.453 -1.684 . . . . 50.0 106.453 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -61.73 142.23 93.25 Favored 'Trans proline' 0 CA--C 1.509 -0.771 0 N-CA-C 115.885 1.456 . . . . 75.0 115.885 -169.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.0 m -140.83 167.08 18.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 105.759 -1.941 . . . . 50.0 105.759 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.415 ' HB3' ' HB2' ' A' ' 35' ' ' HIS . 44.3 t -134.76 133.16 39.6 Favored 'General case' 0 C--O 1.244 0.816 0 CA-C-O 120.962 0.411 . . . . 50.0 110.472 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.15 176.53 54.65 Favored Glycine 0 N--CA 1.453 -0.17 0 CA-C-N 115.837 -0.62 . . . . 50.0 113.586 -177.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -71.81 -12.89 61.51 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 122.32 -0.518 . . . . 50.0 111.317 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.9 p-10 -94.8 9.18 40.06 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.172 -0.467 . . . . 50.0 111.239 177.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.09 -3.73 75.05 Favored Glycine 0 C--O 1.227 -0.305 0 N-CA-C 116.053 1.181 . . . . 25.0 116.053 176.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -82.37 137.19 34.82 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 118.626 1.213 . . . . 50.0 111.948 -177.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 94.2 m -83.8 128.85 34.84 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.175 -0.921 . . . . 25.0 109.007 176.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -114.93 139.08 50.1 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.308 -0.997 . . . . 50.0 108.308 176.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.62 -56.86 16.65 Favored 'General case' 0 C--O 1.215 -0.718 0 N-CA-C 113.097 0.777 . . . . 50.0 113.097 -173.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -113.06 174.35 5.94 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.984 0.421 . . . . 50.0 110.824 166.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 39.4 tp -64.31 -27.36 68.98 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.723 -0.671 . . . . 50.0 112.213 173.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 47.3 t -63.28 -47.71 81.19 Favored 'General case' 0 C--O 1.216 -0.675 0 O-C-N 121.722 -0.611 . . . . 50.0 111.018 178.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 62.1 m95 -62.47 -31.61 72.37 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.243 -0.583 . . . . 50.0 111.491 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -64.49 -45.41 87.44 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 109.307 -0.627 . . . . 50.0 109.307 175.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -66.17 -41.4 90.38 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.329 -0.396 . . . . 50.0 111.831 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -64.67 -31.25 72.39 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.667 0.27 . . . . 50.0 111.165 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.39 -15.88 59.84 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.701 0.286 . . . . 25.0 111.053 178.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.08 7.72 88.2 Favored Glycine 0 C--O 1.23 -0.103 0 N-CA-C 114.838 0.695 . . . . 25.0 114.838 175.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -85.29 144.37 9.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.079 -1.082 . . . . 50.0 108.079 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.09 150.81 49.38 Favored Glycine 0 C--N 1.316 -0.582 0 N-CA-C 108.564 -1.814 . . . . 50.0 108.564 173.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 60.8 tp -74.5 145.56 43.44 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.053 -0.721 . . . . 50.0 109.053 177.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -128.37 -58.85 1.18 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.005 0.372 . . . . 50.0 112.005 173.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.415 ' HB2' ' HB3' ' A' ' 13' ' ' CYS . 44.0 m-70 -112.1 160.69 17.29 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.522 0.201 . . . . 25.0 111.358 178.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -99.69 149.3 23.46 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 102.89 -3.004 . . . . 50.0 102.89 166.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.8 178.64 47.75 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 110.748 -0.941 . . . . 50.0 110.748 -177.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -78.07 160.92 27.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.749 0.309 . . . . 50.0 111.564 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.7 m . . . . . 0 C--N 1.324 -0.515 0 N-CA-C 108.328 -0.989 . . . . 50.0 108.328 173.652 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 52.1 t0 . . . . . 0 N--CA 1.454 -0.236 0 N-CA-C 109.253 -0.647 . . . . 50.0 109.253 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -65.4 138.49 55.42 Favored 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 114.646 -3.103 . . . . 75.0 113.491 -176.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.6 m -144.26 161.04 15.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 105.561 -2.015 . . . . 50.0 105.561 -178.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 50.8 t -131.47 126.37 34.85 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.097 -0.705 . . . . 50.0 109.097 -177.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.37 178.5 53.87 Favored Glycine 0 C--O 1.225 -0.437 0 CA-C-N 115.761 -0.654 . . . . 50.0 113.247 -175.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -66.56 -19.83 65.87 Favored 'General case' 0 C--O 1.214 -0.786 0 O-C-N 122.616 -0.343 . . . . 50.0 111.435 177.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -82.57 3.78 27.25 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 121.768 0.794 . . . . 50.0 110.708 177.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.21 -4.41 54.91 Favored Glycine 0 C--O 1.224 -0.484 0 O-C-N 121.839 -0.538 . . . . 25.0 114.134 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -81.86 134.26 35.39 Favored 'General case' 0 C--O 1.239 0.527 0 O-C-N 122.109 -0.641 . . . . 50.0 110.776 -176.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.2 m -86.73 132.39 33.88 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.605 -0.725 . . . . 25.0 109.502 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -114.69 137.4 51.96 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 106.11 -1.811 . . . . 50.0 106.11 175.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 79.8 p -66.81 -47.42 72.13 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 111.974 0.361 . . . . 50.0 111.974 -173.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -109.19 164.55 12.35 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.701 -0.851 . . . . 50.0 108.701 172.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 63.6 tp -68.32 -23.65 64.74 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.496 -0.775 . . . . 50.0 109.104 172.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.8 t -55.59 -51.0 68.61 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.618 -0.719 . . . . 50.0 111.344 175.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 24.0 m95 -69.89 -31.13 68.77 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.389 -0.524 . . . . 50.0 111.351 -176.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -64.47 -44.47 90.97 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.331 -0.618 . . . . 50.0 109.331 175.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.36 -46.26 90.94 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.141 -0.481 . . . . 50.0 110.521 -178.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -74.83 -23.58 58.48 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.634 0.605 . . . . 50.0 112.634 -176.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.27 -18.02 57.91 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.779 0.323 . . . . 25.0 110.611 176.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.74 5.37 86.35 Favored Glycine 0 CA--C 1.517 0.206 0 N-CA-C 115.114 0.806 . . . . 25.0 115.114 176.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -74.81 137.25 23.43 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 N-CA-C 107.529 -1.286 . . . . 50.0 107.529 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.51 143.85 46.32 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 107.548 -2.221 . . . . 50.0 107.548 175.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 57.9 tp -70.34 142.68 52.14 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.335 -0.987 . . . . 50.0 108.335 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -126.03 -58.91 1.36 Allowed 'General case' 0 C--O 1.22 -0.472 0 C-N-CA 120.983 -0.287 . . . . 50.0 110.258 173.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -111.92 154.44 25.22 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.802 -0.444 . . . . 25.0 109.802 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -102.72 145.63 29.43 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 102.432 -3.173 . . . . 50.0 102.432 167.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.91 171.26 43.38 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 109.681 -1.368 . . . . 50.0 109.681 -172.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -72.65 153.5 41.18 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 113.376 0.88 . . . . 50.0 113.376 -176.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 51.6 m . . . . . 0 C--O 1.241 0.614 0 N-CA-C 103.388 -2.819 . . . . 50.0 103.388 163.565 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 39.4 t0 . . . . . 0 C--O 1.236 0.368 0 N-CA-C 107.944 -1.132 . . . . 50.0 107.944 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -65.65 135.68 42.92 Favored 'Trans proline' 0 CA--C 1.509 -0.745 0 C-N-CA 117.616 -1.122 . . . . 75.0 113.213 -174.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.4 m -141.17 159.81 22.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 105.935 -1.876 . . . . 50.0 105.935 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 38.8 t -119.27 124.34 46.45 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.197 -1.038 . . . . 50.0 108.197 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -79.32 170.77 54.63 Favored Glycine 0 C--O 1.226 -0.361 0 C-N-CA 120.792 -0.718 . . . . 50.0 111.34 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -68.32 -12.01 60.39 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 112.481 0.548 . . . . 50.0 112.481 178.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -81.68 1.01 36.15 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.549 0.69 . . . . 50.0 110.181 174.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 76.98 16.66 80.59 Favored Glycine 0 C--O 1.222 -0.596 0 O-C-N 121.555 -0.716 . . . . 25.0 113.112 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -108.11 138.81 43.74 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 122.128 -0.631 . . . . 50.0 111.085 -176.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 54.6 m -81.52 133.26 35.37 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.916 -0.584 . . . . 25.0 109.489 176.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -114.89 137.13 52.33 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.045 -1.465 . . . . 50.0 107.045 173.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.9 m -59.99 -57.02 14.66 Favored 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 112.945 0.721 . . . . 50.0 112.945 -173.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 47.8 p30 -109.07 167.6 9.98 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.122 0.486 . . . . 50.0 110.457 167.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 59.8 tp -62.47 -26.78 68.7 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.844 -0.616 . . . . 50.0 110.62 172.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.4 m -61.47 -44.63 96.75 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 122.04 -0.413 . . . . 50.0 111.793 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 65.0 m95 -68.77 -30.88 69.57 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 121.762 -0.586 . . . . 50.0 111.519 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -63.05 -44.48 95.75 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.437 -0.949 . . . . 50.0 108.437 175.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -66.12 -41.51 90.46 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.032 -0.531 . . . . 50.0 111.492 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -62.99 -32.78 74.2 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 111.668 0.247 . . . . 50.0 111.668 178.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.77 -14.16 59.42 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.673 0.273 . . . . 25.0 111.434 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.18 11.16 85.8 Favored Glycine 0 C--O 1.23 -0.135 0 N-CA-C 115.031 0.772 . . . . 25.0 115.031 176.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -87.41 146.41 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 N-CA-C 107.791 -1.189 . . . . 50.0 107.791 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.69 152.26 47.37 Favored Glycine 0 C--N 1.316 -0.553 0 N-CA-C 107.803 -2.119 . . . . 50.0 107.803 173.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 8.4 tt -78.49 141.86 37.89 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.579 -1.267 . . . . 50.0 107.579 176.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -117.06 -58.35 2.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.82 0.343 . . . . 50.0 110.405 174.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -111.97 156.54 21.97 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.311 -0.243 . . . . 25.0 111.02 176.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -98.8 146.38 25.99 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 103.708 -2.701 . . . . 50.0 103.708 168.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.53 171.2 40.89 Favored Glycine 0 N--CA 1.451 -0.312 0 N-CA-C 109.552 -1.419 . . . . 50.0 109.552 -174.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -81.31 158.18 24.83 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.104 -0.702 . . . . 50.0 109.104 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 27.8 p . . . . . 0 C--N 1.325 -0.498 0 C-N-CA 122.923 0.489 . . . . 50.0 109.735 -178.132 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 59.2 t0 . . . . . 0 C--O 1.238 0.467 0 N-CA-C 109.142 -0.688 . . . . 50.0 109.142 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.97 134.6 43.86 Favored 'Trans proline' 0 CA--C 1.506 -0.885 0 C-N-CA 117.517 -1.188 . . . . 75.0 112.621 -176.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.4 m -142.72 162.06 18.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 105.989 -1.856 . . . . 50.0 105.989 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 43.8 t -123.75 123.33 40.27 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.839 -0.8 . . . . 50.0 108.839 -177.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.18 164.68 48.08 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.065 -0.588 . . . . 50.0 112.244 -178.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -62.75 -17.6 61.2 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.113 0.783 . . . . 50.0 113.113 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -79.61 5.6 12.74 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 122.334 -0.229 . . . . 50.0 111.146 175.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.59 17.24 71.32 Favored Glycine 0 C--O 1.225 -0.427 0 C-N-CA 120.677 -0.773 . . . . 25.0 113.8 175.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 32.2 mmtm -121.26 138.49 54.21 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 117.559 0.679 . . . . 50.0 112.152 -173.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 38.4 m -83.17 133.84 35.01 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.969 -1.014 . . . . 25.0 111.241 -179.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -114.83 138.33 50.9 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.285 -1.376 . . . . 50.0 107.285 173.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.1 p -62.69 -52.4 63.43 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.567 0.58 . . . . 50.0 112.567 -174.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 -108.24 168.01 9.61 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.371 -0.974 . . . . 50.0 108.371 171.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 59.6 tp -68.68 -26.1 65.13 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.039 -1.096 . . . . 50.0 108.039 171.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 48.6 t -55.01 -52.33 63.48 Favored 'General case' 0 C--O 1.219 -0.513 0 CA-C-N 115.046 -0.979 . . . . 50.0 111.262 175.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 72.7 m95 -69.42 -27.41 65.25 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.068 0.395 . . . . 50.0 112.068 -175.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -65.86 -49.41 68.22 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.931 -0.766 . . . . 50.0 108.931 175.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -66.75 -40.73 88.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.913 -0.585 . . . . 50.0 111.473 -177.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -67.28 -27.81 67.5 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 120.965 -0.294 . . . . 50.0 111.646 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.34 -12.76 59.55 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.624 0.249 . . . . 25.0 111.138 178.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.06 19.46 78.6 Favored Glycine 0 C--O 1.23 -0.146 0 N-CA-C 114.744 0.658 . . . . 25.0 114.744 175.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -93.15 144.2 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 N-CA-C 107.457 -1.312 . . . . 50.0 107.457 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.62 148.75 45.66 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 107.106 -2.398 . . . . 50.0 107.106 173.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 8.2 tt -78.56 141.01 38.44 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.516 -1.291 . . . . 50.0 107.516 176.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -116.24 -58.13 2.13 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.101 -0.333 . . . . 50.0 110.101 174.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 5.3 m170 -112.03 157.88 20.22 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 110.105 -0.332 . . . . 25.0 110.105 176.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -99.79 147.78 25.11 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 102.677 -3.082 . . . . 50.0 102.677 165.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.46 169.0 41.62 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 109.735 -1.346 . . . . 50.0 109.735 -173.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -72.72 161.56 30.59 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.974 0.731 . . . . 50.0 112.974 -178.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 9.4 m . . . . . 0 C--O 1.239 0.507 0 N-CA-C 104.901 -2.259 . . . . 50.0 104.901 169.008 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 44.2 t0 . . . . . 0 CA--C 1.511 -0.533 0 N-CA-C 108.12 -1.067 . . . . 50.0 108.12 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -62.87 133.61 42.6 Favored 'Trans proline' 0 CA--C 1.503 -1.07 0 O-C-N 122.309 0.636 . . . . 75.0 112.081 -173.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.5 m -139.55 161.18 27.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 107.282 -1.377 . . . . 50.0 107.282 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.1 t -131.55 121.69 24.85 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.889 -1.152 . . . . 50.0 107.889 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.98 173.58 54.67 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.815 -0.629 . . . . 50.0 112.823 -176.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp -64.2 -16.07 61.23 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.325 0.861 . . . . 50.0 113.325 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -92.07 10.65 28.27 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.736 0.303 . . . . 50.0 110.218 177.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.95 -2.34 65.17 Favored Glycine 0 C--O 1.223 -0.557 0 N-CA-C 114.281 0.472 . . . . 25.0 114.281 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -82.73 130.74 35.17 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 121.883 -0.775 . . . . 50.0 111.973 -175.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 70.3 m -84.79 128.39 34.59 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.986 -1.007 . . . . 25.0 110.87 177.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -114.88 137.02 52.46 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.002 -0.74 . . . . 50.0 109.002 174.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.3 m -60.51 -54.91 39.82 Favored 'General case' 0 C--O 1.217 -0.611 0 N-CA-C 112.701 0.63 . . . . 50.0 112.701 -174.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -109.1 168.41 9.39 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.07 0.462 . . . . 50.0 110.525 167.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 39.8 tp -65.76 -23.02 66.63 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.967 -0.561 . . . . 50.0 111.041 172.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 22.5 t -60.87 -50.35 73.8 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 121.956 -0.465 . . . . 50.0 111.001 178.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -64.38 -31.18 72.29 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 122.113 -0.367 . . . . 50.0 111.556 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -63.41 -46.39 86.6 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 109.159 -0.682 . . . . 50.0 109.159 176.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.08 -42.37 94.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.059 -0.519 . . . . 50.0 110.468 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -65.32 -33.13 75.25 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.598 0.221 . . . . 50.0 111.598 -179.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.76 -12.2 60.01 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 111.779 0.289 . . . . 25.0 111.779 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.4 19.99 79.78 Favored Glycine 0 C--O 1.229 -0.194 0 N-CA-C 115.005 0.762 . . . . 25.0 115.005 176.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -91.81 142.44 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 N-CA-C 107.542 -1.281 . . . . 50.0 107.542 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.53 147.17 46.64 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 108.005 -2.038 . . . . 50.0 108.005 173.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 62.0 tp -75.07 144.47 42.95 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.939 -1.134 . . . . 50.0 107.939 176.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -122.38 -59.15 1.66 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.401 -0.52 . . . . 50.0 110.218 172.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -113.82 153.05 29.78 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.512 0.56 . . . . 25.0 112.512 173.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -85.86 148.69 25.69 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 100.952 -3.722 . . . . 50.0 100.952 159.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.3 152.84 26.71 Favored Glycine 0 C--N 1.318 -0.449 0 N-CA-C 110.656 -0.977 . . . . 50.0 110.656 -176.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -83.66 151.75 25.12 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.66 0.615 . . . . 50.0 112.66 -176.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 76.2 m . . . . . 0 C--O 1.24 0.592 0 N-CA-C 105.692 -1.966 . . . . 50.0 105.692 171.758 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.5 t0 . . . . . 0 C--O 1.239 0.521 0 N-CA-C 106.997 -1.483 . . . . 50.0 106.997 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.77 139.51 44.01 Favored 'Trans proline' 0 CA--C 1.51 -0.699 0 C-N-CA 117.186 -1.41 . . . . 75.0 114.081 -172.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.0 m -141.9 162.3 20.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 105.995 -1.854 . . . . 50.0 105.995 178.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.8 t -128.53 127.1 41.73 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-O 121.02 0.438 . . . . 50.0 110.04 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.33 175.31 54.95 Favored Glycine 0 C--O 1.227 -0.318 0 C-N-CA 121.06 -0.59 . . . . 50.0 112.427 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -66.53 -18.07 65.16 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 122.477 -0.425 . . . . 50.0 111.841 177.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -79.23 0.75 27.27 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.564 0.697 . . . . 50.0 110.82 176.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 75.46 16.71 80.46 Favored Glycine 0 C--O 1.222 -0.626 0 C-N-CA 120.87 -0.681 . . . . 25.0 113.209 178.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -106.04 137.3 44.2 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 122.246 -0.561 . . . . 50.0 110.667 -177.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 60.8 m -82.46 134.28 35.22 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.799 -0.637 . . . . 25.0 109.526 177.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -114.95 137.92 51.43 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 106.566 -1.642 . . . . 50.0 106.566 174.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.5 p -60.26 -55.83 28.89 Favored 'General case' 0 C--O 1.219 -0.511 0 N-CA-C 112.382 0.512 . . . . 50.0 112.382 -173.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 36.8 p30 -109.06 166.14 11.06 Favored 'General case' 0 C--O 1.244 0.79 0 CA-C-O 121.306 0.574 . . . . 50.0 110.892 166.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 60.9 tp -63.15 -25.72 68.48 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.207 0.527 . . . . 50.0 111.15 172.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 68.5 m -63.63 -41.45 98.26 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 121.792 -0.568 . . . . 50.0 112.213 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 60.4 m95 -70.62 -29.56 65.97 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 121.428 -0.795 . . . . 50.0 110.721 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.94 -42.66 99.88 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.286 -1.005 . . . . 50.0 108.286 173.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -63.66 -41.36 98.21 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 111.696 0.258 . . . . 50.0 111.696 177.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -63.68 -36.04 82.53 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 117.831 0.287 . . . . 50.0 111.722 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.38 -17.92 57.78 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.668 0.271 . . . . 25.0 111.63 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.67 5.6 83.57 Favored Glycine 0 CA--C 1.518 0.227 0 N-CA-C 115.109 0.804 . . . . 25.0 115.109 176.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -74.31 140.46 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.654 0 N-CA-C 107.467 -1.308 . . . . 50.0 107.467 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.28 147.15 49.76 Favored Glycine 0 C--N 1.315 -0.59 0 N-CA-C 107.608 -2.197 . . . . 50.0 107.608 174.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 56.5 tp -72.92 143.52 47.68 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.475 -0.935 . . . . 50.0 108.475 177.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -124.36 -59.1 1.49 Allowed 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 121.179 -0.208 . . . . 50.0 110.888 173.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -111.91 154.26 25.48 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.418 -0.216 . . . . 25.0 110.418 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -98.92 143.94 28.65 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 102.41 -3.182 . . . . 50.0 102.41 167.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 93.19 170.16 39.54 Favored Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 109.1 -1.6 . . . . 50.0 109.1 -173.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -78.5 162.32 26.43 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.426 -0.583 . . . . 50.0 109.426 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 26.3 p . . . . . 0 C--N 1.323 -0.568 0 N-CA-C 108.523 -0.917 . . . . 50.0 108.523 -179.586 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 36.4 t70 . . . . . 0 C--O 1.233 0.206 0 N-CA-C 109.559 -0.534 . . . . 50.0 109.559 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -65.4 134.15 37.62 Favored 'Trans proline' 0 CA--C 1.51 -0.689 0 C-N-CA 116.716 -1.723 . . . . 75.0 113.637 -173.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.9 m -141.62 161.61 21.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 106.112 -1.81 . . . . 50.0 106.112 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.418 ' HB3' ' HB2' ' A' ' 35' ' ' HIS . 50.4 t -129.11 125.08 36.37 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.966 -0.753 . . . . 50.0 108.966 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.84 175.29 54.09 Favored Glycine 0 C--O 1.227 -0.32 0 CA-C-N 115.918 -0.583 . . . . 50.0 114.078 -175.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -67.56 -12.07 59.53 Favored 'General case' 0 C--O 1.215 -0.735 0 N-CA-C 112.487 0.551 . . . . 50.0 112.487 177.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -91.41 8.94 33.84 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.711 0.291 . . . . 50.0 110.453 176.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.5 -18.5 8.5 Favored Glycine 0 C--O 1.222 -0.652 0 N-CA-C 114.926 0.731 . . . . 25.0 114.926 177.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -73.11 139.41 46.42 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 121.312 0.577 . . . . 50.0 112.289 -177.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 98.8 m -86.05 132.63 34.0 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.653 -1.158 . . . . 25.0 108.882 175.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -115.0 136.97 52.54 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.114 -1.069 . . . . 50.0 108.114 176.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.8 m -62.33 -51.68 66.66 Favored 'General case' 0 C--O 1.223 -0.327 0 N-CA-C 112.714 0.635 . . . . 50.0 112.714 -174.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 45.9 p30 -113.9 170.08 8.53 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 121.109 0.48 . . . . 50.0 110.546 168.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 41.5 tp -63.79 -25.57 68.24 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.902 -0.59 . . . . 50.0 110.66 172.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 19.5 m -61.53 -46.05 91.58 Favored 'General case' 0 C--O 1.218 -0.571 0 O-C-N 122.144 -0.347 . . . . 50.0 111.916 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 24.5 m95 -70.08 -28.41 65.41 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 121.788 -0.57 . . . . 50.0 111.201 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -64.51 -45.32 87.74 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.5 -0.926 . . . . 50.0 108.5 175.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -66.05 -42.22 89.8 Favored 'General case' 0 C--O 1.22 -0.467 0 CA-C-N 115.782 -0.644 . . . . 50.0 111.78 178.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -63.61 -33.56 75.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.718 0.294 . . . . 50.0 111.414 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.27 -12.22 59.98 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.602 0.239 . . . . 25.0 111.323 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.0 21.78 77.85 Favored Glycine 0 C--O 1.23 -0.11 0 N-CA-C 114.385 0.514 . . . . 25.0 114.385 174.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -99.52 143.2 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 N-CA-C 109.09 -0.707 . . . . 50.0 109.09 -178.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.06 149.06 47.07 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 107.848 -2.101 . . . . 50.0 107.848 172.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 7.7 tt -74.73 147.97 40.89 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.073 -1.084 . . . . 50.0 108.073 177.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -129.34 -47.52 1.19 Allowed 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 112.98 0.733 . . . . 50.0 112.98 172.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.418 ' HB2' ' HB3' ' A' ' 13' ' ' CYS . 52.4 m-70 -114.46 156.44 24.54 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.356 -0.609 . . . . 25.0 109.356 174.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -100.01 146.15 27.06 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 102.784 -3.043 . . . . 50.0 102.784 169.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.19 175.58 47.7 Favored Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 109.305 -1.518 . . . . 50.0 109.305 -174.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -75.63 160.53 30.0 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.994 0.426 . . . . 50.0 112.013 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 16.8 m . . . . . 0 C--N 1.323 -0.553 0 N-CA-C 104.581 -2.377 . . . . 50.0 104.581 167.896 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 56.2 t0 . . . . . 0 C--O 1.237 0.436 0 N-CA-C 108.203 -1.036 . . . . 50.0 108.203 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.37 130.29 24.9 Favored 'Trans proline' 0 CA--C 1.507 -0.847 0 C-N-CA 117.099 -1.467 . . . . 75.0 112.758 -175.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.1 m -140.59 162.14 23.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 104.929 -2.249 . . . . 50.0 104.929 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.404 ' HB3' ' HB2' ' A' ' 35' ' ' HIS . 53.4 t -133.62 129.22 36.62 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.687 -0.857 . . . . 50.0 108.687 -179.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.92 -179.69 52.98 Favored Glycine 0 N--CA 1.452 -0.257 0 CA-C-O 121.651 0.584 . . . . 50.0 114.158 -174.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -71.63 -12.07 61.16 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.179 0.514 . . . . 50.0 110.456 176.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -86.96 0.84 54.43 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.532 -0.758 . . . . 50.0 110.688 175.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 78.56 -1.9 69.96 Favored Glycine 0 C--O 1.228 -0.248 0 N-CA-C 114.611 0.604 . . . . 25.0 114.611 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.9 mtmm -88.64 140.49 29.4 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 118.178 0.989 . . . . 50.0 111.522 -177.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 94.3 m -81.94 131.72 35.25 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.891 -1.049 . . . . 25.0 108.845 175.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -114.8 137.39 52.0 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 106.036 -1.839 . . . . 50.0 106.036 174.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.8 p -66.63 -52.09 48.99 Favored 'General case' 0 C--O 1.22 -0.491 0 N-CA-C 111.677 0.251 . . . . 50.0 111.677 -173.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 30.4 p30 -109.1 167.01 10.41 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-O 121.732 0.777 . . . . 50.0 111.691 167.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 45.7 tp -64.84 -24.79 67.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.151 -0.932 . . . . 50.0 110.714 172.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.4 t -59.88 -49.97 75.61 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 122.167 -0.333 . . . . 50.0 111.323 179.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.7 m95 -69.53 -28.18 65.8 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.265 -0.574 . . . . 50.0 111.572 -179.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -63.0 -44.8 95.03 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.399 -0.963 . . . . 50.0 108.399 174.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.36 -41.9 93.35 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.14 -0.482 . . . . 50.0 111.017 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -65.47 -32.89 74.75 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 122.183 -0.323 . . . . 50.0 111.244 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.52 -13.76 60.07 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.715 0.293 . . . . 25.0 111.373 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.76 12.86 83.56 Favored Glycine 0 CA--C 1.516 0.111 0 N-CA-C 114.946 0.739 . . . . 25.0 114.946 175.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -88.01 142.68 12.6 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.674 0 N-CA-C 108.516 -0.92 . . . . 50.0 108.516 -178.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.44 142.12 32.08 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 107.302 -2.319 . . . . 50.0 107.302 173.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 9.0 tt -65.9 142.47 57.89 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.045 -1.094 . . . . 50.0 108.045 177.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -121.51 -55.17 1.94 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 122.43 -0.169 . . . . 50.0 110.767 175.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.404 ' HB2' ' HB3' ' A' ' 13' ' ' CYS . 29.6 m-70 -111.96 154.32 25.44 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.849 -0.797 . . . . 25.0 108.849 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -98.29 143.78 28.41 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 103.198 -2.89 . . . . 50.0 103.198 170.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.45 177.4 48.48 Favored Glycine 0 C--N 1.321 -0.293 0 N-CA-C 109.968 -1.253 . . . . 50.0 109.968 -175.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -74.31 159.77 31.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.971 0.415 . . . . 50.0 112.115 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 22.3 m . . . . . 0 C--N 1.324 -0.538 0 N-CA-C 104.806 -2.294 . . . . 50.0 104.806 167.494 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 60.1 t0 . . . . . 0 CA--C 1.514 -0.412 0 N-CA-C 106.612 -1.625 . . . . 50.0 106.612 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.28 132.71 37.29 Favored 'Trans proline' 0 CA--C 1.506 -0.913 0 C-N-CA 116.621 -1.786 . . . . 75.0 112.228 -175.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.8 m -144.34 162.98 14.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 105.73 -1.952 . . . . 50.0 105.73 -178.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 45.2 t -132.94 130.39 39.52 Favored 'General case' 0 C--O 1.245 0.833 0 N-CA-C 109.586 -0.524 . . . . 50.0 109.586 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -77.91 174.93 54.73 Favored Glycine 0 N--CA 1.453 -0.171 0 CA-C-N 115.528 -0.76 . . . . 50.0 113.619 -176.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -68.23 -17.88 64.42 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.199 0.444 . . . . 50.0 112.199 178.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -94.39 9.89 36.51 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.995 0.426 . . . . 50.0 111.073 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.25 -0.65 89.31 Favored Glycine 0 C--O 1.227 -0.328 0 N-CA-C 117.267 1.667 . . . . 25.0 117.267 174.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 11.9 mmtp -83.27 138.29 33.64 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.19 1.495 . . . . 50.0 111.772 -177.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 97.5 m -84.84 129.17 34.85 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.537 -0.756 . . . . 25.0 109.266 175.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -114.7 138.02 51.21 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.827 -1.175 . . . . 50.0 107.827 175.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.0 p -68.85 -54.75 13.92 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.057 0.391 . . . . 50.0 112.057 -175.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -108.98 162.91 13.78 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.398 -0.964 . . . . 50.0 108.398 174.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 41.9 tp -65.65 -30.09 70.75 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.186 -0.461 . . . . 50.0 111.08 177.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 68.7 m -65.86 -26.07 67.48 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 121.182 -0.948 . . . . 50.0 113.02 177.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -75.02 -34.43 61.91 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 121.7 -0.625 . . . . 50.0 109.652 177.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -64.06 -44.94 90.9 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.391 -0.966 . . . . 50.0 108.391 174.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.7 -41.65 99.24 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.599 -0.728 . . . . 50.0 111.675 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -67.17 -33.54 75.61 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.51 0.195 . . . . 50.0 111.485 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.43 -18.61 58.73 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.777 0.322 . . . . 25.0 110.959 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.33 7.78 86.97 Favored Glycine 0 CA--C 1.517 0.159 0 N-CA-C 114.936 0.734 . . . . 25.0 114.936 176.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -77.58 142.1 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 N-CA-C 108.594 -0.891 . . . . 50.0 108.594 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.18 148.88 49.48 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 107.953 -2.059 . . . . 50.0 107.953 173.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.6 tp -70.79 142.77 51.33 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.992 -0.744 . . . . 50.0 108.992 177.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -126.51 -58.15 1.34 Allowed 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 121.137 -0.225 . . . . 50.0 110.834 173.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -112.02 153.44 26.83 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.439 -0.578 . . . . 25.0 109.439 178.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -102.07 144.18 30.97 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 102.834 -3.024 . . . . 50.0 102.834 168.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.82 171.67 42.12 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 109.021 -1.632 . . . . 50.0 109.021 -172.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -73.58 160.9 30.96 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.107 0.41 . . . . 50.0 112.107 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 4.3 m . . . . . 0 C--N 1.324 -0.515 0 N-CA-C 106.187 -1.783 . . . . 50.0 106.187 170.305 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 38.9 t0 . . . . . 0 C--O 1.242 0.669 0 N-CA-C 106.881 -1.526 . . . . 50.0 106.881 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.77 134.59 41.2 Favored 'Trans proline' 0 CA--C 1.507 -0.859 0 C-N-CA 117.666 -1.09 . . . . 75.0 113.505 -173.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.7 m -140.94 162.18 22.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 106.85 -1.537 . . . . 50.0 106.85 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.409 ' HB3' ' HB2' ' A' ' 35' ' ' HIS . 37.4 t -131.06 125.72 33.96 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.069 -0.715 . . . . 50.0 109.069 -178.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -79.82 179.01 53.49 Favored Glycine 0 C--N 1.323 -0.175 0 C-N-CA 121.062 -0.589 . . . . 50.0 112.544 -177.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -64.66 -23.31 67.22 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.393 0.277 . . . . 50.0 111.443 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -73.7 -4.05 32.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.342 0.591 . . . . 50.0 110.969 177.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 79.54 7.39 88.52 Favored Glycine 0 C--O 1.228 -0.279 0 C-N-CA 121.474 -0.393 . . . . 25.0 112.533 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.6 mmmt -102.52 141.79 34.77 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.716 0.769 . . . . 50.0 112.573 -177.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 44.7 m -85.26 133.63 34.16 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.038 -1.437 . . . . 25.0 112.788 -176.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -114.67 137.13 52.28 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 106.933 -1.506 . . . . 50.0 106.933 171.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.8 m -61.28 -55.37 32.7 Favored 'General case' 0 C--O 1.221 -0.435 0 N-CA-C 112.741 0.645 . . . . 50.0 112.741 -174.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -108.78 153.78 23.0 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 109.17 -0.678 . . . . 50.0 109.17 170.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 67.7 tp -57.95 -27.77 63.71 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 116.016 -0.538 . . . . 50.0 110.992 174.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -61.68 -36.69 81.6 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.757 0.651 . . . . 50.0 112.757 178.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 12.3 m95 -72.37 -35.19 68.42 Favored 'General case' 0 C--O 1.22 -0.475 0 C-N-CA 119.703 -0.799 . . . . 50.0 110.048 177.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -61.91 -44.21 97.26 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 108.941 -0.763 . . . . 50.0 108.941 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -63.99 -42.12 97.31 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.006 -0.543 . . . . 50.0 111.825 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -69.67 -30.88 68.66 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 111.912 0.338 . . . . 50.0 111.912 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.25 -19.35 59.78 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.812 0.339 . . . . 25.0 110.887 177.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.74 -0.46 88.19 Favored Glycine 0 CA--C 1.516 0.137 0 N-CA-C 115.117 0.807 . . . . 25.0 115.117 176.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.9 t -68.69 138.12 23.03 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.614 0 N-CA-C 107.955 -1.128 . . . . 50.0 107.955 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.02 142.65 45.25 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 108.249 -1.94 . . . . 50.0 108.249 174.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.4 tp -72.14 142.56 49.11 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.074 -1.084 . . . . 50.0 108.074 177.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -125.64 -57.38 1.46 Allowed 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 121.06 -0.256 . . . . 50.0 110.918 175.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.409 ' HB2' ' HB3' ' A' ' 13' ' ' CYS . 7.2 m170 -111.94 153.03 27.35 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.881 -0.415 . . . . 25.0 109.881 176.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -98.52 146.96 25.25 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 101.285 -3.598 . . . . 50.0 101.285 163.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.54 165.93 36.24 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 108.184 -1.966 . . . . 50.0 108.184 -171.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -91.63 154.39 19.06 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 113.085 0.772 . . . . 50.0 113.085 -175.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 82.8 m . . . . . 0 C--N 1.325 -0.468 0 N-CA-C 106.197 -1.779 . . . . 50.0 106.197 172.68 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.2 t0 . . . . . 0 C--O 1.236 0.363 0 N-CA-C 107.545 -1.28 . . . . 50.0 107.545 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.63 139.49 44.53 Favored 'Trans proline' 0 CA--C 1.508 -0.782 0 C-N-CA 117.279 -1.347 . . . . 75.0 114.303 -171.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.8 m -141.08 162.07 22.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 106.588 -1.634 . . . . 50.0 106.588 178.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 37.5 t -122.55 126.55 47.99 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.065 -0.717 . . . . 50.0 109.065 179.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.92 172.96 44.55 Favored Glycine 0 C--O 1.225 -0.433 0 C-N-CA 120.691 -0.766 . . . . 50.0 112.026 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 37.2 mttp -65.52 -12.36 52.11 Favored 'General case' 0 C--O 1.215 -0.727 0 C-N-CA 123.017 0.527 . . . . 50.0 112.42 176.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -76.0 -2.48 30.75 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.262 0.625 . . . . 50.0 110.222 175.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.86 16.69 79.65 Favored Glycine 0 C--O 1.223 -0.587 0 C-N-CA 121.414 -0.422 . . . . 25.0 112.833 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 63.8 mttt -125.97 145.93 50.08 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.142 0.496 . . . . 50.0 112.311 -172.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 99.6 m -79.65 135.66 36.62 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.895 -1.048 . . . . 25.0 111.046 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -114.78 137.33 52.06 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 105.822 -1.918 . . . . 50.0 105.822 171.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.6 p -60.45 -54.96 39.32 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 113.08 0.77 . . . . 50.0 113.08 -172.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 29.7 p30 -109.61 165.76 11.42 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 121.182 0.515 . . . . 50.0 110.576 166.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 65.1 tp -64.61 -24.16 67.5 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.15 0.5 . . . . 50.0 111.669 174.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.0 t -64.25 -45.4 88.31 Favored 'General case' 0 C--O 1.216 -0.686 0 O-C-N 121.754 -0.591 . . . . 50.0 110.826 178.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 46.0 m95 -65.63 -31.31 72.26 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 121.768 -0.582 . . . . 50.0 111.144 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -62.46 -44.86 95.4 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.917 -0.771 . . . . 50.0 108.917 174.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -65.18 -41.9 94.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.139 -0.482 . . . . 50.0 111.732 178.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -65.83 -30.86 71.55 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.633 0.254 . . . . 50.0 111.113 -178.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.95 -15.82 58.67 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.753 0.311 . . . . 25.0 111.17 177.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.66 15.92 80.03 Favored Glycine 0 C--O 1.231 -0.084 0 N-CA-C 114.775 0.67 . . . . 25.0 114.775 175.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.3 t -89.31 147.63 5.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 107.622 -1.251 . . . . 50.0 107.622 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.25 144.61 34.83 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 107.912 -2.075 . . . . 50.0 107.912 174.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 63.4 tp -70.31 142.36 52.24 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.348 -1.353 . . . . 50.0 107.348 176.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -122.92 -58.83 1.64 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.901 -0.319 . . . . 50.0 110.953 175.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 21.2 m-70 -112.01 153.77 26.33 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 122.351 -0.218 . . . . 25.0 111.584 176.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -95.2 145.92 24.7 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 103.582 -2.747 . . . . 50.0 103.582 167.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.02 168.21 40.46 Favored Glycine 0 N--CA 1.452 -0.27 0 N-CA-C 109.989 -1.244 . . . . 50.0 109.989 -175.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -80.14 159.23 26.11 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.397 -0.594 . . . . 50.0 109.397 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 27.7 p . . . . . 0 C--N 1.324 -0.54 0 C-N-CA 122.921 0.488 . . . . 50.0 109.983 -177.488 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 32.2 t0 . . . . . 0 C--O 1.236 0.372 0 N-CA-C 107.864 -1.161 . . . . 50.0 107.864 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.04 134.43 36.92 Favored 'Trans proline' 0 CA--C 1.506 -0.886 0 C-N-CA 117.379 -1.281 . . . . 75.0 113.059 -173.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 m -140.33 159.52 25.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 106.012 -1.847 . . . . 50.0 106.012 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.404 ' HB3' ' HB2' ' A' ' 35' ' ' HIS . 52.1 t -131.83 124.47 29.67 Favored 'General case' 0 C--O 1.246 0.91 0 CA-C-O 121.41 0.624 . . . . 50.0 109.715 -177.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -82.78 176.27 53.35 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 115.561 -0.745 . . . . 50.0 114.071 -175.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -67.9 -13.1 61.88 Favored 'General case' 0 C--O 1.216 -0.694 0 N-CA-C 112.186 0.439 . . . . 50.0 112.186 177.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.6 p-10 -82.77 0.84 41.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.363 -0.38 . . . . 50.0 111.043 175.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 76.88 16.94 80.34 Favored Glycine 0 C--O 1.225 -0.427 0 CA-C-O 119.565 -0.575 . . . . 25.0 114.106 178.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -115.8 143.86 44.81 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 118.028 0.914 . . . . 50.0 112.098 -176.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 91.1 m -84.97 132.97 34.28 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.241 -1.345 . . . . 25.0 110.659 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -114.93 138.56 50.68 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 106.745 -1.576 . . . . 50.0 106.745 174.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.3 p -62.52 -55.73 24.69 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 123.316 0.385 . . . . 50.0 111.889 -173.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 52.8 p30 -109.19 169.31 8.77 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-O 121.478 0.656 . . . . 50.0 111.386 166.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 45.5 tp -63.69 -23.7 67.48 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.765 -0.652 . . . . 50.0 111.283 172.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 31.1 t -61.12 -50.42 73.31 Favored 'General case' 0 C--O 1.22 -0.497 0 O-C-N 122.043 -0.411 . . . . 50.0 111.033 178.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 72.2 m95 -66.96 -28.72 68.51 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.209 -0.596 . . . . 50.0 111.492 -179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -64.0 -45.72 87.74 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 108.886 -0.783 . . . . 50.0 108.886 174.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -65.6 -42.88 91.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.159 -0.473 . . . . 50.0 112.242 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -64.95 -31.84 73.26 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.745 0.307 . . . . 50.0 111.337 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.28 -13.36 59.95 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.659 0.266 . . . . 25.0 111.241 178.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.34 16.87 79.7 Favored Glycine 0 C--O 1.23 -0.144 0 N-CA-C 114.71 0.644 . . . . 25.0 114.71 175.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -88.52 140.81 15.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 108.42 -0.955 . . . . 50.0 108.42 -178.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.26 144.63 44.81 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 107.515 -2.234 . . . . 50.0 107.515 173.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 65.8 tp -72.24 145.38 47.98 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.208 -1.034 . . . . 50.0 108.208 177.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -129.98 -53.34 1.13 Allowed 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 113.107 0.78 . . . . 50.0 113.107 171.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.404 ' HB2' ' HB3' ' A' ' 13' ' ' CYS . 54.4 m-70 -112.13 143.47 43.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 118.154 0.434 . . . . 25.0 110.232 176.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.3 mp0 -85.79 145.11 27.38 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 102.072 -3.307 . . . . 50.0 102.072 166.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 93.03 176.07 40.9 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 109.711 -1.356 . . . . 50.0 109.711 -176.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.47 154.32 19.21 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.857 0.361 . . . . 50.0 111.654 -176.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 57.8 m . . . . . 0 C--N 1.325 -0.491 0 N-CA-C 106.824 -1.547 . . . . 50.0 106.824 173.661 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 50.4 t0 . . . . . 0 N--CA 1.454 -0.228 0 N-CA-C 108.012 -1.107 . . . . 50.0 108.012 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -65.81 136.28 44.81 Favored 'Trans proline' 0 CA--C 1.512 -0.611 0 O-C-N 122.505 0.739 . . . . 75.0 112.948 -174.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.4 m -147.08 161.11 8.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 114.97 -1.014 . . . . 50.0 108.808 -177.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 9.0 t -120.82 124.69 45.68 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.086 -1.079 . . . . 50.0 108.086 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.95 167.82 44.38 Favored Glycine 0 C--O 1.225 -0.466 0 C-N-CA 120.75 -0.738 . . . . 50.0 111.841 -179.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 24.3 mtpp -66.81 -14.41 62.61 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 112.698 0.629 . . . . 50.0 112.698 178.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -82.24 3.35 27.79 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.695 0.76 . . . . 50.0 110.083 176.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.78 17.04 80.08 Favored Glycine 0 C--O 1.222 -0.644 0 O-C-N 121.502 -0.749 . . . . 25.0 112.658 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -105.55 135.59 46.67 Favored 'General case' 0 C--O 1.239 0.518 0 O-C-N 122.359 -0.494 . . . . 50.0 110.478 -177.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.6 m -87.58 128.91 35.26 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.634 -0.712 . . . . 25.0 110.578 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -114.83 137.16 52.29 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.939 -1.134 . . . . 50.0 107.939 176.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 93.7 p -71.83 -46.33 58.41 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.918 0.389 . . . . 50.0 111.467 -175.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -108.42 162.18 14.35 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 107.351 -1.351 . . . . 50.0 107.351 174.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 36.1 tp -68.52 -26.66 65.55 Favored 'General case' 0 C--O 1.212 -0.898 0 N-CA-C 107.94 -1.133 . . . . 50.0 107.94 173.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -52.39 -52.62 52.68 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 115.633 -0.712 . . . . 50.0 112.031 174.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 49.1 m95 -65.78 -34.24 77.73 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.539 -0.464 . . . . 50.0 110.541 -176.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.47 -45.67 86.37 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.0 0.429 . . . . 50.0 109.96 175.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -68.85 -34.51 75.59 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.342 0.497 . . . . 50.0 112.342 -177.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -79.13 -30.12 43.5 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 121.111 -0.235 . . . . 50.0 110.38 -177.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.2 -21.54 58.62 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.025 0.44 . . . . 25.0 109.952 175.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.84 15.86 80.0 Favored Glycine 0 C--O 1.228 -0.271 0 N-CA-C 114.561 0.584 . . . . 25.0 114.561 175.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.2 t -80.12 143.81 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 N-CA-C 108.036 -1.098 . . . . 50.0 108.036 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.37 152.57 52.73 Favored Glycine 0 C--N 1.316 -0.554 0 N-CA-C 108.092 -2.003 . . . . 50.0 108.092 173.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 57.4 tp -81.19 142.25 33.39 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.977 -0.749 . . . . 50.0 108.977 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -120.91 -58.71 1.79 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.72 0.295 . . . . 50.0 110.965 174.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 4.5 m170 -112.18 147.7 35.61 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 110.194 -0.298 . . . . 25.0 110.194 175.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -92.71 140.67 29.29 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 103.555 -2.757 . . . . 50.0 103.555 167.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.75 165.35 33.04 Favored Glycine 0 C--N 1.321 -0.278 0 N-CA-C 109.52 -1.432 . . . . 50.0 109.52 -174.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.54 160.46 30.88 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.296 -0.631 . . . . 50.0 109.296 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 28.1 p . . . . . 0 C--N 1.323 -0.569 0 N-CA-C 106.875 -1.528 . . . . 50.0 106.875 179.439 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 24.7 t0 . . . . . 0 N--CA 1.454 -0.264 0 N-CA-C 109.333 -0.617 . . . . 50.0 109.333 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -66.35 134.97 37.97 Favored 'Trans proline' 0 CA--C 1.506 -0.918 0 C-N-CA 116.706 -1.729 . . . . 75.0 112.966 -174.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.2 m -141.57 163.81 19.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 106.259 -1.756 . . . . 50.0 106.259 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.8 t -129.88 128.85 43.05 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.749 -0.834 . . . . 50.0 108.749 -178.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.07 173.37 48.56 Favored Glycine 0 C--O 1.226 -0.369 0 C-N-CA 121.028 -0.606 . . . . 50.0 112.349 -178.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 17.7 mtpp -65.81 -12.13 51.76 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.213 1.19 . . . . 50.0 114.213 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -89.69 8.67 30.42 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.955 0.407 . . . . 50.0 110.093 174.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 78.64 2.74 85.96 Favored Glycine 0 C--O 1.22 -0.739 0 N-CA-C 114.784 0.673 . . . . 25.0 114.784 176.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.8 mmmt -96.65 138.83 33.62 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 118.11 0.955 . . . . 50.0 112.938 -176.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 37.2 m -82.09 132.61 35.25 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 113.907 -1.497 . . . . 25.0 111.697 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -114.96 137.14 52.34 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.105 -1.072 . . . . 50.0 108.105 173.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.7 m -58.83 -57.11 14.49 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.717 0.636 . . . . 50.0 112.717 -174.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 53.8 p30 -109.35 168.68 9.21 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 121.154 0.502 . . . . 50.0 110.608 165.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 41.7 tp -63.26 -22.29 66.78 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.913 -0.585 . . . . 50.0 111.332 172.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 5.7 t -61.82 -45.29 94.47 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 121.885 -0.509 . . . . 50.0 111.537 178.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 67.6 m95 -70.86 -30.4 66.78 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.303 -0.559 . . . . 50.0 110.816 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -62.67 -48.01 81.17 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 109.073 -0.714 . . . . 50.0 109.073 175.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -63.88 -42.59 97.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.846 -0.615 . . . . 50.0 112.076 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -66.46 -31.1 71.64 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 111.737 0.273 . . . . 50.0 111.737 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.67 -13.65 59.84 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.711 0.291 . . . . 25.0 111.11 178.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.97 14.44 82.2 Favored Glycine 0 CA--C 1.516 0.123 0 N-CA-C 114.778 0.671 . . . . 25.0 114.778 175.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.5 t -83.45 141.1 15.29 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.643 0 N-CA-C 107.907 -1.145 . . . . 50.0 107.907 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.53 144.89 47.93 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 107.307 -2.317 . . . . 50.0 107.307 172.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.8 tp -74.54 146.53 42.56 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.027 -1.101 . . . . 50.0 108.027 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -130.65 -59.19 1.02 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.167 0.508 . . . . 50.0 111.688 177.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 4.0 m170 -115.99 155.63 27.72 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.328 0.492 . . . . 25.0 112.328 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -95.02 143.82 26.19 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 104.495 -2.409 . . . . 50.0 104.495 166.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.54 174.78 43.17 Favored Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 110.99 -0.844 . . . . 50.0 110.99 -177.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -77.77 159.72 28.85 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 113.861 1.059 . . . . 50.0 113.861 -177.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 34.4 m . . . . . 0 C--N 1.324 -0.532 0 N-CA-C 104.719 -2.326 . . . . 50.0 104.719 170.617 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.6 t0 . . . . . 0 C--O 1.239 0.51 0 N-CA-C 107.878 -1.156 . . . . 50.0 107.878 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -68.65 138.63 42.1 Favored 'Trans proline' 0 CA--C 1.506 -0.917 0 C-N-CA 117.372 -1.285 . . . . 75.0 113.556 -172.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.6 m -139.47 158.37 27.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 105.396 -2.076 . . . . 50.0 105.396 176.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 39.0 t -116.65 121.93 43.11 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.79 -1.189 . . . . 50.0 107.79 -179.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -77.66 169.22 54.66 Favored Glycine 0 C--O 1.227 -0.309 0 N-CA-C 110.763 -0.935 . . . . 50.0 110.763 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -66.24 -12.05 53.91 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 113.058 0.762 . . . . 50.0 113.058 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -78.83 0.48 26.94 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.823 0.345 . . . . 50.0 110.266 173.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.44 17.04 74.57 Favored Glycine 0 C--O 1.218 -0.873 0 CA-C-O 119.431 -0.649 . . . . 25.0 114.465 177.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.9 mmtt -122.2 147.72 45.84 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.041 0.92 . . . . 50.0 112.563 -175.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 85.4 m -79.1 136.61 37.2 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.337 -0.847 . . . . 25.0 112.147 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -114.86 137.04 52.43 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 105.487 -2.042 . . . . 50.0 105.487 170.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.9 p -59.82 -56.03 26.86 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 112.655 0.613 . . . . 50.0 112.655 -171.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 42.2 p30 -109.01 166.57 10.73 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 121.21 0.528 . . . . 50.0 110.418 166.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 63.6 tp -63.59 -25.12 68.09 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.188 0.518 . . . . 50.0 111.262 173.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 32.6 t -62.66 -46.48 87.98 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 121.889 -0.507 . . . . 50.0 111.207 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 54.7 m95 -67.19 -29.75 69.51 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 121.652 -0.655 . . . . 50.0 111.474 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -62.47 -45.64 92.11 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.642 -0.873 . . . . 50.0 108.642 174.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -63.4 -43.48 97.41 Favored 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 116.112 -0.494 . . . . 50.0 111.864 178.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 -68.3 -26.51 65.67 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.098 0.407 . . . . 50.0 112.098 -178.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.2 -14.88 58.8 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.586 0.231 . . . . 25.0 110.799 177.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.25 18.53 78.14 Favored Glycine 0 C--O 1.23 -0.12 0 N-CA-C 114.333 0.493 . . . . 25.0 114.333 175.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -95.64 142.77 13.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 107.781 -1.192 . . . . 50.0 107.781 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.2 155.63 53.51 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 108.102 -1.999 . . . . 50.0 108.102 172.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.8 tt -82.54 142.39 31.86 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.146 -1.057 . . . . 50.0 108.146 176.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -114.32 -58.81 2.1 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.624 -0.51 . . . . 50.0 109.624 174.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 3.5 m170 -111.82 157.72 20.24 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 110.222 -0.288 . . . . 25.0 110.222 176.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -96.23 148.43 22.73 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 101.738 -3.43 . . . . 50.0 101.738 161.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.1 165.82 39.22 Favored Glycine 0 C--N 1.32 -0.336 0 N-CA-C 110.085 -1.206 . . . . 50.0 110.085 -173.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -81.71 162.67 22.89 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.324 0.583 . . . . 50.0 112.203 -177.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 24.6 p . . . . . 0 C--N 1.324 -0.517 0 N-CA-C 106.213 -1.773 . . . . 50.0 106.213 179.655 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 42.5 t0 . . . . . 0 C--O 1.237 0.432 0 N-CA-C 107.187 -1.412 . . . . 50.0 107.187 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -64.23 135.07 45.08 Favored 'Trans proline' 0 CA--C 1.506 -0.892 0 C-N-CA 118.049 -0.834 . . . . 75.0 113.27 -173.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.0 m -141.64 156.23 20.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 106.256 -1.757 . . . . 50.0 106.256 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.0 t -126.69 121.99 33.65 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.764 -0.828 . . . . 50.0 108.764 -177.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -78.69 176.76 54.33 Favored Glycine 0 C--O 1.226 -0.355 0 CA-C-N 115.929 -0.578 . . . . 50.0 112.833 -176.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -65.9 -21.54 66.45 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 122.582 -0.364 . . . . 50.0 111.552 178.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -75.23 -7.62 54.39 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.083 -0.508 . . . . 50.0 111.459 176.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.79 -7.66 73.08 Favored Glycine 0 C--O 1.224 -0.487 0 N-CA-C 111.483 -0.647 . . . . 25.0 111.483 -173.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -70.79 126.18 28.89 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 122.5 -0.412 . . . . 50.0 111.022 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.0 m -85.2 130.8 34.53 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.593 -0.731 . . . . 25.0 109.375 175.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -114.66 141.18 48.14 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.352 -0.981 . . . . 50.0 108.352 175.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.0 p -64.68 -57.89 7.78 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 112.682 0.623 . . . . 50.0 112.682 -174.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -109.27 166.37 10.92 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 121.452 0.644 . . . . 50.0 110.489 168.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 59.2 tp -62.16 -27.32 68.87 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.446 -0.797 . . . . 50.0 111.749 176.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 20.9 m -65.56 -40.42 92.8 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 121.73 -0.607 . . . . 50.0 111.734 -178.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -66.63 -34.77 78.61 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.387 -0.525 . . . . 50.0 110.62 176.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.64 -45.51 89.89 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.171 -0.677 . . . . 50.0 109.171 176.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -63.7 -43.41 96.67 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.315 0.487 . . . . 50.0 112.315 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -68.21 -29.37 68.2 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.48 0.178 . . . . 50.0 111.48 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.39 -16.45 57.63 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.691 0.281 . . . . 25.0 111.259 178.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.7 9.39 86.34 Favored Glycine 0 CA--C 1.518 0.24 0 N-CA-C 115.413 0.925 . . . . 25.0 115.413 176.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.5 t -78.92 138.91 19.24 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 N-CA-C 107.847 -1.168 . . . . 50.0 107.847 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.87 149.54 50.47 Favored Glycine 0 C--N 1.315 -0.61 0 N-CA-C 107.989 -2.044 . . . . 50.0 107.989 174.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 59.0 tp -74.03 145.58 44.41 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.062 -0.718 . . . . 50.0 109.062 178.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -125.09 -58.93 1.44 Allowed 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 121.147 -0.221 . . . . 50.0 110.438 172.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 26.8 m-70 -111.75 143.8 42.08 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.96 0.355 . . . . 25.0 111.96 176.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 33.0 mp0 -84.12 138.93 32.77 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 102.595 -3.113 . . . . 50.0 102.595 168.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.53 169.06 40.15 Favored Glycine 0 C--N 1.321 -0.276 0 N-CA-C 109.328 -1.509 . . . . 50.0 109.328 -174.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -83.33 160.6 21.64 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 122.668 -0.313 . . . . 50.0 111.32 -177.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 67.4 m . . . . . 0 C--O 1.24 0.571 0 N-CA-C 105.097 -2.186 . . . . 50.0 105.097 170.971 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 25.2 t0 . . . . . 0 C--O 1.238 0.488 0 N-CA-C 107.682 -1.229 . . . . 50.0 107.682 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.58 138.85 46.9 Favored 'Trans proline' 0 CA--C 1.507 -0.831 0 C-N-CA 117.228 -1.381 . . . . 75.0 112.524 -175.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.2 m -142.39 161.04 19.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 104.911 -2.255 . . . . 50.0 104.911 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -126.41 127.54 45.61 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.693 -0.854 . . . . 50.0 108.693 178.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -79.58 177.34 54.32 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 121.033 -0.604 . . . . 50.0 113.613 -176.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -71.16 -12.13 61.32 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 122.389 -0.477 . . . . 50.0 110.648 176.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 42.8 p-10 -82.77 -3.46 56.64 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.473 -0.785 . . . . 50.0 111.212 176.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 79.25 16.9 77.54 Favored Glycine 0 C--O 1.224 -0.501 0 C-N-CA 121.177 -0.535 . . . . 25.0 113.792 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.7 mmtp -110.31 141.38 43.4 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 118.047 0.924 . . . . 50.0 110.854 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.1 m -82.28 132.16 35.23 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.423 -0.955 . . . . 25.0 108.423 175.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -114.91 137.11 52.36 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 106.502 -1.666 . . . . 50.0 106.502 173.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.0 m -64.61 -55.8 17.96 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.577 0.584 . . . . 50.0 112.577 -173.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -113.77 158.72 20.59 Favored 'General case' 0 C--O 1.25 1.08 0 CA-C-O 121.216 0.531 . . . . 50.0 109.671 170.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 30.0 tp -57.35 -24.62 56.37 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.631 -0.713 . . . . 50.0 112.002 177.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.3 m -58.46 -42.95 88.6 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 121.951 -0.468 . . . . 50.0 112.178 177.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 40.1 m95 -73.81 -33.37 64.15 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.779 -0.452 . . . . 50.0 109.779 -177.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -61.45 -45.92 92.23 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.049 -0.723 . . . . 50.0 109.049 176.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -65.05 -41.15 95.42 Favored 'General case' 0 C--O 1.218 -0.569 0 CA-C-N 115.813 -0.631 . . . . 50.0 112.151 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -68.08 -30.79 70.06 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.906 0.336 . . . . 50.0 111.906 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.71 -14.76 59.92 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.899 0.38 . . . . 25.0 110.387 177.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.21 16.3 79.83 Favored Glycine 0 C--N 1.328 0.109 0 N-CA-C 114.149 0.42 . . . . 25.0 114.149 175.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -93.82 142.99 12.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 109.235 -0.654 . . . . 50.0 109.235 -178.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.12 152.36 49.91 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 108.43 -1.868 . . . . 50.0 108.43 171.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.1 tt -75.6 138.92 41.76 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.08 -1.081 . . . . 50.0 108.08 177.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -117.84 -50.24 2.5 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.564 0.221 . . . . 50.0 110.962 175.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 -112.01 151.97 28.69 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.873 -0.417 . . . . 25.0 109.873 175.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -94.5 146.42 24.11 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 102.895 -3.002 . . . . 50.0 102.895 166.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.97 170.14 46.83 Favored Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 110.201 -1.16 . . . . 50.0 110.201 -175.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -79.36 151.34 31.05 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.338 -0.986 . . . . 50.0 108.338 178.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.6 p . . . . . 0 C--N 1.325 -0.461 0 CA-C-O 120.701 0.286 . . . . 50.0 111.088 -178.414 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 110.056 -0.35 . . . . 25.0 110.056 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.71 -138.52 0.09 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 102.475 -3.158 . . . . 25.0 102.475 176.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.39 166.84 9.49 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 104.943 -2.243 . . . . 25.0 104.943 164.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.2 m -106.25 -34.78 3.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 119.548 -0.861 . . . . 50.0 112.287 -175.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 86.5 m -117.65 159.96 22.07 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.376 -0.374 . . . . 25.0 110.748 168.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 41.0 p -85.35 173.91 9.96 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.007 -1.109 . . . . 25.0 108.007 173.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.6 p -102.62 18.95 20.05 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 122.355 1.074 . . . . 25.0 109.68 176.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -70.43 130.02 40.81 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.603 -1.181 . . . . 50.0 111.707 -177.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 73.7 t-105 -83.19 99.21 9.79 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.116 -1.068 . . . . 50.0 108.116 170.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -137.64 73.38 48.12 Favored Pre-proline 0 C--O 1.243 0.714 0 N-CA-C 106.453 -1.684 . . . . 50.0 106.453 177.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -61.73 142.23 93.25 Favored 'Trans proline' 0 CA--C 1.509 -0.771 0 N-CA-C 115.885 1.456 . . . . 75.0 115.885 -169.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.0 m -140.83 167.08 18.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 105.759 -1.941 . . . . 50.0 105.759 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.415 ' HB3' ' HB2' ' A' ' 35' ' ' HIS . 44.3 t -134.76 133.16 39.6 Favored 'General case' 0 C--O 1.244 0.816 0 CA-C-O 120.962 0.411 . . . . 50.0 110.472 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.15 176.53 54.65 Favored Glycine 0 N--CA 1.453 -0.17 0 CA-C-N 115.837 -0.62 . . . . 50.0 113.586 -177.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -71.81 -12.89 61.51 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 122.32 -0.518 . . . . 50.0 111.317 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.9 p-10 -94.8 9.18 40.06 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.172 -0.467 . . . . 50.0 111.239 177.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.09 -3.73 75.05 Favored Glycine 0 C--O 1.227 -0.305 0 N-CA-C 116.053 1.181 . . . . 25.0 116.053 176.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -82.37 137.19 34.82 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 118.626 1.213 . . . . 50.0 111.948 -177.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 94.2 m -83.8 128.85 34.84 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.175 -0.921 . . . . 25.0 109.007 176.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -114.93 139.08 50.1 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.308 -0.997 . . . . 50.0 108.308 176.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.62 -56.86 16.65 Favored 'General case' 0 C--O 1.215 -0.718 0 N-CA-C 113.097 0.777 . . . . 50.0 113.097 -173.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -113.06 174.35 5.94 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.984 0.421 . . . . 50.0 110.824 166.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 39.4 tp -64.31 -27.36 68.98 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.723 -0.671 . . . . 50.0 112.213 173.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 47.3 t -63.28 -47.71 81.19 Favored 'General case' 0 C--O 1.216 -0.675 0 O-C-N 121.722 -0.611 . . . . 50.0 111.018 178.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 62.1 m95 -62.47 -31.61 72.37 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.243 -0.583 . . . . 50.0 111.491 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -64.49 -45.41 87.44 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 109.307 -0.627 . . . . 50.0 109.307 175.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -66.17 -41.4 90.38 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.329 -0.396 . . . . 50.0 111.831 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -64.67 -31.25 72.39 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.667 0.27 . . . . 50.0 111.165 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.39 -15.88 59.84 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.701 0.286 . . . . 25.0 111.053 178.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.08 7.72 88.2 Favored Glycine 0 C--O 1.23 -0.103 0 N-CA-C 114.838 0.695 . . . . 25.0 114.838 175.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -85.29 144.37 9.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.079 -1.082 . . . . 50.0 108.079 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.09 150.81 49.38 Favored Glycine 0 C--N 1.316 -0.582 0 N-CA-C 108.564 -1.814 . . . . 50.0 108.564 173.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 60.8 tp -74.5 145.56 43.44 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.053 -0.721 . . . . 50.0 109.053 177.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -128.37 -58.85 1.18 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.005 0.372 . . . . 50.0 112.005 173.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.415 ' HB2' ' HB3' ' A' ' 13' ' ' CYS . 44.0 m-70 -112.1 160.69 17.29 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.522 0.201 . . . . 25.0 111.358 178.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -99.69 149.3 23.46 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 102.89 -3.004 . . . . 50.0 102.89 166.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.8 178.64 47.75 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 110.748 -0.941 . . . . 50.0 110.748 -177.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -78.07 160.92 27.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.749 0.309 . . . . 50.0 111.564 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.7 m -116.02 167.81 10.65 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.328 -0.989 . . . . 50.0 108.328 173.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.5 pt? . . . . . 0 C--O 1.244 0.769 0 N-CA-C 103.633 -2.728 . . . . 25.0 103.633 176.314 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.875 -0.417 . . . . 25.0 109.875 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.91 -157.45 0.52 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 103.52 -2.77 . . . . 25.0 103.52 -177.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.08 -67.43 0.41 Allowed 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 104.141 -2.54 . . . . 25.0 104.141 167.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.25 -41.73 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.171 -1.048 . . . . 50.0 108.171 159.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.0 t -114.31 160.01 19.56 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.036 -1.438 . . . . 25.0 110.799 165.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.608 ' H ' ' HB2' ' A' ' 24' ' ' CYS . 19.3 p -95.7 156.01 16.51 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 104.403 -2.443 . . . . 25.0 104.403 165.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.0 p -102.93 -0.57 30.86 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 123.886 1.803 . . . . 25.0 110.901 171.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -76.21 129.78 37.23 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 111.329 -2.669 . . . . 50.0 113.007 -178.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 42.4 t-105 -68.5 105.73 2.31 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 104.653 -2.351 . . . . 50.0 104.653 169.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -137.83 73.53 46.6 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 109.253 -0.647 . . . . 50.0 109.253 -176.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -65.4 138.49 55.42 Favored 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 114.646 -3.103 . . . . 75.0 113.491 -176.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.6 m -144.26 161.04 15.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 105.561 -2.015 . . . . 50.0 105.561 -178.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 50.8 t -131.47 126.37 34.85 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.097 -0.705 . . . . 50.0 109.097 -177.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.37 178.5 53.87 Favored Glycine 0 C--O 1.225 -0.437 0 CA-C-N 115.761 -0.654 . . . . 50.0 113.247 -175.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -66.56 -19.83 65.87 Favored 'General case' 0 C--O 1.214 -0.786 0 O-C-N 122.616 -0.343 . . . . 50.0 111.435 177.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -82.57 3.78 27.25 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 121.768 0.794 . . . . 50.0 110.708 177.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.21 -4.41 54.91 Favored Glycine 0 C--O 1.224 -0.484 0 O-C-N 121.839 -0.538 . . . . 25.0 114.134 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -81.86 134.26 35.39 Favored 'General case' 0 C--O 1.239 0.527 0 O-C-N 122.109 -0.641 . . . . 50.0 110.776 -176.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.2 m -86.73 132.39 33.88 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.605 -0.725 . . . . 25.0 109.502 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -114.69 137.4 51.96 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 106.11 -1.811 . . . . 50.0 106.11 175.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 79.8 p -66.81 -47.42 72.13 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 111.974 0.361 . . . . 50.0 111.974 -173.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -109.19 164.55 12.35 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.701 -0.851 . . . . 50.0 108.701 172.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 63.6 tp -68.32 -23.65 64.74 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.496 -0.775 . . . . 50.0 109.104 172.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.608 ' HB2' ' H ' ' A' ' 6' ' ' THR . 3.8 t -55.59 -51.0 68.61 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.618 -0.719 . . . . 50.0 111.344 175.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 24.0 m95 -69.89 -31.13 68.77 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.389 -0.524 . . . . 50.0 111.351 -176.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -64.47 -44.47 90.97 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.331 -0.618 . . . . 50.0 109.331 175.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.36 -46.26 90.94 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.141 -0.481 . . . . 50.0 110.521 -178.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -74.83 -23.58 58.48 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.634 0.605 . . . . 50.0 112.634 -176.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.27 -18.02 57.91 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.779 0.323 . . . . 25.0 110.611 176.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.74 5.37 86.35 Favored Glycine 0 CA--C 1.517 0.206 0 N-CA-C 115.114 0.806 . . . . 25.0 115.114 176.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -74.81 137.25 23.43 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 N-CA-C 107.529 -1.286 . . . . 50.0 107.529 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.51 143.85 46.32 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 107.548 -2.221 . . . . 50.0 107.548 175.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 57.9 tp -70.34 142.68 52.14 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.335 -0.987 . . . . 50.0 108.335 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -126.03 -58.91 1.36 Allowed 'General case' 0 C--O 1.22 -0.472 0 C-N-CA 120.983 -0.287 . . . . 50.0 110.258 173.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -111.92 154.44 25.22 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.802 -0.444 . . . . 25.0 109.802 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -102.72 145.63 29.43 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 102.432 -3.173 . . . . 50.0 102.432 167.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.91 171.26 43.38 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 109.681 -1.368 . . . . 50.0 109.681 -172.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -72.65 153.5 41.18 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 113.376 0.88 . . . . 50.0 113.376 -176.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 51.6 m -110.39 164.29 12.83 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 103.388 -2.819 . . . . 50.0 103.388 163.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 62.5 tp . . . . . 0 C--O 1.252 1.236 0 N-CA-C 104.245 -2.502 . . . . 25.0 104.245 178.02 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 23.3 tp10 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.997 -0.372 . . . . 25.0 109.997 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.35 153.43 43.61 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.168 -0.678 . . . . 25.0 109.168 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.22 142.55 50.6 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 107.736 -1.209 . . . . 25.0 107.736 176.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.3 m -124.75 -0.17 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 112.615 0.598 . . . . 50.0 112.615 -177.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 t -81.02 140.03 35.4 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.224 -0.658 . . . . 25.0 109.224 -176.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 50.0 p -95.61 167.93 10.99 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 113.945 1.091 . . . . 25.0 113.945 -175.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.1 p -90.59 19.5 5.31 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 122.066 0.936 . . . . 25.0 111.161 176.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -71.46 129.91 39.98 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.958 -1.019 . . . . 50.0 111.149 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 54.2 t-105 -57.41 108.39 0.54 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 107.417 -1.327 . . . . 50.0 107.417 173.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -137.97 72.99 46.7 Favored Pre-proline 0 C--N 1.321 -0.632 0 N-CA-C 107.944 -1.132 . . . . 50.0 107.944 -176.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -65.65 135.68 42.92 Favored 'Trans proline' 0 CA--C 1.509 -0.745 0 C-N-CA 117.616 -1.122 . . . . 75.0 113.213 -174.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.4 m -141.17 159.81 22.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 105.935 -1.876 . . . . 50.0 105.935 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 38.8 t -119.27 124.34 46.45 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.197 -1.038 . . . . 50.0 108.197 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -79.32 170.77 54.63 Favored Glycine 0 C--O 1.226 -0.361 0 C-N-CA 120.792 -0.718 . . . . 50.0 111.34 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -68.32 -12.01 60.39 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 112.481 0.548 . . . . 50.0 112.481 178.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -81.68 1.01 36.15 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.549 0.69 . . . . 50.0 110.181 174.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 76.98 16.66 80.59 Favored Glycine 0 C--O 1.222 -0.596 0 O-C-N 121.555 -0.716 . . . . 25.0 113.112 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -108.11 138.81 43.74 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 122.128 -0.631 . . . . 50.0 111.085 -176.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 54.6 m -81.52 133.26 35.37 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.916 -0.584 . . . . 25.0 109.489 176.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -114.89 137.13 52.33 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.045 -1.465 . . . . 50.0 107.045 173.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.9 m -59.99 -57.02 14.66 Favored 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 112.945 0.721 . . . . 50.0 112.945 -173.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 47.8 p30 -109.07 167.6 9.98 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.122 0.486 . . . . 50.0 110.457 167.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 59.8 tp -62.47 -26.78 68.7 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.844 -0.616 . . . . 50.0 110.62 172.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.4 m -61.47 -44.63 96.75 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 122.04 -0.413 . . . . 50.0 111.793 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 65.0 m95 -68.77 -30.88 69.57 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 121.762 -0.586 . . . . 50.0 111.519 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -63.05 -44.48 95.75 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.437 -0.949 . . . . 50.0 108.437 175.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -66.12 -41.51 90.46 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.032 -0.531 . . . . 50.0 111.492 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -62.99 -32.78 74.2 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 111.668 0.247 . . . . 50.0 111.668 178.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.77 -14.16 59.42 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.673 0.273 . . . . 25.0 111.434 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.18 11.16 85.8 Favored Glycine 0 C--O 1.23 -0.135 0 N-CA-C 115.031 0.772 . . . . 25.0 115.031 176.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -87.41 146.41 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 N-CA-C 107.791 -1.189 . . . . 50.0 107.791 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.69 152.26 47.37 Favored Glycine 0 C--N 1.316 -0.553 0 N-CA-C 107.803 -2.119 . . . . 50.0 107.803 173.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 8.4 tt -78.49 141.86 37.89 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.579 -1.267 . . . . 50.0 107.579 176.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -117.06 -58.35 2.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.82 0.343 . . . . 50.0 110.405 174.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -111.97 156.54 21.97 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.311 -0.243 . . . . 25.0 111.02 176.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -98.8 146.38 25.99 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 103.708 -2.701 . . . . 50.0 103.708 168.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.53 171.2 40.89 Favored Glycine 0 N--CA 1.451 -0.312 0 N-CA-C 109.552 -1.419 . . . . 50.0 109.552 -174.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -81.31 158.18 24.83 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.104 -0.702 . . . . 50.0 109.104 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 27.8 p -140.58 169.21 18.08 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 122.923 0.489 . . . . 50.0 109.735 -178.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 98.6 mt . . . . . 0 C--O 1.244 0.775 0 N-CA-C 103.287 -2.857 . . . . 25.0 103.287 177.207 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 118.022 -0.99 . . . . 25.0 109.251 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.99 -38.13 89.97 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 108.069 -1.085 . . . . 25.0 108.069 175.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -86.63 128.46 35.0 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 107.001 -1.481 . . . . 25.0 107.001 172.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.3 m -126.24 -15.59 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 113.154 0.798 . . . . 50.0 113.154 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 43.4 t -112.85 136.88 51.99 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 121.906 -0.496 . . . . 25.0 111.346 -177.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 42.5 p -96.17 156.1 16.48 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.993 -1.114 . . . . 25.0 107.993 164.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 39.8 p -102.97 -0.52 30.83 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 123.91 1.814 . . . . 25.0 109.129 163.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.74 130.08 38.09 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 111.031 -2.804 . . . . 50.0 111.535 177.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.406 ' CE2' ' HD3' ' A' ' 11' ' ' PRO . 34.0 t-105 -58.78 105.38 0.3 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 106.529 -1.656 . . . . 50.0 106.529 171.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -136.9 73.89 52.11 Favored Pre-proline 0 C--N 1.318 -0.803 0 CA-C-N 115.554 -0.748 . . . . 50.0 109.142 -174.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.406 ' HD3' ' CE2' ' A' ' 9' ' ' TRP . 37.5 Cg_endo -63.97 134.6 43.86 Favored 'Trans proline' 0 CA--C 1.506 -0.885 0 C-N-CA 117.517 -1.188 . . . . 75.0 112.621 -176.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.4 m -142.72 162.06 18.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 105.989 -1.856 . . . . 50.0 105.989 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 43.8 t -123.75 123.33 40.27 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.839 -0.8 . . . . 50.0 108.839 -177.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.18 164.68 48.08 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.065 -0.588 . . . . 50.0 112.244 -178.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -62.75 -17.6 61.2 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.113 0.783 . . . . 50.0 113.113 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -79.61 5.6 12.74 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 122.334 -0.229 . . . . 50.0 111.146 175.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.59 17.24 71.32 Favored Glycine 0 C--O 1.225 -0.427 0 C-N-CA 120.677 -0.773 . . . . 25.0 113.8 175.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 32.2 mmtm -121.26 138.49 54.21 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 117.559 0.679 . . . . 50.0 112.152 -173.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 38.4 m -83.17 133.84 35.01 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.969 -1.014 . . . . 25.0 111.241 -179.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -114.83 138.33 50.9 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.285 -1.376 . . . . 50.0 107.285 173.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.1 p -62.69 -52.4 63.43 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.567 0.58 . . . . 50.0 112.567 -174.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 -108.24 168.01 9.61 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.371 -0.974 . . . . 50.0 108.371 171.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 59.6 tp -68.68 -26.1 65.13 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.039 -1.096 . . . . 50.0 108.039 171.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 48.6 t -55.01 -52.33 63.48 Favored 'General case' 0 C--O 1.219 -0.513 0 CA-C-N 115.046 -0.979 . . . . 50.0 111.262 175.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 72.7 m95 -69.42 -27.41 65.25 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.068 0.395 . . . . 50.0 112.068 -175.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -65.86 -49.41 68.22 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.931 -0.766 . . . . 50.0 108.931 175.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -66.75 -40.73 88.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.913 -0.585 . . . . 50.0 111.473 -177.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -67.28 -27.81 67.5 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 120.965 -0.294 . . . . 50.0 111.646 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.34 -12.76 59.55 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.624 0.249 . . . . 25.0 111.138 178.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.06 19.46 78.6 Favored Glycine 0 C--O 1.23 -0.146 0 N-CA-C 114.744 0.658 . . . . 25.0 114.744 175.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -93.15 144.2 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 N-CA-C 107.457 -1.312 . . . . 50.0 107.457 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.62 148.75 45.66 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 107.106 -2.398 . . . . 50.0 107.106 173.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 8.2 tt -78.56 141.01 38.44 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.516 -1.291 . . . . 50.0 107.516 176.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -116.24 -58.13 2.13 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.101 -0.333 . . . . 50.0 110.101 174.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 5.3 m170 -112.03 157.88 20.22 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 110.105 -0.332 . . . . 25.0 110.105 176.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -99.79 147.78 25.11 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 102.677 -3.082 . . . . 50.0 102.677 165.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.46 169.0 41.62 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 109.735 -1.346 . . . . 50.0 109.735 -173.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -72.72 161.56 30.59 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.974 0.731 . . . . 50.0 112.974 -178.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 9.4 m -119.59 168.7 10.75 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 104.901 -2.259 . . . . 50.0 104.901 169.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 62.8 tp . . . . . 0 C--O 1.244 0.81 0 N-CA-C 103.269 -2.863 . . . . 25.0 103.269 175.081 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 6.1 pm0 . . . . . 0 N--CA 1.496 1.86 0 N-CA-C 109.774 -0.454 . . . . 25.0 109.774 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.87 -138.51 1.1 Allowed 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 104.667 -2.346 . . . . 25.0 104.667 -164.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.19 -80.28 0.09 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 104.832 -2.284 . . . . 25.0 104.832 168.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.1 m -138.25 -37.62 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.542 -0.754 . . . . 50.0 110.89 165.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.7 t -114.9 145.59 42.03 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.041 -0.981 . . . . 25.0 110.628 173.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.1 p -95.96 151.1 19.74 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 106.775 -1.565 . . . . 25.0 106.775 164.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.0 p -103.09 5.02 37.74 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 122.946 1.355 . . . . 25.0 112.739 172.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.03 130.03 37.76 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 113.271 -1.786 . . . . 50.0 111.68 -175.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.422 ' CE2' ' HD3' ' A' ' 11' ' ' PRO . 55.7 t-105 -61.53 105.99 0.6 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 107.385 -1.339 . . . . 50.0 107.385 174.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -137.93 73.17 46.59 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 108.12 -1.067 . . . . 50.0 108.12 -176.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.422 ' HD3' ' CE2' ' A' ' 9' ' ' TRP . 33.6 Cg_endo -62.87 133.61 42.6 Favored 'Trans proline' 0 CA--C 1.503 -1.07 0 O-C-N 122.309 0.636 . . . . 75.0 112.081 -173.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.5 m -139.55 161.18 27.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 107.282 -1.377 . . . . 50.0 107.282 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.1 t -131.55 121.69 24.85 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.889 -1.152 . . . . 50.0 107.889 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.98 173.58 54.67 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.815 -0.629 . . . . 50.0 112.823 -176.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp -64.2 -16.07 61.23 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.325 0.861 . . . . 50.0 113.325 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -92.07 10.65 28.27 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.736 0.303 . . . . 50.0 110.218 177.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.95 -2.34 65.17 Favored Glycine 0 C--O 1.223 -0.557 0 N-CA-C 114.281 0.472 . . . . 25.0 114.281 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -82.73 130.74 35.17 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 121.883 -0.775 . . . . 50.0 111.973 -175.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 70.3 m -84.79 128.39 34.59 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.986 -1.007 . . . . 25.0 110.87 177.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -114.88 137.02 52.46 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.002 -0.74 . . . . 50.0 109.002 174.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.3 m -60.51 -54.91 39.82 Favored 'General case' 0 C--O 1.217 -0.611 0 N-CA-C 112.701 0.63 . . . . 50.0 112.701 -174.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -109.1 168.41 9.39 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.07 0.462 . . . . 50.0 110.525 167.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 39.8 tp -65.76 -23.02 66.63 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.967 -0.561 . . . . 50.0 111.041 172.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 22.5 t -60.87 -50.35 73.8 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 121.956 -0.465 . . . . 50.0 111.001 178.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -64.38 -31.18 72.29 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 122.113 -0.367 . . . . 50.0 111.556 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -63.41 -46.39 86.6 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 109.159 -0.682 . . . . 50.0 109.159 176.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.08 -42.37 94.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.059 -0.519 . . . . 50.0 110.468 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -65.32 -33.13 75.25 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.598 0.221 . . . . 50.0 111.598 -179.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.76 -12.2 60.01 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 111.779 0.289 . . . . 25.0 111.779 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.4 19.99 79.78 Favored Glycine 0 C--O 1.229 -0.194 0 N-CA-C 115.005 0.762 . . . . 25.0 115.005 176.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -91.81 142.44 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 N-CA-C 107.542 -1.281 . . . . 50.0 107.542 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.53 147.17 46.64 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 108.005 -2.038 . . . . 50.0 108.005 173.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 62.0 tp -75.07 144.47 42.95 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.939 -1.134 . . . . 50.0 107.939 176.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -122.38 -59.15 1.66 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.401 -0.52 . . . . 50.0 110.218 172.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -113.82 153.05 29.78 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.512 0.56 . . . . 25.0 112.512 173.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -85.86 148.69 25.69 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 100.952 -3.722 . . . . 50.0 100.952 159.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.3 152.84 26.71 Favored Glycine 0 C--N 1.318 -0.449 0 N-CA-C 110.656 -0.977 . . . . 50.0 110.656 -176.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -83.66 151.75 25.12 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.66 0.615 . . . . 50.0 112.66 -176.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 76.2 m -108.09 -177.95 3.47 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 105.692 -1.966 . . . . 50.0 105.692 171.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 65.1 tp . . . . . 0 C--O 1.25 1.102 0 N-CA-C 105.226 -2.139 . . . . 25.0 105.226 175.298 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 . . . . . 0 N--CA 1.497 1.923 0 N-CA-C 110.925 -0.028 . . . . 25.0 110.925 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.17 144.86 56.39 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 122.053 -0.404 . . . . 25.0 110.447 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -79.64 52.19 1.39 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.137 0.575 . . . . 25.0 112.015 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.7 m -106.65 0.47 10.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.552 0.691 . . . . 50.0 109.933 -178.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 45.1 t -81.05 139.99 35.39 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.064 -0.516 . . . . 25.0 109.627 -178.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 39.9 p -80.63 166.43 21.1 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.408 0.623 . . . . 25.0 111.215 -178.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.4 p -83.48 24.94 0.79 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.208 0.528 . . . . 25.0 112.387 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -61.79 130.05 43.91 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.047 0.451 . . . . 50.0 110.593 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 65.1 t-105 -65.85 104.98 1.18 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.361 -0.836 . . . . 50.0 110.302 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -137.72 74.25 45.85 Favored Pre-proline 0 C--O 1.239 0.521 0 N-CA-C 106.997 -1.483 . . . . 50.0 106.997 177.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.77 139.51 44.01 Favored 'Trans proline' 0 CA--C 1.51 -0.699 0 C-N-CA 117.186 -1.41 . . . . 75.0 114.081 -172.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.0 m -141.9 162.3 20.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 105.995 -1.854 . . . . 50.0 105.995 178.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.8 t -128.53 127.1 41.73 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-O 121.02 0.438 . . . . 50.0 110.04 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.33 175.31 54.95 Favored Glycine 0 C--O 1.227 -0.318 0 C-N-CA 121.06 -0.59 . . . . 50.0 112.427 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -66.53 -18.07 65.16 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 122.477 -0.425 . . . . 50.0 111.841 177.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -79.23 0.75 27.27 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.564 0.697 . . . . 50.0 110.82 176.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 75.46 16.71 80.46 Favored Glycine 0 C--O 1.222 -0.626 0 C-N-CA 120.87 -0.681 . . . . 25.0 113.209 178.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -106.04 137.3 44.2 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 122.246 -0.561 . . . . 50.0 110.667 -177.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 60.8 m -82.46 134.28 35.22 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.799 -0.637 . . . . 25.0 109.526 177.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -114.95 137.92 51.43 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 106.566 -1.642 . . . . 50.0 106.566 174.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.5 p -60.26 -55.83 28.89 Favored 'General case' 0 C--O 1.219 -0.511 0 N-CA-C 112.382 0.512 . . . . 50.0 112.382 -173.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 36.8 p30 -109.06 166.14 11.06 Favored 'General case' 0 C--O 1.244 0.79 0 CA-C-O 121.306 0.574 . . . . 50.0 110.892 166.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 60.9 tp -63.15 -25.72 68.48 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.207 0.527 . . . . 50.0 111.15 172.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 68.5 m -63.63 -41.45 98.26 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 121.792 -0.568 . . . . 50.0 112.213 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 60.4 m95 -70.62 -29.56 65.97 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 121.428 -0.795 . . . . 50.0 110.721 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.94 -42.66 99.88 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.286 -1.005 . . . . 50.0 108.286 173.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -63.66 -41.36 98.21 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 111.696 0.258 . . . . 50.0 111.696 177.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -63.68 -36.04 82.53 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 117.831 0.287 . . . . 50.0 111.722 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.38 -17.92 57.78 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.668 0.271 . . . . 25.0 111.63 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.67 5.6 83.57 Favored Glycine 0 CA--C 1.518 0.227 0 N-CA-C 115.109 0.804 . . . . 25.0 115.109 176.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -74.31 140.46 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.654 0 N-CA-C 107.467 -1.308 . . . . 50.0 107.467 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.28 147.15 49.76 Favored Glycine 0 C--N 1.315 -0.59 0 N-CA-C 107.608 -2.197 . . . . 50.0 107.608 174.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 56.5 tp -72.92 143.52 47.68 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.475 -0.935 . . . . 50.0 108.475 177.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -124.36 -59.1 1.49 Allowed 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 121.179 -0.208 . . . . 50.0 110.888 173.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -111.91 154.26 25.48 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.418 -0.216 . . . . 25.0 110.418 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -98.92 143.94 28.65 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 102.41 -3.182 . . . . 50.0 102.41 167.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 93.19 170.16 39.54 Favored Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 109.1 -1.6 . . . . 50.0 109.1 -173.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -78.5 162.32 26.43 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.426 -0.583 . . . . 50.0 109.426 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 26.3 p -141.66 169.24 17.96 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.523 -0.917 . . . . 50.0 108.523 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 62.3 tp . . . . . 0 C--O 1.244 0.79 0 N-CA-C 102.624 -3.102 . . . . 25.0 102.624 178.608 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 8.9 pm0 . . . . . 0 N--CA 1.496 1.862 0 CA-C-O 119.425 -0.322 . . . . 25.0 110.238 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.36 -33.23 55.34 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.134 0.42 . . . . 25.0 112.134 -176.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -152.16 169.28 22.83 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 106.3 -1.741 . . . . 25.0 106.3 -179.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.0 m -126.07 -21.62 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 113.944 1.09 . . . . 50.0 113.944 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.03 160.0 18.59 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.818 0.303 . . . . 25.0 111.818 -177.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 61.1 p -95.98 168.48 10.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.101 0.476 . . . . 25.0 111.717 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.1 p -99.98 22.2 11.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.684 0.754 . . . . 25.0 111.516 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -67.73 130.0 41.65 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.678 -0.692 . . . . 50.0 111.365 -178.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 66.6 t-105 -62.89 106.93 0.89 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.315 -0.624 . . . . 50.0 109.315 177.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -138.04 72.97 46.19 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.831 -0.622 . . . . 50.0 109.559 -178.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -65.4 134.15 37.62 Favored 'Trans proline' 0 CA--C 1.51 -0.689 0 C-N-CA 116.716 -1.723 . . . . 75.0 113.637 -173.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.9 m -141.62 161.61 21.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 106.112 -1.81 . . . . 50.0 106.112 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.418 ' HB3' ' HB2' ' A' ' 35' ' ' HIS . 50.4 t -129.11 125.08 36.37 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.966 -0.753 . . . . 50.0 108.966 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.84 175.29 54.09 Favored Glycine 0 C--O 1.227 -0.32 0 CA-C-N 115.918 -0.583 . . . . 50.0 114.078 -175.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -67.56 -12.07 59.53 Favored 'General case' 0 C--O 1.215 -0.735 0 N-CA-C 112.487 0.551 . . . . 50.0 112.487 177.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -91.41 8.94 33.84 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.711 0.291 . . . . 50.0 110.453 176.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.5 -18.5 8.5 Favored Glycine 0 C--O 1.222 -0.652 0 N-CA-C 114.926 0.731 . . . . 25.0 114.926 177.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -73.11 139.41 46.42 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 121.312 0.577 . . . . 50.0 112.289 -177.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 98.8 m -86.05 132.63 34.0 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.653 -1.158 . . . . 25.0 108.882 175.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -115.0 136.97 52.54 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.114 -1.069 . . . . 50.0 108.114 176.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.8 m -62.33 -51.68 66.66 Favored 'General case' 0 C--O 1.223 -0.327 0 N-CA-C 112.714 0.635 . . . . 50.0 112.714 -174.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 45.9 p30 -113.9 170.08 8.53 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 121.109 0.48 . . . . 50.0 110.546 168.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 41.5 tp -63.79 -25.57 68.24 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.902 -0.59 . . . . 50.0 110.66 172.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 19.5 m -61.53 -46.05 91.58 Favored 'General case' 0 C--O 1.218 -0.571 0 O-C-N 122.144 -0.347 . . . . 50.0 111.916 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 24.5 m95 -70.08 -28.41 65.41 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 121.788 -0.57 . . . . 50.0 111.201 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -64.51 -45.32 87.74 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.5 -0.926 . . . . 50.0 108.5 175.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -66.05 -42.22 89.8 Favored 'General case' 0 C--O 1.22 -0.467 0 CA-C-N 115.782 -0.644 . . . . 50.0 111.78 178.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -63.61 -33.56 75.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.718 0.294 . . . . 50.0 111.414 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.27 -12.22 59.98 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.602 0.239 . . . . 25.0 111.323 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.0 21.78 77.85 Favored Glycine 0 C--O 1.23 -0.11 0 N-CA-C 114.385 0.514 . . . . 25.0 114.385 174.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -99.52 143.2 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 N-CA-C 109.09 -0.707 . . . . 50.0 109.09 -178.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.06 149.06 47.07 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 107.848 -2.101 . . . . 50.0 107.848 172.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 7.7 tt -74.73 147.97 40.89 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.073 -1.084 . . . . 50.0 108.073 177.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -129.34 -47.52 1.19 Allowed 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 112.98 0.733 . . . . 50.0 112.98 172.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.418 ' HB2' ' HB3' ' A' ' 13' ' ' CYS . 52.4 m-70 -114.46 156.44 24.54 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.356 -0.609 . . . . 25.0 109.356 174.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -100.01 146.15 27.06 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 102.784 -3.043 . . . . 50.0 102.784 169.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.19 175.58 47.7 Favored Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 109.305 -1.518 . . . . 50.0 109.305 -174.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -75.63 160.53 30.0 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.994 0.426 . . . . 50.0 112.013 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 16.8 m -111.77 161.72 16.01 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 104.581 -2.377 . . . . 50.0 104.581 167.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 61.5 tp . . . . . 0 C--O 1.242 0.701 0 N-CA-C 103.902 -2.629 . . . . 25.0 103.902 178.438 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 7.0 pm0 . . . . . 0 N--CA 1.494 1.729 0 N-CA-C 110.253 -0.277 . . . . 25.0 110.253 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.44 -81.8 0.18 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 102.233 -3.247 . . . . 25.0 102.233 174.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.26 153.47 42.39 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 101.93 -3.359 . . . . 25.0 101.93 160.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.9 m -106.36 -34.33 2.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 120.152 -0.619 . . . . 50.0 112.524 -176.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.6 t -113.26 139.91 48.41 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.315 -0.994 . . . . 25.0 108.315 169.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.452 ' H ' ' HB2' ' A' ' 24' ' ' CYS . 12.5 p -96.03 151.25 19.62 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.284 -1.376 . . . . 25.0 107.284 167.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.0 p -103.08 5.06 37.78 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 123.262 1.506 . . . . 25.0 111.277 171.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -75.88 130.01 37.86 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 112.661 -2.063 . . . . 50.0 111.396 -177.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 43.8 t-105 -60.26 107.23 0.62 Allowed 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 105.823 -1.917 . . . . 50.0 105.823 169.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -137.91 73.35 46.35 Favored Pre-proline 0 C--N 1.32 -0.693 0 N-CA-C 108.203 -1.036 . . . . 50.0 108.203 -173.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.37 130.29 24.9 Favored 'Trans proline' 0 CA--C 1.507 -0.847 0 C-N-CA 117.099 -1.467 . . . . 75.0 112.758 -175.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.1 m -140.59 162.14 23.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 104.929 -2.249 . . . . 50.0 104.929 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.404 ' HB3' ' HB2' ' A' ' 35' ' ' HIS . 53.4 t -133.62 129.22 36.62 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.687 -0.857 . . . . 50.0 108.687 -179.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.92 -179.69 52.98 Favored Glycine 0 N--CA 1.452 -0.257 0 CA-C-O 121.651 0.584 . . . . 50.0 114.158 -174.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -71.63 -12.07 61.16 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.179 0.514 . . . . 50.0 110.456 176.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -86.96 0.84 54.43 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.532 -0.758 . . . . 50.0 110.688 175.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 78.56 -1.9 69.96 Favored Glycine 0 C--O 1.228 -0.248 0 N-CA-C 114.611 0.604 . . . . 25.0 114.611 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.9 mtmm -88.64 140.49 29.4 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 118.178 0.989 . . . . 50.0 111.522 -177.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 94.3 m -81.94 131.72 35.25 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.891 -1.049 . . . . 25.0 108.845 175.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -114.8 137.39 52.0 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 106.036 -1.839 . . . . 50.0 106.036 174.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.8 p -66.63 -52.09 48.99 Favored 'General case' 0 C--O 1.22 -0.491 0 N-CA-C 111.677 0.251 . . . . 50.0 111.677 -173.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 30.4 p30 -109.1 167.01 10.41 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-O 121.732 0.777 . . . . 50.0 111.691 167.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 45.7 tp -64.84 -24.79 67.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.151 -0.932 . . . . 50.0 110.714 172.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.452 ' HB2' ' H ' ' A' ' 6' ' ' THR . 43.4 t -59.88 -49.97 75.61 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 122.167 -0.333 . . . . 50.0 111.323 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.7 m95 -69.53 -28.18 65.8 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.265 -0.574 . . . . 50.0 111.572 -179.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -63.0 -44.8 95.03 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.399 -0.963 . . . . 50.0 108.399 174.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.36 -41.9 93.35 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.14 -0.482 . . . . 50.0 111.017 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -65.47 -32.89 74.75 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 122.183 -0.323 . . . . 50.0 111.244 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.52 -13.76 60.07 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.715 0.293 . . . . 25.0 111.373 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.76 12.86 83.56 Favored Glycine 0 CA--C 1.516 0.111 0 N-CA-C 114.946 0.739 . . . . 25.0 114.946 175.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -88.01 142.68 12.6 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.674 0 N-CA-C 108.516 -0.92 . . . . 50.0 108.516 -178.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.44 142.12 32.08 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 107.302 -2.319 . . . . 50.0 107.302 173.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 9.0 tt -65.9 142.47 57.89 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.045 -1.094 . . . . 50.0 108.045 177.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -121.51 -55.17 1.94 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 122.43 -0.169 . . . . 50.0 110.767 175.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.404 ' HB2' ' HB3' ' A' ' 13' ' ' CYS . 29.6 m-70 -111.96 154.32 25.44 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.849 -0.797 . . . . 25.0 108.849 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -98.29 143.78 28.41 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 103.198 -2.89 . . . . 50.0 103.198 170.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.45 177.4 48.48 Favored Glycine 0 C--N 1.321 -0.293 0 N-CA-C 109.968 -1.253 . . . . 50.0 109.968 -175.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -74.31 159.77 31.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.971 0.415 . . . . 50.0 112.115 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 22.3 m -109.71 156.36 20.37 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 104.806 -2.294 . . . . 50.0 104.806 167.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.0 mp . . . . . 0 C--O 1.243 0.753 0 N-CA-C 103.339 -2.837 . . . . 25.0 103.339 177.422 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 119.353 -0.356 . . . . 25.0 110.041 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.53 -43.03 77.59 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.885 1.068 . . . . 25.0 113.885 -174.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -151.86 155.12 37.5 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.72 -0.844 . . . . 25.0 108.72 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 17.3 m -130.27 -27.02 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 113.14 0.792 . . . . 50.0 113.14 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 32.1 p -113.01 156.51 22.94 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.273 -0.421 . . . . 25.0 110.827 -179.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.2 p -95.93 155.66 16.66 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 111.689 0.255 . . . . 25.0 111.689 176.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.6 p -103.01 -0.24 31.12 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 123.987 1.851 . . . . 25.0 110.449 170.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -75.57 135.36 40.56 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 110.898 -2.865 . . . . 50.0 108.223 176.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.41 ' CE2' ' HD3' ' A' ' 11' ' ' PRO . 44.8 t-105 -48.13 105.34 0.07 Allowed 'General case' 0 N--CA 1.476 0.871 0 O-C-N 124.362 1.039 . . . . 50.0 108.508 178.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -137.82 74.71 44.31 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 106.612 -1.625 . . . . 50.0 106.612 -174.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.41 ' HD3' ' CE2' ' A' ' 9' ' ' TRP . 29.7 Cg_endo -63.28 132.71 37.29 Favored 'Trans proline' 0 CA--C 1.506 -0.913 0 C-N-CA 116.621 -1.786 . . . . 75.0 112.228 -175.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.8 m -144.34 162.98 14.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 105.73 -1.952 . . . . 50.0 105.73 -178.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 45.2 t -132.94 130.39 39.52 Favored 'General case' 0 C--O 1.245 0.833 0 N-CA-C 109.586 -0.524 . . . . 50.0 109.586 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -77.91 174.93 54.73 Favored Glycine 0 N--CA 1.453 -0.171 0 CA-C-N 115.528 -0.76 . . . . 50.0 113.619 -176.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -68.23 -17.88 64.42 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.199 0.444 . . . . 50.0 112.199 178.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -94.39 9.89 36.51 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.995 0.426 . . . . 50.0 111.073 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.25 -0.65 89.31 Favored Glycine 0 C--O 1.227 -0.328 0 N-CA-C 117.267 1.667 . . . . 25.0 117.267 174.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 11.9 mmtp -83.27 138.29 33.64 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.19 1.495 . . . . 50.0 111.772 -177.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 97.5 m -84.84 129.17 34.85 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.537 -0.756 . . . . 25.0 109.266 175.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -114.7 138.02 51.21 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.827 -1.175 . . . . 50.0 107.827 175.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.0 p -68.85 -54.75 13.92 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.057 0.391 . . . . 50.0 112.057 -175.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -108.98 162.91 13.78 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.398 -0.964 . . . . 50.0 108.398 174.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 41.9 tp -65.65 -30.09 70.75 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.186 -0.461 . . . . 50.0 111.08 177.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 68.7 m -65.86 -26.07 67.48 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 121.182 -0.948 . . . . 50.0 113.02 177.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -75.02 -34.43 61.91 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 121.7 -0.625 . . . . 50.0 109.652 177.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -64.06 -44.94 90.9 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.391 -0.966 . . . . 50.0 108.391 174.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.7 -41.65 99.24 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.599 -0.728 . . . . 50.0 111.675 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -67.17 -33.54 75.61 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.51 0.195 . . . . 50.0 111.485 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.43 -18.61 58.73 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.777 0.322 . . . . 25.0 110.959 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.33 7.78 86.97 Favored Glycine 0 CA--C 1.517 0.159 0 N-CA-C 114.936 0.734 . . . . 25.0 114.936 176.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -77.58 142.1 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 N-CA-C 108.594 -0.891 . . . . 50.0 108.594 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.18 148.88 49.48 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 107.953 -2.059 . . . . 50.0 107.953 173.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.6 tp -70.79 142.77 51.33 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.992 -0.744 . . . . 50.0 108.992 177.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -126.51 -58.15 1.34 Allowed 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 121.137 -0.225 . . . . 50.0 110.834 173.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -112.02 153.44 26.83 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.439 -0.578 . . . . 25.0 109.439 178.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -102.07 144.18 30.97 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 102.834 -3.024 . . . . 50.0 102.834 168.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.82 171.67 42.12 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 109.021 -1.632 . . . . 50.0 109.021 -172.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -73.58 160.9 30.96 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.107 0.41 . . . . 50.0 112.107 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 4.3 m -109.95 164.47 12.57 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 106.187 -1.783 . . . . 50.0 106.187 170.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 67.7 tp . . . . . 0 C--O 1.253 1.282 0 N-CA-C 104.173 -2.529 . . . . 25.0 104.173 176.907 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 8.8 pm0 . . . . . 0 N--CA 1.496 1.862 0 CA-C-O 119.403 -0.332 . . . . 25.0 110.292 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.82 168.3 25.55 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 105.921 -1.881 . . . . 25.0 105.921 178.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.13 103.97 6.43 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.129 -1.063 . . . . 25.0 108.129 176.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.8 m -107.05 0.52 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 121.465 0.65 . . . . 50.0 110.268 -178.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -81.4 154.18 26.56 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.955 -0.566 . . . . 25.0 110.346 -179.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 43.0 p -95.03 173.65 7.48 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.266 0.555 . . . . 25.0 111.799 -176.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.1 p -93.19 19.86 7.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 122.035 0.921 . . . . 25.0 110.527 176.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -64.27 129.92 41.83 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.75 -1.114 . . . . 50.0 108.333 177.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 72.1 t-105 -51.1 103.9 0.07 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.605 0.717 . . . . 50.0 111.233 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -137.68 73.66 47.31 Favored Pre-proline 0 C--O 1.242 0.669 0 N-CA-C 106.881 -1.526 . . . . 50.0 106.881 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.77 134.59 41.2 Favored 'Trans proline' 0 CA--C 1.507 -0.859 0 C-N-CA 117.666 -1.09 . . . . 75.0 113.505 -173.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.7 m -140.94 162.18 22.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 106.85 -1.537 . . . . 50.0 106.85 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.409 ' HB3' ' HB2' ' A' ' 35' ' ' HIS . 37.4 t -131.06 125.72 33.96 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.069 -0.715 . . . . 50.0 109.069 -178.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -79.82 179.01 53.49 Favored Glycine 0 C--N 1.323 -0.175 0 C-N-CA 121.062 -0.589 . . . . 50.0 112.544 -177.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -64.66 -23.31 67.22 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.393 0.277 . . . . 50.0 111.443 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -73.7 -4.05 32.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.342 0.591 . . . . 50.0 110.969 177.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 79.54 7.39 88.52 Favored Glycine 0 C--O 1.228 -0.279 0 C-N-CA 121.474 -0.393 . . . . 25.0 112.533 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.6 mmmt -102.52 141.79 34.77 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.716 0.769 . . . . 50.0 112.573 -177.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 44.7 m -85.26 133.63 34.16 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.038 -1.437 . . . . 25.0 112.788 -176.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -114.67 137.13 52.28 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 106.933 -1.506 . . . . 50.0 106.933 171.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.8 m -61.28 -55.37 32.7 Favored 'General case' 0 C--O 1.221 -0.435 0 N-CA-C 112.741 0.645 . . . . 50.0 112.741 -174.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -108.78 153.78 23.0 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 109.17 -0.678 . . . . 50.0 109.17 170.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 67.7 tp -57.95 -27.77 63.71 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 116.016 -0.538 . . . . 50.0 110.992 174.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -61.68 -36.69 81.6 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.757 0.651 . . . . 50.0 112.757 178.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 12.3 m95 -72.37 -35.19 68.42 Favored 'General case' 0 C--O 1.22 -0.475 0 C-N-CA 119.703 -0.799 . . . . 50.0 110.048 177.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -61.91 -44.21 97.26 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 108.941 -0.763 . . . . 50.0 108.941 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -63.99 -42.12 97.31 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.006 -0.543 . . . . 50.0 111.825 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -69.67 -30.88 68.66 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 111.912 0.338 . . . . 50.0 111.912 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.25 -19.35 59.78 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.812 0.339 . . . . 25.0 110.887 177.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.74 -0.46 88.19 Favored Glycine 0 CA--C 1.516 0.137 0 N-CA-C 115.117 0.807 . . . . 25.0 115.117 176.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.9 t -68.69 138.12 23.03 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.614 0 N-CA-C 107.955 -1.128 . . . . 50.0 107.955 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.02 142.65 45.25 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 108.249 -1.94 . . . . 50.0 108.249 174.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.4 tp -72.14 142.56 49.11 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.074 -1.084 . . . . 50.0 108.074 177.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -125.64 -57.38 1.46 Allowed 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 121.06 -0.256 . . . . 50.0 110.918 175.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.409 ' HB2' ' HB3' ' A' ' 13' ' ' CYS . 7.2 m170 -111.94 153.03 27.35 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.881 -0.415 . . . . 25.0 109.881 176.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -98.52 146.96 25.25 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 101.285 -3.598 . . . . 50.0 101.285 163.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.54 165.93 36.24 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 108.184 -1.966 . . . . 50.0 108.184 -171.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -91.63 154.39 19.06 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 113.085 0.772 . . . . 50.0 113.085 -175.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 82.8 m -108.68 -179.56 3.9 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 106.197 -1.779 . . . . 50.0 106.197 172.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.0 tm? . . . . . 0 C--O 1.253 1.279 0 N-CA-C 104.602 -2.37 . . . . 25.0 104.602 173.882 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 109.752 -0.462 . . . . 25.0 109.752 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.53 166.12 33.01 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 104.653 -2.351 . . . . 25.0 104.653 178.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.16 144.11 55.11 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.894 -0.78 . . . . 25.0 108.894 177.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.0 m -108.18 0.28 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-O 121.577 0.703 . . . . 50.0 110.505 -178.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 75.3 m -80.97 141.84 34.05 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.806 -0.634 . . . . 25.0 112.206 -172.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 48.7 p -77.81 170.99 15.65 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.615 -0.72 . . . . 25.0 111.818 -177.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.9 p -79.03 25.15 0.29 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.348 0.87 . . . . 25.0 113.348 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -57.84 129.86 43.85 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.434 -0.348 . . . . 50.0 110.456 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 63.1 t-105 -77.24 102.65 6.77 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.072 -0.714 . . . . 50.0 109.072 175.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -136.42 73.03 57.14 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 107.545 -1.28 . . . . 50.0 107.545 177.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.63 139.49 44.53 Favored 'Trans proline' 0 CA--C 1.508 -0.782 0 C-N-CA 117.279 -1.347 . . . . 75.0 114.303 -171.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.8 m -141.08 162.07 22.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 106.588 -1.634 . . . . 50.0 106.588 178.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 37.5 t -122.55 126.55 47.99 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.065 -0.717 . . . . 50.0 109.065 179.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.92 172.96 44.55 Favored Glycine 0 C--O 1.225 -0.433 0 C-N-CA 120.691 -0.766 . . . . 50.0 112.026 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 37.2 mttp -65.52 -12.36 52.11 Favored 'General case' 0 C--O 1.215 -0.727 0 C-N-CA 123.017 0.527 . . . . 50.0 112.42 176.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -76.0 -2.48 30.75 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.262 0.625 . . . . 50.0 110.222 175.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.86 16.69 79.65 Favored Glycine 0 C--O 1.223 -0.587 0 C-N-CA 121.414 -0.422 . . . . 25.0 112.833 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 63.8 mttt -125.97 145.93 50.08 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.142 0.496 . . . . 50.0 112.311 -172.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 99.6 m -79.65 135.66 36.62 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.895 -1.048 . . . . 25.0 111.046 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -114.78 137.33 52.06 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 105.822 -1.918 . . . . 50.0 105.822 171.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.6 p -60.45 -54.96 39.32 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 113.08 0.77 . . . . 50.0 113.08 -172.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 29.7 p30 -109.61 165.76 11.42 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 121.182 0.515 . . . . 50.0 110.576 166.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 65.1 tp -64.61 -24.16 67.5 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.15 0.5 . . . . 50.0 111.669 174.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.0 t -64.25 -45.4 88.31 Favored 'General case' 0 C--O 1.216 -0.686 0 O-C-N 121.754 -0.591 . . . . 50.0 110.826 178.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 46.0 m95 -65.63 -31.31 72.26 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 121.768 -0.582 . . . . 50.0 111.144 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -62.46 -44.86 95.4 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.917 -0.771 . . . . 50.0 108.917 174.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -65.18 -41.9 94.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.139 -0.482 . . . . 50.0 111.732 178.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -65.83 -30.86 71.55 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.633 0.254 . . . . 50.0 111.113 -178.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.95 -15.82 58.67 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.753 0.311 . . . . 25.0 111.17 177.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.66 15.92 80.03 Favored Glycine 0 C--O 1.231 -0.084 0 N-CA-C 114.775 0.67 . . . . 25.0 114.775 175.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.3 t -89.31 147.63 5.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 107.622 -1.251 . . . . 50.0 107.622 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.25 144.61 34.83 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 107.912 -2.075 . . . . 50.0 107.912 174.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 63.4 tp -70.31 142.36 52.24 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.348 -1.353 . . . . 50.0 107.348 176.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -122.92 -58.83 1.64 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.901 -0.319 . . . . 50.0 110.953 175.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 21.2 m-70 -112.01 153.77 26.33 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 122.351 -0.218 . . . . 25.0 111.584 176.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -95.2 145.92 24.7 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 103.582 -2.747 . . . . 50.0 103.582 167.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.02 168.21 40.46 Favored Glycine 0 N--CA 1.452 -0.27 0 N-CA-C 109.989 -1.244 . . . . 50.0 109.989 -175.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -80.14 159.23 26.11 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.397 -0.594 . . . . 50.0 109.397 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 27.7 p -142.17 167.42 22.16 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 122.921 0.488 . . . . 50.0 109.983 -177.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 62.8 tp . . . . . 0 C--O 1.244 0.781 0 N-CA-C 102.486 -3.153 . . . . 25.0 102.486 177.824 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 . . . . . 0 N--CA 1.496 1.836 0 CA-C-O 118.765 -0.636 . . . . 25.0 109.429 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.53 -39.7 70.57 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.567 0.622 . . . . 25.0 110.133 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -158.94 164.02 35.99 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 104.697 -2.334 . . . . 25.0 104.697 178.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.2 m -137.75 -34.4 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-O 121.205 0.526 . . . . 50.0 112.328 175.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 96.8 m -112.96 158.95 19.61 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 112.964 0.727 . . . . 25.0 112.964 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 20.3 p -89.77 156.16 18.7 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.153 -1.054 . . . . 25.0 108.153 172.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.9 p -102.94 7.25 39.24 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 123.264 1.507 . . . . 25.0 110.722 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -75.96 134.91 40.07 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 112.548 -2.115 . . . . 50.0 112.977 -177.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 54.3 t-105 -58.58 109.93 0.89 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.41 -1.33 . . . . 50.0 107.41 175.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -138.03 73.23 45.77 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 107.864 -1.161 . . . . 50.0 107.864 -176.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.04 134.43 36.92 Favored 'Trans proline' 0 CA--C 1.506 -0.886 0 C-N-CA 117.379 -1.281 . . . . 75.0 113.059 -173.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 m -140.33 159.52 25.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 106.012 -1.847 . . . . 50.0 106.012 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.404 ' HB3' ' HB2' ' A' ' 35' ' ' HIS . 52.1 t -131.83 124.47 29.67 Favored 'General case' 0 C--O 1.246 0.91 0 CA-C-O 121.41 0.624 . . . . 50.0 109.715 -177.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -82.78 176.27 53.35 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 115.561 -0.745 . . . . 50.0 114.071 -175.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -67.9 -13.1 61.88 Favored 'General case' 0 C--O 1.216 -0.694 0 N-CA-C 112.186 0.439 . . . . 50.0 112.186 177.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.6 p-10 -82.77 0.84 41.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.363 -0.38 . . . . 50.0 111.043 175.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 76.88 16.94 80.34 Favored Glycine 0 C--O 1.225 -0.427 0 CA-C-O 119.565 -0.575 . . . . 25.0 114.106 178.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -115.8 143.86 44.81 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 118.028 0.914 . . . . 50.0 112.098 -176.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 91.1 m -84.97 132.97 34.28 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.241 -1.345 . . . . 25.0 110.659 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -114.93 138.56 50.68 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 106.745 -1.576 . . . . 50.0 106.745 174.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.3 p -62.52 -55.73 24.69 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 123.316 0.385 . . . . 50.0 111.889 -173.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 52.8 p30 -109.19 169.31 8.77 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-O 121.478 0.656 . . . . 50.0 111.386 166.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 45.5 tp -63.69 -23.7 67.48 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.765 -0.652 . . . . 50.0 111.283 172.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 31.1 t -61.12 -50.42 73.31 Favored 'General case' 0 C--O 1.22 -0.497 0 O-C-N 122.043 -0.411 . . . . 50.0 111.033 178.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 72.2 m95 -66.96 -28.72 68.51 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.209 -0.596 . . . . 50.0 111.492 -179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -64.0 -45.72 87.74 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 108.886 -0.783 . . . . 50.0 108.886 174.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -65.6 -42.88 91.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.159 -0.473 . . . . 50.0 112.242 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -64.95 -31.84 73.26 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.745 0.307 . . . . 50.0 111.337 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.28 -13.36 59.95 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.659 0.266 . . . . 25.0 111.241 178.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.34 16.87 79.7 Favored Glycine 0 C--O 1.23 -0.144 0 N-CA-C 114.71 0.644 . . . . 25.0 114.71 175.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -88.52 140.81 15.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 108.42 -0.955 . . . . 50.0 108.42 -178.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.26 144.63 44.81 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 107.515 -2.234 . . . . 50.0 107.515 173.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 65.8 tp -72.24 145.38 47.98 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.208 -1.034 . . . . 50.0 108.208 177.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -129.98 -53.34 1.13 Allowed 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 113.107 0.78 . . . . 50.0 113.107 171.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.404 ' HB2' ' HB3' ' A' ' 13' ' ' CYS . 54.4 m-70 -112.13 143.47 43.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 118.154 0.434 . . . . 25.0 110.232 176.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.3 mp0 -85.79 145.11 27.38 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 102.072 -3.307 . . . . 50.0 102.072 166.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 93.03 176.07 40.9 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 109.711 -1.356 . . . . 50.0 109.711 -176.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.47 154.32 19.21 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.857 0.361 . . . . 50.0 111.654 -176.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 57.8 m -108.21 169.98 8.29 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 106.824 -1.547 . . . . 50.0 106.824 173.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 66.5 tp . . . . . 0 C--O 1.251 1.169 0 N-CA-C 104.555 -2.387 . . . . 25.0 104.555 176.024 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 110.293 -0.262 . . . . 25.0 110.293 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.36 -157.75 0.52 Allowed 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 102.561 -3.125 . . . . 25.0 102.561 -179.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.31 -76.38 0.07 Allowed 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 102.852 -3.018 . . . . 25.0 102.852 165.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.33 -48.27 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.69 0 N-CA-C 105.582 -2.007 . . . . 50.0 105.582 156.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 t -124.9 159.97 29.91 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.233 -1.349 . . . . 25.0 110.43 159.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.648 ' H ' ' HB2' ' A' ' 24' ' ' CYS . 16.6 p -95.9 155.96 16.53 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 100.853 -3.758 . . . . 25.0 100.853 159.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 42.2 p -102.65 5.06 38.88 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 123.432 1.587 . . . . 25.0 112.346 -179.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 31.4 mp0 -75.91 130.19 38.11 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 112.283 -2.235 . . . . 50.0 114.676 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 44.1 t-105 -69.2 104.84 2.3 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 105.007 -2.22 . . . . 50.0 105.007 171.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -137.9 73.73 45.72 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 108.012 -1.107 . . . . 50.0 108.012 -177.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -65.81 136.28 44.81 Favored 'Trans proline' 0 CA--C 1.512 -0.611 0 O-C-N 122.505 0.739 . . . . 75.0 112.948 -174.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.4 m -147.08 161.11 8.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 114.97 -1.014 . . . . 50.0 108.808 -177.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 9.0 t -120.82 124.69 45.68 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.086 -1.079 . . . . 50.0 108.086 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.95 167.82 44.38 Favored Glycine 0 C--O 1.225 -0.466 0 C-N-CA 120.75 -0.738 . . . . 50.0 111.841 -179.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 24.3 mtpp -66.81 -14.41 62.61 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 112.698 0.629 . . . . 50.0 112.698 178.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -82.24 3.35 27.79 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.695 0.76 . . . . 50.0 110.083 176.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.78 17.04 80.08 Favored Glycine 0 C--O 1.222 -0.644 0 O-C-N 121.502 -0.749 . . . . 25.0 112.658 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -105.55 135.59 46.67 Favored 'General case' 0 C--O 1.239 0.518 0 O-C-N 122.359 -0.494 . . . . 50.0 110.478 -177.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.6 m -87.58 128.91 35.26 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.634 -0.712 . . . . 25.0 110.578 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -114.83 137.16 52.29 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.939 -1.134 . . . . 50.0 107.939 176.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 93.7 p -71.83 -46.33 58.41 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.918 0.389 . . . . 50.0 111.467 -175.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -108.42 162.18 14.35 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 107.351 -1.351 . . . . 50.0 107.351 174.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 36.1 tp -68.52 -26.66 65.55 Favored 'General case' 0 C--O 1.212 -0.898 0 N-CA-C 107.94 -1.133 . . . . 50.0 107.94 173.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.648 ' HB2' ' H ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -52.39 -52.62 52.68 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 115.633 -0.712 . . . . 50.0 112.031 174.989 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 49.1 m95 -65.78 -34.24 77.73 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.539 -0.464 . . . . 50.0 110.541 -176.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.47 -45.67 86.37 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.0 0.429 . . . . 50.0 109.96 175.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -68.85 -34.51 75.59 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.342 0.497 . . . . 50.0 112.342 -177.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -79.13 -30.12 43.5 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 121.111 -0.235 . . . . 50.0 110.38 -177.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.2 -21.54 58.62 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.025 0.44 . . . . 25.0 109.952 175.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.84 15.86 80.0 Favored Glycine 0 C--O 1.228 -0.271 0 N-CA-C 114.561 0.584 . . . . 25.0 114.561 175.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.2 t -80.12 143.81 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 N-CA-C 108.036 -1.098 . . . . 50.0 108.036 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.37 152.57 52.73 Favored Glycine 0 C--N 1.316 -0.554 0 N-CA-C 108.092 -2.003 . . . . 50.0 108.092 173.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 57.4 tp -81.19 142.25 33.39 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.977 -0.749 . . . . 50.0 108.977 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -120.91 -58.71 1.79 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.72 0.295 . . . . 50.0 110.965 174.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 4.5 m170 -112.18 147.7 35.61 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 110.194 -0.298 . . . . 25.0 110.194 175.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -92.71 140.67 29.29 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 103.555 -2.757 . . . . 50.0 103.555 167.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.75 165.35 33.04 Favored Glycine 0 C--N 1.321 -0.278 0 N-CA-C 109.52 -1.432 . . . . 50.0 109.52 -174.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.54 160.46 30.88 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.296 -0.631 . . . . 50.0 109.296 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 28.1 p -142.68 173.04 11.89 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 106.875 -1.528 . . . . 50.0 106.875 179.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.0 pp . . . . . 0 C--O 1.243 0.712 0 N-CA-C 102.762 -3.051 . . . . 25.0 102.762 177.644 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 . . . . . 0 N--CA 1.495 1.78 0 CA-C-O 119.087 -0.482 . . . . 25.0 111.275 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.32 -31.85 71.71 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.739 0.781 . . . . 25.0 109.349 178.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -145.67 156.86 43.91 Favored 'General case' 0 C--O 1.245 0.836 0 N-CA-C 101.524 -3.51 . . . . 25.0 101.524 169.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 13.8 m -138.24 -34.97 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 113.085 0.772 . . . . 50.0 113.085 176.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 28.5 p -117.71 160.05 21.96 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.851 -0.613 . . . . 25.0 112.517 177.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.4 p -95.98 164.75 12.58 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 107.637 -1.246 . . . . 25.0 107.637 170.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.9 p -94.74 18.97 10.69 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.864 0.84 . . . . 25.0 112.016 -179.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -66.07 133.11 50.07 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.175 -0.92 . . . . 50.0 111.15 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.405 ' CE2' ' HD3' ' A' ' 11' ' ' PRO . 58.9 t-105 -58.98 108.98 0.74 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.267 -1.012 . . . . 50.0 108.267 177.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -138.03 73.11 45.99 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.333 -0.617 . . . . 50.0 109.333 -176.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.405 ' HD3' ' CE2' ' A' ' 9' ' ' TRP . 43.6 Cg_endo -66.35 134.97 37.97 Favored 'Trans proline' 0 CA--C 1.506 -0.918 0 C-N-CA 116.706 -1.729 . . . . 75.0 112.966 -174.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.2 m -141.57 163.81 19.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 106.259 -1.756 . . . . 50.0 106.259 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.8 t -129.88 128.85 43.05 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.749 -0.834 . . . . 50.0 108.749 -178.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.07 173.37 48.56 Favored Glycine 0 C--O 1.226 -0.369 0 C-N-CA 121.028 -0.606 . . . . 50.0 112.349 -178.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 17.7 mtpp -65.81 -12.13 51.76 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.213 1.19 . . . . 50.0 114.213 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -89.69 8.67 30.42 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.955 0.407 . . . . 50.0 110.093 174.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 78.64 2.74 85.96 Favored Glycine 0 C--O 1.22 -0.739 0 N-CA-C 114.784 0.673 . . . . 25.0 114.784 176.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.8 mmmt -96.65 138.83 33.62 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 118.11 0.955 . . . . 50.0 112.938 -176.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 37.2 m -82.09 132.61 35.25 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 113.907 -1.497 . . . . 25.0 111.697 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -114.96 137.14 52.34 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.105 -1.072 . . . . 50.0 108.105 173.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.7 m -58.83 -57.11 14.49 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.717 0.636 . . . . 50.0 112.717 -174.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 53.8 p30 -109.35 168.68 9.21 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 121.154 0.502 . . . . 50.0 110.608 165.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 41.7 tp -63.26 -22.29 66.78 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.913 -0.585 . . . . 50.0 111.332 172.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 5.7 t -61.82 -45.29 94.47 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 121.885 -0.509 . . . . 50.0 111.537 178.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 67.6 m95 -70.86 -30.4 66.78 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.303 -0.559 . . . . 50.0 110.816 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -62.67 -48.01 81.17 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 109.073 -0.714 . . . . 50.0 109.073 175.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -63.88 -42.59 97.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.846 -0.615 . . . . 50.0 112.076 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -66.46 -31.1 71.64 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 111.737 0.273 . . . . 50.0 111.737 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.67 -13.65 59.84 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.711 0.291 . . . . 25.0 111.11 178.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.97 14.44 82.2 Favored Glycine 0 CA--C 1.516 0.123 0 N-CA-C 114.778 0.671 . . . . 25.0 114.778 175.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.5 t -83.45 141.1 15.29 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.643 0 N-CA-C 107.907 -1.145 . . . . 50.0 107.907 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.53 144.89 47.93 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 107.307 -2.317 . . . . 50.0 107.307 172.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.8 tp -74.54 146.53 42.56 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.027 -1.101 . . . . 50.0 108.027 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -130.65 -59.19 1.02 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.167 0.508 . . . . 50.0 111.688 177.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 4.0 m170 -115.99 155.63 27.72 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.328 0.492 . . . . 25.0 112.328 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -95.02 143.82 26.19 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 104.495 -2.409 . . . . 50.0 104.495 166.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.54 174.78 43.17 Favored Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 110.99 -0.844 . . . . 50.0 110.99 -177.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -77.77 159.72 28.85 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 113.861 1.059 . . . . 50.0 113.861 -177.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 34.4 m -123.61 173.4 8.1 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 104.719 -2.326 . . . . 50.0 104.719 170.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.6 mp . . . . . 0 C--O 1.247 0.953 0 N-CA-C 107.013 -1.476 . . . . 25.0 107.013 175.144 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 4.8 pm0 . . . . . 0 N--CA 1.497 1.904 0 CA-C-O 119.961 -0.066 . . . . 25.0 111.151 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.74 175.4 13.97 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 103.425 -2.806 . . . . 25.0 103.425 178.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.88 133.74 45.62 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.504 -1.665 . . . . 25.0 106.504 173.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.5 m -125.42 0.31 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 112.256 0.465 . . . . 50.0 112.256 -176.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 80.9 m -81.1 139.97 35.33 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 121.828 -0.545 . . . . 25.0 111.047 -176.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 36.6 p -95.95 168.01 10.89 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.112 -0.699 . . . . 25.0 109.112 177.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.3 p -89.58 24.92 2.14 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.389 0.614 . . . . 25.0 110.822 176.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -68.07 130.33 42.63 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.957 -0.565 . . . . 50.0 110.748 -178.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 64.2 t-105 -65.04 106.19 1.21 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.454 -0.943 . . . . 50.0 108.454 177.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -136.8 73.34 53.9 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 107.878 -1.156 . . . . 50.0 107.878 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -68.65 138.63 42.1 Favored 'Trans proline' 0 CA--C 1.506 -0.917 0 C-N-CA 117.372 -1.285 . . . . 75.0 113.556 -172.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.6 m -139.47 158.37 27.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 105.396 -2.076 . . . . 50.0 105.396 176.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 39.0 t -116.65 121.93 43.11 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.79 -1.189 . . . . 50.0 107.79 -179.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -77.66 169.22 54.66 Favored Glycine 0 C--O 1.227 -0.309 0 N-CA-C 110.763 -0.935 . . . . 50.0 110.763 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -66.24 -12.05 53.91 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 113.058 0.762 . . . . 50.0 113.058 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -78.83 0.48 26.94 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.823 0.345 . . . . 50.0 110.266 173.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.44 17.04 74.57 Favored Glycine 0 C--O 1.218 -0.873 0 CA-C-O 119.431 -0.649 . . . . 25.0 114.465 177.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.9 mmtt -122.2 147.72 45.84 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.041 0.92 . . . . 50.0 112.563 -175.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 85.4 m -79.1 136.61 37.2 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.337 -0.847 . . . . 25.0 112.147 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -114.86 137.04 52.43 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 105.487 -2.042 . . . . 50.0 105.487 170.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.9 p -59.82 -56.03 26.86 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 112.655 0.613 . . . . 50.0 112.655 -171.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 42.2 p30 -109.01 166.57 10.73 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 121.21 0.528 . . . . 50.0 110.418 166.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 63.6 tp -63.59 -25.12 68.09 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.188 0.518 . . . . 50.0 111.262 173.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 32.6 t -62.66 -46.48 87.98 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 121.889 -0.507 . . . . 50.0 111.207 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 54.7 m95 -67.19 -29.75 69.51 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 121.652 -0.655 . . . . 50.0 111.474 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -62.47 -45.64 92.11 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.642 -0.873 . . . . 50.0 108.642 174.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -63.4 -43.48 97.41 Favored 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 116.112 -0.494 . . . . 50.0 111.864 178.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 -68.3 -26.51 65.67 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.098 0.407 . . . . 50.0 112.098 -178.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.2 -14.88 58.8 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.586 0.231 . . . . 25.0 110.799 177.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.25 18.53 78.14 Favored Glycine 0 C--O 1.23 -0.12 0 N-CA-C 114.333 0.493 . . . . 25.0 114.333 175.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -95.64 142.77 13.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 107.781 -1.192 . . . . 50.0 107.781 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.2 155.63 53.51 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 108.102 -1.999 . . . . 50.0 108.102 172.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.8 tt -82.54 142.39 31.86 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.146 -1.057 . . . . 50.0 108.146 176.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -114.32 -58.81 2.1 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.624 -0.51 . . . . 50.0 109.624 174.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 3.5 m170 -111.82 157.72 20.24 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 110.222 -0.288 . . . . 25.0 110.222 176.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -96.23 148.43 22.73 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 101.738 -3.43 . . . . 50.0 101.738 161.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.1 165.82 39.22 Favored Glycine 0 C--N 1.32 -0.336 0 N-CA-C 110.085 -1.206 . . . . 50.0 110.085 -173.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -81.71 162.67 22.89 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.324 0.583 . . . . 50.0 112.203 -177.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 24.6 p -147.02 -174.75 4.58 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 106.213 -1.773 . . . . 50.0 106.213 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.5 tm? . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.143 -0.932 . . . . 25.0 109.442 179.756 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 119.284 -0.388 . . . . 25.0 110.148 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.47 -12.52 58.85 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.134 0.492 . . . . 25.0 110.575 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -72.11 100.56 2.56 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.998 -0.547 . . . . 25.0 110.301 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.5 m -106.78 0.35 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 108.274 -1.009 . . . . 50.0 108.274 177.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.2 p -81.48 159.79 24.12 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.697 -1.138 . . . . 25.0 110.933 -176.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 36.0 p -86.38 169.45 12.9 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.742 -0.663 . . . . 25.0 110.103 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.0 p -85.25 13.16 6.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 122.324 1.059 . . . . 25.0 112.569 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -63.2 130.12 43.2 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 113.762 -1.563 . . . . 50.0 110.462 176.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 53.2 t-105 -48.85 107.77 0.15 Allowed 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.727 -0.842 . . . . 50.0 108.727 176.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -137.74 73.77 46.68 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 107.187 -1.412 . . . . 50.0 107.187 -176.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -64.23 135.07 45.08 Favored 'Trans proline' 0 CA--C 1.506 -0.892 0 C-N-CA 118.049 -0.834 . . . . 75.0 113.27 -173.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.0 m -141.64 156.23 20.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 106.256 -1.757 . . . . 50.0 106.256 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.0 t -126.69 121.99 33.65 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.764 -0.828 . . . . 50.0 108.764 -177.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -78.69 176.76 54.33 Favored Glycine 0 C--O 1.226 -0.355 0 CA-C-N 115.929 -0.578 . . . . 50.0 112.833 -176.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -65.9 -21.54 66.45 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 122.582 -0.364 . . . . 50.0 111.552 178.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -75.23 -7.62 54.39 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.083 -0.508 . . . . 50.0 111.459 176.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.79 -7.66 73.08 Favored Glycine 0 C--O 1.224 -0.487 0 N-CA-C 111.483 -0.647 . . . . 25.0 111.483 -173.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -70.79 126.18 28.89 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 122.5 -0.412 . . . . 50.0 111.022 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.0 m -85.2 130.8 34.53 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.593 -0.731 . . . . 25.0 109.375 175.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -114.66 141.18 48.14 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.352 -0.981 . . . . 50.0 108.352 175.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.0 p -64.68 -57.89 7.78 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 112.682 0.623 . . . . 50.0 112.682 -174.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -109.27 166.37 10.92 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 121.452 0.644 . . . . 50.0 110.489 168.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 59.2 tp -62.16 -27.32 68.87 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.446 -0.797 . . . . 50.0 111.749 176.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 20.9 m -65.56 -40.42 92.8 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 121.73 -0.607 . . . . 50.0 111.734 -178.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -66.63 -34.77 78.61 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.387 -0.525 . . . . 50.0 110.62 176.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.64 -45.51 89.89 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.171 -0.677 . . . . 50.0 109.171 176.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -63.7 -43.41 96.67 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.315 0.487 . . . . 50.0 112.315 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -68.21 -29.37 68.2 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.48 0.178 . . . . 50.0 111.48 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.39 -16.45 57.63 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.691 0.281 . . . . 25.0 111.259 178.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.7 9.39 86.34 Favored Glycine 0 CA--C 1.518 0.24 0 N-CA-C 115.413 0.925 . . . . 25.0 115.413 176.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.5 t -78.92 138.91 19.24 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 N-CA-C 107.847 -1.168 . . . . 50.0 107.847 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.87 149.54 50.47 Favored Glycine 0 C--N 1.315 -0.61 0 N-CA-C 107.989 -2.044 . . . . 50.0 107.989 174.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 59.0 tp -74.03 145.58 44.41 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.062 -0.718 . . . . 50.0 109.062 178.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -125.09 -58.93 1.44 Allowed 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 121.147 -0.221 . . . . 50.0 110.438 172.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 26.8 m-70 -111.75 143.8 42.08 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.96 0.355 . . . . 25.0 111.96 176.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 33.0 mp0 -84.12 138.93 32.77 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 102.595 -3.113 . . . . 50.0 102.595 168.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.53 169.06 40.15 Favored Glycine 0 C--N 1.321 -0.276 0 N-CA-C 109.328 -1.509 . . . . 50.0 109.328 -174.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -83.33 160.6 21.64 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 122.668 -0.313 . . . . 50.0 111.32 -177.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 67.4 m -108.23 158.4 17.49 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 105.097 -2.186 . . . . 50.0 105.097 170.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 94.0 mt . . . . . 0 C--O 1.242 0.703 0 N-CA-C 104.78 -2.304 . . . . 25.0 104.78 179.411 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 22.2 pm0 . . . . . 0 N--CA 1.496 1.852 0 CA-C-O 119.29 -0.386 . . . . 25.0 110.197 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.87 41.49 3.15 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.167 0.508 . . . . 25.0 110.549 -177.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -139.3 138.27 36.57 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 106.527 -1.657 . . . . 25.0 106.527 178.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.17 -14.4 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 113.028 0.751 . . . . 50.0 113.028 -176.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 52.2 t -113.02 139.97 48.22 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 122.317 -0.24 . . . . 25.0 111.484 -177.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.0 p -95.97 155.85 16.58 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.05 -1.093 . . . . 25.0 108.05 171.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 36.1 p -102.84 10.07 38.59 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 122.845 1.307 . . . . 25.0 110.567 177.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -75.9 131.32 39.58 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 113.325 -1.761 . . . . 50.0 110.963 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 53.6 t-105 -59.02 108.62 0.7 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.108 -1.442 . . . . 50.0 107.108 173.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -137.72 73.41 47.55 Favored Pre-proline 0 C--N 1.322 -0.611 0 N-CA-C 107.682 -1.229 . . . . 50.0 107.682 -176.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.58 138.85 46.9 Favored 'Trans proline' 0 CA--C 1.507 -0.831 0 C-N-CA 117.228 -1.381 . . . . 75.0 112.524 -175.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.2 m -142.39 161.04 19.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 104.911 -2.255 . . . . 50.0 104.911 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -126.41 127.54 45.61 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.693 -0.854 . . . . 50.0 108.693 178.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -79.58 177.34 54.32 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 121.033 -0.604 . . . . 50.0 113.613 -176.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -71.16 -12.13 61.32 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 122.389 -0.477 . . . . 50.0 110.648 176.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 42.8 p-10 -82.77 -3.46 56.64 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.473 -0.785 . . . . 50.0 111.212 176.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 79.25 16.9 77.54 Favored Glycine 0 C--O 1.224 -0.501 0 C-N-CA 121.177 -0.535 . . . . 25.0 113.792 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.7 mmtp -110.31 141.38 43.4 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 118.047 0.924 . . . . 50.0 110.854 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.1 m -82.28 132.16 35.23 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.423 -0.955 . . . . 25.0 108.423 175.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -114.91 137.11 52.36 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 106.502 -1.666 . . . . 50.0 106.502 173.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.0 m -64.61 -55.8 17.96 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.577 0.584 . . . . 50.0 112.577 -173.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -113.77 158.72 20.59 Favored 'General case' 0 C--O 1.25 1.08 0 CA-C-O 121.216 0.531 . . . . 50.0 109.671 170.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 30.0 tp -57.35 -24.62 56.37 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.631 -0.713 . . . . 50.0 112.002 177.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.3 m -58.46 -42.95 88.6 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 121.951 -0.468 . . . . 50.0 112.178 177.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 40.1 m95 -73.81 -33.37 64.15 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.779 -0.452 . . . . 50.0 109.779 -177.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -61.45 -45.92 92.23 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.049 -0.723 . . . . 50.0 109.049 176.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -65.05 -41.15 95.42 Favored 'General case' 0 C--O 1.218 -0.569 0 CA-C-N 115.813 -0.631 . . . . 50.0 112.151 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -68.08 -30.79 70.06 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.906 0.336 . . . . 50.0 111.906 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.71 -14.76 59.92 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.899 0.38 . . . . 25.0 110.387 177.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.21 16.3 79.83 Favored Glycine 0 C--N 1.328 0.109 0 N-CA-C 114.149 0.42 . . . . 25.0 114.149 175.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -93.82 142.99 12.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 109.235 -0.654 . . . . 50.0 109.235 -178.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.12 152.36 49.91 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 108.43 -1.868 . . . . 50.0 108.43 171.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.1 tt -75.6 138.92 41.76 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.08 -1.081 . . . . 50.0 108.08 177.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -117.84 -50.24 2.5 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.564 0.221 . . . . 50.0 110.962 175.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 -112.01 151.97 28.69 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.873 -0.417 . . . . 25.0 109.873 175.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -94.5 146.42 24.11 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 102.895 -3.002 . . . . 50.0 102.895 166.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.97 170.14 46.83 Favored Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 110.201 -1.16 . . . . 50.0 110.201 -175.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -79.36 151.34 31.05 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.338 -0.986 . . . . 50.0 108.338 178.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.6 p -148.97 173.37 13.41 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.701 0.286 . . . . 50.0 111.088 -178.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.258 1.524 0 N-CA-C 102.902 -2.999 . . . . 25.0 102.902 174.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.7 t70 . . . . . 0 C--O 1.243 0.714 0 N-CA-C 106.453 -1.684 . . . . 25.0 106.453 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -61.73 142.23 93.25 Favored 'Trans proline' 0 CA--C 1.509 -0.771 0 N-CA-C 115.885 1.456 . . . . 25.0 115.885 -169.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.0 m -140.83 167.08 18.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 105.759 -1.941 . . . . 25.0 105.759 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.434 ' HB3' ' HB2' ' A' ' 35' ' ' HIS . 44.3 t -134.76 133.16 39.6 Favored 'General case' 0 C--O 1.244 0.816 0 CA-C-O 120.962 0.411 . . . . 25.0 110.472 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.15 176.53 54.65 Favored Glycine 0 N--CA 1.453 -0.17 0 CA-C-N 115.837 -0.62 . . . . 25.0 113.586 -177.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -71.81 -12.89 61.51 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 122.32 -0.518 . . . . 25.0 111.317 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.9 p-10 -94.8 9.18 40.06 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.172 -0.467 . . . . 25.0 111.239 177.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.09 -3.73 75.05 Favored Glycine 0 C--O 1.227 -0.305 0 N-CA-C 116.053 1.181 . . . . 25.0 116.053 176.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -82.37 137.19 34.82 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 118.626 1.213 . . . . 25.0 111.948 -177.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 94.2 m -83.8 128.85 34.84 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.175 -0.921 . . . . 25.0 109.007 176.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -114.93 139.08 50.1 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.308 -0.997 . . . . 25.0 108.308 176.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.62 -56.86 16.65 Favored 'General case' 0 C--O 1.215 -0.718 0 N-CA-C 113.097 0.777 . . . . 25.0 113.097 -173.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -113.06 174.35 5.94 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.984 0.421 . . . . 25.0 110.824 166.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 39.4 tp -64.31 -27.36 68.98 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.723 -0.671 . . . . 25.0 112.213 173.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 47.3 t -63.28 -47.71 81.19 Favored 'General case' 0 C--O 1.216 -0.675 0 O-C-N 121.722 -0.611 . . . . 25.0 111.018 178.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 62.1 m95 -62.47 -31.61 72.37 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.243 -0.583 . . . . 25.0 111.491 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -64.49 -45.41 87.44 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 109.307 -0.627 . . . . 25.0 109.307 175.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -66.17 -41.4 90.38 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.329 -0.396 . . . . 25.0 111.831 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -64.67 -31.25 72.39 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.667 0.27 . . . . 25.0 111.165 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.39 -15.88 59.84 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.701 0.286 . . . . 25.0 111.053 178.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.08 7.72 88.2 Favored Glycine 0 C--O 1.23 -0.103 0 N-CA-C 114.838 0.695 . . . . 25.0 114.838 175.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -85.29 144.37 9.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.079 -1.082 . . . . 25.0 108.079 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.09 150.81 49.38 Favored Glycine 0 C--N 1.316 -0.582 0 N-CA-C 108.564 -1.814 . . . . 25.0 108.564 173.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 60.8 tp -74.5 145.56 43.44 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.053 -0.721 . . . . 25.0 109.053 177.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -128.37 -58.85 1.18 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.005 0.372 . . . . 25.0 112.005 173.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.434 ' HB2' ' HB3' ' A' ' 13' ' ' CYS . 16.2 m80 -112.1 160.69 17.29 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.522 0.201 . . . . 25.0 111.358 178.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -99.69 149.3 23.46 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 102.89 -3.004 . . . . 25.0 102.89 166.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.8 178.64 47.75 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 110.748 -0.941 . . . . 25.0 110.748 -177.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -78.07 160.92 27.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.749 0.309 . . . . 25.0 111.564 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.7 m . . . . . 0 C--N 1.324 -0.515 0 N-CA-C 108.328 -0.989 . . . . 25.0 108.328 173.652 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 52.1 t0 . . . . . 0 N--CA 1.454 -0.236 0 N-CA-C 109.253 -0.647 . . . . 25.0 109.253 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -65.4 138.49 55.42 Favored 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 114.646 -3.103 . . . . 25.0 113.491 -176.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.6 m -144.26 161.04 15.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 105.561 -2.015 . . . . 25.0 105.561 -178.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 50.8 t -131.47 126.37 34.85 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.097 -0.705 . . . . 25.0 109.097 -177.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.37 178.5 53.87 Favored Glycine 0 C--O 1.225 -0.437 0 CA-C-N 115.761 -0.654 . . . . 25.0 113.247 -175.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -66.56 -19.83 65.87 Favored 'General case' 0 C--O 1.214 -0.786 0 O-C-N 122.616 -0.343 . . . . 25.0 111.435 177.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -82.57 3.78 27.25 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 121.768 0.794 . . . . 25.0 110.708 177.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.21 -4.41 54.91 Favored Glycine 0 C--O 1.224 -0.484 0 O-C-N 121.839 -0.538 . . . . 25.0 114.134 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -81.86 134.26 35.39 Favored 'General case' 0 C--O 1.239 0.527 0 O-C-N 122.109 -0.641 . . . . 25.0 110.776 -176.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.2 m -86.73 132.39 33.88 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.605 -0.725 . . . . 25.0 109.502 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -114.69 137.4 51.96 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 106.11 -1.811 . . . . 25.0 106.11 175.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 79.8 p -66.81 -47.42 72.13 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 111.974 0.361 . . . . 25.0 111.974 -173.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -109.19 164.55 12.35 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.701 -0.851 . . . . 25.0 108.701 172.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 63.6 tp -68.32 -23.65 64.74 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.496 -0.775 . . . . 25.0 109.104 172.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.8 t -55.59 -51.0 68.61 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.618 -0.719 . . . . 25.0 111.344 175.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 24.0 m95 -69.89 -31.13 68.77 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.389 -0.524 . . . . 25.0 111.351 -176.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -64.47 -44.47 90.97 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.331 -0.618 . . . . 25.0 109.331 175.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -61.36 -46.26 90.94 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.141 -0.481 . . . . 25.0 110.521 -178.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -74.83 -23.58 58.48 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.634 0.605 . . . . 25.0 112.634 -176.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.27 -18.02 57.91 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.779 0.323 . . . . 25.0 110.611 176.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.74 5.37 86.35 Favored Glycine 0 CA--C 1.517 0.206 0 N-CA-C 115.114 0.806 . . . . 25.0 115.114 176.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -74.81 137.25 23.43 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 N-CA-C 107.529 -1.286 . . . . 25.0 107.529 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.51 143.85 46.32 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 107.548 -2.221 . . . . 25.0 107.548 175.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 57.9 tp -70.34 142.68 52.14 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.335 -0.987 . . . . 25.0 108.335 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -126.03 -58.91 1.36 Allowed 'General case' 0 C--O 1.22 -0.472 0 C-N-CA 120.983 -0.287 . . . . 25.0 110.258 173.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 7.0 m80 -111.92 154.44 25.22 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.802 -0.444 . . . . 25.0 109.802 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -102.72 145.63 29.43 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 102.432 -3.173 . . . . 25.0 102.432 167.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.91 171.26 43.38 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 109.681 -1.368 . . . . 25.0 109.681 -172.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -72.65 153.5 41.18 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 113.376 0.88 . . . . 25.0 113.376 -176.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 51.6 m . . . . . 0 C--O 1.241 0.614 0 N-CA-C 103.388 -2.819 . . . . 25.0 103.388 163.565 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 39.4 t0 . . . . . 0 C--O 1.236 0.368 0 N-CA-C 107.944 -1.132 . . . . 25.0 107.944 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -65.65 135.68 42.92 Favored 'Trans proline' 0 CA--C 1.509 -0.745 0 C-N-CA 117.616 -1.122 . . . . 25.0 113.213 -174.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.4 m -141.17 159.81 22.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 105.935 -1.876 . . . . 25.0 105.935 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 38.8 t -119.27 124.34 46.45 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.197 -1.038 . . . . 25.0 108.197 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -79.32 170.77 54.63 Favored Glycine 0 C--O 1.226 -0.361 0 C-N-CA 120.792 -0.718 . . . . 25.0 111.34 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -68.32 -12.01 60.39 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 112.481 0.548 . . . . 25.0 112.481 178.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -81.68 1.01 36.15 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.549 0.69 . . . . 25.0 110.181 174.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 76.98 16.66 80.59 Favored Glycine 0 C--O 1.222 -0.596 0 O-C-N 121.555 -0.716 . . . . 25.0 113.112 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -108.11 138.81 43.74 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 122.128 -0.631 . . . . 25.0 111.085 -176.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 54.6 m -81.52 133.26 35.37 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.916 -0.584 . . . . 25.0 109.489 176.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -114.89 137.13 52.33 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.045 -1.465 . . . . 25.0 107.045 173.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.9 m -59.99 -57.02 14.66 Favored 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 112.945 0.721 . . . . 25.0 112.945 -173.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 47.8 p30 -109.07 167.6 9.98 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.122 0.486 . . . . 25.0 110.457 167.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 59.8 tp -62.47 -26.78 68.7 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.844 -0.616 . . . . 25.0 110.62 172.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.4 m -61.47 -44.63 96.75 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 122.04 -0.413 . . . . 25.0 111.793 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 65.0 m95 -68.77 -30.88 69.57 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 121.762 -0.586 . . . . 25.0 111.519 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -63.05 -44.48 95.75 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.437 -0.949 . . . . 25.0 108.437 175.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -66.12 -41.51 90.46 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.032 -0.531 . . . . 25.0 111.492 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -62.99 -32.78 74.2 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 111.668 0.247 . . . . 25.0 111.668 178.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.77 -14.16 59.42 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.673 0.273 . . . . 25.0 111.434 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.18 11.16 85.8 Favored Glycine 0 C--O 1.23 -0.135 0 N-CA-C 115.031 0.772 . . . . 25.0 115.031 176.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -87.41 146.41 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 N-CA-C 107.791 -1.189 . . . . 25.0 107.791 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.69 152.26 47.37 Favored Glycine 0 C--N 1.316 -0.553 0 N-CA-C 107.803 -2.119 . . . . 25.0 107.803 173.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 8.4 tt -78.49 141.86 37.89 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.579 -1.267 . . . . 25.0 107.579 176.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -117.06 -58.35 2.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.82 0.343 . . . . 25.0 110.405 174.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -111.97 156.54 21.97 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.311 -0.243 . . . . 25.0 111.02 176.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -98.8 146.38 25.99 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 103.708 -2.701 . . . . 25.0 103.708 168.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.53 171.2 40.89 Favored Glycine 0 N--CA 1.451 -0.312 0 N-CA-C 109.552 -1.419 . . . . 25.0 109.552 -174.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -81.31 158.18 24.83 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.104 -0.702 . . . . 25.0 109.104 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 27.8 p . . . . . 0 C--N 1.325 -0.498 0 C-N-CA 122.923 0.489 . . . . 25.0 109.735 -178.132 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 59.2 t0 . . . . . 0 C--O 1.238 0.467 0 N-CA-C 109.142 -0.688 . . . . 25.0 109.142 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.97 134.6 43.86 Favored 'Trans proline' 0 CA--C 1.506 -0.885 0 C-N-CA 117.517 -1.188 . . . . 25.0 112.621 -176.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.4 m -142.72 162.06 18.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 105.989 -1.856 . . . . 25.0 105.989 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 43.8 t -123.75 123.33 40.27 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.839 -0.8 . . . . 25.0 108.839 -177.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.18 164.68 48.08 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.065 -0.588 . . . . 25.0 112.244 -178.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -62.75 -17.6 61.2 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.113 0.783 . . . . 25.0 113.113 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -79.61 5.6 12.74 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 122.334 -0.229 . . . . 25.0 111.146 175.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.59 17.24 71.32 Favored Glycine 0 C--O 1.225 -0.427 0 C-N-CA 120.677 -0.773 . . . . 25.0 113.8 175.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 32.2 mmtm -121.26 138.49 54.21 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 117.559 0.679 . . . . 25.0 112.152 -173.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 38.4 m -83.17 133.84 35.01 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.969 -1.014 . . . . 25.0 111.241 -179.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -114.83 138.33 50.9 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.285 -1.376 . . . . 25.0 107.285 173.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.1 p -62.69 -52.4 63.43 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.567 0.58 . . . . 25.0 112.567 -174.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.417 ' H ' ' HD1' ' A' ' 25' ' ' TRP . 23.1 m-20 -108.24 168.01 9.61 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.371 -0.974 . . . . 25.0 108.371 171.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 59.6 tp -68.68 -26.1 65.13 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.039 -1.096 . . . . 25.0 108.039 171.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 48.6 t -55.01 -52.33 63.48 Favored 'General case' 0 C--O 1.219 -0.513 0 CA-C-N 115.046 -0.979 . . . . 25.0 111.262 175.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.417 ' HD1' ' H ' ' A' ' 22' ' ' ASN . 72.7 m95 -69.42 -27.41 65.25 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.068 0.395 . . . . 25.0 112.068 -175.233 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -65.86 -49.41 68.22 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.931 -0.766 . . . . 25.0 108.931 175.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -66.75 -40.73 88.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.913 -0.585 . . . . 25.0 111.473 -177.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -67.28 -27.81 67.5 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 120.965 -0.294 . . . . 25.0 111.646 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.34 -12.76 59.55 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.624 0.249 . . . . 25.0 111.138 178.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.06 19.46 78.6 Favored Glycine 0 C--O 1.23 -0.146 0 N-CA-C 114.744 0.658 . . . . 25.0 114.744 175.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -93.15 144.2 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 N-CA-C 107.457 -1.312 . . . . 25.0 107.457 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.62 148.75 45.66 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 107.106 -2.398 . . . . 25.0 107.106 173.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 8.2 tt -78.56 141.01 38.44 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.516 -1.291 . . . . 25.0 107.516 176.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -116.24 -58.13 2.13 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.101 -0.333 . . . . 25.0 110.101 174.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 5.3 m170 -112.03 157.88 20.22 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 110.105 -0.332 . . . . 25.0 110.105 176.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -99.79 147.78 25.11 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 102.677 -3.082 . . . . 25.0 102.677 165.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.46 169.0 41.62 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 109.735 -1.346 . . . . 25.0 109.735 -173.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -72.72 161.56 30.59 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.974 0.731 . . . . 25.0 112.974 -178.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 9.4 m . . . . . 0 C--O 1.239 0.507 0 N-CA-C 104.901 -2.259 . . . . 25.0 104.901 169.008 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 44.2 t0 . . . . . 0 CA--C 1.511 -0.533 0 N-CA-C 108.12 -1.067 . . . . 25.0 108.12 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -62.87 133.61 42.6 Favored 'Trans proline' 0 CA--C 1.503 -1.07 0 O-C-N 122.309 0.636 . . . . 25.0 112.081 -173.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.5 m -139.55 161.18 27.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 107.282 -1.377 . . . . 25.0 107.282 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.1 t -131.55 121.69 24.85 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.889 -1.152 . . . . 25.0 107.889 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.98 173.58 54.67 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.815 -0.629 . . . . 25.0 112.823 -176.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp -64.2 -16.07 61.23 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.325 0.861 . . . . 25.0 113.325 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -92.07 10.65 28.27 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.736 0.303 . . . . 25.0 110.218 177.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.95 -2.34 65.17 Favored Glycine 0 C--O 1.223 -0.557 0 N-CA-C 114.281 0.472 . . . . 25.0 114.281 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -82.73 130.74 35.17 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 121.883 -0.775 . . . . 25.0 111.973 -175.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 70.3 m -84.79 128.39 34.59 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.986 -1.007 . . . . 25.0 110.87 177.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -114.88 137.02 52.46 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.002 -0.74 . . . . 25.0 109.002 174.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.3 m -60.51 -54.91 39.82 Favored 'General case' 0 C--O 1.217 -0.611 0 N-CA-C 112.701 0.63 . . . . 25.0 112.701 -174.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -109.1 168.41 9.39 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.07 0.462 . . . . 25.0 110.525 167.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 39.8 tp -65.76 -23.02 66.63 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.967 -0.561 . . . . 25.0 111.041 172.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 22.5 t -60.87 -50.35 73.8 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 121.956 -0.465 . . . . 25.0 111.001 178.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -64.38 -31.18 72.29 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 122.113 -0.367 . . . . 25.0 111.556 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -63.41 -46.39 86.6 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 109.159 -0.682 . . . . 25.0 109.159 176.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -65.08 -42.37 94.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.059 -0.519 . . . . 25.0 110.468 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -65.32 -33.13 75.25 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.598 0.221 . . . . 25.0 111.598 -179.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.76 -12.2 60.01 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 111.779 0.289 . . . . 25.0 111.779 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.4 19.99 79.78 Favored Glycine 0 C--O 1.229 -0.194 0 N-CA-C 115.005 0.762 . . . . 25.0 115.005 176.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -91.81 142.44 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 N-CA-C 107.542 -1.281 . . . . 25.0 107.542 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.53 147.17 46.64 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 108.005 -2.038 . . . . 25.0 108.005 173.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 62.0 tp -75.07 144.47 42.95 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.939 -1.134 . . . . 25.0 107.939 176.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -122.38 -59.15 1.66 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.401 -0.52 . . . . 25.0 110.218 172.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -113.82 153.05 29.78 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.512 0.56 . . . . 25.0 112.512 173.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -85.86 148.69 25.69 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 100.952 -3.722 . . . . 25.0 100.952 159.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.3 152.84 26.71 Favored Glycine 0 C--N 1.318 -0.449 0 N-CA-C 110.656 -0.977 . . . . 25.0 110.656 -176.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -83.66 151.75 25.12 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.66 0.615 . . . . 25.0 112.66 -176.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 76.2 m . . . . . 0 C--O 1.24 0.592 0 N-CA-C 105.692 -1.966 . . . . 25.0 105.692 171.758 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.5 t0 . . . . . 0 C--O 1.239 0.521 0 N-CA-C 106.997 -1.483 . . . . 25.0 106.997 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.77 139.51 44.01 Favored 'Trans proline' 0 CA--C 1.51 -0.699 0 C-N-CA 117.186 -1.41 . . . . 25.0 114.081 -172.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.0 m -141.9 162.3 20.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 105.995 -1.854 . . . . 25.0 105.995 178.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.8 t -128.53 127.1 41.73 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-O 121.02 0.438 . . . . 25.0 110.04 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.33 175.31 54.95 Favored Glycine 0 C--O 1.227 -0.318 0 C-N-CA 121.06 -0.59 . . . . 25.0 112.427 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -66.53 -18.07 65.16 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 122.477 -0.425 . . . . 25.0 111.841 177.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -79.23 0.75 27.27 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.564 0.697 . . . . 25.0 110.82 176.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 75.46 16.71 80.46 Favored Glycine 0 C--O 1.222 -0.626 0 C-N-CA 120.87 -0.681 . . . . 25.0 113.209 178.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -106.04 137.3 44.2 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 122.246 -0.561 . . . . 25.0 110.667 -177.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 60.8 m -82.46 134.28 35.22 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.799 -0.637 . . . . 25.0 109.526 177.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -114.95 137.92 51.43 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 106.566 -1.642 . . . . 25.0 106.566 174.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.5 p -60.26 -55.83 28.89 Favored 'General case' 0 C--O 1.219 -0.511 0 N-CA-C 112.382 0.512 . . . . 25.0 112.382 -173.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 36.8 p30 -109.06 166.14 11.06 Favored 'General case' 0 C--O 1.244 0.79 0 CA-C-O 121.306 0.574 . . . . 25.0 110.892 166.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 60.9 tp -63.15 -25.72 68.48 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.207 0.527 . . . . 25.0 111.15 172.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 68.5 m -63.63 -41.45 98.26 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 121.792 -0.568 . . . . 25.0 112.213 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 60.4 m95 -70.62 -29.56 65.97 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 121.428 -0.795 . . . . 25.0 110.721 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.94 -42.66 99.88 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.286 -1.005 . . . . 25.0 108.286 173.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -63.66 -41.36 98.21 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 111.696 0.258 . . . . 25.0 111.696 177.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -63.68 -36.04 82.53 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 117.831 0.287 . . . . 25.0 111.722 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.38 -17.92 57.78 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.668 0.271 . . . . 25.0 111.63 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.67 5.6 83.57 Favored Glycine 0 CA--C 1.518 0.227 0 N-CA-C 115.109 0.804 . . . . 25.0 115.109 176.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -74.31 140.46 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.654 0 N-CA-C 107.467 -1.308 . . . . 25.0 107.467 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.28 147.15 49.76 Favored Glycine 0 C--N 1.315 -0.59 0 N-CA-C 107.608 -2.197 . . . . 25.0 107.608 174.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 56.5 tp -72.92 143.52 47.68 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.475 -0.935 . . . . 25.0 108.475 177.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -124.36 -59.1 1.49 Allowed 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 121.179 -0.208 . . . . 25.0 110.888 173.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 7.5 m80 -111.91 154.26 25.48 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.418 -0.216 . . . . 25.0 110.418 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -98.92 143.94 28.65 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 102.41 -3.182 . . . . 25.0 102.41 167.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 93.19 170.16 39.54 Favored Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 109.1 -1.6 . . . . 25.0 109.1 -173.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -78.5 162.32 26.43 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.426 -0.583 . . . . 25.0 109.426 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 26.3 p . . . . . 0 C--N 1.323 -0.568 0 N-CA-C 108.523 -0.917 . . . . 25.0 108.523 -179.586 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 36.4 t70 . . . . . 0 C--O 1.233 0.206 0 N-CA-C 109.559 -0.534 . . . . 25.0 109.559 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -65.4 134.15 37.62 Favored 'Trans proline' 0 CA--C 1.51 -0.689 0 C-N-CA 116.716 -1.723 . . . . 25.0 113.637 -173.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.9 m -141.62 161.61 21.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 106.112 -1.81 . . . . 25.0 106.112 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.439 ' HB3' ' HB2' ' A' ' 35' ' ' HIS . 50.4 t -129.11 125.08 36.37 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.966 -0.753 . . . . 25.0 108.966 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.84 175.29 54.09 Favored Glycine 0 C--O 1.227 -0.32 0 CA-C-N 115.918 -0.583 . . . . 25.0 114.078 -175.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -67.56 -12.07 59.53 Favored 'General case' 0 C--O 1.215 -0.735 0 N-CA-C 112.487 0.551 . . . . 25.0 112.487 177.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -91.41 8.94 33.84 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.711 0.291 . . . . 25.0 110.453 176.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.5 -18.5 8.5 Favored Glycine 0 C--O 1.222 -0.652 0 N-CA-C 114.926 0.731 . . . . 25.0 114.926 177.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -73.11 139.41 46.42 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 121.312 0.577 . . . . 25.0 112.289 -177.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 98.8 m -86.05 132.63 34.0 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.653 -1.158 . . . . 25.0 108.882 175.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -115.0 136.97 52.54 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.114 -1.069 . . . . 25.0 108.114 176.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.8 m -62.33 -51.68 66.66 Favored 'General case' 0 C--O 1.223 -0.327 0 N-CA-C 112.714 0.635 . . . . 25.0 112.714 -174.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 45.9 p30 -113.9 170.08 8.53 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 121.109 0.48 . . . . 25.0 110.546 168.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 41.5 tp -63.79 -25.57 68.24 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.902 -0.59 . . . . 25.0 110.66 172.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 19.5 m -61.53 -46.05 91.58 Favored 'General case' 0 C--O 1.218 -0.571 0 O-C-N 122.144 -0.347 . . . . 25.0 111.916 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 24.5 m95 -70.08 -28.41 65.41 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 121.788 -0.57 . . . . 25.0 111.201 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -64.51 -45.32 87.74 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.5 -0.926 . . . . 25.0 108.5 175.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -66.05 -42.22 89.8 Favored 'General case' 0 C--O 1.22 -0.467 0 CA-C-N 115.782 -0.644 . . . . 25.0 111.78 178.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -63.61 -33.56 75.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.718 0.294 . . . . 25.0 111.414 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.27 -12.22 59.98 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.602 0.239 . . . . 25.0 111.323 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.0 21.78 77.85 Favored Glycine 0 C--O 1.23 -0.11 0 N-CA-C 114.385 0.514 . . . . 25.0 114.385 174.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -99.52 143.2 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 N-CA-C 109.09 -0.707 . . . . 25.0 109.09 -178.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.06 149.06 47.07 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 107.848 -2.101 . . . . 25.0 107.848 172.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 7.7 tt -74.73 147.97 40.89 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.073 -1.084 . . . . 25.0 108.073 177.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -129.34 -47.52 1.19 Allowed 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 112.98 0.733 . . . . 25.0 112.98 172.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.439 ' HB2' ' HB3' ' A' ' 13' ' ' CYS . 52.4 m-70 -114.46 156.44 24.54 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.356 -0.609 . . . . 25.0 109.356 174.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -100.01 146.15 27.06 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 102.784 -3.043 . . . . 25.0 102.784 169.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.19 175.58 47.7 Favored Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 109.305 -1.518 . . . . 25.0 109.305 -174.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -75.63 160.53 30.0 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.994 0.426 . . . . 25.0 112.013 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 16.8 m . . . . . 0 C--N 1.323 -0.553 0 N-CA-C 104.581 -2.377 . . . . 25.0 104.581 167.896 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 56.2 t0 . . . . . 0 C--O 1.237 0.436 0 N-CA-C 108.203 -1.036 . . . . 25.0 108.203 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.37 130.29 24.9 Favored 'Trans proline' 0 CA--C 1.507 -0.847 0 C-N-CA 117.099 -1.467 . . . . 25.0 112.758 -175.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.1 m -140.59 162.14 23.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 104.929 -2.249 . . . . 25.0 104.929 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.419 ' HB3' ' HB2' ' A' ' 35' ' ' HIS . 53.4 t -133.62 129.22 36.62 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.687 -0.857 . . . . 25.0 108.687 -179.175 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.92 -179.69 52.98 Favored Glycine 0 N--CA 1.452 -0.257 0 CA-C-O 121.651 0.584 . . . . 25.0 114.158 -174.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -71.63 -12.07 61.16 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.179 0.514 . . . . 25.0 110.456 176.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -86.96 0.84 54.43 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.532 -0.758 . . . . 25.0 110.688 175.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 78.56 -1.9 69.96 Favored Glycine 0 C--O 1.228 -0.248 0 N-CA-C 114.611 0.604 . . . . 25.0 114.611 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.9 mtmm -88.64 140.49 29.4 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 118.178 0.989 . . . . 25.0 111.522 -177.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 94.3 m -81.94 131.72 35.25 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.891 -1.049 . . . . 25.0 108.845 175.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -114.8 137.39 52.0 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 106.036 -1.839 . . . . 25.0 106.036 174.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.8 p -66.63 -52.09 48.99 Favored 'General case' 0 C--O 1.22 -0.491 0 N-CA-C 111.677 0.251 . . . . 25.0 111.677 -173.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 30.4 p30 -109.1 167.01 10.41 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-O 121.732 0.777 . . . . 25.0 111.691 167.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 45.7 tp -64.84 -24.79 67.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.151 -0.932 . . . . 25.0 110.714 172.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.4 t -59.88 -49.97 75.61 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 122.167 -0.333 . . . . 25.0 111.323 179.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.7 m95 -69.53 -28.18 65.8 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.265 -0.574 . . . . 25.0 111.572 -179.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -63.0 -44.8 95.03 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.399 -0.963 . . . . 25.0 108.399 174.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -65.36 -41.9 93.35 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.14 -0.482 . . . . 25.0 111.017 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -65.47 -32.89 74.75 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 122.183 -0.323 . . . . 25.0 111.244 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.52 -13.76 60.07 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.715 0.293 . . . . 25.0 111.373 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.76 12.86 83.56 Favored Glycine 0 CA--C 1.516 0.111 0 N-CA-C 114.946 0.739 . . . . 25.0 114.946 175.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -88.01 142.68 12.6 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.674 0 N-CA-C 108.516 -0.92 . . . . 25.0 108.516 -178.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.44 142.12 32.08 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 107.302 -2.319 . . . . 25.0 107.302 173.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 9.0 tt -65.9 142.47 57.89 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.045 -1.094 . . . . 25.0 108.045 177.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -121.51 -55.17 1.94 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 122.43 -0.169 . . . . 25.0 110.767 175.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.419 ' HB2' ' HB3' ' A' ' 13' ' ' CYS . 13.2 m80 -111.96 154.32 25.44 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.849 -0.797 . . . . 25.0 108.849 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -98.29 143.78 28.41 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 103.198 -2.89 . . . . 25.0 103.198 170.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.45 177.4 48.48 Favored Glycine 0 C--N 1.321 -0.293 0 N-CA-C 109.968 -1.253 . . . . 25.0 109.968 -175.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -74.31 159.77 31.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.971 0.415 . . . . 25.0 112.115 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 22.3 m . . . . . 0 C--N 1.324 -0.538 0 N-CA-C 104.806 -2.294 . . . . 25.0 104.806 167.494 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 60.1 t0 . . . . . 0 CA--C 1.514 -0.412 0 N-CA-C 106.612 -1.625 . . . . 25.0 106.612 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.28 132.71 37.29 Favored 'Trans proline' 0 CA--C 1.506 -0.913 0 C-N-CA 116.621 -1.786 . . . . 25.0 112.228 -175.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.8 m -144.34 162.98 14.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 105.73 -1.952 . . . . 25.0 105.73 -178.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 35' ' ' HIS . 45.2 t -132.94 130.39 39.52 Favored 'General case' 0 C--O 1.245 0.833 0 N-CA-C 109.586 -0.524 . . . . 25.0 109.586 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -77.91 174.93 54.73 Favored Glycine 0 N--CA 1.453 -0.171 0 CA-C-N 115.528 -0.76 . . . . 25.0 113.619 -176.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -68.23 -17.88 64.42 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.199 0.444 . . . . 25.0 112.199 178.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -94.39 9.89 36.51 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.995 0.426 . . . . 25.0 111.073 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.25 -0.65 89.31 Favored Glycine 0 C--O 1.227 -0.328 0 N-CA-C 117.267 1.667 . . . . 25.0 117.267 174.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 11.9 mmtp -83.27 138.29 33.64 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.19 1.495 . . . . 25.0 111.772 -177.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 97.5 m -84.84 129.17 34.85 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.537 -0.756 . . . . 25.0 109.266 175.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -114.7 138.02 51.21 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.827 -1.175 . . . . 25.0 107.827 175.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.0 p -68.85 -54.75 13.92 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.057 0.391 . . . . 25.0 112.057 -175.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.444 ' H ' ' HD1' ' A' ' 25' ' ' TRP . 10.2 m-20 -108.98 162.91 13.78 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.398 -0.964 . . . . 25.0 108.398 174.435 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 41.9 tp -65.65 -30.09 70.75 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.186 -0.461 . . . . 25.0 111.08 177.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 68.7 m -65.86 -26.07 67.48 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 121.182 -0.948 . . . . 25.0 113.02 177.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.444 ' HD1' ' H ' ' A' ' 22' ' ' ASN . 83.0 m95 -75.02 -34.43 61.91 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 121.7 -0.625 . . . . 25.0 109.652 177.18 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -64.06 -44.94 90.9 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.391 -0.966 . . . . 25.0 108.391 174.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.7 -41.65 99.24 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.599 -0.728 . . . . 25.0 111.675 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -67.17 -33.54 75.61 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.51 0.195 . . . . 25.0 111.485 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.43 -18.61 58.73 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.777 0.322 . . . . 25.0 110.959 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.33 7.78 86.97 Favored Glycine 0 CA--C 1.517 0.159 0 N-CA-C 114.936 0.734 . . . . 25.0 114.936 176.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -77.58 142.1 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 N-CA-C 108.594 -0.891 . . . . 25.0 108.594 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.18 148.88 49.48 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 107.953 -2.059 . . . . 25.0 107.953 173.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.6 tp -70.79 142.77 51.33 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.992 -0.744 . . . . 25.0 108.992 177.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -126.51 -58.15 1.34 Allowed 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 121.137 -0.225 . . . . 25.0 110.834 173.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.41 ' HB2' ' HB3' ' A' ' 13' ' ' CYS . 9.5 m80 -112.02 153.44 26.83 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.439 -0.578 . . . . 25.0 109.439 178.138 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -102.07 144.18 30.97 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 102.834 -3.024 . . . . 25.0 102.834 168.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.82 171.67 42.12 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 109.021 -1.632 . . . . 25.0 109.021 -172.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -73.58 160.9 30.96 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.107 0.41 . . . . 25.0 112.107 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 4.3 m . . . . . 0 C--N 1.324 -0.515 0 N-CA-C 106.187 -1.783 . . . . 25.0 106.187 170.305 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 38.9 t0 . . . . . 0 C--O 1.242 0.669 0 N-CA-C 106.881 -1.526 . . . . 25.0 106.881 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.77 134.59 41.2 Favored 'Trans proline' 0 CA--C 1.507 -0.859 0 C-N-CA 117.666 -1.09 . . . . 25.0 113.505 -173.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.7 m -140.94 162.18 22.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 106.85 -1.537 . . . . 25.0 106.85 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 35' ' ' HIS . 37.4 t -131.06 125.72 33.96 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.069 -0.715 . . . . 25.0 109.069 -178.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -79.82 179.01 53.49 Favored Glycine 0 C--N 1.323 -0.175 0 C-N-CA 121.062 -0.589 . . . . 25.0 112.544 -177.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -64.66 -23.31 67.22 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.393 0.277 . . . . 25.0 111.443 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -73.7 -4.05 32.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.342 0.591 . . . . 25.0 110.969 177.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 79.54 7.39 88.52 Favored Glycine 0 C--O 1.228 -0.279 0 C-N-CA 121.474 -0.393 . . . . 25.0 112.533 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.6 mmmt -102.52 141.79 34.77 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.716 0.769 . . . . 25.0 112.573 -177.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 44.7 m -85.26 133.63 34.16 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.038 -1.437 . . . . 25.0 112.788 -176.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -114.67 137.13 52.28 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 106.933 -1.506 . . . . 25.0 106.933 171.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.8 m -61.28 -55.37 32.7 Favored 'General case' 0 C--O 1.221 -0.435 0 N-CA-C 112.741 0.645 . . . . 25.0 112.741 -174.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -108.78 153.78 23.0 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 109.17 -0.678 . . . . 25.0 109.17 170.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 67.7 tp -57.95 -27.77 63.71 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 116.016 -0.538 . . . . 25.0 110.992 174.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -61.68 -36.69 81.6 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.757 0.651 . . . . 25.0 112.757 178.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 12.3 m95 -72.37 -35.19 68.42 Favored 'General case' 0 C--O 1.22 -0.475 0 C-N-CA 119.703 -0.799 . . . . 25.0 110.048 177.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -61.91 -44.21 97.26 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 108.941 -0.763 . . . . 25.0 108.941 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -63.99 -42.12 97.31 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.006 -0.543 . . . . 25.0 111.825 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -69.67 -30.88 68.66 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 111.912 0.338 . . . . 25.0 111.912 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.25 -19.35 59.78 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.812 0.339 . . . . 25.0 110.887 177.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.74 -0.46 88.19 Favored Glycine 0 CA--C 1.516 0.137 0 N-CA-C 115.117 0.807 . . . . 25.0 115.117 176.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.407 HG23 ' H ' ' A' ' 31' ' ' VAL . 1.9 t -68.69 138.12 23.03 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.614 0 N-CA-C 107.955 -1.128 . . . . 25.0 107.955 179.435 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.02 142.65 45.25 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 108.249 -1.94 . . . . 25.0 108.249 174.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.4 tp -72.14 142.56 49.11 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.074 -1.084 . . . . 25.0 108.074 177.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -125.64 -57.38 1.46 Allowed 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 121.06 -0.256 . . . . 25.0 110.918 175.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.425 ' HB2' ' HB3' ' A' ' 13' ' ' CYS . 7.2 m170 -111.94 153.03 27.35 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.881 -0.415 . . . . 25.0 109.881 176.005 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -98.52 146.96 25.25 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 101.285 -3.598 . . . . 25.0 101.285 163.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.54 165.93 36.24 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 108.184 -1.966 . . . . 25.0 108.184 -171.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -91.63 154.39 19.06 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 113.085 0.772 . . . . 25.0 113.085 -175.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 82.8 m . . . . . 0 C--N 1.325 -0.468 0 N-CA-C 106.197 -1.779 . . . . 25.0 106.197 172.68 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.2 t0 . . . . . 0 C--O 1.236 0.363 0 N-CA-C 107.545 -1.28 . . . . 25.0 107.545 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.63 139.49 44.53 Favored 'Trans proline' 0 CA--C 1.508 -0.782 0 C-N-CA 117.279 -1.347 . . . . 25.0 114.303 -171.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.8 m -141.08 162.07 22.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 106.588 -1.634 . . . . 25.0 106.588 178.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 37.5 t -122.55 126.55 47.99 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.065 -0.717 . . . . 25.0 109.065 179.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.92 172.96 44.55 Favored Glycine 0 C--O 1.225 -0.433 0 C-N-CA 120.691 -0.766 . . . . 25.0 112.026 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 37.2 mttp -65.52 -12.36 52.11 Favored 'General case' 0 C--O 1.215 -0.727 0 C-N-CA 123.017 0.527 . . . . 25.0 112.42 176.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -76.0 -2.48 30.75 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.262 0.625 . . . . 25.0 110.222 175.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.86 16.69 79.65 Favored Glycine 0 C--O 1.223 -0.587 0 C-N-CA 121.414 -0.422 . . . . 25.0 112.833 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 63.8 mttt -125.97 145.93 50.08 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.142 0.496 . . . . 25.0 112.311 -172.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 99.6 m -79.65 135.66 36.62 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.895 -1.048 . . . . 25.0 111.046 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -114.78 137.33 52.06 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 105.822 -1.918 . . . . 25.0 105.822 171.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.6 p -60.45 -54.96 39.32 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 113.08 0.77 . . . . 25.0 113.08 -172.057 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 29.7 p30 -109.61 165.76 11.42 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 121.182 0.515 . . . . 25.0 110.576 166.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 65.1 tp -64.61 -24.16 67.5 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.15 0.5 . . . . 25.0 111.669 174.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.0 t -64.25 -45.4 88.31 Favored 'General case' 0 C--O 1.216 -0.686 0 O-C-N 121.754 -0.591 . . . . 25.0 110.826 178.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 46.0 m95 -65.63 -31.31 72.26 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 121.768 -0.582 . . . . 25.0 111.144 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -62.46 -44.86 95.4 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.917 -0.771 . . . . 25.0 108.917 174.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -65.18 -41.9 94.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.139 -0.482 . . . . 25.0 111.732 178.279 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -65.83 -30.86 71.55 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.633 0.254 . . . . 25.0 111.113 -178.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.95 -15.82 58.67 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.753 0.311 . . . . 25.0 111.17 177.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.66 15.92 80.03 Favored Glycine 0 C--O 1.231 -0.084 0 N-CA-C 114.775 0.67 . . . . 25.0 114.775 175.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.3 t -89.31 147.63 5.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 107.622 -1.251 . . . . 25.0 107.622 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.25 144.61 34.83 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 107.912 -2.075 . . . . 25.0 107.912 174.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 63.4 tp -70.31 142.36 52.24 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.348 -1.353 . . . . 25.0 107.348 176.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -122.92 -58.83 1.64 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.901 -0.319 . . . . 25.0 110.953 175.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -112.01 153.77 26.33 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 122.351 -0.218 . . . . 25.0 111.584 176.268 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -95.2 145.92 24.7 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 103.582 -2.747 . . . . 25.0 103.582 167.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.02 168.21 40.46 Favored Glycine 0 N--CA 1.452 -0.27 0 N-CA-C 109.989 -1.244 . . . . 25.0 109.989 -175.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -80.14 159.23 26.11 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.397 -0.594 . . . . 25.0 109.397 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 27.7 p . . . . . 0 C--N 1.324 -0.54 0 C-N-CA 122.921 0.488 . . . . 25.0 109.983 -177.488 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 32.2 t0 . . . . . 0 C--O 1.236 0.372 0 N-CA-C 107.864 -1.161 . . . . 25.0 107.864 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.04 134.43 36.92 Favored 'Trans proline' 0 CA--C 1.506 -0.886 0 C-N-CA 117.379 -1.281 . . . . 25.0 113.059 -173.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 m -140.33 159.52 25.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 106.012 -1.847 . . . . 25.0 106.012 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 35' ' ' HIS . 52.1 t -131.83 124.47 29.67 Favored 'General case' 0 C--O 1.246 0.91 0 CA-C-O 121.41 0.624 . . . . 25.0 109.715 -177.622 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -82.78 176.27 53.35 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 115.561 -0.745 . . . . 25.0 114.071 -175.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -67.9 -13.1 61.88 Favored 'General case' 0 C--O 1.216 -0.694 0 N-CA-C 112.186 0.439 . . . . 25.0 112.186 177.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.6 p-10 -82.77 0.84 41.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.363 -0.38 . . . . 25.0 111.043 175.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 76.88 16.94 80.34 Favored Glycine 0 C--O 1.225 -0.427 0 CA-C-O 119.565 -0.575 . . . . 25.0 114.106 178.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -115.8 143.86 44.81 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 118.028 0.914 . . . . 25.0 112.098 -176.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 91.1 m -84.97 132.97 34.28 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.241 -1.345 . . . . 25.0 110.659 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -114.93 138.56 50.68 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 106.745 -1.576 . . . . 25.0 106.745 174.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.3 p -62.52 -55.73 24.69 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 123.316 0.385 . . . . 25.0 111.889 -173.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 52.8 p30 -109.19 169.31 8.77 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-O 121.478 0.656 . . . . 25.0 111.386 166.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 45.5 tp -63.69 -23.7 67.48 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.765 -0.652 . . . . 25.0 111.283 172.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 31.1 t -61.12 -50.42 73.31 Favored 'General case' 0 C--O 1.22 -0.497 0 O-C-N 122.043 -0.411 . . . . 25.0 111.033 178.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 72.2 m95 -66.96 -28.72 68.51 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.209 -0.596 . . . . 25.0 111.492 -179.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -64.0 -45.72 87.74 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 108.886 -0.783 . . . . 25.0 108.886 174.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -65.6 -42.88 91.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.159 -0.473 . . . . 25.0 112.242 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -64.95 -31.84 73.26 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.745 0.307 . . . . 25.0 111.337 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.28 -13.36 59.95 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.659 0.266 . . . . 25.0 111.241 178.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.34 16.87 79.7 Favored Glycine 0 C--O 1.23 -0.144 0 N-CA-C 114.71 0.644 . . . . 25.0 114.71 175.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -88.52 140.81 15.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 108.42 -0.955 . . . . 25.0 108.42 -178.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.26 144.63 44.81 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 107.515 -2.234 . . . . 25.0 107.515 173.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 65.8 tp -72.24 145.38 47.98 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.208 -1.034 . . . . 25.0 108.208 177.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -129.98 -53.34 1.13 Allowed 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 113.107 0.78 . . . . 25.0 113.107 171.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.425 ' HB2' ' HB3' ' A' ' 13' ' ' CYS . 54.4 m-70 -112.13 143.47 43.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 118.154 0.434 . . . . 25.0 110.232 176.03 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.3 mp0 -85.79 145.11 27.38 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 102.072 -3.307 . . . . 25.0 102.072 166.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 93.03 176.07 40.9 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 109.711 -1.356 . . . . 25.0 109.711 -176.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.47 154.32 19.21 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.857 0.361 . . . . 25.0 111.654 -176.799 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 57.8 m . . . . . 0 C--N 1.325 -0.491 0 N-CA-C 106.824 -1.547 . . . . 25.0 106.824 173.661 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 50.4 t0 . . . . . 0 N--CA 1.454 -0.228 0 N-CA-C 108.012 -1.107 . . . . 25.0 108.012 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -65.81 136.28 44.81 Favored 'Trans proline' 0 CA--C 1.512 -0.611 0 O-C-N 122.505 0.739 . . . . 25.0 112.948 -174.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.4 m -147.08 161.11 8.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 114.97 -1.014 . . . . 25.0 108.808 -177.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 9.0 t -120.82 124.69 45.68 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.086 -1.079 . . . . 25.0 108.086 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.95 167.82 44.38 Favored Glycine 0 C--O 1.225 -0.466 0 C-N-CA 120.75 -0.738 . . . . 25.0 111.841 -179.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 24.3 mtpp -66.81 -14.41 62.61 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 112.698 0.629 . . . . 25.0 112.698 178.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -82.24 3.35 27.79 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.695 0.76 . . . . 25.0 110.083 176.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.78 17.04 80.08 Favored Glycine 0 C--O 1.222 -0.644 0 O-C-N 121.502 -0.749 . . . . 25.0 112.658 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -105.55 135.59 46.67 Favored 'General case' 0 C--O 1.239 0.518 0 O-C-N 122.359 -0.494 . . . . 25.0 110.478 -177.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.6 m -87.58 128.91 35.26 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.634 -0.712 . . . . 25.0 110.578 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -114.83 137.16 52.29 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.939 -1.134 . . . . 25.0 107.939 176.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 93.7 p -71.83 -46.33 58.41 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.918 0.389 . . . . 25.0 111.467 -175.316 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -108.42 162.18 14.35 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 107.351 -1.351 . . . . 25.0 107.351 174.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 36.1 tp -68.52 -26.66 65.55 Favored 'General case' 0 C--O 1.212 -0.898 0 N-CA-C 107.94 -1.133 . . . . 25.0 107.94 173.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -52.39 -52.62 52.68 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 115.633 -0.712 . . . . 25.0 112.031 174.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 49.1 m95 -65.78 -34.24 77.73 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.539 -0.464 . . . . 25.0 110.541 -176.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.47 -45.67 86.37 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.0 0.429 . . . . 25.0 109.96 175.034 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -68.85 -34.51 75.59 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.342 0.497 . . . . 25.0 112.342 -177.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -79.13 -30.12 43.5 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 121.111 -0.235 . . . . 25.0 110.38 -177.252 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.2 -21.54 58.62 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.025 0.44 . . . . 25.0 109.952 175.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.84 15.86 80.0 Favored Glycine 0 C--O 1.228 -0.271 0 N-CA-C 114.561 0.584 . . . . 25.0 114.561 175.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.2 t -80.12 143.81 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 N-CA-C 108.036 -1.098 . . . . 25.0 108.036 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.37 152.57 52.73 Favored Glycine 0 C--N 1.316 -0.554 0 N-CA-C 108.092 -2.003 . . . . 25.0 108.092 173.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 57.4 tp -81.19 142.25 33.39 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.977 -0.749 . . . . 25.0 108.977 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -120.91 -58.71 1.79 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.72 0.295 . . . . 25.0 110.965 174.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 4.5 m170 -112.18 147.7 35.61 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 110.194 -0.298 . . . . 25.0 110.194 175.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -92.71 140.67 29.29 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 103.555 -2.757 . . . . 25.0 103.555 167.316 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.75 165.35 33.04 Favored Glycine 0 C--N 1.321 -0.278 0 N-CA-C 109.52 -1.432 . . . . 25.0 109.52 -174.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.54 160.46 30.88 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.296 -0.631 . . . . 25.0 109.296 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 28.1 p . . . . . 0 C--N 1.323 -0.569 0 N-CA-C 106.875 -1.528 . . . . 25.0 106.875 179.439 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 24.7 t0 . . . . . 0 N--CA 1.454 -0.264 0 N-CA-C 109.333 -0.617 . . . . 25.0 109.333 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -66.35 134.97 37.97 Favored 'Trans proline' 0 CA--C 1.506 -0.918 0 C-N-CA 116.706 -1.729 . . . . 25.0 112.966 -174.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.2 m -141.57 163.81 19.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 106.259 -1.756 . . . . 25.0 106.259 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.408 ' HB3' ' HB2' ' A' ' 35' ' ' HIS . 48.8 t -129.88 128.85 43.05 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.749 -0.834 . . . . 25.0 108.749 -178.358 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.07 173.37 48.56 Favored Glycine 0 C--O 1.226 -0.369 0 C-N-CA 121.028 -0.606 . . . . 25.0 112.349 -178.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 17.7 mtpp -65.81 -12.13 51.76 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.213 1.19 . . . . 25.0 114.213 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -89.69 8.67 30.42 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.955 0.407 . . . . 25.0 110.093 174.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 78.64 2.74 85.96 Favored Glycine 0 C--O 1.22 -0.739 0 N-CA-C 114.784 0.673 . . . . 25.0 114.784 176.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.8 mmmt -96.65 138.83 33.62 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 118.11 0.955 . . . . 25.0 112.938 -176.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 37.2 m -82.09 132.61 35.25 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 113.907 -1.497 . . . . 25.0 111.697 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -114.96 137.14 52.34 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.105 -1.072 . . . . 25.0 108.105 173.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.7 m -58.83 -57.11 14.49 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.717 0.636 . . . . 25.0 112.717 -174.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 53.8 p30 -109.35 168.68 9.21 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 121.154 0.502 . . . . 25.0 110.608 165.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 41.7 tp -63.26 -22.29 66.78 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.913 -0.585 . . . . 25.0 111.332 172.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 5.7 t -61.82 -45.29 94.47 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 121.885 -0.509 . . . . 25.0 111.537 178.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 67.6 m95 -70.86 -30.4 66.78 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.303 -0.559 . . . . 25.0 110.816 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -62.67 -48.01 81.17 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 109.073 -0.714 . . . . 25.0 109.073 175.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -63.88 -42.59 97.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.846 -0.615 . . . . 25.0 112.076 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -66.46 -31.1 71.64 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 111.737 0.273 . . . . 25.0 111.737 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.67 -13.65 59.84 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.711 0.291 . . . . 25.0 111.11 178.191 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.97 14.44 82.2 Favored Glycine 0 CA--C 1.516 0.123 0 N-CA-C 114.778 0.671 . . . . 25.0 114.778 175.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.5 t -83.45 141.1 15.29 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.643 0 N-CA-C 107.907 -1.145 . . . . 25.0 107.907 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.53 144.89 47.93 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 107.307 -2.317 . . . . 25.0 107.307 172.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.8 tp -74.54 146.53 42.56 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.027 -1.101 . . . . 25.0 108.027 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -130.65 -59.19 1.02 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.167 0.508 . . . . 25.0 111.688 177.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.408 ' HB2' ' HB3' ' A' ' 13' ' ' CYS . 4.0 m170 -115.99 155.63 27.72 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.328 0.492 . . . . 25.0 112.328 -179.225 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -95.02 143.82 26.19 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 104.495 -2.409 . . . . 25.0 104.495 166.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.54 174.78 43.17 Favored Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 110.99 -0.844 . . . . 25.0 110.99 -177.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -77.77 159.72 28.85 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 113.861 1.059 . . . . 25.0 113.861 -177.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 34.4 m . . . . . 0 C--N 1.324 -0.532 0 N-CA-C 104.719 -2.326 . . . . 25.0 104.719 170.617 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.6 t0 . . . . . 0 C--O 1.239 0.51 0 N-CA-C 107.878 -1.156 . . . . 25.0 107.878 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -68.65 138.63 42.1 Favored 'Trans proline' 0 CA--C 1.506 -0.917 0 C-N-CA 117.372 -1.285 . . . . 25.0 113.556 -172.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.6 m -139.47 158.37 27.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 105.396 -2.076 . . . . 25.0 105.396 176.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 39.0 t -116.65 121.93 43.11 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.79 -1.189 . . . . 25.0 107.79 -179.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -77.66 169.22 54.66 Favored Glycine 0 C--O 1.227 -0.309 0 N-CA-C 110.763 -0.935 . . . . 25.0 110.763 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -66.24 -12.05 53.91 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 113.058 0.762 . . . . 25.0 113.058 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -78.83 0.48 26.94 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.823 0.345 . . . . 25.0 110.266 173.324 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.44 17.04 74.57 Favored Glycine 0 C--O 1.218 -0.873 0 CA-C-O 119.431 -0.649 . . . . 25.0 114.465 177.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.9 mmtt -122.2 147.72 45.84 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.041 0.92 . . . . 25.0 112.563 -175.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 85.4 m -79.1 136.61 37.2 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.337 -0.847 . . . . 25.0 112.147 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -114.86 137.04 52.43 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 105.487 -2.042 . . . . 25.0 105.487 170.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.9 p -59.82 -56.03 26.86 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 112.655 0.613 . . . . 25.0 112.655 -171.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 42.2 p30 -109.01 166.57 10.73 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 121.21 0.528 . . . . 25.0 110.418 166.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 63.6 tp -63.59 -25.12 68.09 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.188 0.518 . . . . 25.0 111.262 173.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 32.6 t -62.66 -46.48 87.98 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 121.889 -0.507 . . . . 25.0 111.207 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 54.7 m95 -67.19 -29.75 69.51 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 121.652 -0.655 . . . . 25.0 111.474 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -62.47 -45.64 92.11 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.642 -0.873 . . . . 25.0 108.642 174.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -63.4 -43.48 97.41 Favored 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 116.112 -0.494 . . . . 25.0 111.864 178.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 -68.3 -26.51 65.67 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.098 0.407 . . . . 25.0 112.098 -178.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.2 -14.88 58.8 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.586 0.231 . . . . 25.0 110.799 177.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.25 18.53 78.14 Favored Glycine 0 C--O 1.23 -0.12 0 N-CA-C 114.333 0.493 . . . . 25.0 114.333 175.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -95.64 142.77 13.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 107.781 -1.192 . . . . 25.0 107.781 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.2 155.63 53.51 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 108.102 -1.999 . . . . 25.0 108.102 172.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.8 tt -82.54 142.39 31.86 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.146 -1.057 . . . . 25.0 108.146 176.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -114.32 -58.81 2.1 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.624 -0.51 . . . . 25.0 109.624 174.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 3.5 m170 -111.82 157.72 20.24 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 110.222 -0.288 . . . . 25.0 110.222 176.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -96.23 148.43 22.73 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 101.738 -3.43 . . . . 25.0 101.738 161.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.1 165.82 39.22 Favored Glycine 0 C--N 1.32 -0.336 0 N-CA-C 110.085 -1.206 . . . . 25.0 110.085 -173.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -81.71 162.67 22.89 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.324 0.583 . . . . 25.0 112.203 -177.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 24.6 p . . . . . 0 C--N 1.324 -0.517 0 N-CA-C 106.213 -1.773 . . . . 25.0 106.213 179.655 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 42.5 t0 . . . . . 0 C--O 1.237 0.432 0 N-CA-C 107.187 -1.412 . . . . 25.0 107.187 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -64.23 135.07 45.08 Favored 'Trans proline' 0 CA--C 1.506 -0.892 0 C-N-CA 118.049 -0.834 . . . . 25.0 113.27 -173.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.0 m -141.64 156.23 20.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 106.256 -1.757 . . . . 25.0 106.256 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.0 t -126.69 121.99 33.65 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.764 -0.828 . . . . 25.0 108.764 -177.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -78.69 176.76 54.33 Favored Glycine 0 C--O 1.226 -0.355 0 CA-C-N 115.929 -0.578 . . . . 25.0 112.833 -176.082 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -65.9 -21.54 66.45 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 122.582 -0.364 . . . . 25.0 111.552 178.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -75.23 -7.62 54.39 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.083 -0.508 . . . . 25.0 111.459 176.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.79 -7.66 73.08 Favored Glycine 0 C--O 1.224 -0.487 0 N-CA-C 111.483 -0.647 . . . . 25.0 111.483 -173.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -70.79 126.18 28.89 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 122.5 -0.412 . . . . 25.0 111.022 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.0 m -85.2 130.8 34.53 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.593 -0.731 . . . . 25.0 109.375 175.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -114.66 141.18 48.14 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.352 -0.981 . . . . 25.0 108.352 175.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.0 p -64.68 -57.89 7.78 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 112.682 0.623 . . . . 25.0 112.682 -174.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -109.27 166.37 10.92 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 121.452 0.644 . . . . 25.0 110.489 168.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 59.2 tp -62.16 -27.32 68.87 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.446 -0.797 . . . . 25.0 111.749 176.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 20.9 m -65.56 -40.42 92.8 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 121.73 -0.607 . . . . 25.0 111.734 -178.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -66.63 -34.77 78.61 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.387 -0.525 . . . . 25.0 110.62 176.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.64 -45.51 89.89 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.171 -0.677 . . . . 25.0 109.171 176.004 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -63.7 -43.41 96.67 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.315 0.487 . . . . 25.0 112.315 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -68.21 -29.37 68.2 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.48 0.178 . . . . 25.0 111.48 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.39 -16.45 57.63 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.691 0.281 . . . . 25.0 111.259 178.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.7 9.39 86.34 Favored Glycine 0 CA--C 1.518 0.24 0 N-CA-C 115.413 0.925 . . . . 25.0 115.413 176.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.5 t -78.92 138.91 19.24 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 N-CA-C 107.847 -1.168 . . . . 25.0 107.847 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.87 149.54 50.47 Favored Glycine 0 C--N 1.315 -0.61 0 N-CA-C 107.989 -2.044 . . . . 25.0 107.989 174.057 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 59.0 tp -74.03 145.58 44.41 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.062 -0.718 . . . . 25.0 109.062 178.009 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -125.09 -58.93 1.44 Allowed 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 121.147 -0.221 . . . . 25.0 110.438 172.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 10.4 m80 -111.75 143.8 42.08 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.96 0.355 . . . . 25.0 111.96 176.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 33.0 mp0 -84.12 138.93 32.77 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 102.595 -3.113 . . . . 25.0 102.595 168.233 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.53 169.06 40.15 Favored Glycine 0 C--N 1.321 -0.276 0 N-CA-C 109.328 -1.509 . . . . 25.0 109.328 -174.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -83.33 160.6 21.64 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 122.668 -0.313 . . . . 25.0 111.32 -177.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 67.4 m . . . . . 0 C--O 1.24 0.571 0 N-CA-C 105.097 -2.186 . . . . 25.0 105.097 170.971 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 25.2 t0 . . . . . 0 C--O 1.238 0.488 0 N-CA-C 107.682 -1.229 . . . . 25.0 107.682 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.58 138.85 46.9 Favored 'Trans proline' 0 CA--C 1.507 -0.831 0 C-N-CA 117.228 -1.381 . . . . 25.0 112.524 -175.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.2 m -142.39 161.04 19.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 104.911 -2.255 . . . . 25.0 104.911 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -126.41 127.54 45.61 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.693 -0.854 . . . . 25.0 108.693 178.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -79.58 177.34 54.32 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 121.033 -0.604 . . . . 25.0 113.613 -176.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -71.16 -12.13 61.32 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 122.389 -0.477 . . . . 25.0 110.648 176.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 42.8 p-10 -82.77 -3.46 56.64 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.473 -0.785 . . . . 25.0 111.212 176.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 79.25 16.9 77.54 Favored Glycine 0 C--O 1.224 -0.501 0 C-N-CA 121.177 -0.535 . . . . 25.0 113.792 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.7 mmtp -110.31 141.38 43.4 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 118.047 0.924 . . . . 25.0 110.854 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.1 m -82.28 132.16 35.23 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.423 -0.955 . . . . 25.0 108.423 175.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -114.91 137.11 52.36 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 106.502 -1.666 . . . . 25.0 106.502 173.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.0 m -64.61 -55.8 17.96 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.577 0.584 . . . . 25.0 112.577 -173.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -113.77 158.72 20.59 Favored 'General case' 0 C--O 1.25 1.08 0 CA-C-O 121.216 0.531 . . . . 25.0 109.671 170.576 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 30.0 tp -57.35 -24.62 56.37 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.631 -0.713 . . . . 25.0 112.002 177.158 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.3 m -58.46 -42.95 88.6 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 121.951 -0.468 . . . . 25.0 112.178 177.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 40.1 m95 -73.81 -33.37 64.15 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.779 -0.452 . . . . 25.0 109.779 -177.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -61.45 -45.92 92.23 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.049 -0.723 . . . . 25.0 109.049 176.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -65.05 -41.15 95.42 Favored 'General case' 0 C--O 1.218 -0.569 0 CA-C-N 115.813 -0.631 . . . . 25.0 112.151 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -68.08 -30.79 70.06 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.906 0.336 . . . . 25.0 111.906 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.71 -14.76 59.92 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.899 0.38 . . . . 25.0 110.387 177.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.21 16.3 79.83 Favored Glycine 0 C--N 1.328 0.109 0 N-CA-C 114.149 0.42 . . . . 25.0 114.149 175.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -93.82 142.99 12.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 109.235 -0.654 . . . . 25.0 109.235 -178.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.12 152.36 49.91 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 108.43 -1.868 . . . . 25.0 108.43 171.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.1 tt -75.6 138.92 41.76 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.08 -1.081 . . . . 25.0 108.08 177.262 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -117.84 -50.24 2.5 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.564 0.221 . . . . 25.0 110.962 175.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 17.9 m80 -112.01 151.97 28.69 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.873 -0.417 . . . . 25.0 109.873 175.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -94.5 146.42 24.11 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 102.895 -3.002 . . . . 25.0 102.895 166.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.97 170.14 46.83 Favored Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 110.201 -1.16 . . . . 25.0 110.201 -175.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -79.36 151.34 31.05 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.338 -0.986 . . . . 25.0 108.338 178.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.6 p . . . . . 0 C--N 1.325 -0.461 0 CA-C-O 120.701 0.286 . . . . 25.0 111.088 -178.414 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 110.056 -0.35 . . . . 25.0 110.056 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.71 -138.52 0.09 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 102.475 -3.158 . . . . 25.0 102.475 176.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.39 166.84 9.49 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 104.943 -2.243 . . . . 25.0 104.943 164.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.2 m -106.25 -34.78 3.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 119.548 -0.861 . . . . 25.0 112.287 -175.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 86.5 m -117.65 159.96 22.07 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.376 -0.374 . . . . 25.0 110.748 168.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 41.0 p -85.35 173.91 9.96 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.007 -1.109 . . . . 25.0 108.007 173.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.6 p -102.62 18.95 20.05 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 122.355 1.074 . . . . 25.0 109.68 176.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -70.43 130.02 40.81 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.603 -1.181 . . . . 25.0 111.707 -177.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 73.7 t-105 -83.19 99.21 9.79 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.116 -1.068 . . . . 25.0 108.116 170.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -137.64 73.38 48.12 Favored Pre-proline 0 C--O 1.243 0.714 0 N-CA-C 106.453 -1.684 . . . . 25.0 106.453 177.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -61.73 142.23 93.25 Favored 'Trans proline' 0 CA--C 1.509 -0.771 0 N-CA-C 115.885 1.456 . . . . 25.0 115.885 -169.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.0 m -140.83 167.08 18.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 105.759 -1.941 . . . . 25.0 105.759 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.434 ' HB3' ' HB2' ' A' ' 35' ' ' HIS . 44.3 t -134.76 133.16 39.6 Favored 'General case' 0 C--O 1.244 0.816 0 CA-C-O 120.962 0.411 . . . . 25.0 110.472 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.15 176.53 54.65 Favored Glycine 0 N--CA 1.453 -0.17 0 CA-C-N 115.837 -0.62 . . . . 25.0 113.586 -177.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -71.81 -12.89 61.51 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 122.32 -0.518 . . . . 25.0 111.317 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.9 p-10 -94.8 9.18 40.06 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.172 -0.467 . . . . 25.0 111.239 177.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.09 -3.73 75.05 Favored Glycine 0 C--O 1.227 -0.305 0 N-CA-C 116.053 1.181 . . . . 25.0 116.053 176.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -82.37 137.19 34.82 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 118.626 1.213 . . . . 25.0 111.948 -177.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 94.2 m -83.8 128.85 34.84 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.175 -0.921 . . . . 25.0 109.007 176.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -114.93 139.08 50.1 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.308 -0.997 . . . . 25.0 108.308 176.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.62 -56.86 16.65 Favored 'General case' 0 C--O 1.215 -0.718 0 N-CA-C 113.097 0.777 . . . . 25.0 113.097 -173.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -113.06 174.35 5.94 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.984 0.421 . . . . 25.0 110.824 166.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 39.4 tp -64.31 -27.36 68.98 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.723 -0.671 . . . . 25.0 112.213 173.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 47.3 t -63.28 -47.71 81.19 Favored 'General case' 0 C--O 1.216 -0.675 0 O-C-N 121.722 -0.611 . . . . 25.0 111.018 178.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 62.1 m95 -62.47 -31.61 72.37 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.243 -0.583 . . . . 25.0 111.491 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -64.49 -45.41 87.44 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 109.307 -0.627 . . . . 25.0 109.307 175.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -66.17 -41.4 90.38 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.329 -0.396 . . . . 25.0 111.831 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -64.67 -31.25 72.39 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.667 0.27 . . . . 25.0 111.165 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.39 -15.88 59.84 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.701 0.286 . . . . 25.0 111.053 178.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.08 7.72 88.2 Favored Glycine 0 C--O 1.23 -0.103 0 N-CA-C 114.838 0.695 . . . . 25.0 114.838 175.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -85.29 144.37 9.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.079 -1.082 . . . . 25.0 108.079 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.09 150.81 49.38 Favored Glycine 0 C--N 1.316 -0.582 0 N-CA-C 108.564 -1.814 . . . . 25.0 108.564 173.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 60.8 tp -74.5 145.56 43.44 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.053 -0.721 . . . . 25.0 109.053 177.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -128.37 -58.85 1.18 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.005 0.372 . . . . 25.0 112.005 173.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.434 ' HB2' ' HB3' ' A' ' 13' ' ' CYS . 16.2 m80 -112.1 160.69 17.29 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.522 0.201 . . . . 25.0 111.358 178.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -99.69 149.3 23.46 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 102.89 -3.004 . . . . 25.0 102.89 166.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.8 178.64 47.75 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 110.748 -0.941 . . . . 25.0 110.748 -177.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -78.07 160.92 27.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.749 0.309 . . . . 25.0 111.564 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.7 m -116.02 167.81 10.65 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.328 -0.989 . . . . 25.0 108.328 173.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.5 pt? . . . . . 0 C--O 1.244 0.769 0 N-CA-C 103.633 -2.728 . . . . 25.0 103.633 176.314 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.875 -0.417 . . . . 25.0 109.875 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.91 -157.45 0.52 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 103.52 -2.77 . . . . 25.0 103.52 -177.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.08 -67.43 0.41 Allowed 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 104.141 -2.54 . . . . 25.0 104.141 167.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.25 -41.73 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.171 -1.048 . . . . 25.0 108.171 159.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.0 t -114.31 160.01 19.56 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.036 -1.438 . . . . 25.0 110.799 165.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.696 ' H ' ' HB2' ' A' ' 24' ' ' CYS . 19.3 p -95.7 156.01 16.51 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 104.403 -2.443 . . . . 25.0 104.403 165.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.0 p -102.93 -0.57 30.86 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 123.886 1.803 . . . . 25.0 110.901 171.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -76.21 129.78 37.23 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 111.329 -2.669 . . . . 25.0 113.007 -178.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 42.4 t-105 -68.5 105.73 2.31 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 104.653 -2.351 . . . . 25.0 104.653 169.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -137.83 73.53 46.6 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 109.253 -0.647 . . . . 25.0 109.253 -176.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -65.4 138.49 55.42 Favored 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 114.646 -3.103 . . . . 25.0 113.491 -176.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.6 m -144.26 161.04 15.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 105.561 -2.015 . . . . 25.0 105.561 -178.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 50.8 t -131.47 126.37 34.85 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.097 -0.705 . . . . 25.0 109.097 -177.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.37 178.5 53.87 Favored Glycine 0 C--O 1.225 -0.437 0 CA-C-N 115.761 -0.654 . . . . 25.0 113.247 -175.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -66.56 -19.83 65.87 Favored 'General case' 0 C--O 1.214 -0.786 0 O-C-N 122.616 -0.343 . . . . 25.0 111.435 177.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -82.57 3.78 27.25 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 121.768 0.794 . . . . 25.0 110.708 177.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.21 -4.41 54.91 Favored Glycine 0 C--O 1.224 -0.484 0 O-C-N 121.839 -0.538 . . . . 25.0 114.134 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -81.86 134.26 35.39 Favored 'General case' 0 C--O 1.239 0.527 0 O-C-N 122.109 -0.641 . . . . 25.0 110.776 -176.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.2 m -86.73 132.39 33.88 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.605 -0.725 . . . . 25.0 109.502 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -114.69 137.4 51.96 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 106.11 -1.811 . . . . 25.0 106.11 175.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 79.8 p -66.81 -47.42 72.13 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 111.974 0.361 . . . . 25.0 111.974 -173.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -109.19 164.55 12.35 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.701 -0.851 . . . . 25.0 108.701 172.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 63.6 tp -68.32 -23.65 64.74 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.496 -0.775 . . . . 25.0 109.104 172.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.696 ' HB2' ' H ' ' A' ' 6' ' ' THR . 3.8 t -55.59 -51.0 68.61 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.618 -0.719 . . . . 25.0 111.344 175.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 24.0 m95 -69.89 -31.13 68.77 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.389 -0.524 . . . . 25.0 111.351 -176.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -64.47 -44.47 90.97 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.331 -0.618 . . . . 25.0 109.331 175.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.36 -46.26 90.94 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.141 -0.481 . . . . 25.0 110.521 -178.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -74.83 -23.58 58.48 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.634 0.605 . . . . 25.0 112.634 -176.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.27 -18.02 57.91 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.779 0.323 . . . . 25.0 110.611 176.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.74 5.37 86.35 Favored Glycine 0 CA--C 1.517 0.206 0 N-CA-C 115.114 0.806 . . . . 25.0 115.114 176.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -74.81 137.25 23.43 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 N-CA-C 107.529 -1.286 . . . . 25.0 107.529 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.51 143.85 46.32 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 107.548 -2.221 . . . . 25.0 107.548 175.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 57.9 tp -70.34 142.68 52.14 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.335 -0.987 . . . . 25.0 108.335 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -126.03 -58.91 1.36 Allowed 'General case' 0 C--O 1.22 -0.472 0 C-N-CA 120.983 -0.287 . . . . 25.0 110.258 173.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 7.0 m80 -111.92 154.44 25.22 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.802 -0.444 . . . . 25.0 109.802 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -102.72 145.63 29.43 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 102.432 -3.173 . . . . 25.0 102.432 167.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.91 171.26 43.38 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 109.681 -1.368 . . . . 25.0 109.681 -172.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -72.65 153.5 41.18 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 113.376 0.88 . . . . 25.0 113.376 -176.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 51.6 m -110.39 164.29 12.83 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 103.388 -2.819 . . . . 25.0 103.388 163.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 62.5 tp . . . . . 0 C--O 1.252 1.236 0 N-CA-C 104.245 -2.502 . . . . 25.0 104.245 178.02 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 23.3 tp10 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.997 -0.372 . . . . 25.0 109.997 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.35 153.43 43.61 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.168 -0.678 . . . . 25.0 109.168 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.22 142.55 50.6 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 107.736 -1.209 . . . . 25.0 107.736 176.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.3 m -124.75 -0.17 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 112.615 0.598 . . . . 25.0 112.615 -177.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 t -81.02 140.03 35.4 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.224 -0.658 . . . . 25.0 109.224 -176.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 50.0 p -95.61 167.93 10.99 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 113.945 1.091 . . . . 25.0 113.945 -175.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.1 p -90.59 19.5 5.31 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 122.066 0.936 . . . . 25.0 111.161 176.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -71.46 129.91 39.98 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.958 -1.019 . . . . 25.0 111.149 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 54.2 t-105 -57.41 108.39 0.54 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 107.417 -1.327 . . . . 25.0 107.417 173.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -137.97 72.99 46.7 Favored Pre-proline 0 C--N 1.321 -0.632 0 N-CA-C 107.944 -1.132 . . . . 25.0 107.944 -176.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -65.65 135.68 42.92 Favored 'Trans proline' 0 CA--C 1.509 -0.745 0 C-N-CA 117.616 -1.122 . . . . 25.0 113.213 -174.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.4 m -141.17 159.81 22.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 105.935 -1.876 . . . . 25.0 105.935 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 38.8 t -119.27 124.34 46.45 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.197 -1.038 . . . . 25.0 108.197 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -79.32 170.77 54.63 Favored Glycine 0 C--O 1.226 -0.361 0 C-N-CA 120.792 -0.718 . . . . 25.0 111.34 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -68.32 -12.01 60.39 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 112.481 0.548 . . . . 25.0 112.481 178.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -81.68 1.01 36.15 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.549 0.69 . . . . 25.0 110.181 174.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 76.98 16.66 80.59 Favored Glycine 0 C--O 1.222 -0.596 0 O-C-N 121.555 -0.716 . . . . 25.0 113.112 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -108.11 138.81 43.74 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 122.128 -0.631 . . . . 25.0 111.085 -176.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 54.6 m -81.52 133.26 35.37 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.916 -0.584 . . . . 25.0 109.489 176.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -114.89 137.13 52.33 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.045 -1.465 . . . . 25.0 107.045 173.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.9 m -59.99 -57.02 14.66 Favored 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 112.945 0.721 . . . . 25.0 112.945 -173.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 47.8 p30 -109.07 167.6 9.98 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.122 0.486 . . . . 25.0 110.457 167.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 59.8 tp -62.47 -26.78 68.7 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.844 -0.616 . . . . 25.0 110.62 172.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.4 m -61.47 -44.63 96.75 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 122.04 -0.413 . . . . 25.0 111.793 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 65.0 m95 -68.77 -30.88 69.57 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 121.762 -0.586 . . . . 25.0 111.519 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -63.05 -44.48 95.75 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.437 -0.949 . . . . 25.0 108.437 175.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -66.12 -41.51 90.46 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.032 -0.531 . . . . 25.0 111.492 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -62.99 -32.78 74.2 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 111.668 0.247 . . . . 25.0 111.668 178.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.77 -14.16 59.42 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.673 0.273 . . . . 25.0 111.434 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.18 11.16 85.8 Favored Glycine 0 C--O 1.23 -0.135 0 N-CA-C 115.031 0.772 . . . . 25.0 115.031 176.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -87.41 146.41 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 N-CA-C 107.791 -1.189 . . . . 25.0 107.791 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.69 152.26 47.37 Favored Glycine 0 C--N 1.316 -0.553 0 N-CA-C 107.803 -2.119 . . . . 25.0 107.803 173.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 8.4 tt -78.49 141.86 37.89 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.579 -1.267 . . . . 25.0 107.579 176.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -117.06 -58.35 2.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.82 0.343 . . . . 25.0 110.405 174.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -111.97 156.54 21.97 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.311 -0.243 . . . . 25.0 111.02 176.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -98.8 146.38 25.99 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 103.708 -2.701 . . . . 25.0 103.708 168.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.53 171.2 40.89 Favored Glycine 0 N--CA 1.451 -0.312 0 N-CA-C 109.552 -1.419 . . . . 25.0 109.552 -174.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -81.31 158.18 24.83 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.104 -0.702 . . . . 25.0 109.104 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 27.8 p -140.58 169.21 18.08 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 122.923 0.489 . . . . 25.0 109.735 -178.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 98.6 mt . . . . . 0 C--O 1.244 0.775 0 N-CA-C 103.287 -2.857 . . . . 25.0 103.287 177.207 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 118.022 -0.99 . . . . 25.0 109.251 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.99 -38.13 89.97 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 108.069 -1.085 . . . . 25.0 108.069 175.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -86.63 128.46 35.0 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 107.001 -1.481 . . . . 25.0 107.001 172.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.3 m -126.24 -15.59 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 113.154 0.798 . . . . 25.0 113.154 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 43.4 t -112.85 136.88 51.99 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 121.906 -0.496 . . . . 25.0 111.346 -177.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 42.5 p -96.17 156.1 16.48 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.993 -1.114 . . . . 25.0 107.993 164.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 39.8 p -102.97 -0.52 30.83 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 123.91 1.814 . . . . 25.0 109.129 163.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.74 130.08 38.09 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 111.031 -2.804 . . . . 25.0 111.535 177.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.413 ' CE2' ' HD3' ' A' ' 11' ' ' PRO . 34.0 t-105 -58.78 105.38 0.3 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 106.529 -1.656 . . . . 25.0 106.529 171.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -136.9 73.89 52.11 Favored Pre-proline 0 C--N 1.318 -0.803 0 CA-C-N 115.554 -0.748 . . . . 25.0 109.142 -174.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.413 ' HD3' ' CE2' ' A' ' 9' ' ' TRP . 37.5 Cg_endo -63.97 134.6 43.86 Favored 'Trans proline' 0 CA--C 1.506 -0.885 0 C-N-CA 117.517 -1.188 . . . . 25.0 112.621 -176.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.4 m -142.72 162.06 18.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 105.989 -1.856 . . . . 25.0 105.989 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 43.8 t -123.75 123.33 40.27 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.839 -0.8 . . . . 25.0 108.839 -177.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.18 164.68 48.08 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.065 -0.588 . . . . 25.0 112.244 -178.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -62.75 -17.6 61.2 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.113 0.783 . . . . 25.0 113.113 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -79.61 5.6 12.74 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 122.334 -0.229 . . . . 25.0 111.146 175.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.59 17.24 71.32 Favored Glycine 0 C--O 1.225 -0.427 0 C-N-CA 120.677 -0.773 . . . . 25.0 113.8 175.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 32.2 mmtm -121.26 138.49 54.21 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 117.559 0.679 . . . . 25.0 112.152 -173.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 38.4 m -83.17 133.84 35.01 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.969 -1.014 . . . . 25.0 111.241 -179.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -114.83 138.33 50.9 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.285 -1.376 . . . . 25.0 107.285 173.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.1 p -62.69 -52.4 63.43 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.567 0.58 . . . . 25.0 112.567 -174.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.417 ' H ' ' HD1' ' A' ' 25' ' ' TRP . 23.1 m-20 -108.24 168.01 9.61 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.371 -0.974 . . . . 25.0 108.371 171.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 59.6 tp -68.68 -26.1 65.13 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.039 -1.096 . . . . 25.0 108.039 171.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 48.6 t -55.01 -52.33 63.48 Favored 'General case' 0 C--O 1.219 -0.513 0 CA-C-N 115.046 -0.979 . . . . 25.0 111.262 175.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.417 ' HD1' ' H ' ' A' ' 22' ' ' ASN . 72.7 m95 -69.42 -27.41 65.25 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.068 0.395 . . . . 25.0 112.068 -175.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -65.86 -49.41 68.22 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.931 -0.766 . . . . 25.0 108.931 175.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -66.75 -40.73 88.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.913 -0.585 . . . . 25.0 111.473 -177.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -67.28 -27.81 67.5 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 120.965 -0.294 . . . . 25.0 111.646 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.34 -12.76 59.55 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.624 0.249 . . . . 25.0 111.138 178.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.06 19.46 78.6 Favored Glycine 0 C--O 1.23 -0.146 0 N-CA-C 114.744 0.658 . . . . 25.0 114.744 175.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -93.15 144.2 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 N-CA-C 107.457 -1.312 . . . . 25.0 107.457 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.62 148.75 45.66 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 107.106 -2.398 . . . . 25.0 107.106 173.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 8.2 tt -78.56 141.01 38.44 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.516 -1.291 . . . . 25.0 107.516 176.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -116.24 -58.13 2.13 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.101 -0.333 . . . . 25.0 110.101 174.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 5.3 m170 -112.03 157.88 20.22 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 110.105 -0.332 . . . . 25.0 110.105 176.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -99.79 147.78 25.11 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 102.677 -3.082 . . . . 25.0 102.677 165.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.46 169.0 41.62 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 109.735 -1.346 . . . . 25.0 109.735 -173.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -72.72 161.56 30.59 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.974 0.731 . . . . 25.0 112.974 -178.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 9.4 m -119.59 168.7 10.75 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 104.901 -2.259 . . . . 25.0 104.901 169.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 62.8 tp . . . . . 0 C--O 1.244 0.81 0 N-CA-C 103.269 -2.863 . . . . 25.0 103.269 175.081 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 6.1 pm0 . . . . . 0 N--CA 1.496 1.86 0 N-CA-C 109.774 -0.454 . . . . 25.0 109.774 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.87 -138.51 1.1 Allowed 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 104.667 -2.346 . . . . 25.0 104.667 -164.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.19 -80.28 0.09 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 104.832 -2.284 . . . . 25.0 104.832 168.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.1 m -138.25 -37.62 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.542 -0.754 . . . . 25.0 110.89 165.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.7 t -114.9 145.59 42.03 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.041 -0.981 . . . . 25.0 110.628 173.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.1 p -95.96 151.1 19.74 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 106.775 -1.565 . . . . 25.0 106.775 164.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.0 p -103.09 5.02 37.74 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 122.946 1.355 . . . . 25.0 112.739 172.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.03 130.03 37.76 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 113.271 -1.786 . . . . 25.0 111.68 -175.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.429 ' CE2' ' HD3' ' A' ' 11' ' ' PRO . 55.7 t-105 -61.53 105.99 0.6 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 107.385 -1.339 . . . . 25.0 107.385 174.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -137.93 73.17 46.59 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 108.12 -1.067 . . . . 25.0 108.12 -176.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.429 ' HD3' ' CE2' ' A' ' 9' ' ' TRP . 33.6 Cg_endo -62.87 133.61 42.6 Favored 'Trans proline' 0 CA--C 1.503 -1.07 0 O-C-N 122.309 0.636 . . . . 25.0 112.081 -173.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.5 m -139.55 161.18 27.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 107.282 -1.377 . . . . 25.0 107.282 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.1 t -131.55 121.69 24.85 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.889 -1.152 . . . . 25.0 107.889 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.98 173.58 54.67 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.815 -0.629 . . . . 25.0 112.823 -176.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp -64.2 -16.07 61.23 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.325 0.861 . . . . 25.0 113.325 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -92.07 10.65 28.27 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.736 0.303 . . . . 25.0 110.218 177.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.95 -2.34 65.17 Favored Glycine 0 C--O 1.223 -0.557 0 N-CA-C 114.281 0.472 . . . . 25.0 114.281 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -82.73 130.74 35.17 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 121.883 -0.775 . . . . 25.0 111.973 -175.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 70.3 m -84.79 128.39 34.59 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.986 -1.007 . . . . 25.0 110.87 177.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -114.88 137.02 52.46 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.002 -0.74 . . . . 25.0 109.002 174.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.3 m -60.51 -54.91 39.82 Favored 'General case' 0 C--O 1.217 -0.611 0 N-CA-C 112.701 0.63 . . . . 25.0 112.701 -174.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -109.1 168.41 9.39 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.07 0.462 . . . . 25.0 110.525 167.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 39.8 tp -65.76 -23.02 66.63 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.967 -0.561 . . . . 25.0 111.041 172.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 22.5 t -60.87 -50.35 73.8 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 121.956 -0.465 . . . . 25.0 111.001 178.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -64.38 -31.18 72.29 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 122.113 -0.367 . . . . 25.0 111.556 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -63.41 -46.39 86.6 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 109.159 -0.682 . . . . 25.0 109.159 176.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -65.08 -42.37 94.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.059 -0.519 . . . . 25.0 110.468 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -65.32 -33.13 75.25 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.598 0.221 . . . . 25.0 111.598 -179.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.76 -12.2 60.01 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 111.779 0.289 . . . . 25.0 111.779 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.4 19.99 79.78 Favored Glycine 0 C--O 1.229 -0.194 0 N-CA-C 115.005 0.762 . . . . 25.0 115.005 176.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -91.81 142.44 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 N-CA-C 107.542 -1.281 . . . . 25.0 107.542 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.53 147.17 46.64 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 108.005 -2.038 . . . . 25.0 108.005 173.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 62.0 tp -75.07 144.47 42.95 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.939 -1.134 . . . . 25.0 107.939 176.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -122.38 -59.15 1.66 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.401 -0.52 . . . . 25.0 110.218 172.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -113.82 153.05 29.78 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.512 0.56 . . . . 25.0 112.512 173.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -85.86 148.69 25.69 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 100.952 -3.722 . . . . 25.0 100.952 159.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.3 152.84 26.71 Favored Glycine 0 C--N 1.318 -0.449 0 N-CA-C 110.656 -0.977 . . . . 25.0 110.656 -176.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -83.66 151.75 25.12 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.66 0.615 . . . . 25.0 112.66 -176.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 76.2 m -108.09 -177.95 3.47 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 105.692 -1.966 . . . . 25.0 105.692 171.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 65.1 tp . . . . . 0 C--O 1.25 1.102 0 N-CA-C 105.226 -2.139 . . . . 25.0 105.226 175.298 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 . . . . . 0 N--CA 1.497 1.923 0 N-CA-C 110.925 -0.028 . . . . 25.0 110.925 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.17 144.86 56.39 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 122.053 -0.404 . . . . 25.0 110.447 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -79.64 52.19 1.39 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.137 0.575 . . . . 25.0 112.015 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.7 m -106.65 0.47 10.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.552 0.691 . . . . 25.0 109.933 -178.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 45.1 t -81.05 139.99 35.39 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.064 -0.516 . . . . 25.0 109.627 -178.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 39.9 p -80.63 166.43 21.1 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.408 0.623 . . . . 25.0 111.215 -178.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.4 p -83.48 24.94 0.79 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.208 0.528 . . . . 25.0 112.387 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -61.79 130.05 43.91 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.047 0.451 . . . . 25.0 110.593 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 65.1 t-105 -65.85 104.98 1.18 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.361 -0.836 . . . . 25.0 110.302 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -137.72 74.25 45.85 Favored Pre-proline 0 C--O 1.239 0.521 0 N-CA-C 106.997 -1.483 . . . . 25.0 106.997 177.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.77 139.51 44.01 Favored 'Trans proline' 0 CA--C 1.51 -0.699 0 C-N-CA 117.186 -1.41 . . . . 25.0 114.081 -172.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.0 m -141.9 162.3 20.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 105.995 -1.854 . . . . 25.0 105.995 178.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.8 t -128.53 127.1 41.73 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-O 121.02 0.438 . . . . 25.0 110.04 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.33 175.31 54.95 Favored Glycine 0 C--O 1.227 -0.318 0 C-N-CA 121.06 -0.59 . . . . 25.0 112.427 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -66.53 -18.07 65.16 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 122.477 -0.425 . . . . 25.0 111.841 177.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -79.23 0.75 27.27 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.564 0.697 . . . . 25.0 110.82 176.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 75.46 16.71 80.46 Favored Glycine 0 C--O 1.222 -0.626 0 C-N-CA 120.87 -0.681 . . . . 25.0 113.209 178.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -106.04 137.3 44.2 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 122.246 -0.561 . . . . 25.0 110.667 -177.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 60.8 m -82.46 134.28 35.22 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.799 -0.637 . . . . 25.0 109.526 177.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -114.95 137.92 51.43 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 106.566 -1.642 . . . . 25.0 106.566 174.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.5 p -60.26 -55.83 28.89 Favored 'General case' 0 C--O 1.219 -0.511 0 N-CA-C 112.382 0.512 . . . . 25.0 112.382 -173.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 36.8 p30 -109.06 166.14 11.06 Favored 'General case' 0 C--O 1.244 0.79 0 CA-C-O 121.306 0.574 . . . . 25.0 110.892 166.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 60.9 tp -63.15 -25.72 68.48 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.207 0.527 . . . . 25.0 111.15 172.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 68.5 m -63.63 -41.45 98.26 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 121.792 -0.568 . . . . 25.0 112.213 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 60.4 m95 -70.62 -29.56 65.97 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 121.428 -0.795 . . . . 25.0 110.721 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.94 -42.66 99.88 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.286 -1.005 . . . . 25.0 108.286 173.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -63.66 -41.36 98.21 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 111.696 0.258 . . . . 25.0 111.696 177.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -63.68 -36.04 82.53 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 117.831 0.287 . . . . 25.0 111.722 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.38 -17.92 57.78 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.668 0.271 . . . . 25.0 111.63 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.67 5.6 83.57 Favored Glycine 0 CA--C 1.518 0.227 0 N-CA-C 115.109 0.804 . . . . 25.0 115.109 176.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -74.31 140.46 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.654 0 N-CA-C 107.467 -1.308 . . . . 25.0 107.467 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.28 147.15 49.76 Favored Glycine 0 C--N 1.315 -0.59 0 N-CA-C 107.608 -2.197 . . . . 25.0 107.608 174.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 56.5 tp -72.92 143.52 47.68 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.475 -0.935 . . . . 25.0 108.475 177.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -124.36 -59.1 1.49 Allowed 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 121.179 -0.208 . . . . 25.0 110.888 173.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 7.5 m80 -111.91 154.26 25.48 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.418 -0.216 . . . . 25.0 110.418 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -98.92 143.94 28.65 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 102.41 -3.182 . . . . 25.0 102.41 167.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 93.19 170.16 39.54 Favored Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 109.1 -1.6 . . . . 25.0 109.1 -173.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -78.5 162.32 26.43 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.426 -0.583 . . . . 25.0 109.426 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 26.3 p -141.66 169.24 17.96 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.523 -0.917 . . . . 25.0 108.523 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 62.3 tp . . . . . 0 C--O 1.244 0.79 0 N-CA-C 102.624 -3.102 . . . . 25.0 102.624 178.608 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 8.9 pm0 . . . . . 0 N--CA 1.496 1.862 0 CA-C-O 119.425 -0.322 . . . . 25.0 110.238 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.36 -33.23 55.34 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.134 0.42 . . . . 25.0 112.134 -176.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -152.16 169.28 22.83 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 106.3 -1.741 . . . . 25.0 106.3 -179.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.0 m -126.07 -21.62 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 113.944 1.09 . . . . 25.0 113.944 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.03 160.0 18.59 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.818 0.303 . . . . 25.0 111.818 -177.434 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 61.1 p -95.98 168.48 10.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.101 0.476 . . . . 25.0 111.717 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.1 p -99.98 22.2 11.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.684 0.754 . . . . 25.0 111.516 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -67.73 130.0 41.65 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.678 -0.692 . . . . 25.0 111.365 -178.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 66.6 t-105 -62.89 106.93 0.89 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.315 -0.624 . . . . 25.0 109.315 177.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -138.04 72.97 46.19 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.831 -0.622 . . . . 25.0 109.559 -178.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -65.4 134.15 37.62 Favored 'Trans proline' 0 CA--C 1.51 -0.689 0 C-N-CA 116.716 -1.723 . . . . 25.0 113.637 -173.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.9 m -141.62 161.61 21.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 106.112 -1.81 . . . . 25.0 106.112 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.439 ' HB3' ' HB2' ' A' ' 35' ' ' HIS . 50.4 t -129.11 125.08 36.37 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.966 -0.753 . . . . 25.0 108.966 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.84 175.29 54.09 Favored Glycine 0 C--O 1.227 -0.32 0 CA-C-N 115.918 -0.583 . . . . 25.0 114.078 -175.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -67.56 -12.07 59.53 Favored 'General case' 0 C--O 1.215 -0.735 0 N-CA-C 112.487 0.551 . . . . 25.0 112.487 177.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -91.41 8.94 33.84 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.711 0.291 . . . . 25.0 110.453 176.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.5 -18.5 8.5 Favored Glycine 0 C--O 1.222 -0.652 0 N-CA-C 114.926 0.731 . . . . 25.0 114.926 177.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -73.11 139.41 46.42 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 121.312 0.577 . . . . 25.0 112.289 -177.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 98.8 m -86.05 132.63 34.0 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.653 -1.158 . . . . 25.0 108.882 175.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -115.0 136.97 52.54 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.114 -1.069 . . . . 25.0 108.114 176.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.8 m -62.33 -51.68 66.66 Favored 'General case' 0 C--O 1.223 -0.327 0 N-CA-C 112.714 0.635 . . . . 25.0 112.714 -174.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 45.9 p30 -113.9 170.08 8.53 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 121.109 0.48 . . . . 25.0 110.546 168.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 41.5 tp -63.79 -25.57 68.24 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.902 -0.59 . . . . 25.0 110.66 172.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 19.5 m -61.53 -46.05 91.58 Favored 'General case' 0 C--O 1.218 -0.571 0 O-C-N 122.144 -0.347 . . . . 25.0 111.916 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 24.5 m95 -70.08 -28.41 65.41 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 121.788 -0.57 . . . . 25.0 111.201 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -64.51 -45.32 87.74 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.5 -0.926 . . . . 25.0 108.5 175.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -66.05 -42.22 89.8 Favored 'General case' 0 C--O 1.22 -0.467 0 CA-C-N 115.782 -0.644 . . . . 25.0 111.78 178.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -63.61 -33.56 75.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.718 0.294 . . . . 25.0 111.414 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.27 -12.22 59.98 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.602 0.239 . . . . 25.0 111.323 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.0 21.78 77.85 Favored Glycine 0 C--O 1.23 -0.11 0 N-CA-C 114.385 0.514 . . . . 25.0 114.385 174.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -99.52 143.2 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 N-CA-C 109.09 -0.707 . . . . 25.0 109.09 -178.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.06 149.06 47.07 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 107.848 -2.101 . . . . 25.0 107.848 172.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 7.7 tt -74.73 147.97 40.89 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.073 -1.084 . . . . 25.0 108.073 177.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -129.34 -47.52 1.19 Allowed 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 112.98 0.733 . . . . 25.0 112.98 172.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.439 ' HB2' ' HB3' ' A' ' 13' ' ' CYS . 52.4 m-70 -114.46 156.44 24.54 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.356 -0.609 . . . . 25.0 109.356 174.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -100.01 146.15 27.06 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 102.784 -3.043 . . . . 25.0 102.784 169.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.19 175.58 47.7 Favored Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 109.305 -1.518 . . . . 25.0 109.305 -174.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -75.63 160.53 30.0 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.994 0.426 . . . . 25.0 112.013 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 16.8 m -111.77 161.72 16.01 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 104.581 -2.377 . . . . 25.0 104.581 167.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 61.5 tp . . . . . 0 C--O 1.242 0.701 0 N-CA-C 103.902 -2.629 . . . . 25.0 103.902 178.438 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 7.0 pm0 . . . . . 0 N--CA 1.494 1.729 0 N-CA-C 110.253 -0.277 . . . . 25.0 110.253 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.44 -81.8 0.18 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 102.233 -3.247 . . . . 25.0 102.233 174.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.26 153.47 42.39 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 101.93 -3.359 . . . . 25.0 101.93 160.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.9 m -106.36 -34.33 2.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 120.152 -0.619 . . . . 25.0 112.524 -176.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.6 t -113.26 139.91 48.41 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.315 -0.994 . . . . 25.0 108.315 169.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.414 ' H ' ' HB2' ' A' ' 24' ' ' CYS . 12.5 p -96.03 151.25 19.62 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.284 -1.376 . . . . 25.0 107.284 167.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.0 p -103.08 5.06 37.78 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 123.262 1.506 . . . . 25.0 111.277 171.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -75.88 130.01 37.86 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 112.661 -2.063 . . . . 25.0 111.396 -177.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 43.8 t-105 -60.26 107.23 0.62 Allowed 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 105.823 -1.917 . . . . 25.0 105.823 169.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -137.91 73.35 46.35 Favored Pre-proline 0 C--N 1.32 -0.693 0 N-CA-C 108.203 -1.036 . . . . 25.0 108.203 -173.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.37 130.29 24.9 Favored 'Trans proline' 0 CA--C 1.507 -0.847 0 C-N-CA 117.099 -1.467 . . . . 25.0 112.758 -175.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.1 m -140.59 162.14 23.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 104.929 -2.249 . . . . 25.0 104.929 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.419 ' HB3' ' HB2' ' A' ' 35' ' ' HIS . 53.4 t -133.62 129.22 36.62 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.687 -0.857 . . . . 25.0 108.687 -179.175 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.92 -179.69 52.98 Favored Glycine 0 N--CA 1.452 -0.257 0 CA-C-O 121.651 0.584 . . . . 25.0 114.158 -174.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -71.63 -12.07 61.16 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.179 0.514 . . . . 25.0 110.456 176.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -86.96 0.84 54.43 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.532 -0.758 . . . . 25.0 110.688 175.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 78.56 -1.9 69.96 Favored Glycine 0 C--O 1.228 -0.248 0 N-CA-C 114.611 0.604 . . . . 25.0 114.611 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.9 mtmm -88.64 140.49 29.4 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 118.178 0.989 . . . . 25.0 111.522 -177.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 94.3 m -81.94 131.72 35.25 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.891 -1.049 . . . . 25.0 108.845 175.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -114.8 137.39 52.0 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 106.036 -1.839 . . . . 25.0 106.036 174.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.8 p -66.63 -52.09 48.99 Favored 'General case' 0 C--O 1.22 -0.491 0 N-CA-C 111.677 0.251 . . . . 25.0 111.677 -173.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 30.4 p30 -109.1 167.01 10.41 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-O 121.732 0.777 . . . . 25.0 111.691 167.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 45.7 tp -64.84 -24.79 67.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.151 -0.932 . . . . 25.0 110.714 172.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.414 ' HB2' ' H ' ' A' ' 6' ' ' THR . 43.4 t -59.88 -49.97 75.61 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 122.167 -0.333 . . . . 25.0 111.323 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.7 m95 -69.53 -28.18 65.8 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.265 -0.574 . . . . 25.0 111.572 -179.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -63.0 -44.8 95.03 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.399 -0.963 . . . . 25.0 108.399 174.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -65.36 -41.9 93.35 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.14 -0.482 . . . . 25.0 111.017 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -65.47 -32.89 74.75 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 122.183 -0.323 . . . . 25.0 111.244 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.52 -13.76 60.07 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.715 0.293 . . . . 25.0 111.373 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.76 12.86 83.56 Favored Glycine 0 CA--C 1.516 0.111 0 N-CA-C 114.946 0.739 . . . . 25.0 114.946 175.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -88.01 142.68 12.6 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.674 0 N-CA-C 108.516 -0.92 . . . . 25.0 108.516 -178.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.44 142.12 32.08 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 107.302 -2.319 . . . . 25.0 107.302 173.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 9.0 tt -65.9 142.47 57.89 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.045 -1.094 . . . . 25.0 108.045 177.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -121.51 -55.17 1.94 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 122.43 -0.169 . . . . 25.0 110.767 175.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.419 ' HB2' ' HB3' ' A' ' 13' ' ' CYS . 13.2 m80 -111.96 154.32 25.44 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.849 -0.797 . . . . 25.0 108.849 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -98.29 143.78 28.41 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 103.198 -2.89 . . . . 25.0 103.198 170.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.45 177.4 48.48 Favored Glycine 0 C--N 1.321 -0.293 0 N-CA-C 109.968 -1.253 . . . . 25.0 109.968 -175.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -74.31 159.77 31.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.971 0.415 . . . . 25.0 112.115 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 22.3 m -109.71 156.36 20.37 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 104.806 -2.294 . . . . 25.0 104.806 167.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.0 mp . . . . . 0 C--O 1.243 0.753 0 N-CA-C 103.339 -2.837 . . . . 25.0 103.339 177.422 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 119.353 -0.356 . . . . 25.0 110.041 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.53 -43.03 77.59 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.885 1.068 . . . . 25.0 113.885 -174.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -151.86 155.12 37.5 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.72 -0.844 . . . . 25.0 108.72 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 17.3 m -130.27 -27.02 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 113.14 0.792 . . . . 25.0 113.14 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 32.1 p -113.01 156.51 22.94 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.273 -0.421 . . . . 25.0 110.827 -179.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.2 p -95.93 155.66 16.66 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 111.689 0.255 . . . . 25.0 111.689 176.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.6 p -103.01 -0.24 31.12 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 123.987 1.851 . . . . 25.0 110.449 170.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -75.57 135.36 40.56 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 110.898 -2.865 . . . . 25.0 108.223 176.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.406 ' CE2' ' HD3' ' A' ' 11' ' ' PRO . 44.8 t-105 -48.13 105.34 0.07 Allowed 'General case' 0 N--CA 1.476 0.871 0 O-C-N 124.362 1.039 . . . . 25.0 108.508 178.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -137.82 74.71 44.31 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 106.612 -1.625 . . . . 25.0 106.612 -174.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.406 ' HD3' ' CE2' ' A' ' 9' ' ' TRP . 29.7 Cg_endo -63.28 132.71 37.29 Favored 'Trans proline' 0 CA--C 1.506 -0.913 0 C-N-CA 116.621 -1.786 . . . . 25.0 112.228 -175.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.8 m -144.34 162.98 14.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 105.73 -1.952 . . . . 25.0 105.73 -178.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 35' ' ' HIS . 45.2 t -132.94 130.39 39.52 Favored 'General case' 0 C--O 1.245 0.833 0 N-CA-C 109.586 -0.524 . . . . 25.0 109.586 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -77.91 174.93 54.73 Favored Glycine 0 N--CA 1.453 -0.171 0 CA-C-N 115.528 -0.76 . . . . 25.0 113.619 -176.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -68.23 -17.88 64.42 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.199 0.444 . . . . 25.0 112.199 178.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -94.39 9.89 36.51 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.995 0.426 . . . . 25.0 111.073 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.25 -0.65 89.31 Favored Glycine 0 C--O 1.227 -0.328 0 N-CA-C 117.267 1.667 . . . . 25.0 117.267 174.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 11.9 mmtp -83.27 138.29 33.64 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.19 1.495 . . . . 25.0 111.772 -177.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 97.5 m -84.84 129.17 34.85 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.537 -0.756 . . . . 25.0 109.266 175.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -114.7 138.02 51.21 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.827 -1.175 . . . . 25.0 107.827 175.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.0 p -68.85 -54.75 13.92 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.057 0.391 . . . . 25.0 112.057 -175.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.444 ' H ' ' HD1' ' A' ' 25' ' ' TRP . 10.2 m-20 -108.98 162.91 13.78 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.398 -0.964 . . . . 25.0 108.398 174.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 41.9 tp -65.65 -30.09 70.75 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.186 -0.461 . . . . 25.0 111.08 177.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 68.7 m -65.86 -26.07 67.48 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 121.182 -0.948 . . . . 25.0 113.02 177.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.444 ' HD1' ' H ' ' A' ' 22' ' ' ASN . 83.0 m95 -75.02 -34.43 61.91 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 121.7 -0.625 . . . . 25.0 109.652 177.18 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -64.06 -44.94 90.9 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.391 -0.966 . . . . 25.0 108.391 174.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.7 -41.65 99.24 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.599 -0.728 . . . . 25.0 111.675 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -67.17 -33.54 75.61 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.51 0.195 . . . . 25.0 111.485 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.43 -18.61 58.73 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.777 0.322 . . . . 25.0 110.959 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.33 7.78 86.97 Favored Glycine 0 CA--C 1.517 0.159 0 N-CA-C 114.936 0.734 . . . . 25.0 114.936 176.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -77.58 142.1 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 N-CA-C 108.594 -0.891 . . . . 25.0 108.594 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.18 148.88 49.48 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 107.953 -2.059 . . . . 25.0 107.953 173.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.6 tp -70.79 142.77 51.33 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.992 -0.744 . . . . 25.0 108.992 177.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -126.51 -58.15 1.34 Allowed 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 121.137 -0.225 . . . . 25.0 110.834 173.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.41 ' HB2' ' HB3' ' A' ' 13' ' ' CYS . 9.5 m80 -112.02 153.44 26.83 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.439 -0.578 . . . . 25.0 109.439 178.138 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -102.07 144.18 30.97 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 102.834 -3.024 . . . . 25.0 102.834 168.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.82 171.67 42.12 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 109.021 -1.632 . . . . 25.0 109.021 -172.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -73.58 160.9 30.96 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.107 0.41 . . . . 25.0 112.107 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 4.3 m -109.95 164.47 12.57 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 106.187 -1.783 . . . . 25.0 106.187 170.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 67.7 tp . . . . . 0 C--O 1.253 1.282 0 N-CA-C 104.173 -2.529 . . . . 25.0 104.173 176.907 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 8.8 pm0 . . . . . 0 N--CA 1.496 1.862 0 CA-C-O 119.403 -0.332 . . . . 25.0 110.292 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.82 168.3 25.55 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 105.921 -1.881 . . . . 25.0 105.921 178.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.13 103.97 6.43 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.129 -1.063 . . . . 25.0 108.129 176.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.8 m -107.05 0.52 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 121.465 0.65 . . . . 25.0 110.268 -178.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -81.4 154.18 26.56 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.955 -0.566 . . . . 25.0 110.346 -179.292 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 43.0 p -95.03 173.65 7.48 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.266 0.555 . . . . 25.0 111.799 -176.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.1 p -93.19 19.86 7.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 122.035 0.921 . . . . 25.0 110.527 176.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -64.27 129.92 41.83 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.75 -1.114 . . . . 25.0 108.333 177.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 72.1 t-105 -51.1 103.9 0.07 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.605 0.717 . . . . 25.0 111.233 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -137.68 73.66 47.31 Favored Pre-proline 0 C--O 1.242 0.669 0 N-CA-C 106.881 -1.526 . . . . 25.0 106.881 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.77 134.59 41.2 Favored 'Trans proline' 0 CA--C 1.507 -0.859 0 C-N-CA 117.666 -1.09 . . . . 25.0 113.505 -173.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.7 m -140.94 162.18 22.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 106.85 -1.537 . . . . 25.0 106.85 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 35' ' ' HIS . 37.4 t -131.06 125.72 33.96 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.069 -0.715 . . . . 25.0 109.069 -178.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -79.82 179.01 53.49 Favored Glycine 0 C--N 1.323 -0.175 0 C-N-CA 121.062 -0.589 . . . . 25.0 112.544 -177.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -64.66 -23.31 67.22 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.393 0.277 . . . . 25.0 111.443 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -73.7 -4.05 32.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.342 0.591 . . . . 25.0 110.969 177.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 79.54 7.39 88.52 Favored Glycine 0 C--O 1.228 -0.279 0 C-N-CA 121.474 -0.393 . . . . 25.0 112.533 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.6 mmmt -102.52 141.79 34.77 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.716 0.769 . . . . 25.0 112.573 -177.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 44.7 m -85.26 133.63 34.16 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.038 -1.437 . . . . 25.0 112.788 -176.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -114.67 137.13 52.28 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 106.933 -1.506 . . . . 25.0 106.933 171.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.8 m -61.28 -55.37 32.7 Favored 'General case' 0 C--O 1.221 -0.435 0 N-CA-C 112.741 0.645 . . . . 25.0 112.741 -174.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -108.78 153.78 23.0 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 109.17 -0.678 . . . . 25.0 109.17 170.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 67.7 tp -57.95 -27.77 63.71 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 116.016 -0.538 . . . . 25.0 110.992 174.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -61.68 -36.69 81.6 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.757 0.651 . . . . 25.0 112.757 178.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 12.3 m95 -72.37 -35.19 68.42 Favored 'General case' 0 C--O 1.22 -0.475 0 C-N-CA 119.703 -0.799 . . . . 25.0 110.048 177.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -61.91 -44.21 97.26 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 108.941 -0.763 . . . . 25.0 108.941 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -63.99 -42.12 97.31 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.006 -0.543 . . . . 25.0 111.825 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -69.67 -30.88 68.66 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 111.912 0.338 . . . . 25.0 111.912 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.25 -19.35 59.78 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.812 0.339 . . . . 25.0 110.887 177.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.74 -0.46 88.19 Favored Glycine 0 CA--C 1.516 0.137 0 N-CA-C 115.117 0.807 . . . . 25.0 115.117 176.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.407 HG23 ' H ' ' A' ' 31' ' ' VAL . 1.9 t -68.69 138.12 23.03 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.614 0 N-CA-C 107.955 -1.128 . . . . 25.0 107.955 179.435 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.02 142.65 45.25 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 108.249 -1.94 . . . . 25.0 108.249 174.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.4 tp -72.14 142.56 49.11 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.074 -1.084 . . . . 25.0 108.074 177.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -125.64 -57.38 1.46 Allowed 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 121.06 -0.256 . . . . 25.0 110.918 175.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.425 ' HB2' ' HB3' ' A' ' 13' ' ' CYS . 7.2 m170 -111.94 153.03 27.35 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.881 -0.415 . . . . 25.0 109.881 176.005 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -98.52 146.96 25.25 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 101.285 -3.598 . . . . 25.0 101.285 163.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.54 165.93 36.24 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 108.184 -1.966 . . . . 25.0 108.184 -171.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -91.63 154.39 19.06 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 113.085 0.772 . . . . 25.0 113.085 -175.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 82.8 m -108.68 -179.56 3.9 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 106.197 -1.779 . . . . 25.0 106.197 172.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.0 tm? . . . . . 0 C--O 1.253 1.279 0 N-CA-C 104.602 -2.37 . . . . 25.0 104.602 173.882 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 109.752 -0.462 . . . . 25.0 109.752 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.53 166.12 33.01 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 104.653 -2.351 . . . . 25.0 104.653 178.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.16 144.11 55.11 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.894 -0.78 . . . . 25.0 108.894 177.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.0 m -108.18 0.28 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-O 121.577 0.703 . . . . 25.0 110.505 -178.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 75.3 m -80.97 141.84 34.05 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.806 -0.634 . . . . 25.0 112.206 -172.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 48.7 p -77.81 170.99 15.65 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.615 -0.72 . . . . 25.0 111.818 -177.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.9 p -79.03 25.15 0.29 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.348 0.87 . . . . 25.0 113.348 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -57.84 129.86 43.85 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.434 -0.348 . . . . 25.0 110.456 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 63.1 t-105 -77.24 102.65 6.77 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.072 -0.714 . . . . 25.0 109.072 175.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -136.42 73.03 57.14 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 107.545 -1.28 . . . . 25.0 107.545 177.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.63 139.49 44.53 Favored 'Trans proline' 0 CA--C 1.508 -0.782 0 C-N-CA 117.279 -1.347 . . . . 25.0 114.303 -171.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.8 m -141.08 162.07 22.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 106.588 -1.634 . . . . 25.0 106.588 178.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 37.5 t -122.55 126.55 47.99 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.065 -0.717 . . . . 25.0 109.065 179.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.92 172.96 44.55 Favored Glycine 0 C--O 1.225 -0.433 0 C-N-CA 120.691 -0.766 . . . . 25.0 112.026 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 37.2 mttp -65.52 -12.36 52.11 Favored 'General case' 0 C--O 1.215 -0.727 0 C-N-CA 123.017 0.527 . . . . 25.0 112.42 176.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -76.0 -2.48 30.75 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.262 0.625 . . . . 25.0 110.222 175.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.86 16.69 79.65 Favored Glycine 0 C--O 1.223 -0.587 0 C-N-CA 121.414 -0.422 . . . . 25.0 112.833 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 63.8 mttt -125.97 145.93 50.08 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.142 0.496 . . . . 25.0 112.311 -172.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 99.6 m -79.65 135.66 36.62 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.895 -1.048 . . . . 25.0 111.046 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -114.78 137.33 52.06 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 105.822 -1.918 . . . . 25.0 105.822 171.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.6 p -60.45 -54.96 39.32 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 113.08 0.77 . . . . 25.0 113.08 -172.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 29.7 p30 -109.61 165.76 11.42 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 121.182 0.515 . . . . 25.0 110.576 166.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 65.1 tp -64.61 -24.16 67.5 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.15 0.5 . . . . 25.0 111.669 174.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.0 t -64.25 -45.4 88.31 Favored 'General case' 0 C--O 1.216 -0.686 0 O-C-N 121.754 -0.591 . . . . 25.0 110.826 178.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 46.0 m95 -65.63 -31.31 72.26 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 121.768 -0.582 . . . . 25.0 111.144 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -62.46 -44.86 95.4 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.917 -0.771 . . . . 25.0 108.917 174.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -65.18 -41.9 94.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.139 -0.482 . . . . 25.0 111.732 178.279 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -65.83 -30.86 71.55 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.633 0.254 . . . . 25.0 111.113 -178.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.95 -15.82 58.67 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.753 0.311 . . . . 25.0 111.17 177.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.66 15.92 80.03 Favored Glycine 0 C--O 1.231 -0.084 0 N-CA-C 114.775 0.67 . . . . 25.0 114.775 175.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.3 t -89.31 147.63 5.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 107.622 -1.251 . . . . 25.0 107.622 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.25 144.61 34.83 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 107.912 -2.075 . . . . 25.0 107.912 174.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 63.4 tp -70.31 142.36 52.24 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.348 -1.353 . . . . 25.0 107.348 176.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -122.92 -58.83 1.64 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.901 -0.319 . . . . 25.0 110.953 175.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -112.01 153.77 26.33 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 122.351 -0.218 . . . . 25.0 111.584 176.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -95.2 145.92 24.7 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 103.582 -2.747 . . . . 25.0 103.582 167.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.02 168.21 40.46 Favored Glycine 0 N--CA 1.452 -0.27 0 N-CA-C 109.989 -1.244 . . . . 25.0 109.989 -175.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -80.14 159.23 26.11 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.397 -0.594 . . . . 25.0 109.397 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 27.7 p -142.17 167.42 22.16 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 122.921 0.488 . . . . 25.0 109.983 -177.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 62.8 tp . . . . . 0 C--O 1.244 0.781 0 N-CA-C 102.486 -3.153 . . . . 25.0 102.486 177.824 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 . . . . . 0 N--CA 1.496 1.836 0 CA-C-O 118.765 -0.636 . . . . 25.0 109.429 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.53 -39.7 70.57 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.567 0.622 . . . . 25.0 110.133 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -158.94 164.02 35.99 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 104.697 -2.334 . . . . 25.0 104.697 178.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.2 m -137.75 -34.4 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-O 121.205 0.526 . . . . 25.0 112.328 175.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 96.8 m -112.96 158.95 19.61 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 112.964 0.727 . . . . 25.0 112.964 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 20.3 p -89.77 156.16 18.7 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.153 -1.054 . . . . 25.0 108.153 172.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.9 p -102.94 7.25 39.24 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 123.264 1.507 . . . . 25.0 110.722 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -75.96 134.91 40.07 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 112.548 -2.115 . . . . 25.0 112.977 -177.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 54.3 t-105 -58.58 109.93 0.89 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.41 -1.33 . . . . 25.0 107.41 175.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -138.03 73.23 45.77 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 107.864 -1.161 . . . . 25.0 107.864 -176.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.04 134.43 36.92 Favored 'Trans proline' 0 CA--C 1.506 -0.886 0 C-N-CA 117.379 -1.281 . . . . 25.0 113.059 -173.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 m -140.33 159.52 25.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 106.012 -1.847 . . . . 25.0 106.012 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 35' ' ' HIS . 52.1 t -131.83 124.47 29.67 Favored 'General case' 0 C--O 1.246 0.91 0 CA-C-O 121.41 0.624 . . . . 25.0 109.715 -177.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -82.78 176.27 53.35 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 115.561 -0.745 . . . . 25.0 114.071 -175.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -67.9 -13.1 61.88 Favored 'General case' 0 C--O 1.216 -0.694 0 N-CA-C 112.186 0.439 . . . . 25.0 112.186 177.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.6 p-10 -82.77 0.84 41.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.363 -0.38 . . . . 25.0 111.043 175.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 76.88 16.94 80.34 Favored Glycine 0 C--O 1.225 -0.427 0 CA-C-O 119.565 -0.575 . . . . 25.0 114.106 178.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -115.8 143.86 44.81 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 118.028 0.914 . . . . 25.0 112.098 -176.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 91.1 m -84.97 132.97 34.28 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.241 -1.345 . . . . 25.0 110.659 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -114.93 138.56 50.68 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 106.745 -1.576 . . . . 25.0 106.745 174.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.3 p -62.52 -55.73 24.69 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 123.316 0.385 . . . . 25.0 111.889 -173.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 52.8 p30 -109.19 169.31 8.77 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-O 121.478 0.656 . . . . 25.0 111.386 166.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 45.5 tp -63.69 -23.7 67.48 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.765 -0.652 . . . . 25.0 111.283 172.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 31.1 t -61.12 -50.42 73.31 Favored 'General case' 0 C--O 1.22 -0.497 0 O-C-N 122.043 -0.411 . . . . 25.0 111.033 178.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 72.2 m95 -66.96 -28.72 68.51 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.209 -0.596 . . . . 25.0 111.492 -179.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -64.0 -45.72 87.74 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 108.886 -0.783 . . . . 25.0 108.886 174.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -65.6 -42.88 91.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.159 -0.473 . . . . 25.0 112.242 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -64.95 -31.84 73.26 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.745 0.307 . . . . 25.0 111.337 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.28 -13.36 59.95 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.659 0.266 . . . . 25.0 111.241 178.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.34 16.87 79.7 Favored Glycine 0 C--O 1.23 -0.144 0 N-CA-C 114.71 0.644 . . . . 25.0 114.71 175.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -88.52 140.81 15.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 108.42 -0.955 . . . . 25.0 108.42 -178.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.26 144.63 44.81 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 107.515 -2.234 . . . . 25.0 107.515 173.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 65.8 tp -72.24 145.38 47.98 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.208 -1.034 . . . . 25.0 108.208 177.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -129.98 -53.34 1.13 Allowed 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 113.107 0.78 . . . . 25.0 113.107 171.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.425 ' HB2' ' HB3' ' A' ' 13' ' ' CYS . 54.4 m-70 -112.13 143.47 43.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 118.154 0.434 . . . . 25.0 110.232 176.03 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.3 mp0 -85.79 145.11 27.38 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 102.072 -3.307 . . . . 25.0 102.072 166.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 93.03 176.07 40.9 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 109.711 -1.356 . . . . 25.0 109.711 -176.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.47 154.32 19.21 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.857 0.361 . . . . 25.0 111.654 -176.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 57.8 m -108.21 169.98 8.29 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 106.824 -1.547 . . . . 25.0 106.824 173.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 66.5 tp . . . . . 0 C--O 1.251 1.169 0 N-CA-C 104.555 -2.387 . . . . 25.0 104.555 176.024 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 110.293 -0.262 . . . . 25.0 110.293 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.36 -157.75 0.52 Allowed 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 102.561 -3.125 . . . . 25.0 102.561 -179.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.31 -76.38 0.07 Allowed 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 102.852 -3.018 . . . . 25.0 102.852 165.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.33 -48.27 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.69 0 N-CA-C 105.582 -2.007 . . . . 25.0 105.582 156.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 t -124.9 159.97 29.91 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.233 -1.349 . . . . 25.0 110.43 159.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.767 ' H ' ' HB2' ' A' ' 24' ' ' CYS . 16.6 p -95.9 155.96 16.53 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 100.853 -3.758 . . . . 25.0 100.853 159.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 42.2 p -102.65 5.06 38.88 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 123.432 1.587 . . . . 25.0 112.346 -179.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 31.4 mp0 -75.91 130.19 38.11 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 112.283 -2.235 . . . . 25.0 114.676 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 44.1 t-105 -69.2 104.84 2.3 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 105.007 -2.22 . . . . 25.0 105.007 171.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -137.9 73.73 45.72 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 108.012 -1.107 . . . . 25.0 108.012 -177.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -65.81 136.28 44.81 Favored 'Trans proline' 0 CA--C 1.512 -0.611 0 O-C-N 122.505 0.739 . . . . 25.0 112.948 -174.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.4 m -147.08 161.11 8.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 114.97 -1.014 . . . . 25.0 108.808 -177.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 9.0 t -120.82 124.69 45.68 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.086 -1.079 . . . . 25.0 108.086 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.95 167.82 44.38 Favored Glycine 0 C--O 1.225 -0.466 0 C-N-CA 120.75 -0.738 . . . . 25.0 111.841 -179.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 24.3 mtpp -66.81 -14.41 62.61 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 112.698 0.629 . . . . 25.0 112.698 178.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -82.24 3.35 27.79 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.695 0.76 . . . . 25.0 110.083 176.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.78 17.04 80.08 Favored Glycine 0 C--O 1.222 -0.644 0 O-C-N 121.502 -0.749 . . . . 25.0 112.658 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -105.55 135.59 46.67 Favored 'General case' 0 C--O 1.239 0.518 0 O-C-N 122.359 -0.494 . . . . 25.0 110.478 -177.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.6 m -87.58 128.91 35.26 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.634 -0.712 . . . . 25.0 110.578 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -114.83 137.16 52.29 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.939 -1.134 . . . . 25.0 107.939 176.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 93.7 p -71.83 -46.33 58.41 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.918 0.389 . . . . 25.0 111.467 -175.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -108.42 162.18 14.35 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 107.351 -1.351 . . . . 25.0 107.351 174.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 36.1 tp -68.52 -26.66 65.55 Favored 'General case' 0 C--O 1.212 -0.898 0 N-CA-C 107.94 -1.133 . . . . 25.0 107.94 173.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.767 ' HB2' ' H ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -52.39 -52.62 52.68 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 115.633 -0.712 . . . . 25.0 112.031 174.989 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 49.1 m95 -65.78 -34.24 77.73 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.539 -0.464 . . . . 25.0 110.541 -176.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.47 -45.67 86.37 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.0 0.429 . . . . 25.0 109.96 175.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -68.85 -34.51 75.59 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.342 0.497 . . . . 25.0 112.342 -177.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -79.13 -30.12 43.5 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 121.111 -0.235 . . . . 25.0 110.38 -177.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.2 -21.54 58.62 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.025 0.44 . . . . 25.0 109.952 175.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.84 15.86 80.0 Favored Glycine 0 C--O 1.228 -0.271 0 N-CA-C 114.561 0.584 . . . . 25.0 114.561 175.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.2 t -80.12 143.81 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 N-CA-C 108.036 -1.098 . . . . 25.0 108.036 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.37 152.57 52.73 Favored Glycine 0 C--N 1.316 -0.554 0 N-CA-C 108.092 -2.003 . . . . 25.0 108.092 173.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 57.4 tp -81.19 142.25 33.39 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.977 -0.749 . . . . 25.0 108.977 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -120.91 -58.71 1.79 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.72 0.295 . . . . 25.0 110.965 174.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 4.5 m170 -112.18 147.7 35.61 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 110.194 -0.298 . . . . 25.0 110.194 175.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -92.71 140.67 29.29 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 103.555 -2.757 . . . . 25.0 103.555 167.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.75 165.35 33.04 Favored Glycine 0 C--N 1.321 -0.278 0 N-CA-C 109.52 -1.432 . . . . 25.0 109.52 -174.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.54 160.46 30.88 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.296 -0.631 . . . . 25.0 109.296 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 28.1 p -142.68 173.04 11.89 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 106.875 -1.528 . . . . 25.0 106.875 179.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.0 pp . . . . . 0 C--O 1.243 0.712 0 N-CA-C 102.762 -3.051 . . . . 25.0 102.762 177.644 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 . . . . . 0 N--CA 1.495 1.78 0 CA-C-O 119.087 -0.482 . . . . 25.0 111.275 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.32 -31.85 71.71 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.739 0.781 . . . . 25.0 109.349 178.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -145.67 156.86 43.91 Favored 'General case' 0 C--O 1.245 0.836 0 N-CA-C 101.524 -3.51 . . . . 25.0 101.524 169.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 13.8 m -138.24 -34.97 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 113.085 0.772 . . . . 25.0 113.085 176.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 28.5 p -117.71 160.05 21.96 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.851 -0.613 . . . . 25.0 112.517 177.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.4 p -95.98 164.75 12.58 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 107.637 -1.246 . . . . 25.0 107.637 170.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.9 p -94.74 18.97 10.69 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.864 0.84 . . . . 25.0 112.016 -179.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -66.07 133.11 50.07 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.175 -0.92 . . . . 25.0 111.15 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.412 ' CE2' ' HD3' ' A' ' 11' ' ' PRO . 58.9 t-105 -58.98 108.98 0.74 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.267 -1.012 . . . . 25.0 108.267 177.189 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -138.03 73.11 45.99 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.333 -0.617 . . . . 25.0 109.333 -176.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.412 ' HD3' ' CE2' ' A' ' 9' ' ' TRP . 43.6 Cg_endo -66.35 134.97 37.97 Favored 'Trans proline' 0 CA--C 1.506 -0.918 0 C-N-CA 116.706 -1.729 . . . . 25.0 112.966 -174.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.2 m -141.57 163.81 19.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 106.259 -1.756 . . . . 25.0 106.259 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.408 ' HB3' ' HB2' ' A' ' 35' ' ' HIS . 48.8 t -129.88 128.85 43.05 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.749 -0.834 . . . . 25.0 108.749 -178.358 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.07 173.37 48.56 Favored Glycine 0 C--O 1.226 -0.369 0 C-N-CA 121.028 -0.606 . . . . 25.0 112.349 -178.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 17.7 mtpp -65.81 -12.13 51.76 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.213 1.19 . . . . 25.0 114.213 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -89.69 8.67 30.42 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.955 0.407 . . . . 25.0 110.093 174.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 78.64 2.74 85.96 Favored Glycine 0 C--O 1.22 -0.739 0 N-CA-C 114.784 0.673 . . . . 25.0 114.784 176.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.8 mmmt -96.65 138.83 33.62 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 118.11 0.955 . . . . 25.0 112.938 -176.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 37.2 m -82.09 132.61 35.25 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 113.907 -1.497 . . . . 25.0 111.697 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -114.96 137.14 52.34 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.105 -1.072 . . . . 25.0 108.105 173.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.7 m -58.83 -57.11 14.49 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.717 0.636 . . . . 25.0 112.717 -174.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 53.8 p30 -109.35 168.68 9.21 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 121.154 0.502 . . . . 25.0 110.608 165.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 41.7 tp -63.26 -22.29 66.78 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.913 -0.585 . . . . 25.0 111.332 172.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 5.7 t -61.82 -45.29 94.47 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 121.885 -0.509 . . . . 25.0 111.537 178.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 67.6 m95 -70.86 -30.4 66.78 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.303 -0.559 . . . . 25.0 110.816 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -62.67 -48.01 81.17 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 109.073 -0.714 . . . . 25.0 109.073 175.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -63.88 -42.59 97.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.846 -0.615 . . . . 25.0 112.076 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -66.46 -31.1 71.64 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 111.737 0.273 . . . . 25.0 111.737 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.67 -13.65 59.84 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.711 0.291 . . . . 25.0 111.11 178.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.97 14.44 82.2 Favored Glycine 0 CA--C 1.516 0.123 0 N-CA-C 114.778 0.671 . . . . 25.0 114.778 175.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.5 t -83.45 141.1 15.29 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.643 0 N-CA-C 107.907 -1.145 . . . . 25.0 107.907 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.53 144.89 47.93 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 107.307 -2.317 . . . . 25.0 107.307 172.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.8 tp -74.54 146.53 42.56 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.027 -1.101 . . . . 25.0 108.027 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -130.65 -59.19 1.02 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.167 0.508 . . . . 25.0 111.688 177.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.408 ' HB2' ' HB3' ' A' ' 13' ' ' CYS . 4.0 m170 -115.99 155.63 27.72 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.328 0.492 . . . . 25.0 112.328 -179.225 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -95.02 143.82 26.19 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 104.495 -2.409 . . . . 25.0 104.495 166.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.54 174.78 43.17 Favored Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 110.99 -0.844 . . . . 25.0 110.99 -177.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -77.77 159.72 28.85 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 113.861 1.059 . . . . 25.0 113.861 -177.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 34.4 m -123.61 173.4 8.1 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 104.719 -2.326 . . . . 25.0 104.719 170.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.6 mp . . . . . 0 C--O 1.247 0.953 0 N-CA-C 107.013 -1.476 . . . . 25.0 107.013 175.144 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 4.8 pm0 . . . . . 0 N--CA 1.497 1.904 0 CA-C-O 119.961 -0.066 . . . . 25.0 111.151 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.74 175.4 13.97 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 103.425 -2.806 . . . . 25.0 103.425 178.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.88 133.74 45.62 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.504 -1.665 . . . . 25.0 106.504 173.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.5 m -125.42 0.31 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 112.256 0.465 . . . . 25.0 112.256 -176.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 80.9 m -81.1 139.97 35.33 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 121.828 -0.545 . . . . 25.0 111.047 -176.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 36.6 p -95.95 168.01 10.89 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.112 -0.699 . . . . 25.0 109.112 177.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.3 p -89.58 24.92 2.14 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.389 0.614 . . . . 25.0 110.822 176.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -68.07 130.33 42.63 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.957 -0.565 . . . . 25.0 110.748 -178.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 64.2 t-105 -65.04 106.19 1.21 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.454 -0.943 . . . . 25.0 108.454 177.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -136.8 73.34 53.9 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 107.878 -1.156 . . . . 25.0 107.878 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -68.65 138.63 42.1 Favored 'Trans proline' 0 CA--C 1.506 -0.917 0 C-N-CA 117.372 -1.285 . . . . 25.0 113.556 -172.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.6 m -139.47 158.37 27.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 105.396 -2.076 . . . . 25.0 105.396 176.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 39.0 t -116.65 121.93 43.11 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.79 -1.189 . . . . 25.0 107.79 -179.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -77.66 169.22 54.66 Favored Glycine 0 C--O 1.227 -0.309 0 N-CA-C 110.763 -0.935 . . . . 25.0 110.763 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -66.24 -12.05 53.91 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 113.058 0.762 . . . . 25.0 113.058 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -78.83 0.48 26.94 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.823 0.345 . . . . 25.0 110.266 173.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.44 17.04 74.57 Favored Glycine 0 C--O 1.218 -0.873 0 CA-C-O 119.431 -0.649 . . . . 25.0 114.465 177.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.9 mmtt -122.2 147.72 45.84 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.041 0.92 . . . . 25.0 112.563 -175.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 85.4 m -79.1 136.61 37.2 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.337 -0.847 . . . . 25.0 112.147 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -114.86 137.04 52.43 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 105.487 -2.042 . . . . 25.0 105.487 170.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.9 p -59.82 -56.03 26.86 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 112.655 0.613 . . . . 25.0 112.655 -171.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 42.2 p30 -109.01 166.57 10.73 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 121.21 0.528 . . . . 25.0 110.418 166.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 63.6 tp -63.59 -25.12 68.09 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.188 0.518 . . . . 25.0 111.262 173.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 32.6 t -62.66 -46.48 87.98 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 121.889 -0.507 . . . . 25.0 111.207 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 54.7 m95 -67.19 -29.75 69.51 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 121.652 -0.655 . . . . 25.0 111.474 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -62.47 -45.64 92.11 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.642 -0.873 . . . . 25.0 108.642 174.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -63.4 -43.48 97.41 Favored 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 116.112 -0.494 . . . . 25.0 111.864 178.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 -68.3 -26.51 65.67 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.098 0.407 . . . . 25.0 112.098 -178.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.2 -14.88 58.8 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.586 0.231 . . . . 25.0 110.799 177.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.25 18.53 78.14 Favored Glycine 0 C--O 1.23 -0.12 0 N-CA-C 114.333 0.493 . . . . 25.0 114.333 175.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -95.64 142.77 13.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 107.781 -1.192 . . . . 25.0 107.781 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.2 155.63 53.51 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 108.102 -1.999 . . . . 25.0 108.102 172.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.8 tt -82.54 142.39 31.86 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.146 -1.057 . . . . 25.0 108.146 176.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -114.32 -58.81 2.1 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.624 -0.51 . . . . 25.0 109.624 174.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 3.5 m170 -111.82 157.72 20.24 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 110.222 -0.288 . . . . 25.0 110.222 176.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -96.23 148.43 22.73 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 101.738 -3.43 . . . . 25.0 101.738 161.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.1 165.82 39.22 Favored Glycine 0 C--N 1.32 -0.336 0 N-CA-C 110.085 -1.206 . . . . 25.0 110.085 -173.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -81.71 162.67 22.89 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.324 0.583 . . . . 25.0 112.203 -177.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 24.6 p -147.02 -174.75 4.58 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 106.213 -1.773 . . . . 25.0 106.213 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.5 tm? . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.143 -0.932 . . . . 25.0 109.442 179.756 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 119.284 -0.388 . . . . 25.0 110.148 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.47 -12.52 58.85 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.134 0.492 . . . . 25.0 110.575 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -72.11 100.56 2.56 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.998 -0.547 . . . . 25.0 110.301 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.5 m -106.78 0.35 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 108.274 -1.009 . . . . 25.0 108.274 177.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.2 p -81.48 159.79 24.12 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.697 -1.138 . . . . 25.0 110.933 -176.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 36.0 p -86.38 169.45 12.9 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.742 -0.663 . . . . 25.0 110.103 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.0 p -85.25 13.16 6.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 122.324 1.059 . . . . 25.0 112.569 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -63.2 130.12 43.2 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 113.762 -1.563 . . . . 25.0 110.462 176.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 53.2 t-105 -48.85 107.77 0.15 Allowed 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.727 -0.842 . . . . 25.0 108.727 176.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -137.74 73.77 46.68 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 107.187 -1.412 . . . . 25.0 107.187 -176.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -64.23 135.07 45.08 Favored 'Trans proline' 0 CA--C 1.506 -0.892 0 C-N-CA 118.049 -0.834 . . . . 25.0 113.27 -173.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.0 m -141.64 156.23 20.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 106.256 -1.757 . . . . 25.0 106.256 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.0 t -126.69 121.99 33.65 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.764 -0.828 . . . . 25.0 108.764 -177.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -78.69 176.76 54.33 Favored Glycine 0 C--O 1.226 -0.355 0 CA-C-N 115.929 -0.578 . . . . 25.0 112.833 -176.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -65.9 -21.54 66.45 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 122.582 -0.364 . . . . 25.0 111.552 178.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -75.23 -7.62 54.39 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.083 -0.508 . . . . 25.0 111.459 176.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.79 -7.66 73.08 Favored Glycine 0 C--O 1.224 -0.487 0 N-CA-C 111.483 -0.647 . . . . 25.0 111.483 -173.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -70.79 126.18 28.89 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 122.5 -0.412 . . . . 25.0 111.022 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.0 m -85.2 130.8 34.53 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.593 -0.731 . . . . 25.0 109.375 175.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -114.66 141.18 48.14 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.352 -0.981 . . . . 25.0 108.352 175.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.0 p -64.68 -57.89 7.78 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 112.682 0.623 . . . . 25.0 112.682 -174.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -109.27 166.37 10.92 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 121.452 0.644 . . . . 25.0 110.489 168.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 59.2 tp -62.16 -27.32 68.87 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.446 -0.797 . . . . 25.0 111.749 176.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 20.9 m -65.56 -40.42 92.8 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 121.73 -0.607 . . . . 25.0 111.734 -178.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -66.63 -34.77 78.61 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.387 -0.525 . . . . 25.0 110.62 176.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.64 -45.51 89.89 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.171 -0.677 . . . . 25.0 109.171 176.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -63.7 -43.41 96.67 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.315 0.487 . . . . 25.0 112.315 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -68.21 -29.37 68.2 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.48 0.178 . . . . 25.0 111.48 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.39 -16.45 57.63 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.691 0.281 . . . . 25.0 111.259 178.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.7 9.39 86.34 Favored Glycine 0 CA--C 1.518 0.24 0 N-CA-C 115.413 0.925 . . . . 25.0 115.413 176.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.5 t -78.92 138.91 19.24 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 N-CA-C 107.847 -1.168 . . . . 25.0 107.847 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.87 149.54 50.47 Favored Glycine 0 C--N 1.315 -0.61 0 N-CA-C 107.989 -2.044 . . . . 25.0 107.989 174.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 59.0 tp -74.03 145.58 44.41 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.062 -0.718 . . . . 25.0 109.062 178.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -125.09 -58.93 1.44 Allowed 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 121.147 -0.221 . . . . 25.0 110.438 172.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 10.4 m80 -111.75 143.8 42.08 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.96 0.355 . . . . 25.0 111.96 176.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 33.0 mp0 -84.12 138.93 32.77 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 102.595 -3.113 . . . . 25.0 102.595 168.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.53 169.06 40.15 Favored Glycine 0 C--N 1.321 -0.276 0 N-CA-C 109.328 -1.509 . . . . 25.0 109.328 -174.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -83.33 160.6 21.64 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 122.668 -0.313 . . . . 25.0 111.32 -177.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 67.4 m -108.23 158.4 17.49 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 105.097 -2.186 . . . . 25.0 105.097 170.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 94.0 mt . . . . . 0 C--O 1.242 0.703 0 N-CA-C 104.78 -2.304 . . . . 25.0 104.78 179.411 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 22.2 pm0 . . . . . 0 N--CA 1.496 1.852 0 CA-C-O 119.29 -0.386 . . . . 25.0 110.197 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.87 41.49 3.15 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.167 0.508 . . . . 25.0 110.549 -177.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -139.3 138.27 36.57 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 106.527 -1.657 . . . . 25.0 106.527 178.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.17 -14.4 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 113.028 0.751 . . . . 25.0 113.028 -176.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 52.2 t -113.02 139.97 48.22 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 122.317 -0.24 . . . . 25.0 111.484 -177.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.0 p -95.97 155.85 16.58 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.05 -1.093 . . . . 25.0 108.05 171.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 36.1 p -102.84 10.07 38.59 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 122.845 1.307 . . . . 25.0 110.567 177.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -75.9 131.32 39.58 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 113.325 -1.761 . . . . 25.0 110.963 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 53.6 t-105 -59.02 108.62 0.7 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.108 -1.442 . . . . 25.0 107.108 173.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -137.72 73.41 47.55 Favored Pre-proline 0 C--N 1.322 -0.611 0 N-CA-C 107.682 -1.229 . . . . 25.0 107.682 -176.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.58 138.85 46.9 Favored 'Trans proline' 0 CA--C 1.507 -0.831 0 C-N-CA 117.228 -1.381 . . . . 25.0 112.524 -175.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.2 m -142.39 161.04 19.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 104.911 -2.255 . . . . 25.0 104.911 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -126.41 127.54 45.61 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.693 -0.854 . . . . 25.0 108.693 178.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -79.58 177.34 54.32 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 121.033 -0.604 . . . . 25.0 113.613 -176.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -71.16 -12.13 61.32 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 122.389 -0.477 . . . . 25.0 110.648 176.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 42.8 p-10 -82.77 -3.46 56.64 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.473 -0.785 . . . . 25.0 111.212 176.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 79.25 16.9 77.54 Favored Glycine 0 C--O 1.224 -0.501 0 C-N-CA 121.177 -0.535 . . . . 25.0 113.792 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.7 mmtp -110.31 141.38 43.4 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 118.047 0.924 . . . . 25.0 110.854 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.1 m -82.28 132.16 35.23 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.423 -0.955 . . . . 25.0 108.423 175.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -114.91 137.11 52.36 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 106.502 -1.666 . . . . 25.0 106.502 173.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.0 m -64.61 -55.8 17.96 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.577 0.584 . . . . 25.0 112.577 -173.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -113.77 158.72 20.59 Favored 'General case' 0 C--O 1.25 1.08 0 CA-C-O 121.216 0.531 . . . . 25.0 109.671 170.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 30.0 tp -57.35 -24.62 56.37 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.631 -0.713 . . . . 25.0 112.002 177.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.3 m -58.46 -42.95 88.6 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 121.951 -0.468 . . . . 25.0 112.178 177.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 40.1 m95 -73.81 -33.37 64.15 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.779 -0.452 . . . . 25.0 109.779 -177.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -61.45 -45.92 92.23 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.049 -0.723 . . . . 25.0 109.049 176.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -65.05 -41.15 95.42 Favored 'General case' 0 C--O 1.218 -0.569 0 CA-C-N 115.813 -0.631 . . . . 25.0 112.151 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -68.08 -30.79 70.06 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.906 0.336 . . . . 25.0 111.906 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.71 -14.76 59.92 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.899 0.38 . . . . 25.0 110.387 177.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.21 16.3 79.83 Favored Glycine 0 C--N 1.328 0.109 0 N-CA-C 114.149 0.42 . . . . 25.0 114.149 175.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -93.82 142.99 12.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 109.235 -0.654 . . . . 25.0 109.235 -178.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.12 152.36 49.91 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 108.43 -1.868 . . . . 25.0 108.43 171.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.1 tt -75.6 138.92 41.76 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.08 -1.081 . . . . 25.0 108.08 177.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -117.84 -50.24 2.5 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.564 0.221 . . . . 25.0 110.962 175.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 17.9 m80 -112.01 151.97 28.69 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.873 -0.417 . . . . 25.0 109.873 175.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -94.5 146.42 24.11 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 102.895 -3.002 . . . . 25.0 102.895 166.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.97 170.14 46.83 Favored Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 110.201 -1.16 . . . . 25.0 110.201 -175.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -79.36 151.34 31.05 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.338 -0.986 . . . . 25.0 108.338 178.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.6 p -148.97 173.37 13.41 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.701 0.286 . . . . 25.0 111.088 -178.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.258 1.524 0 N-CA-C 102.902 -2.999 . . . . 25.0 102.902 174.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.7 t70 . . . . . 0 C--O 1.243 0.714 0 N-CA-C 106.453 -1.684 . . . . 25.0 106.453 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -61.73 142.23 93.25 Favored 'Trans proline' 0 CA--C 1.509 -0.771 0 N-CA-C 115.885 1.456 . . . . 25.0 115.885 -169.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.0 m -140.83 167.08 18.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 105.759 -1.941 . . . . 25.0 105.759 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.434 ' HB3' ' HB2' ' A' ' 35' ' ' HIS . 44.3 t -134.76 133.16 39.6 Favored 'General case' 0 C--O 1.244 0.816 0 CA-C-O 120.962 0.411 . . . . 25.0 110.472 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.15 176.53 54.65 Favored Glycine 0 N--CA 1.453 -0.17 0 CA-C-N 115.837 -0.62 . . . . 25.0 113.586 -177.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -71.81 -12.89 61.51 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 122.32 -0.518 . . . . 25.0 111.317 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.9 p-10 -94.8 9.18 40.06 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.172 -0.467 . . . . 25.0 111.239 177.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.09 -3.73 75.05 Favored Glycine 0 C--O 1.227 -0.305 0 N-CA-C 116.053 1.181 . . . . 25.0 116.053 176.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -82.37 137.19 34.82 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 118.626 1.213 . . . . 25.0 111.948 -177.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 94.2 m -83.8 128.85 34.84 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.175 -0.921 . . . . 25.0 109.007 176.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -114.93 139.08 50.1 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.308 -0.997 . . . . 25.0 108.308 176.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.62 -56.86 16.65 Favored 'General case' 0 C--O 1.215 -0.718 0 N-CA-C 113.097 0.777 . . . . 25.0 113.097 -173.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -113.06 174.35 5.94 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.984 0.421 . . . . 25.0 110.824 166.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 39.4 tp -64.31 -27.36 68.98 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.723 -0.671 . . . . 25.0 112.213 173.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 47.3 t -63.28 -47.71 81.19 Favored 'General case' 0 C--O 1.216 -0.675 0 O-C-N 121.722 -0.611 . . . . 25.0 111.018 178.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 62.1 m95 -62.47 -31.61 72.37 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.243 -0.583 . . . . 25.0 111.491 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -64.49 -45.41 87.44 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 109.307 -0.627 . . . . 25.0 109.307 175.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -66.17 -41.4 90.38 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.329 -0.396 . . . . 25.0 111.831 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -64.67 -31.25 72.39 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.667 0.27 . . . . 25.0 111.165 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.39 -15.88 59.84 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.701 0.286 . . . . 25.0 111.053 178.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.08 7.72 88.2 Favored Glycine 0 C--O 1.23 -0.103 0 N-CA-C 114.838 0.695 . . . . 25.0 114.838 175.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -85.29 144.37 9.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.079 -1.082 . . . . 25.0 108.079 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.09 150.81 49.38 Favored Glycine 0 C--N 1.316 -0.582 0 N-CA-C 108.564 -1.814 . . . . 25.0 108.564 173.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 60.8 tp -74.5 145.56 43.44 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.053 -0.721 . . . . 25.0 109.053 177.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -128.37 -58.85 1.18 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.005 0.372 . . . . 25.0 112.005 173.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.434 ' HB2' ' HB3' ' A' ' 13' ' ' CYS . 44.0 m-70 -112.1 160.69 17.29 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.522 0.201 . . . . 25.0 111.358 178.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -99.69 149.3 23.46 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 102.89 -3.004 . . . . 25.0 102.89 166.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.8 178.64 47.75 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 110.748 -0.941 . . . . 25.0 110.748 -177.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -78.07 160.92 27.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.749 0.309 . . . . 25.0 111.564 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.7 m . . . . . 0 C--N 1.324 -0.515 0 N-CA-C 108.328 -0.989 . . . . 25.0 108.328 173.652 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 52.1 t0 . . . . . 0 N--CA 1.454 -0.236 0 N-CA-C 109.253 -0.647 . . . . 25.0 109.253 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -65.4 138.49 55.42 Favored 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 114.646 -3.103 . . . . 25.0 113.491 -176.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.6 m -144.26 161.04 15.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 105.561 -2.015 . . . . 25.0 105.561 -178.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 50.8 t -131.47 126.37 34.85 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.097 -0.705 . . . . 25.0 109.097 -177.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.37 178.5 53.87 Favored Glycine 0 C--O 1.225 -0.437 0 CA-C-N 115.761 -0.654 . . . . 25.0 113.247 -175.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -66.56 -19.83 65.87 Favored 'General case' 0 C--O 1.214 -0.786 0 O-C-N 122.616 -0.343 . . . . 25.0 111.435 177.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -82.57 3.78 27.25 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 121.768 0.794 . . . . 25.0 110.708 177.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.21 -4.41 54.91 Favored Glycine 0 C--O 1.224 -0.484 0 O-C-N 121.839 -0.538 . . . . 25.0 114.134 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -81.86 134.26 35.39 Favored 'General case' 0 C--O 1.239 0.527 0 O-C-N 122.109 -0.641 . . . . 25.0 110.776 -176.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.2 m -86.73 132.39 33.88 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.605 -0.725 . . . . 25.0 109.502 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -114.69 137.4 51.96 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 106.11 -1.811 . . . . 25.0 106.11 175.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 79.8 p -66.81 -47.42 72.13 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 111.974 0.361 . . . . 25.0 111.974 -173.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -109.19 164.55 12.35 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.701 -0.851 . . . . 25.0 108.701 172.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 63.6 tp -68.32 -23.65 64.74 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.496 -0.775 . . . . 25.0 109.104 172.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.8 t -55.59 -51.0 68.61 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.618 -0.719 . . . . 25.0 111.344 175.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 24.0 m95 -69.89 -31.13 68.77 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.389 -0.524 . . . . 25.0 111.351 -176.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -64.47 -44.47 90.97 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.331 -0.618 . . . . 25.0 109.331 175.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.36 -46.26 90.94 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.141 -0.481 . . . . 25.0 110.521 -178.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -74.83 -23.58 58.48 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.634 0.605 . . . . 25.0 112.634 -176.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.27 -18.02 57.91 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.779 0.323 . . . . 25.0 110.611 176.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.74 5.37 86.35 Favored Glycine 0 CA--C 1.517 0.206 0 N-CA-C 115.114 0.806 . . . . 25.0 115.114 176.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -74.81 137.25 23.43 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 N-CA-C 107.529 -1.286 . . . . 25.0 107.529 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.51 143.85 46.32 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 107.548 -2.221 . . . . 25.0 107.548 175.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 57.9 tp -70.34 142.68 52.14 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.335 -0.987 . . . . 25.0 108.335 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -126.03 -58.91 1.36 Allowed 'General case' 0 C--O 1.22 -0.472 0 C-N-CA 120.983 -0.287 . . . . 25.0 110.258 173.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -111.92 154.44 25.22 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.802 -0.444 . . . . 25.0 109.802 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -102.72 145.63 29.43 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 102.432 -3.173 . . . . 25.0 102.432 167.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.91 171.26 43.38 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 109.681 -1.368 . . . . 25.0 109.681 -172.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -72.65 153.5 41.18 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 113.376 0.88 . . . . 25.0 113.376 -176.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 51.6 m . . . . . 0 C--O 1.241 0.614 0 N-CA-C 103.388 -2.819 . . . . 25.0 103.388 163.565 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 39.4 t0 . . . . . 0 C--O 1.236 0.368 0 N-CA-C 107.944 -1.132 . . . . 25.0 107.944 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -65.65 135.68 42.92 Favored 'Trans proline' 0 CA--C 1.509 -0.745 0 C-N-CA 117.616 -1.122 . . . . 25.0 113.213 -174.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.4 m -141.17 159.81 22.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 105.935 -1.876 . . . . 25.0 105.935 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 38.8 t -119.27 124.34 46.45 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.197 -1.038 . . . . 25.0 108.197 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -79.32 170.77 54.63 Favored Glycine 0 C--O 1.226 -0.361 0 C-N-CA 120.792 -0.718 . . . . 25.0 111.34 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -68.32 -12.01 60.39 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 112.481 0.548 . . . . 25.0 112.481 178.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -81.68 1.01 36.15 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.549 0.69 . . . . 25.0 110.181 174.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 76.98 16.66 80.59 Favored Glycine 0 C--O 1.222 -0.596 0 O-C-N 121.555 -0.716 . . . . 25.0 113.112 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -108.11 138.81 43.74 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 122.128 -0.631 . . . . 25.0 111.085 -176.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 54.6 m -81.52 133.26 35.37 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.916 -0.584 . . . . 25.0 109.489 176.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -114.89 137.13 52.33 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.045 -1.465 . . . . 25.0 107.045 173.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.9 m -59.99 -57.02 14.66 Favored 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 112.945 0.721 . . . . 25.0 112.945 -173.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 47.8 p30 -109.07 167.6 9.98 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.122 0.486 . . . . 25.0 110.457 167.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 59.8 tp -62.47 -26.78 68.7 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.844 -0.616 . . . . 25.0 110.62 172.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.4 m -61.47 -44.63 96.75 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 122.04 -0.413 . . . . 25.0 111.793 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 65.0 m95 -68.77 -30.88 69.57 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 121.762 -0.586 . . . . 25.0 111.519 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -63.05 -44.48 95.75 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.437 -0.949 . . . . 25.0 108.437 175.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -66.12 -41.51 90.46 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.032 -0.531 . . . . 25.0 111.492 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -62.99 -32.78 74.2 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 111.668 0.247 . . . . 25.0 111.668 178.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.77 -14.16 59.42 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.673 0.273 . . . . 25.0 111.434 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.18 11.16 85.8 Favored Glycine 0 C--O 1.23 -0.135 0 N-CA-C 115.031 0.772 . . . . 25.0 115.031 176.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -87.41 146.41 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 N-CA-C 107.791 -1.189 . . . . 25.0 107.791 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.69 152.26 47.37 Favored Glycine 0 C--N 1.316 -0.553 0 N-CA-C 107.803 -2.119 . . . . 25.0 107.803 173.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 8.4 tt -78.49 141.86 37.89 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.579 -1.267 . . . . 25.0 107.579 176.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -117.06 -58.35 2.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.82 0.343 . . . . 25.0 110.405 174.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -111.97 156.54 21.97 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.311 -0.243 . . . . 25.0 111.02 176.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -98.8 146.38 25.99 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 103.708 -2.701 . . . . 25.0 103.708 168.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.53 171.2 40.89 Favored Glycine 0 N--CA 1.451 -0.312 0 N-CA-C 109.552 -1.419 . . . . 25.0 109.552 -174.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -81.31 158.18 24.83 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.104 -0.702 . . . . 25.0 109.104 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 27.8 p . . . . . 0 C--N 1.325 -0.498 0 C-N-CA 122.923 0.489 . . . . 25.0 109.735 -178.132 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 59.2 t0 . . . . . 0 C--O 1.238 0.467 0 N-CA-C 109.142 -0.688 . . . . 25.0 109.142 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.97 134.6 43.86 Favored 'Trans proline' 0 CA--C 1.506 -0.885 0 C-N-CA 117.517 -1.188 . . . . 25.0 112.621 -176.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.4 m -142.72 162.06 18.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 105.989 -1.856 . . . . 25.0 105.989 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 43.8 t -123.75 123.33 40.27 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.839 -0.8 . . . . 25.0 108.839 -177.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.18 164.68 48.08 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.065 -0.588 . . . . 25.0 112.244 -178.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -62.75 -17.6 61.2 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.113 0.783 . . . . 25.0 113.113 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -79.61 5.6 12.74 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 122.334 -0.229 . . . . 25.0 111.146 175.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.59 17.24 71.32 Favored Glycine 0 C--O 1.225 -0.427 0 C-N-CA 120.677 -0.773 . . . . 25.0 113.8 175.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 32.2 mmtm -121.26 138.49 54.21 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 117.559 0.679 . . . . 25.0 112.152 -173.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 38.4 m -83.17 133.84 35.01 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.969 -1.014 . . . . 25.0 111.241 -179.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -114.83 138.33 50.9 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.285 -1.376 . . . . 25.0 107.285 173.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.1 p -62.69 -52.4 63.43 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.567 0.58 . . . . 25.0 112.567 -174.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.417 ' H ' ' HD1' ' A' ' 25' ' ' TRP . 23.1 m-20 -108.24 168.01 9.61 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.371 -0.974 . . . . 25.0 108.371 171.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 59.6 tp -68.68 -26.1 65.13 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.039 -1.096 . . . . 25.0 108.039 171.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 48.6 t -55.01 -52.33 63.48 Favored 'General case' 0 C--O 1.219 -0.513 0 CA-C-N 115.046 -0.979 . . . . 25.0 111.262 175.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.417 ' HD1' ' H ' ' A' ' 22' ' ' ASN . 72.7 m95 -69.42 -27.41 65.25 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.068 0.395 . . . . 25.0 112.068 -175.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -65.86 -49.41 68.22 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.931 -0.766 . . . . 25.0 108.931 175.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -66.75 -40.73 88.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.913 -0.585 . . . . 25.0 111.473 -177.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -67.28 -27.81 67.5 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 120.965 -0.294 . . . . 25.0 111.646 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.34 -12.76 59.55 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.624 0.249 . . . . 25.0 111.138 178.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.06 19.46 78.6 Favored Glycine 0 C--O 1.23 -0.146 0 N-CA-C 114.744 0.658 . . . . 25.0 114.744 175.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -93.15 144.2 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 N-CA-C 107.457 -1.312 . . . . 25.0 107.457 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.62 148.75 45.66 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 107.106 -2.398 . . . . 25.0 107.106 173.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 8.2 tt -78.56 141.01 38.44 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.516 -1.291 . . . . 25.0 107.516 176.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -116.24 -58.13 2.13 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.101 -0.333 . . . . 25.0 110.101 174.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 5.3 m170 -112.03 157.88 20.22 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 110.105 -0.332 . . . . 25.0 110.105 176.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -99.79 147.78 25.11 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 102.677 -3.082 . . . . 25.0 102.677 165.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.46 169.0 41.62 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 109.735 -1.346 . . . . 25.0 109.735 -173.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -72.72 161.56 30.59 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.974 0.731 . . . . 25.0 112.974 -178.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 9.4 m . . . . . 0 C--O 1.239 0.507 0 N-CA-C 104.901 -2.259 . . . . 25.0 104.901 169.008 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 44.2 t0 . . . . . 0 CA--C 1.511 -0.533 0 N-CA-C 108.12 -1.067 . . . . 25.0 108.12 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -62.87 133.61 42.6 Favored 'Trans proline' 0 CA--C 1.503 -1.07 0 O-C-N 122.309 0.636 . . . . 25.0 112.081 -173.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.5 m -139.55 161.18 27.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 107.282 -1.377 . . . . 25.0 107.282 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.1 t -131.55 121.69 24.85 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.889 -1.152 . . . . 25.0 107.889 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.98 173.58 54.67 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.815 -0.629 . . . . 25.0 112.823 -176.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp -64.2 -16.07 61.23 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.325 0.861 . . . . 25.0 113.325 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -92.07 10.65 28.27 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.736 0.303 . . . . 25.0 110.218 177.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.95 -2.34 65.17 Favored Glycine 0 C--O 1.223 -0.557 0 N-CA-C 114.281 0.472 . . . . 25.0 114.281 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -82.73 130.74 35.17 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 121.883 -0.775 . . . . 25.0 111.973 -175.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 70.3 m -84.79 128.39 34.59 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.986 -1.007 . . . . 25.0 110.87 177.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -114.88 137.02 52.46 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.002 -0.74 . . . . 25.0 109.002 174.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.3 m -60.51 -54.91 39.82 Favored 'General case' 0 C--O 1.217 -0.611 0 N-CA-C 112.701 0.63 . . . . 25.0 112.701 -174.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -109.1 168.41 9.39 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.07 0.462 . . . . 25.0 110.525 167.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 39.8 tp -65.76 -23.02 66.63 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.967 -0.561 . . . . 25.0 111.041 172.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 22.5 t -60.87 -50.35 73.8 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 121.956 -0.465 . . . . 25.0 111.001 178.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -64.38 -31.18 72.29 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 122.113 -0.367 . . . . 25.0 111.556 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -63.41 -46.39 86.6 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 109.159 -0.682 . . . . 25.0 109.159 176.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.08 -42.37 94.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.059 -0.519 . . . . 25.0 110.468 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -65.32 -33.13 75.25 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.598 0.221 . . . . 25.0 111.598 -179.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.76 -12.2 60.01 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 111.779 0.289 . . . . 25.0 111.779 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.4 19.99 79.78 Favored Glycine 0 C--O 1.229 -0.194 0 N-CA-C 115.005 0.762 . . . . 25.0 115.005 176.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -91.81 142.44 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 N-CA-C 107.542 -1.281 . . . . 25.0 107.542 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.53 147.17 46.64 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 108.005 -2.038 . . . . 25.0 108.005 173.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 62.0 tp -75.07 144.47 42.95 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.939 -1.134 . . . . 25.0 107.939 176.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -122.38 -59.15 1.66 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.401 -0.52 . . . . 25.0 110.218 172.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -113.82 153.05 29.78 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.512 0.56 . . . . 25.0 112.512 173.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -85.86 148.69 25.69 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 100.952 -3.722 . . . . 25.0 100.952 159.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.3 152.84 26.71 Favored Glycine 0 C--N 1.318 -0.449 0 N-CA-C 110.656 -0.977 . . . . 25.0 110.656 -176.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -83.66 151.75 25.12 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.66 0.615 . . . . 25.0 112.66 -176.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 76.2 m . . . . . 0 C--O 1.24 0.592 0 N-CA-C 105.692 -1.966 . . . . 25.0 105.692 171.758 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.5 t0 . . . . . 0 C--O 1.239 0.521 0 N-CA-C 106.997 -1.483 . . . . 25.0 106.997 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.77 139.51 44.01 Favored 'Trans proline' 0 CA--C 1.51 -0.699 0 C-N-CA 117.186 -1.41 . . . . 25.0 114.081 -172.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.0 m -141.9 162.3 20.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 105.995 -1.854 . . . . 25.0 105.995 178.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.8 t -128.53 127.1 41.73 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-O 121.02 0.438 . . . . 25.0 110.04 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.33 175.31 54.95 Favored Glycine 0 C--O 1.227 -0.318 0 C-N-CA 121.06 -0.59 . . . . 25.0 112.427 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -66.53 -18.07 65.16 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 122.477 -0.425 . . . . 25.0 111.841 177.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -79.23 0.75 27.27 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.564 0.697 . . . . 25.0 110.82 176.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 75.46 16.71 80.46 Favored Glycine 0 C--O 1.222 -0.626 0 C-N-CA 120.87 -0.681 . . . . 25.0 113.209 178.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -106.04 137.3 44.2 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 122.246 -0.561 . . . . 25.0 110.667 -177.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 60.8 m -82.46 134.28 35.22 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.799 -0.637 . . . . 25.0 109.526 177.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -114.95 137.92 51.43 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 106.566 -1.642 . . . . 25.0 106.566 174.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.5 p -60.26 -55.83 28.89 Favored 'General case' 0 C--O 1.219 -0.511 0 N-CA-C 112.382 0.512 . . . . 25.0 112.382 -173.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 36.8 p30 -109.06 166.14 11.06 Favored 'General case' 0 C--O 1.244 0.79 0 CA-C-O 121.306 0.574 . . . . 25.0 110.892 166.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 60.9 tp -63.15 -25.72 68.48 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.207 0.527 . . . . 25.0 111.15 172.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 68.5 m -63.63 -41.45 98.26 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 121.792 -0.568 . . . . 25.0 112.213 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 60.4 m95 -70.62 -29.56 65.97 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 121.428 -0.795 . . . . 25.0 110.721 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.94 -42.66 99.88 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.286 -1.005 . . . . 25.0 108.286 173.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -63.66 -41.36 98.21 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 111.696 0.258 . . . . 25.0 111.696 177.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -63.68 -36.04 82.53 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 117.831 0.287 . . . . 25.0 111.722 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.38 -17.92 57.78 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.668 0.271 . . . . 25.0 111.63 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.67 5.6 83.57 Favored Glycine 0 CA--C 1.518 0.227 0 N-CA-C 115.109 0.804 . . . . 25.0 115.109 176.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -74.31 140.46 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.654 0 N-CA-C 107.467 -1.308 . . . . 25.0 107.467 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.28 147.15 49.76 Favored Glycine 0 C--N 1.315 -0.59 0 N-CA-C 107.608 -2.197 . . . . 25.0 107.608 174.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 56.5 tp -72.92 143.52 47.68 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.475 -0.935 . . . . 25.0 108.475 177.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -124.36 -59.1 1.49 Allowed 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 121.179 -0.208 . . . . 25.0 110.888 173.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -111.91 154.26 25.48 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.418 -0.216 . . . . 25.0 110.418 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -98.92 143.94 28.65 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 102.41 -3.182 . . . . 25.0 102.41 167.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 93.19 170.16 39.54 Favored Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 109.1 -1.6 . . . . 25.0 109.1 -173.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -78.5 162.32 26.43 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.426 -0.583 . . . . 25.0 109.426 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 26.3 p . . . . . 0 C--N 1.323 -0.568 0 N-CA-C 108.523 -0.917 . . . . 25.0 108.523 -179.586 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 36.4 t70 . . . . . 0 C--O 1.233 0.206 0 N-CA-C 109.559 -0.534 . . . . 25.0 109.559 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -65.4 134.15 37.62 Favored 'Trans proline' 0 CA--C 1.51 -0.689 0 C-N-CA 116.716 -1.723 . . . . 25.0 113.637 -173.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.9 m -141.62 161.61 21.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 106.112 -1.81 . . . . 25.0 106.112 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.439 ' HB3' ' HB2' ' A' ' 35' ' ' HIS . 50.4 t -129.11 125.08 36.37 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.966 -0.753 . . . . 25.0 108.966 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.84 175.29 54.09 Favored Glycine 0 C--O 1.227 -0.32 0 CA-C-N 115.918 -0.583 . . . . 25.0 114.078 -175.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -67.56 -12.07 59.53 Favored 'General case' 0 C--O 1.215 -0.735 0 N-CA-C 112.487 0.551 . . . . 25.0 112.487 177.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -91.41 8.94 33.84 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.711 0.291 . . . . 25.0 110.453 176.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.5 -18.5 8.5 Favored Glycine 0 C--O 1.222 -0.652 0 N-CA-C 114.926 0.731 . . . . 25.0 114.926 177.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -73.11 139.41 46.42 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 121.312 0.577 . . . . 25.0 112.289 -177.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 98.8 m -86.05 132.63 34.0 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.653 -1.158 . . . . 25.0 108.882 175.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -115.0 136.97 52.54 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.114 -1.069 . . . . 25.0 108.114 176.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.8 m -62.33 -51.68 66.66 Favored 'General case' 0 C--O 1.223 -0.327 0 N-CA-C 112.714 0.635 . . . . 25.0 112.714 -174.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 45.9 p30 -113.9 170.08 8.53 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 121.109 0.48 . . . . 25.0 110.546 168.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 41.5 tp -63.79 -25.57 68.24 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.902 -0.59 . . . . 25.0 110.66 172.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 19.5 m -61.53 -46.05 91.58 Favored 'General case' 0 C--O 1.218 -0.571 0 O-C-N 122.144 -0.347 . . . . 25.0 111.916 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 24.5 m95 -70.08 -28.41 65.41 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 121.788 -0.57 . . . . 25.0 111.201 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -64.51 -45.32 87.74 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.5 -0.926 . . . . 25.0 108.5 175.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -66.05 -42.22 89.8 Favored 'General case' 0 C--O 1.22 -0.467 0 CA-C-N 115.782 -0.644 . . . . 25.0 111.78 178.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -63.61 -33.56 75.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.718 0.294 . . . . 25.0 111.414 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.27 -12.22 59.98 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.602 0.239 . . . . 25.0 111.323 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.0 21.78 77.85 Favored Glycine 0 C--O 1.23 -0.11 0 N-CA-C 114.385 0.514 . . . . 25.0 114.385 174.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -99.52 143.2 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 N-CA-C 109.09 -0.707 . . . . 25.0 109.09 -178.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.06 149.06 47.07 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 107.848 -2.101 . . . . 25.0 107.848 172.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 7.7 tt -74.73 147.97 40.89 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.073 -1.084 . . . . 25.0 108.073 177.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -129.34 -47.52 1.19 Allowed 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 112.98 0.733 . . . . 25.0 112.98 172.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.439 ' HB2' ' HB3' ' A' ' 13' ' ' CYS . 52.4 m-70 -114.46 156.44 24.54 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.356 -0.609 . . . . 25.0 109.356 174.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -100.01 146.15 27.06 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 102.784 -3.043 . . . . 25.0 102.784 169.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.19 175.58 47.7 Favored Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 109.305 -1.518 . . . . 25.0 109.305 -174.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -75.63 160.53 30.0 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.994 0.426 . . . . 25.0 112.013 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 16.8 m . . . . . 0 C--N 1.323 -0.553 0 N-CA-C 104.581 -2.377 . . . . 25.0 104.581 167.896 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 56.2 t0 . . . . . 0 C--O 1.237 0.436 0 N-CA-C 108.203 -1.036 . . . . 25.0 108.203 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.37 130.29 24.9 Favored 'Trans proline' 0 CA--C 1.507 -0.847 0 C-N-CA 117.099 -1.467 . . . . 25.0 112.758 -175.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.1 m -140.59 162.14 23.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 104.929 -2.249 . . . . 25.0 104.929 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.419 ' HB3' ' HB2' ' A' ' 35' ' ' HIS . 53.4 t -133.62 129.22 36.62 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.687 -0.857 . . . . 25.0 108.687 -179.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.92 -179.69 52.98 Favored Glycine 0 N--CA 1.452 -0.257 0 CA-C-O 121.651 0.584 . . . . 25.0 114.158 -174.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -71.63 -12.07 61.16 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.179 0.514 . . . . 25.0 110.456 176.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -86.96 0.84 54.43 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.532 -0.758 . . . . 25.0 110.688 175.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 78.56 -1.9 69.96 Favored Glycine 0 C--O 1.228 -0.248 0 N-CA-C 114.611 0.604 . . . . 25.0 114.611 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.9 mtmm -88.64 140.49 29.4 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 118.178 0.989 . . . . 25.0 111.522 -177.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 94.3 m -81.94 131.72 35.25 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.891 -1.049 . . . . 25.0 108.845 175.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -114.8 137.39 52.0 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 106.036 -1.839 . . . . 25.0 106.036 174.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.8 p -66.63 -52.09 48.99 Favored 'General case' 0 C--O 1.22 -0.491 0 N-CA-C 111.677 0.251 . . . . 25.0 111.677 -173.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 30.4 p30 -109.1 167.01 10.41 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-O 121.732 0.777 . . . . 25.0 111.691 167.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 45.7 tp -64.84 -24.79 67.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.151 -0.932 . . . . 25.0 110.714 172.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.4 t -59.88 -49.97 75.61 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 122.167 -0.333 . . . . 25.0 111.323 179.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.7 m95 -69.53 -28.18 65.8 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.265 -0.574 . . . . 25.0 111.572 -179.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -63.0 -44.8 95.03 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.399 -0.963 . . . . 25.0 108.399 174.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.36 -41.9 93.35 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.14 -0.482 . . . . 25.0 111.017 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -65.47 -32.89 74.75 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 122.183 -0.323 . . . . 25.0 111.244 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.52 -13.76 60.07 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.715 0.293 . . . . 25.0 111.373 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.76 12.86 83.56 Favored Glycine 0 CA--C 1.516 0.111 0 N-CA-C 114.946 0.739 . . . . 25.0 114.946 175.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -88.01 142.68 12.6 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.674 0 N-CA-C 108.516 -0.92 . . . . 25.0 108.516 -178.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.44 142.12 32.08 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 107.302 -2.319 . . . . 25.0 107.302 173.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 9.0 tt -65.9 142.47 57.89 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.045 -1.094 . . . . 25.0 108.045 177.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -121.51 -55.17 1.94 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 122.43 -0.169 . . . . 25.0 110.767 175.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.419 ' HB2' ' HB3' ' A' ' 13' ' ' CYS . 29.6 m-70 -111.96 154.32 25.44 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.849 -0.797 . . . . 25.0 108.849 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -98.29 143.78 28.41 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 103.198 -2.89 . . . . 25.0 103.198 170.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.45 177.4 48.48 Favored Glycine 0 C--N 1.321 -0.293 0 N-CA-C 109.968 -1.253 . . . . 25.0 109.968 -175.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -74.31 159.77 31.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.971 0.415 . . . . 25.0 112.115 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 22.3 m . . . . . 0 C--N 1.324 -0.538 0 N-CA-C 104.806 -2.294 . . . . 25.0 104.806 167.494 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 60.1 t0 . . . . . 0 CA--C 1.514 -0.412 0 N-CA-C 106.612 -1.625 . . . . 25.0 106.612 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.28 132.71 37.29 Favored 'Trans proline' 0 CA--C 1.506 -0.913 0 C-N-CA 116.621 -1.786 . . . . 25.0 112.228 -175.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.8 m -144.34 162.98 14.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 105.73 -1.952 . . . . 25.0 105.73 -178.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 35' ' ' HIS . 45.2 t -132.94 130.39 39.52 Favored 'General case' 0 C--O 1.245 0.833 0 N-CA-C 109.586 -0.524 . . . . 25.0 109.586 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -77.91 174.93 54.73 Favored Glycine 0 N--CA 1.453 -0.171 0 CA-C-N 115.528 -0.76 . . . . 25.0 113.619 -176.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -68.23 -17.88 64.42 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.199 0.444 . . . . 25.0 112.199 178.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -94.39 9.89 36.51 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.995 0.426 . . . . 25.0 111.073 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.25 -0.65 89.31 Favored Glycine 0 C--O 1.227 -0.328 0 N-CA-C 117.267 1.667 . . . . 25.0 117.267 174.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 11.9 mmtp -83.27 138.29 33.64 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.19 1.495 . . . . 25.0 111.772 -177.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 97.5 m -84.84 129.17 34.85 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.537 -0.756 . . . . 25.0 109.266 175.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -114.7 138.02 51.21 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.827 -1.175 . . . . 25.0 107.827 175.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.0 p -68.85 -54.75 13.92 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.057 0.391 . . . . 25.0 112.057 -175.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.444 ' H ' ' HD1' ' A' ' 25' ' ' TRP . 10.2 m-20 -108.98 162.91 13.78 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.398 -0.964 . . . . 25.0 108.398 174.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 41.9 tp -65.65 -30.09 70.75 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.186 -0.461 . . . . 25.0 111.08 177.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 68.7 m -65.86 -26.07 67.48 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 121.182 -0.948 . . . . 25.0 113.02 177.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.444 ' HD1' ' H ' ' A' ' 22' ' ' ASN . 83.0 m95 -75.02 -34.43 61.91 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 121.7 -0.625 . . . . 25.0 109.652 177.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -64.06 -44.94 90.9 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.391 -0.966 . . . . 25.0 108.391 174.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.7 -41.65 99.24 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.599 -0.728 . . . . 25.0 111.675 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -67.17 -33.54 75.61 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.51 0.195 . . . . 25.0 111.485 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.43 -18.61 58.73 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.777 0.322 . . . . 25.0 110.959 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.33 7.78 86.97 Favored Glycine 0 CA--C 1.517 0.159 0 N-CA-C 114.936 0.734 . . . . 25.0 114.936 176.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -77.58 142.1 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 N-CA-C 108.594 -0.891 . . . . 25.0 108.594 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.18 148.88 49.48 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 107.953 -2.059 . . . . 25.0 107.953 173.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.6 tp -70.79 142.77 51.33 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.992 -0.744 . . . . 25.0 108.992 177.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -126.51 -58.15 1.34 Allowed 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 121.137 -0.225 . . . . 25.0 110.834 173.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.41 ' HB2' ' HB3' ' A' ' 13' ' ' CYS . 20.5 m-70 -112.02 153.44 26.83 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.439 -0.578 . . . . 25.0 109.439 178.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -102.07 144.18 30.97 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 102.834 -3.024 . . . . 25.0 102.834 168.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.82 171.67 42.12 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 109.021 -1.632 . . . . 25.0 109.021 -172.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -73.58 160.9 30.96 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.107 0.41 . . . . 25.0 112.107 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 4.3 m . . . . . 0 C--N 1.324 -0.515 0 N-CA-C 106.187 -1.783 . . . . 25.0 106.187 170.305 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 38.9 t0 . . . . . 0 C--O 1.242 0.669 0 N-CA-C 106.881 -1.526 . . . . 25.0 106.881 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.77 134.59 41.2 Favored 'Trans proline' 0 CA--C 1.507 -0.859 0 C-N-CA 117.666 -1.09 . . . . 25.0 113.505 -173.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.7 m -140.94 162.18 22.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 106.85 -1.537 . . . . 25.0 106.85 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 35' ' ' HIS . 37.4 t -131.06 125.72 33.96 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.069 -0.715 . . . . 25.0 109.069 -178.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -79.82 179.01 53.49 Favored Glycine 0 C--N 1.323 -0.175 0 C-N-CA 121.062 -0.589 . . . . 25.0 112.544 -177.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -64.66 -23.31 67.22 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.393 0.277 . . . . 25.0 111.443 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -73.7 -4.05 32.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.342 0.591 . . . . 25.0 110.969 177.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 79.54 7.39 88.52 Favored Glycine 0 C--O 1.228 -0.279 0 C-N-CA 121.474 -0.393 . . . . 25.0 112.533 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.6 mmmt -102.52 141.79 34.77 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.716 0.769 . . . . 25.0 112.573 -177.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 44.7 m -85.26 133.63 34.16 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.038 -1.437 . . . . 25.0 112.788 -176.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -114.67 137.13 52.28 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 106.933 -1.506 . . . . 25.0 106.933 171.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.8 m -61.28 -55.37 32.7 Favored 'General case' 0 C--O 1.221 -0.435 0 N-CA-C 112.741 0.645 . . . . 25.0 112.741 -174.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -108.78 153.78 23.0 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 109.17 -0.678 . . . . 25.0 109.17 170.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 67.7 tp -57.95 -27.77 63.71 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 116.016 -0.538 . . . . 25.0 110.992 174.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -61.68 -36.69 81.6 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.757 0.651 . . . . 25.0 112.757 178.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 12.3 m95 -72.37 -35.19 68.42 Favored 'General case' 0 C--O 1.22 -0.475 0 C-N-CA 119.703 -0.799 . . . . 25.0 110.048 177.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -61.91 -44.21 97.26 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 108.941 -0.763 . . . . 25.0 108.941 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -63.99 -42.12 97.31 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.006 -0.543 . . . . 25.0 111.825 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -69.67 -30.88 68.66 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 111.912 0.338 . . . . 25.0 111.912 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.25 -19.35 59.78 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.812 0.339 . . . . 25.0 110.887 177.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.74 -0.46 88.19 Favored Glycine 0 CA--C 1.516 0.137 0 N-CA-C 115.117 0.807 . . . . 25.0 115.117 176.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.407 HG23 ' H ' ' A' ' 31' ' ' VAL . 1.9 t -68.69 138.12 23.03 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.614 0 N-CA-C 107.955 -1.128 . . . . 25.0 107.955 179.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.02 142.65 45.25 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 108.249 -1.94 . . . . 25.0 108.249 174.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.4 tp -72.14 142.56 49.11 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.074 -1.084 . . . . 25.0 108.074 177.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -125.64 -57.38 1.46 Allowed 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 121.06 -0.256 . . . . 25.0 110.918 175.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.425 ' HB2' ' HB3' ' A' ' 13' ' ' CYS . 7.2 m170 -111.94 153.03 27.35 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.881 -0.415 . . . . 25.0 109.881 176.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -98.52 146.96 25.25 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 101.285 -3.598 . . . . 25.0 101.285 163.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.54 165.93 36.24 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 108.184 -1.966 . . . . 25.0 108.184 -171.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -91.63 154.39 19.06 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 113.085 0.772 . . . . 25.0 113.085 -175.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 82.8 m . . . . . 0 C--N 1.325 -0.468 0 N-CA-C 106.197 -1.779 . . . . 25.0 106.197 172.68 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.2 t0 . . . . . 0 C--O 1.236 0.363 0 N-CA-C 107.545 -1.28 . . . . 25.0 107.545 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.63 139.49 44.53 Favored 'Trans proline' 0 CA--C 1.508 -0.782 0 C-N-CA 117.279 -1.347 . . . . 25.0 114.303 -171.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.8 m -141.08 162.07 22.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 106.588 -1.634 . . . . 25.0 106.588 178.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 37.5 t -122.55 126.55 47.99 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.065 -0.717 . . . . 25.0 109.065 179.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.92 172.96 44.55 Favored Glycine 0 C--O 1.225 -0.433 0 C-N-CA 120.691 -0.766 . . . . 25.0 112.026 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 37.2 mttp -65.52 -12.36 52.11 Favored 'General case' 0 C--O 1.215 -0.727 0 C-N-CA 123.017 0.527 . . . . 25.0 112.42 176.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -76.0 -2.48 30.75 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.262 0.625 . . . . 25.0 110.222 175.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.86 16.69 79.65 Favored Glycine 0 C--O 1.223 -0.587 0 C-N-CA 121.414 -0.422 . . . . 25.0 112.833 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 63.8 mttt -125.97 145.93 50.08 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.142 0.496 . . . . 25.0 112.311 -172.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 99.6 m -79.65 135.66 36.62 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.895 -1.048 . . . . 25.0 111.046 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -114.78 137.33 52.06 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 105.822 -1.918 . . . . 25.0 105.822 171.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.6 p -60.45 -54.96 39.32 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 113.08 0.77 . . . . 25.0 113.08 -172.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 29.7 p30 -109.61 165.76 11.42 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 121.182 0.515 . . . . 25.0 110.576 166.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 65.1 tp -64.61 -24.16 67.5 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.15 0.5 . . . . 25.0 111.669 174.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.0 t -64.25 -45.4 88.31 Favored 'General case' 0 C--O 1.216 -0.686 0 O-C-N 121.754 -0.591 . . . . 25.0 110.826 178.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 46.0 m95 -65.63 -31.31 72.26 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 121.768 -0.582 . . . . 25.0 111.144 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -62.46 -44.86 95.4 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.917 -0.771 . . . . 25.0 108.917 174.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -65.18 -41.9 94.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.139 -0.482 . . . . 25.0 111.732 178.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -65.83 -30.86 71.55 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.633 0.254 . . . . 25.0 111.113 -178.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.95 -15.82 58.67 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.753 0.311 . . . . 25.0 111.17 177.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.66 15.92 80.03 Favored Glycine 0 C--O 1.231 -0.084 0 N-CA-C 114.775 0.67 . . . . 25.0 114.775 175.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.3 t -89.31 147.63 5.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 107.622 -1.251 . . . . 25.0 107.622 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.25 144.61 34.83 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 107.912 -2.075 . . . . 25.0 107.912 174.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 63.4 tp -70.31 142.36 52.24 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.348 -1.353 . . . . 25.0 107.348 176.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -122.92 -58.83 1.64 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.901 -0.319 . . . . 25.0 110.953 175.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 21.2 m-70 -112.01 153.77 26.33 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 122.351 -0.218 . . . . 25.0 111.584 176.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -95.2 145.92 24.7 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 103.582 -2.747 . . . . 25.0 103.582 167.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.02 168.21 40.46 Favored Glycine 0 N--CA 1.452 -0.27 0 N-CA-C 109.989 -1.244 . . . . 25.0 109.989 -175.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -80.14 159.23 26.11 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.397 -0.594 . . . . 25.0 109.397 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 27.7 p . . . . . 0 C--N 1.324 -0.54 0 C-N-CA 122.921 0.488 . . . . 25.0 109.983 -177.488 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 32.2 t0 . . . . . 0 C--O 1.236 0.372 0 N-CA-C 107.864 -1.161 . . . . 25.0 107.864 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.04 134.43 36.92 Favored 'Trans proline' 0 CA--C 1.506 -0.886 0 C-N-CA 117.379 -1.281 . . . . 25.0 113.059 -173.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 m -140.33 159.52 25.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 106.012 -1.847 . . . . 25.0 106.012 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 35' ' ' HIS . 52.1 t -131.83 124.47 29.67 Favored 'General case' 0 C--O 1.246 0.91 0 CA-C-O 121.41 0.624 . . . . 25.0 109.715 -177.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -82.78 176.27 53.35 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 115.561 -0.745 . . . . 25.0 114.071 -175.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -67.9 -13.1 61.88 Favored 'General case' 0 C--O 1.216 -0.694 0 N-CA-C 112.186 0.439 . . . . 25.0 112.186 177.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.6 p-10 -82.77 0.84 41.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.363 -0.38 . . . . 25.0 111.043 175.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 76.88 16.94 80.34 Favored Glycine 0 C--O 1.225 -0.427 0 CA-C-O 119.565 -0.575 . . . . 25.0 114.106 178.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -115.8 143.86 44.81 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 118.028 0.914 . . . . 25.0 112.098 -176.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 91.1 m -84.97 132.97 34.28 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.241 -1.345 . . . . 25.0 110.659 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -114.93 138.56 50.68 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 106.745 -1.576 . . . . 25.0 106.745 174.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.3 p -62.52 -55.73 24.69 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 123.316 0.385 . . . . 25.0 111.889 -173.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 52.8 p30 -109.19 169.31 8.77 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-O 121.478 0.656 . . . . 25.0 111.386 166.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 45.5 tp -63.69 -23.7 67.48 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.765 -0.652 . . . . 25.0 111.283 172.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 31.1 t -61.12 -50.42 73.31 Favored 'General case' 0 C--O 1.22 -0.497 0 O-C-N 122.043 -0.411 . . . . 25.0 111.033 178.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 72.2 m95 -66.96 -28.72 68.51 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.209 -0.596 . . . . 25.0 111.492 -179.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -64.0 -45.72 87.74 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 108.886 -0.783 . . . . 25.0 108.886 174.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -65.6 -42.88 91.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.159 -0.473 . . . . 25.0 112.242 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -64.95 -31.84 73.26 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.745 0.307 . . . . 25.0 111.337 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.28 -13.36 59.95 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.659 0.266 . . . . 25.0 111.241 178.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.34 16.87 79.7 Favored Glycine 0 C--O 1.23 -0.144 0 N-CA-C 114.71 0.644 . . . . 25.0 114.71 175.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -88.52 140.81 15.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 108.42 -0.955 . . . . 25.0 108.42 -178.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.26 144.63 44.81 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 107.515 -2.234 . . . . 25.0 107.515 173.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 65.8 tp -72.24 145.38 47.98 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.208 -1.034 . . . . 25.0 108.208 177.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -129.98 -53.34 1.13 Allowed 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 113.107 0.78 . . . . 25.0 113.107 171.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.425 ' HB2' ' HB3' ' A' ' 13' ' ' CYS . 54.4 m-70 -112.13 143.47 43.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 118.154 0.434 . . . . 25.0 110.232 176.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.3 mp0 -85.79 145.11 27.38 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 102.072 -3.307 . . . . 25.0 102.072 166.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 93.03 176.07 40.9 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 109.711 -1.356 . . . . 25.0 109.711 -176.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.47 154.32 19.21 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.857 0.361 . . . . 25.0 111.654 -176.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 57.8 m . . . . . 0 C--N 1.325 -0.491 0 N-CA-C 106.824 -1.547 . . . . 25.0 106.824 173.661 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 50.4 t0 . . . . . 0 N--CA 1.454 -0.228 0 N-CA-C 108.012 -1.107 . . . . 25.0 108.012 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -65.81 136.28 44.81 Favored 'Trans proline' 0 CA--C 1.512 -0.611 0 O-C-N 122.505 0.739 . . . . 25.0 112.948 -174.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.4 m -147.08 161.11 8.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 114.97 -1.014 . . . . 25.0 108.808 -177.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 9.0 t -120.82 124.69 45.68 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.086 -1.079 . . . . 25.0 108.086 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.95 167.82 44.38 Favored Glycine 0 C--O 1.225 -0.466 0 C-N-CA 120.75 -0.738 . . . . 25.0 111.841 -179.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 24.3 mtpp -66.81 -14.41 62.61 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 112.698 0.629 . . . . 25.0 112.698 178.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -82.24 3.35 27.79 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.695 0.76 . . . . 25.0 110.083 176.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.78 17.04 80.08 Favored Glycine 0 C--O 1.222 -0.644 0 O-C-N 121.502 -0.749 . . . . 25.0 112.658 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -105.55 135.59 46.67 Favored 'General case' 0 C--O 1.239 0.518 0 O-C-N 122.359 -0.494 . . . . 25.0 110.478 -177.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.6 m -87.58 128.91 35.26 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.634 -0.712 . . . . 25.0 110.578 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -114.83 137.16 52.29 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.939 -1.134 . . . . 25.0 107.939 176.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 93.7 p -71.83 -46.33 58.41 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.918 0.389 . . . . 25.0 111.467 -175.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -108.42 162.18 14.35 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 107.351 -1.351 . . . . 25.0 107.351 174.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 36.1 tp -68.52 -26.66 65.55 Favored 'General case' 0 C--O 1.212 -0.898 0 N-CA-C 107.94 -1.133 . . . . 25.0 107.94 173.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -52.39 -52.62 52.68 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 115.633 -0.712 . . . . 25.0 112.031 174.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 49.1 m95 -65.78 -34.24 77.73 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.539 -0.464 . . . . 25.0 110.541 -176.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.47 -45.67 86.37 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.0 0.429 . . . . 25.0 109.96 175.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -68.85 -34.51 75.59 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.342 0.497 . . . . 25.0 112.342 -177.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -79.13 -30.12 43.5 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 121.111 -0.235 . . . . 25.0 110.38 -177.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.2 -21.54 58.62 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.025 0.44 . . . . 25.0 109.952 175.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.84 15.86 80.0 Favored Glycine 0 C--O 1.228 -0.271 0 N-CA-C 114.561 0.584 . . . . 25.0 114.561 175.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.2 t -80.12 143.81 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 N-CA-C 108.036 -1.098 . . . . 25.0 108.036 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.37 152.57 52.73 Favored Glycine 0 C--N 1.316 -0.554 0 N-CA-C 108.092 -2.003 . . . . 25.0 108.092 173.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 57.4 tp -81.19 142.25 33.39 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.977 -0.749 . . . . 25.0 108.977 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -120.91 -58.71 1.79 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.72 0.295 . . . . 25.0 110.965 174.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 4.5 m170 -112.18 147.7 35.61 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 110.194 -0.298 . . . . 25.0 110.194 175.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -92.71 140.67 29.29 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 103.555 -2.757 . . . . 25.0 103.555 167.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.75 165.35 33.04 Favored Glycine 0 C--N 1.321 -0.278 0 N-CA-C 109.52 -1.432 . . . . 25.0 109.52 -174.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.54 160.46 30.88 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.296 -0.631 . . . . 25.0 109.296 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 28.1 p . . . . . 0 C--N 1.323 -0.569 0 N-CA-C 106.875 -1.528 . . . . 25.0 106.875 179.439 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 24.7 t0 . . . . . 0 N--CA 1.454 -0.264 0 N-CA-C 109.333 -0.617 . . . . 25.0 109.333 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -66.35 134.97 37.97 Favored 'Trans proline' 0 CA--C 1.506 -0.918 0 C-N-CA 116.706 -1.729 . . . . 25.0 112.966 -174.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.2 m -141.57 163.81 19.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 106.259 -1.756 . . . . 25.0 106.259 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.408 ' HB3' ' HB2' ' A' ' 35' ' ' HIS . 48.8 t -129.88 128.85 43.05 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.749 -0.834 . . . . 25.0 108.749 -178.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.07 173.37 48.56 Favored Glycine 0 C--O 1.226 -0.369 0 C-N-CA 121.028 -0.606 . . . . 25.0 112.349 -178.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 17.7 mtpp -65.81 -12.13 51.76 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.213 1.19 . . . . 25.0 114.213 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -89.69 8.67 30.42 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.955 0.407 . . . . 25.0 110.093 174.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 78.64 2.74 85.96 Favored Glycine 0 C--O 1.22 -0.739 0 N-CA-C 114.784 0.673 . . . . 25.0 114.784 176.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.8 mmmt -96.65 138.83 33.62 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 118.11 0.955 . . . . 25.0 112.938 -176.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 37.2 m -82.09 132.61 35.25 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 113.907 -1.497 . . . . 25.0 111.697 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -114.96 137.14 52.34 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.105 -1.072 . . . . 25.0 108.105 173.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.7 m -58.83 -57.11 14.49 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.717 0.636 . . . . 25.0 112.717 -174.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 53.8 p30 -109.35 168.68 9.21 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 121.154 0.502 . . . . 25.0 110.608 165.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 41.7 tp -63.26 -22.29 66.78 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.913 -0.585 . . . . 25.0 111.332 172.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 5.7 t -61.82 -45.29 94.47 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 121.885 -0.509 . . . . 25.0 111.537 178.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 67.6 m95 -70.86 -30.4 66.78 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.303 -0.559 . . . . 25.0 110.816 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -62.67 -48.01 81.17 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 109.073 -0.714 . . . . 25.0 109.073 175.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -63.88 -42.59 97.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.846 -0.615 . . . . 25.0 112.076 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -66.46 -31.1 71.64 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 111.737 0.273 . . . . 25.0 111.737 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.67 -13.65 59.84 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.711 0.291 . . . . 25.0 111.11 178.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.97 14.44 82.2 Favored Glycine 0 CA--C 1.516 0.123 0 N-CA-C 114.778 0.671 . . . . 25.0 114.778 175.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.5 t -83.45 141.1 15.29 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.643 0 N-CA-C 107.907 -1.145 . . . . 25.0 107.907 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.53 144.89 47.93 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 107.307 -2.317 . . . . 25.0 107.307 172.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.8 tp -74.54 146.53 42.56 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.027 -1.101 . . . . 25.0 108.027 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -130.65 -59.19 1.02 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.167 0.508 . . . . 25.0 111.688 177.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.408 ' HB2' ' HB3' ' A' ' 13' ' ' CYS . 4.0 m170 -115.99 155.63 27.72 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.328 0.492 . . . . 25.0 112.328 -179.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -95.02 143.82 26.19 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 104.495 -2.409 . . . . 25.0 104.495 166.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.54 174.78 43.17 Favored Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 110.99 -0.844 . . . . 25.0 110.99 -177.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -77.77 159.72 28.85 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 113.861 1.059 . . . . 25.0 113.861 -177.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 34.4 m . . . . . 0 C--N 1.324 -0.532 0 N-CA-C 104.719 -2.326 . . . . 25.0 104.719 170.617 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.6 t0 . . . . . 0 C--O 1.239 0.51 0 N-CA-C 107.878 -1.156 . . . . 25.0 107.878 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -68.65 138.63 42.1 Favored 'Trans proline' 0 CA--C 1.506 -0.917 0 C-N-CA 117.372 -1.285 . . . . 25.0 113.556 -172.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.6 m -139.47 158.37 27.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 105.396 -2.076 . . . . 25.0 105.396 176.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 39.0 t -116.65 121.93 43.11 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.79 -1.189 . . . . 25.0 107.79 -179.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -77.66 169.22 54.66 Favored Glycine 0 C--O 1.227 -0.309 0 N-CA-C 110.763 -0.935 . . . . 25.0 110.763 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -66.24 -12.05 53.91 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 113.058 0.762 . . . . 25.0 113.058 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -78.83 0.48 26.94 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.823 0.345 . . . . 25.0 110.266 173.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.44 17.04 74.57 Favored Glycine 0 C--O 1.218 -0.873 0 CA-C-O 119.431 -0.649 . . . . 25.0 114.465 177.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.9 mmtt -122.2 147.72 45.84 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.041 0.92 . . . . 25.0 112.563 -175.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 85.4 m -79.1 136.61 37.2 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.337 -0.847 . . . . 25.0 112.147 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -114.86 137.04 52.43 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 105.487 -2.042 . . . . 25.0 105.487 170.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.9 p -59.82 -56.03 26.86 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 112.655 0.613 . . . . 25.0 112.655 -171.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 42.2 p30 -109.01 166.57 10.73 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 121.21 0.528 . . . . 25.0 110.418 166.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 63.6 tp -63.59 -25.12 68.09 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.188 0.518 . . . . 25.0 111.262 173.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 32.6 t -62.66 -46.48 87.98 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 121.889 -0.507 . . . . 25.0 111.207 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 54.7 m95 -67.19 -29.75 69.51 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 121.652 -0.655 . . . . 25.0 111.474 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -62.47 -45.64 92.11 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.642 -0.873 . . . . 25.0 108.642 174.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -63.4 -43.48 97.41 Favored 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 116.112 -0.494 . . . . 25.0 111.864 178.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 -68.3 -26.51 65.67 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.098 0.407 . . . . 25.0 112.098 -178.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.2 -14.88 58.8 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.586 0.231 . . . . 25.0 110.799 177.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.25 18.53 78.14 Favored Glycine 0 C--O 1.23 -0.12 0 N-CA-C 114.333 0.493 . . . . 25.0 114.333 175.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -95.64 142.77 13.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 107.781 -1.192 . . . . 25.0 107.781 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.2 155.63 53.51 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 108.102 -1.999 . . . . 25.0 108.102 172.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.8 tt -82.54 142.39 31.86 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.146 -1.057 . . . . 25.0 108.146 176.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -114.32 -58.81 2.1 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.624 -0.51 . . . . 25.0 109.624 174.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 3.5 m170 -111.82 157.72 20.24 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 110.222 -0.288 . . . . 25.0 110.222 176.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -96.23 148.43 22.73 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 101.738 -3.43 . . . . 25.0 101.738 161.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.1 165.82 39.22 Favored Glycine 0 C--N 1.32 -0.336 0 N-CA-C 110.085 -1.206 . . . . 25.0 110.085 -173.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -81.71 162.67 22.89 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.324 0.583 . . . . 25.0 112.203 -177.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 24.6 p . . . . . 0 C--N 1.324 -0.517 0 N-CA-C 106.213 -1.773 . . . . 25.0 106.213 179.655 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 42.5 t0 . . . . . 0 C--O 1.237 0.432 0 N-CA-C 107.187 -1.412 . . . . 25.0 107.187 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -64.23 135.07 45.08 Favored 'Trans proline' 0 CA--C 1.506 -0.892 0 C-N-CA 118.049 -0.834 . . . . 25.0 113.27 -173.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.0 m -141.64 156.23 20.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 106.256 -1.757 . . . . 25.0 106.256 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.0 t -126.69 121.99 33.65 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.764 -0.828 . . . . 25.0 108.764 -177.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -78.69 176.76 54.33 Favored Glycine 0 C--O 1.226 -0.355 0 CA-C-N 115.929 -0.578 . . . . 25.0 112.833 -176.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -65.9 -21.54 66.45 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 122.582 -0.364 . . . . 25.0 111.552 178.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -75.23 -7.62 54.39 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.083 -0.508 . . . . 25.0 111.459 176.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.79 -7.66 73.08 Favored Glycine 0 C--O 1.224 -0.487 0 N-CA-C 111.483 -0.647 . . . . 25.0 111.483 -173.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -70.79 126.18 28.89 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 122.5 -0.412 . . . . 25.0 111.022 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.0 m -85.2 130.8 34.53 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.593 -0.731 . . . . 25.0 109.375 175.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -114.66 141.18 48.14 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.352 -0.981 . . . . 25.0 108.352 175.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.0 p -64.68 -57.89 7.78 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 112.682 0.623 . . . . 25.0 112.682 -174.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -109.27 166.37 10.92 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 121.452 0.644 . . . . 25.0 110.489 168.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 59.2 tp -62.16 -27.32 68.87 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.446 -0.797 . . . . 25.0 111.749 176.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 20.9 m -65.56 -40.42 92.8 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 121.73 -0.607 . . . . 25.0 111.734 -178.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -66.63 -34.77 78.61 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.387 -0.525 . . . . 25.0 110.62 176.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.64 -45.51 89.89 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.171 -0.677 . . . . 25.0 109.171 176.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -63.7 -43.41 96.67 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.315 0.487 . . . . 25.0 112.315 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -68.21 -29.37 68.2 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.48 0.178 . . . . 25.0 111.48 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.39 -16.45 57.63 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.691 0.281 . . . . 25.0 111.259 178.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.7 9.39 86.34 Favored Glycine 0 CA--C 1.518 0.24 0 N-CA-C 115.413 0.925 . . . . 25.0 115.413 176.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.5 t -78.92 138.91 19.24 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 N-CA-C 107.847 -1.168 . . . . 25.0 107.847 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.87 149.54 50.47 Favored Glycine 0 C--N 1.315 -0.61 0 N-CA-C 107.989 -2.044 . . . . 25.0 107.989 174.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 59.0 tp -74.03 145.58 44.41 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.062 -0.718 . . . . 25.0 109.062 178.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -125.09 -58.93 1.44 Allowed 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 121.147 -0.221 . . . . 25.0 110.438 172.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 26.8 m-70 -111.75 143.8 42.08 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.96 0.355 . . . . 25.0 111.96 176.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 33.0 mp0 -84.12 138.93 32.77 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 102.595 -3.113 . . . . 25.0 102.595 168.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.53 169.06 40.15 Favored Glycine 0 C--N 1.321 -0.276 0 N-CA-C 109.328 -1.509 . . . . 25.0 109.328 -174.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -83.33 160.6 21.64 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 122.668 -0.313 . . . . 25.0 111.32 -177.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 67.4 m . . . . . 0 C--O 1.24 0.571 0 N-CA-C 105.097 -2.186 . . . . 25.0 105.097 170.971 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 25.2 t0 . . . . . 0 C--O 1.238 0.488 0 N-CA-C 107.682 -1.229 . . . . 25.0 107.682 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.58 138.85 46.9 Favored 'Trans proline' 0 CA--C 1.507 -0.831 0 C-N-CA 117.228 -1.381 . . . . 25.0 112.524 -175.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.2 m -142.39 161.04 19.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 104.911 -2.255 . . . . 25.0 104.911 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -126.41 127.54 45.61 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.693 -0.854 . . . . 25.0 108.693 178.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -79.58 177.34 54.32 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 121.033 -0.604 . . . . 25.0 113.613 -176.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -71.16 -12.13 61.32 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 122.389 -0.477 . . . . 25.0 110.648 176.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 42.8 p-10 -82.77 -3.46 56.64 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.473 -0.785 . . . . 25.0 111.212 176.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 79.25 16.9 77.54 Favored Glycine 0 C--O 1.224 -0.501 0 C-N-CA 121.177 -0.535 . . . . 25.0 113.792 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.7 mmtp -110.31 141.38 43.4 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 118.047 0.924 . . . . 25.0 110.854 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.1 m -82.28 132.16 35.23 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.423 -0.955 . . . . 25.0 108.423 175.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -114.91 137.11 52.36 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 106.502 -1.666 . . . . 25.0 106.502 173.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.0 m -64.61 -55.8 17.96 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.577 0.584 . . . . 25.0 112.577 -173.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -113.77 158.72 20.59 Favored 'General case' 0 C--O 1.25 1.08 0 CA-C-O 121.216 0.531 . . . . 25.0 109.671 170.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 30.0 tp -57.35 -24.62 56.37 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.631 -0.713 . . . . 25.0 112.002 177.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.3 m -58.46 -42.95 88.6 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 121.951 -0.468 . . . . 25.0 112.178 177.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 40.1 m95 -73.81 -33.37 64.15 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.779 -0.452 . . . . 25.0 109.779 -177.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -61.45 -45.92 92.23 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.049 -0.723 . . . . 25.0 109.049 176.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -65.05 -41.15 95.42 Favored 'General case' 0 C--O 1.218 -0.569 0 CA-C-N 115.813 -0.631 . . . . 25.0 112.151 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -68.08 -30.79 70.06 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.906 0.336 . . . . 25.0 111.906 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.71 -14.76 59.92 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.899 0.38 . . . . 25.0 110.387 177.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.21 16.3 79.83 Favored Glycine 0 C--N 1.328 0.109 0 N-CA-C 114.149 0.42 . . . . 25.0 114.149 175.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -93.82 142.99 12.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 109.235 -0.654 . . . . 25.0 109.235 -178.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.12 152.36 49.91 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 108.43 -1.868 . . . . 25.0 108.43 171.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.1 tt -75.6 138.92 41.76 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.08 -1.081 . . . . 25.0 108.08 177.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -117.84 -50.24 2.5 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.564 0.221 . . . . 25.0 110.962 175.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 -112.01 151.97 28.69 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.873 -0.417 . . . . 25.0 109.873 175.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -94.5 146.42 24.11 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 102.895 -3.002 . . . . 25.0 102.895 166.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.97 170.14 46.83 Favored Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 110.201 -1.16 . . . . 25.0 110.201 -175.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -79.36 151.34 31.05 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.338 -0.986 . . . . 25.0 108.338 178.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.6 p . . . . . 0 C--N 1.325 -0.461 0 CA-C-O 120.701 0.286 . . . . 25.0 111.088 -178.414 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 110.056 -0.35 . . . . 25.0 110.056 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.71 -138.52 0.09 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 102.475 -3.158 . . . . 25.0 102.475 176.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.39 166.84 9.49 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 104.943 -2.243 . . . . 25.0 104.943 164.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.2 m -106.25 -34.78 3.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 119.548 -0.861 . . . . 25.0 112.287 -175.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 86.5 m -117.65 159.96 22.07 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.376 -0.374 . . . . 25.0 110.748 168.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 41.0 p -85.35 173.91 9.96 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.007 -1.109 . . . . 25.0 108.007 173.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.6 p -102.62 18.95 20.05 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 122.355 1.074 . . . . 25.0 109.68 176.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -70.43 130.02 40.81 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.603 -1.181 . . . . 25.0 111.707 -177.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 73.7 t-105 -83.19 99.21 9.79 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.116 -1.068 . . . . 25.0 108.116 170.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -137.64 73.38 48.12 Favored Pre-proline 0 C--O 1.243 0.714 0 N-CA-C 106.453 -1.684 . . . . 25.0 106.453 177.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -61.73 142.23 93.25 Favored 'Trans proline' 0 CA--C 1.509 -0.771 0 N-CA-C 115.885 1.456 . . . . 25.0 115.885 -169.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.0 m -140.83 167.08 18.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 105.759 -1.941 . . . . 25.0 105.759 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.434 ' HB3' ' HB2' ' A' ' 35' ' ' HIS . 44.3 t -134.76 133.16 39.6 Favored 'General case' 0 C--O 1.244 0.816 0 CA-C-O 120.962 0.411 . . . . 25.0 110.472 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.15 176.53 54.65 Favored Glycine 0 N--CA 1.453 -0.17 0 CA-C-N 115.837 -0.62 . . . . 25.0 113.586 -177.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -71.81 -12.89 61.51 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 122.32 -0.518 . . . . 25.0 111.317 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.9 p-10 -94.8 9.18 40.06 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.172 -0.467 . . . . 25.0 111.239 177.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.09 -3.73 75.05 Favored Glycine 0 C--O 1.227 -0.305 0 N-CA-C 116.053 1.181 . . . . 25.0 116.053 176.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -82.37 137.19 34.82 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 118.626 1.213 . . . . 25.0 111.948 -177.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 94.2 m -83.8 128.85 34.84 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.175 -0.921 . . . . 25.0 109.007 176.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -114.93 139.08 50.1 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.308 -0.997 . . . . 25.0 108.308 176.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.62 -56.86 16.65 Favored 'General case' 0 C--O 1.215 -0.718 0 N-CA-C 113.097 0.777 . . . . 25.0 113.097 -173.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -113.06 174.35 5.94 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.984 0.421 . . . . 25.0 110.824 166.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 39.4 tp -64.31 -27.36 68.98 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.723 -0.671 . . . . 25.0 112.213 173.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 47.3 t -63.28 -47.71 81.19 Favored 'General case' 0 C--O 1.216 -0.675 0 O-C-N 121.722 -0.611 . . . . 25.0 111.018 178.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 62.1 m95 -62.47 -31.61 72.37 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.243 -0.583 . . . . 25.0 111.491 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -64.49 -45.41 87.44 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 109.307 -0.627 . . . . 25.0 109.307 175.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -66.17 -41.4 90.38 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.329 -0.396 . . . . 25.0 111.831 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -64.67 -31.25 72.39 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.667 0.27 . . . . 25.0 111.165 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.39 -15.88 59.84 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.701 0.286 . . . . 25.0 111.053 178.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.08 7.72 88.2 Favored Glycine 0 C--O 1.23 -0.103 0 N-CA-C 114.838 0.695 . . . . 25.0 114.838 175.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -85.29 144.37 9.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.079 -1.082 . . . . 25.0 108.079 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.09 150.81 49.38 Favored Glycine 0 C--N 1.316 -0.582 0 N-CA-C 108.564 -1.814 . . . . 25.0 108.564 173.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 60.8 tp -74.5 145.56 43.44 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.053 -0.721 . . . . 25.0 109.053 177.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -128.37 -58.85 1.18 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.005 0.372 . . . . 25.0 112.005 173.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.434 ' HB2' ' HB3' ' A' ' 13' ' ' CYS . 44.0 m-70 -112.1 160.69 17.29 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.522 0.201 . . . . 25.0 111.358 178.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -99.69 149.3 23.46 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 102.89 -3.004 . . . . 25.0 102.89 166.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.8 178.64 47.75 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 110.748 -0.941 . . . . 25.0 110.748 -177.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -78.07 160.92 27.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.749 0.309 . . . . 25.0 111.564 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.7 m -116.02 167.81 10.65 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.328 -0.989 . . . . 25.0 108.328 173.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.5 pt? . . . . . 0 C--O 1.244 0.769 0 N-CA-C 103.633 -2.728 . . . . 25.0 103.633 176.314 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.875 -0.417 . . . . 25.0 109.875 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.91 -157.45 0.52 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 103.52 -2.77 . . . . 25.0 103.52 -177.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.08 -67.43 0.41 Allowed 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 104.141 -2.54 . . . . 25.0 104.141 167.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.25 -41.73 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.171 -1.048 . . . . 25.0 108.171 159.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.0 t -114.31 160.01 19.56 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.036 -1.438 . . . . 25.0 110.799 165.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.696 ' H ' ' HB2' ' A' ' 24' ' ' CYS . 19.3 p -95.7 156.01 16.51 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 104.403 -2.443 . . . . 25.0 104.403 165.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.0 p -102.93 -0.57 30.86 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 123.886 1.803 . . . . 25.0 110.901 171.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -76.21 129.78 37.23 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 111.329 -2.669 . . . . 25.0 113.007 -178.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 42.4 t-105 -68.5 105.73 2.31 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 104.653 -2.351 . . . . 25.0 104.653 169.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -137.83 73.53 46.6 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 109.253 -0.647 . . . . 25.0 109.253 -176.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -65.4 138.49 55.42 Favored 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 114.646 -3.103 . . . . 25.0 113.491 -176.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.6 m -144.26 161.04 15.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 105.561 -2.015 . . . . 25.0 105.561 -178.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 50.8 t -131.47 126.37 34.85 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.097 -0.705 . . . . 25.0 109.097 -177.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.37 178.5 53.87 Favored Glycine 0 C--O 1.225 -0.437 0 CA-C-N 115.761 -0.654 . . . . 25.0 113.247 -175.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -66.56 -19.83 65.87 Favored 'General case' 0 C--O 1.214 -0.786 0 O-C-N 122.616 -0.343 . . . . 25.0 111.435 177.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -82.57 3.78 27.25 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 121.768 0.794 . . . . 25.0 110.708 177.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.21 -4.41 54.91 Favored Glycine 0 C--O 1.224 -0.484 0 O-C-N 121.839 -0.538 . . . . 25.0 114.134 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -81.86 134.26 35.39 Favored 'General case' 0 C--O 1.239 0.527 0 O-C-N 122.109 -0.641 . . . . 25.0 110.776 -176.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.2 m -86.73 132.39 33.88 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.605 -0.725 . . . . 25.0 109.502 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -114.69 137.4 51.96 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 106.11 -1.811 . . . . 25.0 106.11 175.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 79.8 p -66.81 -47.42 72.13 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 111.974 0.361 . . . . 25.0 111.974 -173.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -109.19 164.55 12.35 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.701 -0.851 . . . . 25.0 108.701 172.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 63.6 tp -68.32 -23.65 64.74 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.496 -0.775 . . . . 25.0 109.104 172.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.696 ' HB2' ' H ' ' A' ' 6' ' ' THR . 3.8 t -55.59 -51.0 68.61 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.618 -0.719 . . . . 25.0 111.344 175.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 24.0 m95 -69.89 -31.13 68.77 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.389 -0.524 . . . . 25.0 111.351 -176.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -64.47 -44.47 90.97 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.331 -0.618 . . . . 25.0 109.331 175.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.36 -46.26 90.94 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.141 -0.481 . . . . 25.0 110.521 -178.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -74.83 -23.58 58.48 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.634 0.605 . . . . 25.0 112.634 -176.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.27 -18.02 57.91 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.779 0.323 . . . . 25.0 110.611 176.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.74 5.37 86.35 Favored Glycine 0 CA--C 1.517 0.206 0 N-CA-C 115.114 0.806 . . . . 25.0 115.114 176.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -74.81 137.25 23.43 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 N-CA-C 107.529 -1.286 . . . . 25.0 107.529 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.51 143.85 46.32 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 107.548 -2.221 . . . . 25.0 107.548 175.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 57.9 tp -70.34 142.68 52.14 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.335 -0.987 . . . . 25.0 108.335 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -126.03 -58.91 1.36 Allowed 'General case' 0 C--O 1.22 -0.472 0 C-N-CA 120.983 -0.287 . . . . 25.0 110.258 173.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -111.92 154.44 25.22 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.802 -0.444 . . . . 25.0 109.802 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -102.72 145.63 29.43 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 102.432 -3.173 . . . . 25.0 102.432 167.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.91 171.26 43.38 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 109.681 -1.368 . . . . 25.0 109.681 -172.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -72.65 153.5 41.18 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 113.376 0.88 . . . . 25.0 113.376 -176.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 51.6 m -110.39 164.29 12.83 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 103.388 -2.819 . . . . 25.0 103.388 163.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 62.5 tp . . . . . 0 C--O 1.252 1.236 0 N-CA-C 104.245 -2.502 . . . . 25.0 104.245 178.02 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 23.3 tp10 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.997 -0.372 . . . . 25.0 109.997 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.35 153.43 43.61 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.168 -0.678 . . . . 25.0 109.168 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.22 142.55 50.6 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 107.736 -1.209 . . . . 25.0 107.736 176.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.3 m -124.75 -0.17 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 112.615 0.598 . . . . 25.0 112.615 -177.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 t -81.02 140.03 35.4 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.224 -0.658 . . . . 25.0 109.224 -176.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 50.0 p -95.61 167.93 10.99 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 113.945 1.091 . . . . 25.0 113.945 -175.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.1 p -90.59 19.5 5.31 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 122.066 0.936 . . . . 25.0 111.161 176.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -71.46 129.91 39.98 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.958 -1.019 . . . . 25.0 111.149 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 54.2 t-105 -57.41 108.39 0.54 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 107.417 -1.327 . . . . 25.0 107.417 173.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -137.97 72.99 46.7 Favored Pre-proline 0 C--N 1.321 -0.632 0 N-CA-C 107.944 -1.132 . . . . 25.0 107.944 -176.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -65.65 135.68 42.92 Favored 'Trans proline' 0 CA--C 1.509 -0.745 0 C-N-CA 117.616 -1.122 . . . . 25.0 113.213 -174.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.4 m -141.17 159.81 22.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 105.935 -1.876 . . . . 25.0 105.935 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 38.8 t -119.27 124.34 46.45 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.197 -1.038 . . . . 25.0 108.197 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -79.32 170.77 54.63 Favored Glycine 0 C--O 1.226 -0.361 0 C-N-CA 120.792 -0.718 . . . . 25.0 111.34 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -68.32 -12.01 60.39 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 112.481 0.548 . . . . 25.0 112.481 178.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -81.68 1.01 36.15 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.549 0.69 . . . . 25.0 110.181 174.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 76.98 16.66 80.59 Favored Glycine 0 C--O 1.222 -0.596 0 O-C-N 121.555 -0.716 . . . . 25.0 113.112 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -108.11 138.81 43.74 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 122.128 -0.631 . . . . 25.0 111.085 -176.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 54.6 m -81.52 133.26 35.37 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.916 -0.584 . . . . 25.0 109.489 176.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -114.89 137.13 52.33 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.045 -1.465 . . . . 25.0 107.045 173.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.9 m -59.99 -57.02 14.66 Favored 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 112.945 0.721 . . . . 25.0 112.945 -173.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 47.8 p30 -109.07 167.6 9.98 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.122 0.486 . . . . 25.0 110.457 167.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 59.8 tp -62.47 -26.78 68.7 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.844 -0.616 . . . . 25.0 110.62 172.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.4 m -61.47 -44.63 96.75 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 122.04 -0.413 . . . . 25.0 111.793 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 65.0 m95 -68.77 -30.88 69.57 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 121.762 -0.586 . . . . 25.0 111.519 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -63.05 -44.48 95.75 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.437 -0.949 . . . . 25.0 108.437 175.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -66.12 -41.51 90.46 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.032 -0.531 . . . . 25.0 111.492 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -62.99 -32.78 74.2 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 111.668 0.247 . . . . 25.0 111.668 178.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.77 -14.16 59.42 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.673 0.273 . . . . 25.0 111.434 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.18 11.16 85.8 Favored Glycine 0 C--O 1.23 -0.135 0 N-CA-C 115.031 0.772 . . . . 25.0 115.031 176.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -87.41 146.41 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 N-CA-C 107.791 -1.189 . . . . 25.0 107.791 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.69 152.26 47.37 Favored Glycine 0 C--N 1.316 -0.553 0 N-CA-C 107.803 -2.119 . . . . 25.0 107.803 173.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 8.4 tt -78.49 141.86 37.89 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.579 -1.267 . . . . 25.0 107.579 176.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -117.06 -58.35 2.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.82 0.343 . . . . 25.0 110.405 174.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -111.97 156.54 21.97 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.311 -0.243 . . . . 25.0 111.02 176.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -98.8 146.38 25.99 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 103.708 -2.701 . . . . 25.0 103.708 168.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.53 171.2 40.89 Favored Glycine 0 N--CA 1.451 -0.312 0 N-CA-C 109.552 -1.419 . . . . 25.0 109.552 -174.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -81.31 158.18 24.83 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.104 -0.702 . . . . 25.0 109.104 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 27.8 p -140.58 169.21 18.08 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 122.923 0.489 . . . . 25.0 109.735 -178.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 98.6 mt . . . . . 0 C--O 1.244 0.775 0 N-CA-C 103.287 -2.857 . . . . 25.0 103.287 177.207 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 118.022 -0.99 . . . . 25.0 109.251 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.99 -38.13 89.97 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 108.069 -1.085 . . . . 25.0 108.069 175.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -86.63 128.46 35.0 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 107.001 -1.481 . . . . 25.0 107.001 172.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.3 m -126.24 -15.59 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 113.154 0.798 . . . . 25.0 113.154 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 43.4 t -112.85 136.88 51.99 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 121.906 -0.496 . . . . 25.0 111.346 -177.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 42.5 p -96.17 156.1 16.48 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.993 -1.114 . . . . 25.0 107.993 164.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 39.8 p -102.97 -0.52 30.83 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 123.91 1.814 . . . . 25.0 109.129 163.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.74 130.08 38.09 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 111.031 -2.804 . . . . 25.0 111.535 177.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.413 ' CE2' ' HD3' ' A' ' 11' ' ' PRO . 34.0 t-105 -58.78 105.38 0.3 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 106.529 -1.656 . . . . 25.0 106.529 171.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -136.9 73.89 52.11 Favored Pre-proline 0 C--N 1.318 -0.803 0 CA-C-N 115.554 -0.748 . . . . 25.0 109.142 -174.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.413 ' HD3' ' CE2' ' A' ' 9' ' ' TRP . 37.5 Cg_endo -63.97 134.6 43.86 Favored 'Trans proline' 0 CA--C 1.506 -0.885 0 C-N-CA 117.517 -1.188 . . . . 25.0 112.621 -176.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.4 m -142.72 162.06 18.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 105.989 -1.856 . . . . 25.0 105.989 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 43.8 t -123.75 123.33 40.27 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.839 -0.8 . . . . 25.0 108.839 -177.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.18 164.68 48.08 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.065 -0.588 . . . . 25.0 112.244 -178.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -62.75 -17.6 61.2 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.113 0.783 . . . . 25.0 113.113 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -79.61 5.6 12.74 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 122.334 -0.229 . . . . 25.0 111.146 175.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.59 17.24 71.32 Favored Glycine 0 C--O 1.225 -0.427 0 C-N-CA 120.677 -0.773 . . . . 25.0 113.8 175.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 32.2 mmtm -121.26 138.49 54.21 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 117.559 0.679 . . . . 25.0 112.152 -173.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 38.4 m -83.17 133.84 35.01 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.969 -1.014 . . . . 25.0 111.241 -179.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -114.83 138.33 50.9 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.285 -1.376 . . . . 25.0 107.285 173.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.1 p -62.69 -52.4 63.43 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.567 0.58 . . . . 25.0 112.567 -174.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.417 ' H ' ' HD1' ' A' ' 25' ' ' TRP . 23.1 m-20 -108.24 168.01 9.61 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.371 -0.974 . . . . 25.0 108.371 171.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 59.6 tp -68.68 -26.1 65.13 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.039 -1.096 . . . . 25.0 108.039 171.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 48.6 t -55.01 -52.33 63.48 Favored 'General case' 0 C--O 1.219 -0.513 0 CA-C-N 115.046 -0.979 . . . . 25.0 111.262 175.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.417 ' HD1' ' H ' ' A' ' 22' ' ' ASN . 72.7 m95 -69.42 -27.41 65.25 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.068 0.395 . . . . 25.0 112.068 -175.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -65.86 -49.41 68.22 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.931 -0.766 . . . . 25.0 108.931 175.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -66.75 -40.73 88.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.913 -0.585 . . . . 25.0 111.473 -177.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -67.28 -27.81 67.5 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 120.965 -0.294 . . . . 25.0 111.646 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.34 -12.76 59.55 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.624 0.249 . . . . 25.0 111.138 178.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.06 19.46 78.6 Favored Glycine 0 C--O 1.23 -0.146 0 N-CA-C 114.744 0.658 . . . . 25.0 114.744 175.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -93.15 144.2 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 N-CA-C 107.457 -1.312 . . . . 25.0 107.457 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.62 148.75 45.66 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 107.106 -2.398 . . . . 25.0 107.106 173.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 8.2 tt -78.56 141.01 38.44 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.516 -1.291 . . . . 25.0 107.516 176.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -116.24 -58.13 2.13 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.101 -0.333 . . . . 25.0 110.101 174.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 5.3 m170 -112.03 157.88 20.22 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 110.105 -0.332 . . . . 25.0 110.105 176.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -99.79 147.78 25.11 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 102.677 -3.082 . . . . 25.0 102.677 165.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.46 169.0 41.62 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 109.735 -1.346 . . . . 25.0 109.735 -173.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -72.72 161.56 30.59 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.974 0.731 . . . . 25.0 112.974 -178.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 9.4 m -119.59 168.7 10.75 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 104.901 -2.259 . . . . 25.0 104.901 169.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 62.8 tp . . . . . 0 C--O 1.244 0.81 0 N-CA-C 103.269 -2.863 . . . . 25.0 103.269 175.081 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 6.1 pm0 . . . . . 0 N--CA 1.496 1.86 0 N-CA-C 109.774 -0.454 . . . . 25.0 109.774 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.87 -138.51 1.1 Allowed 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 104.667 -2.346 . . . . 25.0 104.667 -164.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.19 -80.28 0.09 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 104.832 -2.284 . . . . 25.0 104.832 168.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.1 m -138.25 -37.62 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.542 -0.754 . . . . 25.0 110.89 165.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.7 t -114.9 145.59 42.03 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.041 -0.981 . . . . 25.0 110.628 173.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.1 p -95.96 151.1 19.74 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 106.775 -1.565 . . . . 25.0 106.775 164.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.0 p -103.09 5.02 37.74 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 122.946 1.355 . . . . 25.0 112.739 172.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.03 130.03 37.76 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 113.271 -1.786 . . . . 25.0 111.68 -175.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.429 ' CE2' ' HD3' ' A' ' 11' ' ' PRO . 55.7 t-105 -61.53 105.99 0.6 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 107.385 -1.339 . . . . 25.0 107.385 174.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -137.93 73.17 46.59 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 108.12 -1.067 . . . . 25.0 108.12 -176.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.429 ' HD3' ' CE2' ' A' ' 9' ' ' TRP . 33.6 Cg_endo -62.87 133.61 42.6 Favored 'Trans proline' 0 CA--C 1.503 -1.07 0 O-C-N 122.309 0.636 . . . . 25.0 112.081 -173.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.5 m -139.55 161.18 27.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 107.282 -1.377 . . . . 25.0 107.282 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.1 t -131.55 121.69 24.85 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.889 -1.152 . . . . 25.0 107.889 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.98 173.58 54.67 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.815 -0.629 . . . . 25.0 112.823 -176.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp -64.2 -16.07 61.23 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.325 0.861 . . . . 25.0 113.325 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -92.07 10.65 28.27 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.736 0.303 . . . . 25.0 110.218 177.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.95 -2.34 65.17 Favored Glycine 0 C--O 1.223 -0.557 0 N-CA-C 114.281 0.472 . . . . 25.0 114.281 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -82.73 130.74 35.17 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 121.883 -0.775 . . . . 25.0 111.973 -175.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 70.3 m -84.79 128.39 34.59 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.986 -1.007 . . . . 25.0 110.87 177.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -114.88 137.02 52.46 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.002 -0.74 . . . . 25.0 109.002 174.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.3 m -60.51 -54.91 39.82 Favored 'General case' 0 C--O 1.217 -0.611 0 N-CA-C 112.701 0.63 . . . . 25.0 112.701 -174.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -109.1 168.41 9.39 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.07 0.462 . . . . 25.0 110.525 167.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 39.8 tp -65.76 -23.02 66.63 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.967 -0.561 . . . . 25.0 111.041 172.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 22.5 t -60.87 -50.35 73.8 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 121.956 -0.465 . . . . 25.0 111.001 178.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -64.38 -31.18 72.29 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 122.113 -0.367 . . . . 25.0 111.556 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -63.41 -46.39 86.6 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 109.159 -0.682 . . . . 25.0 109.159 176.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.08 -42.37 94.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.059 -0.519 . . . . 25.0 110.468 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -65.32 -33.13 75.25 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.598 0.221 . . . . 25.0 111.598 -179.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.76 -12.2 60.01 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 111.779 0.289 . . . . 25.0 111.779 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.4 19.99 79.78 Favored Glycine 0 C--O 1.229 -0.194 0 N-CA-C 115.005 0.762 . . . . 25.0 115.005 176.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -91.81 142.44 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 N-CA-C 107.542 -1.281 . . . . 25.0 107.542 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.53 147.17 46.64 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 108.005 -2.038 . . . . 25.0 108.005 173.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 62.0 tp -75.07 144.47 42.95 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.939 -1.134 . . . . 25.0 107.939 176.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -122.38 -59.15 1.66 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.401 -0.52 . . . . 25.0 110.218 172.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -113.82 153.05 29.78 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.512 0.56 . . . . 25.0 112.512 173.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -85.86 148.69 25.69 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 100.952 -3.722 . . . . 25.0 100.952 159.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.3 152.84 26.71 Favored Glycine 0 C--N 1.318 -0.449 0 N-CA-C 110.656 -0.977 . . . . 25.0 110.656 -176.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -83.66 151.75 25.12 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.66 0.615 . . . . 25.0 112.66 -176.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 76.2 m -108.09 -177.95 3.47 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 105.692 -1.966 . . . . 25.0 105.692 171.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 65.1 tp . . . . . 0 C--O 1.25 1.102 0 N-CA-C 105.226 -2.139 . . . . 25.0 105.226 175.298 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 . . . . . 0 N--CA 1.497 1.923 0 N-CA-C 110.925 -0.028 . . . . 25.0 110.925 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.17 144.86 56.39 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 122.053 -0.404 . . . . 25.0 110.447 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -79.64 52.19 1.39 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.137 0.575 . . . . 25.0 112.015 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.7 m -106.65 0.47 10.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.552 0.691 . . . . 25.0 109.933 -178.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 45.1 t -81.05 139.99 35.39 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.064 -0.516 . . . . 25.0 109.627 -178.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 39.9 p -80.63 166.43 21.1 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.408 0.623 . . . . 25.0 111.215 -178.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.4 p -83.48 24.94 0.79 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.208 0.528 . . . . 25.0 112.387 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -61.79 130.05 43.91 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.047 0.451 . . . . 25.0 110.593 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 65.1 t-105 -65.85 104.98 1.18 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.361 -0.836 . . . . 25.0 110.302 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -137.72 74.25 45.85 Favored Pre-proline 0 C--O 1.239 0.521 0 N-CA-C 106.997 -1.483 . . . . 25.0 106.997 177.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.77 139.51 44.01 Favored 'Trans proline' 0 CA--C 1.51 -0.699 0 C-N-CA 117.186 -1.41 . . . . 25.0 114.081 -172.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.0 m -141.9 162.3 20.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 105.995 -1.854 . . . . 25.0 105.995 178.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.8 t -128.53 127.1 41.73 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-O 121.02 0.438 . . . . 25.0 110.04 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.33 175.31 54.95 Favored Glycine 0 C--O 1.227 -0.318 0 C-N-CA 121.06 -0.59 . . . . 25.0 112.427 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -66.53 -18.07 65.16 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 122.477 -0.425 . . . . 25.0 111.841 177.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -79.23 0.75 27.27 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.564 0.697 . . . . 25.0 110.82 176.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 75.46 16.71 80.46 Favored Glycine 0 C--O 1.222 -0.626 0 C-N-CA 120.87 -0.681 . . . . 25.0 113.209 178.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -106.04 137.3 44.2 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 122.246 -0.561 . . . . 25.0 110.667 -177.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 60.8 m -82.46 134.28 35.22 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.799 -0.637 . . . . 25.0 109.526 177.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -114.95 137.92 51.43 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 106.566 -1.642 . . . . 25.0 106.566 174.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.5 p -60.26 -55.83 28.89 Favored 'General case' 0 C--O 1.219 -0.511 0 N-CA-C 112.382 0.512 . . . . 25.0 112.382 -173.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 36.8 p30 -109.06 166.14 11.06 Favored 'General case' 0 C--O 1.244 0.79 0 CA-C-O 121.306 0.574 . . . . 25.0 110.892 166.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 60.9 tp -63.15 -25.72 68.48 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.207 0.527 . . . . 25.0 111.15 172.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 68.5 m -63.63 -41.45 98.26 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 121.792 -0.568 . . . . 25.0 112.213 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 60.4 m95 -70.62 -29.56 65.97 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 121.428 -0.795 . . . . 25.0 110.721 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.94 -42.66 99.88 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.286 -1.005 . . . . 25.0 108.286 173.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -63.66 -41.36 98.21 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 111.696 0.258 . . . . 25.0 111.696 177.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -63.68 -36.04 82.53 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 117.831 0.287 . . . . 25.0 111.722 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.38 -17.92 57.78 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.668 0.271 . . . . 25.0 111.63 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.67 5.6 83.57 Favored Glycine 0 CA--C 1.518 0.227 0 N-CA-C 115.109 0.804 . . . . 25.0 115.109 176.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -74.31 140.46 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.654 0 N-CA-C 107.467 -1.308 . . . . 25.0 107.467 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.28 147.15 49.76 Favored Glycine 0 C--N 1.315 -0.59 0 N-CA-C 107.608 -2.197 . . . . 25.0 107.608 174.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 56.5 tp -72.92 143.52 47.68 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.475 -0.935 . . . . 25.0 108.475 177.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -124.36 -59.1 1.49 Allowed 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 121.179 -0.208 . . . . 25.0 110.888 173.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -111.91 154.26 25.48 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.418 -0.216 . . . . 25.0 110.418 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -98.92 143.94 28.65 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 102.41 -3.182 . . . . 25.0 102.41 167.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 93.19 170.16 39.54 Favored Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 109.1 -1.6 . . . . 25.0 109.1 -173.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -78.5 162.32 26.43 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.426 -0.583 . . . . 25.0 109.426 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 26.3 p -141.66 169.24 17.96 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.523 -0.917 . . . . 25.0 108.523 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 62.3 tp . . . . . 0 C--O 1.244 0.79 0 N-CA-C 102.624 -3.102 . . . . 25.0 102.624 178.608 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 8.9 pm0 . . . . . 0 N--CA 1.496 1.862 0 CA-C-O 119.425 -0.322 . . . . 25.0 110.238 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.36 -33.23 55.34 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.134 0.42 . . . . 25.0 112.134 -176.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -152.16 169.28 22.83 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 106.3 -1.741 . . . . 25.0 106.3 -179.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.0 m -126.07 -21.62 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 113.944 1.09 . . . . 25.0 113.944 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.03 160.0 18.59 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.818 0.303 . . . . 25.0 111.818 -177.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 61.1 p -95.98 168.48 10.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.101 0.476 . . . . 25.0 111.717 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.1 p -99.98 22.2 11.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.684 0.754 . . . . 25.0 111.516 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -67.73 130.0 41.65 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.678 -0.692 . . . . 25.0 111.365 -178.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 66.6 t-105 -62.89 106.93 0.89 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.315 -0.624 . . . . 25.0 109.315 177.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -138.04 72.97 46.19 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.831 -0.622 . . . . 25.0 109.559 -178.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -65.4 134.15 37.62 Favored 'Trans proline' 0 CA--C 1.51 -0.689 0 C-N-CA 116.716 -1.723 . . . . 25.0 113.637 -173.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.9 m -141.62 161.61 21.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 106.112 -1.81 . . . . 25.0 106.112 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.439 ' HB3' ' HB2' ' A' ' 35' ' ' HIS . 50.4 t -129.11 125.08 36.37 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.966 -0.753 . . . . 25.0 108.966 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.84 175.29 54.09 Favored Glycine 0 C--O 1.227 -0.32 0 CA-C-N 115.918 -0.583 . . . . 25.0 114.078 -175.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -67.56 -12.07 59.53 Favored 'General case' 0 C--O 1.215 -0.735 0 N-CA-C 112.487 0.551 . . . . 25.0 112.487 177.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -91.41 8.94 33.84 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.711 0.291 . . . . 25.0 110.453 176.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.5 -18.5 8.5 Favored Glycine 0 C--O 1.222 -0.652 0 N-CA-C 114.926 0.731 . . . . 25.0 114.926 177.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -73.11 139.41 46.42 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 121.312 0.577 . . . . 25.0 112.289 -177.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 98.8 m -86.05 132.63 34.0 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.653 -1.158 . . . . 25.0 108.882 175.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -115.0 136.97 52.54 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.114 -1.069 . . . . 25.0 108.114 176.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.8 m -62.33 -51.68 66.66 Favored 'General case' 0 C--O 1.223 -0.327 0 N-CA-C 112.714 0.635 . . . . 25.0 112.714 -174.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 45.9 p30 -113.9 170.08 8.53 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 121.109 0.48 . . . . 25.0 110.546 168.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 41.5 tp -63.79 -25.57 68.24 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.902 -0.59 . . . . 25.0 110.66 172.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 19.5 m -61.53 -46.05 91.58 Favored 'General case' 0 C--O 1.218 -0.571 0 O-C-N 122.144 -0.347 . . . . 25.0 111.916 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 24.5 m95 -70.08 -28.41 65.41 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 121.788 -0.57 . . . . 25.0 111.201 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -64.51 -45.32 87.74 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.5 -0.926 . . . . 25.0 108.5 175.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -66.05 -42.22 89.8 Favored 'General case' 0 C--O 1.22 -0.467 0 CA-C-N 115.782 -0.644 . . . . 25.0 111.78 178.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -63.61 -33.56 75.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.718 0.294 . . . . 25.0 111.414 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.27 -12.22 59.98 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.602 0.239 . . . . 25.0 111.323 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.0 21.78 77.85 Favored Glycine 0 C--O 1.23 -0.11 0 N-CA-C 114.385 0.514 . . . . 25.0 114.385 174.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -99.52 143.2 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 N-CA-C 109.09 -0.707 . . . . 25.0 109.09 -178.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.06 149.06 47.07 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 107.848 -2.101 . . . . 25.0 107.848 172.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 7.7 tt -74.73 147.97 40.89 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.073 -1.084 . . . . 25.0 108.073 177.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -129.34 -47.52 1.19 Allowed 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 112.98 0.733 . . . . 25.0 112.98 172.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.439 ' HB2' ' HB3' ' A' ' 13' ' ' CYS . 52.4 m-70 -114.46 156.44 24.54 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.356 -0.609 . . . . 25.0 109.356 174.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -100.01 146.15 27.06 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 102.784 -3.043 . . . . 25.0 102.784 169.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.19 175.58 47.7 Favored Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 109.305 -1.518 . . . . 25.0 109.305 -174.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -75.63 160.53 30.0 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.994 0.426 . . . . 25.0 112.013 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 16.8 m -111.77 161.72 16.01 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 104.581 -2.377 . . . . 25.0 104.581 167.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 61.5 tp . . . . . 0 C--O 1.242 0.701 0 N-CA-C 103.902 -2.629 . . . . 25.0 103.902 178.438 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 7.0 pm0 . . . . . 0 N--CA 1.494 1.729 0 N-CA-C 110.253 -0.277 . . . . 25.0 110.253 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.44 -81.8 0.18 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 102.233 -3.247 . . . . 25.0 102.233 174.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.26 153.47 42.39 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 101.93 -3.359 . . . . 25.0 101.93 160.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.9 m -106.36 -34.33 2.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 120.152 -0.619 . . . . 25.0 112.524 -176.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.6 t -113.26 139.91 48.41 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.315 -0.994 . . . . 25.0 108.315 169.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.414 ' H ' ' HB2' ' A' ' 24' ' ' CYS . 12.5 p -96.03 151.25 19.62 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.284 -1.376 . . . . 25.0 107.284 167.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.0 p -103.08 5.06 37.78 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 123.262 1.506 . . . . 25.0 111.277 171.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -75.88 130.01 37.86 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 112.661 -2.063 . . . . 25.0 111.396 -177.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 43.8 t-105 -60.26 107.23 0.62 Allowed 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 105.823 -1.917 . . . . 25.0 105.823 169.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -137.91 73.35 46.35 Favored Pre-proline 0 C--N 1.32 -0.693 0 N-CA-C 108.203 -1.036 . . . . 25.0 108.203 -173.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.37 130.29 24.9 Favored 'Trans proline' 0 CA--C 1.507 -0.847 0 C-N-CA 117.099 -1.467 . . . . 25.0 112.758 -175.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.1 m -140.59 162.14 23.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 104.929 -2.249 . . . . 25.0 104.929 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.419 ' HB3' ' HB2' ' A' ' 35' ' ' HIS . 53.4 t -133.62 129.22 36.62 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.687 -0.857 . . . . 25.0 108.687 -179.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.92 -179.69 52.98 Favored Glycine 0 N--CA 1.452 -0.257 0 CA-C-O 121.651 0.584 . . . . 25.0 114.158 -174.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -71.63 -12.07 61.16 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.179 0.514 . . . . 25.0 110.456 176.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -86.96 0.84 54.43 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.532 -0.758 . . . . 25.0 110.688 175.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 78.56 -1.9 69.96 Favored Glycine 0 C--O 1.228 -0.248 0 N-CA-C 114.611 0.604 . . . . 25.0 114.611 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.9 mtmm -88.64 140.49 29.4 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 118.178 0.989 . . . . 25.0 111.522 -177.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 94.3 m -81.94 131.72 35.25 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.891 -1.049 . . . . 25.0 108.845 175.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -114.8 137.39 52.0 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 106.036 -1.839 . . . . 25.0 106.036 174.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.8 p -66.63 -52.09 48.99 Favored 'General case' 0 C--O 1.22 -0.491 0 N-CA-C 111.677 0.251 . . . . 25.0 111.677 -173.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 30.4 p30 -109.1 167.01 10.41 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-O 121.732 0.777 . . . . 25.0 111.691 167.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 45.7 tp -64.84 -24.79 67.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.151 -0.932 . . . . 25.0 110.714 172.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.414 ' HB2' ' H ' ' A' ' 6' ' ' THR . 43.4 t -59.88 -49.97 75.61 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 122.167 -0.333 . . . . 25.0 111.323 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.7 m95 -69.53 -28.18 65.8 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.265 -0.574 . . . . 25.0 111.572 -179.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -63.0 -44.8 95.03 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.399 -0.963 . . . . 25.0 108.399 174.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.36 -41.9 93.35 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.14 -0.482 . . . . 25.0 111.017 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -65.47 -32.89 74.75 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 122.183 -0.323 . . . . 25.0 111.244 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.52 -13.76 60.07 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.715 0.293 . . . . 25.0 111.373 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.76 12.86 83.56 Favored Glycine 0 CA--C 1.516 0.111 0 N-CA-C 114.946 0.739 . . . . 25.0 114.946 175.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -88.01 142.68 12.6 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.674 0 N-CA-C 108.516 -0.92 . . . . 25.0 108.516 -178.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.44 142.12 32.08 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 107.302 -2.319 . . . . 25.0 107.302 173.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 9.0 tt -65.9 142.47 57.89 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.045 -1.094 . . . . 25.0 108.045 177.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -121.51 -55.17 1.94 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 122.43 -0.169 . . . . 25.0 110.767 175.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.419 ' HB2' ' HB3' ' A' ' 13' ' ' CYS . 29.6 m-70 -111.96 154.32 25.44 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.849 -0.797 . . . . 25.0 108.849 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -98.29 143.78 28.41 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 103.198 -2.89 . . . . 25.0 103.198 170.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.45 177.4 48.48 Favored Glycine 0 C--N 1.321 -0.293 0 N-CA-C 109.968 -1.253 . . . . 25.0 109.968 -175.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -74.31 159.77 31.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.971 0.415 . . . . 25.0 112.115 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 22.3 m -109.71 156.36 20.37 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 104.806 -2.294 . . . . 25.0 104.806 167.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.0 mp . . . . . 0 C--O 1.243 0.753 0 N-CA-C 103.339 -2.837 . . . . 25.0 103.339 177.422 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 119.353 -0.356 . . . . 25.0 110.041 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.53 -43.03 77.59 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.885 1.068 . . . . 25.0 113.885 -174.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -151.86 155.12 37.5 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.72 -0.844 . . . . 25.0 108.72 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 17.3 m -130.27 -27.02 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 113.14 0.792 . . . . 25.0 113.14 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 32.1 p -113.01 156.51 22.94 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.273 -0.421 . . . . 25.0 110.827 -179.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.2 p -95.93 155.66 16.66 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 111.689 0.255 . . . . 25.0 111.689 176.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.6 p -103.01 -0.24 31.12 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 123.987 1.851 . . . . 25.0 110.449 170.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -75.57 135.36 40.56 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 110.898 -2.865 . . . . 25.0 108.223 176.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.406 ' CE2' ' HD3' ' A' ' 11' ' ' PRO . 44.8 t-105 -48.13 105.34 0.07 Allowed 'General case' 0 N--CA 1.476 0.871 0 O-C-N 124.362 1.039 . . . . 25.0 108.508 178.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -137.82 74.71 44.31 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 106.612 -1.625 . . . . 25.0 106.612 -174.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.406 ' HD3' ' CE2' ' A' ' 9' ' ' TRP . 29.7 Cg_endo -63.28 132.71 37.29 Favored 'Trans proline' 0 CA--C 1.506 -0.913 0 C-N-CA 116.621 -1.786 . . . . 25.0 112.228 -175.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.8 m -144.34 162.98 14.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 105.73 -1.952 . . . . 25.0 105.73 -178.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 35' ' ' HIS . 45.2 t -132.94 130.39 39.52 Favored 'General case' 0 C--O 1.245 0.833 0 N-CA-C 109.586 -0.524 . . . . 25.0 109.586 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -77.91 174.93 54.73 Favored Glycine 0 N--CA 1.453 -0.171 0 CA-C-N 115.528 -0.76 . . . . 25.0 113.619 -176.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -68.23 -17.88 64.42 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.199 0.444 . . . . 25.0 112.199 178.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -94.39 9.89 36.51 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.995 0.426 . . . . 25.0 111.073 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.25 -0.65 89.31 Favored Glycine 0 C--O 1.227 -0.328 0 N-CA-C 117.267 1.667 . . . . 25.0 117.267 174.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 11.9 mmtp -83.27 138.29 33.64 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.19 1.495 . . . . 25.0 111.772 -177.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 97.5 m -84.84 129.17 34.85 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.537 -0.756 . . . . 25.0 109.266 175.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -114.7 138.02 51.21 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.827 -1.175 . . . . 25.0 107.827 175.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.0 p -68.85 -54.75 13.92 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.057 0.391 . . . . 25.0 112.057 -175.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.444 ' H ' ' HD1' ' A' ' 25' ' ' TRP . 10.2 m-20 -108.98 162.91 13.78 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.398 -0.964 . . . . 25.0 108.398 174.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 41.9 tp -65.65 -30.09 70.75 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.186 -0.461 . . . . 25.0 111.08 177.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 68.7 m -65.86 -26.07 67.48 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 121.182 -0.948 . . . . 25.0 113.02 177.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.444 ' HD1' ' H ' ' A' ' 22' ' ' ASN . 83.0 m95 -75.02 -34.43 61.91 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 121.7 -0.625 . . . . 25.0 109.652 177.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -64.06 -44.94 90.9 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.391 -0.966 . . . . 25.0 108.391 174.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.7 -41.65 99.24 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.599 -0.728 . . . . 25.0 111.675 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -67.17 -33.54 75.61 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.51 0.195 . . . . 25.0 111.485 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.43 -18.61 58.73 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.777 0.322 . . . . 25.0 110.959 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.33 7.78 86.97 Favored Glycine 0 CA--C 1.517 0.159 0 N-CA-C 114.936 0.734 . . . . 25.0 114.936 176.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -77.58 142.1 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 N-CA-C 108.594 -0.891 . . . . 25.0 108.594 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.18 148.88 49.48 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 107.953 -2.059 . . . . 25.0 107.953 173.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.6 tp -70.79 142.77 51.33 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.992 -0.744 . . . . 25.0 108.992 177.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -126.51 -58.15 1.34 Allowed 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 121.137 -0.225 . . . . 25.0 110.834 173.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.41 ' HB2' ' HB3' ' A' ' 13' ' ' CYS . 20.5 m-70 -112.02 153.44 26.83 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.439 -0.578 . . . . 25.0 109.439 178.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -102.07 144.18 30.97 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 102.834 -3.024 . . . . 25.0 102.834 168.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.82 171.67 42.12 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 109.021 -1.632 . . . . 25.0 109.021 -172.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -73.58 160.9 30.96 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.107 0.41 . . . . 25.0 112.107 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 4.3 m -109.95 164.47 12.57 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 106.187 -1.783 . . . . 25.0 106.187 170.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 67.7 tp . . . . . 0 C--O 1.253 1.282 0 N-CA-C 104.173 -2.529 . . . . 25.0 104.173 176.907 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 8.8 pm0 . . . . . 0 N--CA 1.496 1.862 0 CA-C-O 119.403 -0.332 . . . . 25.0 110.292 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.82 168.3 25.55 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 105.921 -1.881 . . . . 25.0 105.921 178.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.13 103.97 6.43 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.129 -1.063 . . . . 25.0 108.129 176.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.8 m -107.05 0.52 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 121.465 0.65 . . . . 25.0 110.268 -178.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -81.4 154.18 26.56 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.955 -0.566 . . . . 25.0 110.346 -179.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 43.0 p -95.03 173.65 7.48 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.266 0.555 . . . . 25.0 111.799 -176.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.1 p -93.19 19.86 7.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 122.035 0.921 . . . . 25.0 110.527 176.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -64.27 129.92 41.83 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.75 -1.114 . . . . 25.0 108.333 177.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 72.1 t-105 -51.1 103.9 0.07 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.605 0.717 . . . . 25.0 111.233 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -137.68 73.66 47.31 Favored Pre-proline 0 C--O 1.242 0.669 0 N-CA-C 106.881 -1.526 . . . . 25.0 106.881 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.77 134.59 41.2 Favored 'Trans proline' 0 CA--C 1.507 -0.859 0 C-N-CA 117.666 -1.09 . . . . 25.0 113.505 -173.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.7 m -140.94 162.18 22.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 106.85 -1.537 . . . . 25.0 106.85 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 35' ' ' HIS . 37.4 t -131.06 125.72 33.96 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.069 -0.715 . . . . 25.0 109.069 -178.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -79.82 179.01 53.49 Favored Glycine 0 C--N 1.323 -0.175 0 C-N-CA 121.062 -0.589 . . . . 25.0 112.544 -177.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -64.66 -23.31 67.22 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.393 0.277 . . . . 25.0 111.443 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -73.7 -4.05 32.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.342 0.591 . . . . 25.0 110.969 177.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 79.54 7.39 88.52 Favored Glycine 0 C--O 1.228 -0.279 0 C-N-CA 121.474 -0.393 . . . . 25.0 112.533 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.6 mmmt -102.52 141.79 34.77 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.716 0.769 . . . . 25.0 112.573 -177.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 44.7 m -85.26 133.63 34.16 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.038 -1.437 . . . . 25.0 112.788 -176.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -114.67 137.13 52.28 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 106.933 -1.506 . . . . 25.0 106.933 171.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.8 m -61.28 -55.37 32.7 Favored 'General case' 0 C--O 1.221 -0.435 0 N-CA-C 112.741 0.645 . . . . 25.0 112.741 -174.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -108.78 153.78 23.0 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 109.17 -0.678 . . . . 25.0 109.17 170.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 67.7 tp -57.95 -27.77 63.71 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 116.016 -0.538 . . . . 25.0 110.992 174.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -61.68 -36.69 81.6 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.757 0.651 . . . . 25.0 112.757 178.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 12.3 m95 -72.37 -35.19 68.42 Favored 'General case' 0 C--O 1.22 -0.475 0 C-N-CA 119.703 -0.799 . . . . 25.0 110.048 177.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -61.91 -44.21 97.26 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 108.941 -0.763 . . . . 25.0 108.941 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -63.99 -42.12 97.31 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.006 -0.543 . . . . 25.0 111.825 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -69.67 -30.88 68.66 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 111.912 0.338 . . . . 25.0 111.912 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.25 -19.35 59.78 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.812 0.339 . . . . 25.0 110.887 177.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.74 -0.46 88.19 Favored Glycine 0 CA--C 1.516 0.137 0 N-CA-C 115.117 0.807 . . . . 25.0 115.117 176.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.407 HG23 ' H ' ' A' ' 31' ' ' VAL . 1.9 t -68.69 138.12 23.03 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.614 0 N-CA-C 107.955 -1.128 . . . . 25.0 107.955 179.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.02 142.65 45.25 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 108.249 -1.94 . . . . 25.0 108.249 174.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.4 tp -72.14 142.56 49.11 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.074 -1.084 . . . . 25.0 108.074 177.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -125.64 -57.38 1.46 Allowed 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 121.06 -0.256 . . . . 25.0 110.918 175.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.425 ' HB2' ' HB3' ' A' ' 13' ' ' CYS . 7.2 m170 -111.94 153.03 27.35 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.881 -0.415 . . . . 25.0 109.881 176.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -98.52 146.96 25.25 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 101.285 -3.598 . . . . 25.0 101.285 163.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.54 165.93 36.24 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 108.184 -1.966 . . . . 25.0 108.184 -171.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -91.63 154.39 19.06 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 113.085 0.772 . . . . 25.0 113.085 -175.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 82.8 m -108.68 -179.56 3.9 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 106.197 -1.779 . . . . 25.0 106.197 172.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.0 tm? . . . . . 0 C--O 1.253 1.279 0 N-CA-C 104.602 -2.37 . . . . 25.0 104.602 173.882 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 109.752 -0.462 . . . . 25.0 109.752 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.53 166.12 33.01 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 104.653 -2.351 . . . . 25.0 104.653 178.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.16 144.11 55.11 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.894 -0.78 . . . . 25.0 108.894 177.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.0 m -108.18 0.28 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-O 121.577 0.703 . . . . 25.0 110.505 -178.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 75.3 m -80.97 141.84 34.05 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.806 -0.634 . . . . 25.0 112.206 -172.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 48.7 p -77.81 170.99 15.65 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.615 -0.72 . . . . 25.0 111.818 -177.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.9 p -79.03 25.15 0.29 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.348 0.87 . . . . 25.0 113.348 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -57.84 129.86 43.85 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.434 -0.348 . . . . 25.0 110.456 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 63.1 t-105 -77.24 102.65 6.77 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.072 -0.714 . . . . 25.0 109.072 175.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -136.42 73.03 57.14 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 107.545 -1.28 . . . . 25.0 107.545 177.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.63 139.49 44.53 Favored 'Trans proline' 0 CA--C 1.508 -0.782 0 C-N-CA 117.279 -1.347 . . . . 25.0 114.303 -171.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.8 m -141.08 162.07 22.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 106.588 -1.634 . . . . 25.0 106.588 178.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 37.5 t -122.55 126.55 47.99 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.065 -0.717 . . . . 25.0 109.065 179.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.92 172.96 44.55 Favored Glycine 0 C--O 1.225 -0.433 0 C-N-CA 120.691 -0.766 . . . . 25.0 112.026 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 37.2 mttp -65.52 -12.36 52.11 Favored 'General case' 0 C--O 1.215 -0.727 0 C-N-CA 123.017 0.527 . . . . 25.0 112.42 176.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -76.0 -2.48 30.75 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.262 0.625 . . . . 25.0 110.222 175.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.86 16.69 79.65 Favored Glycine 0 C--O 1.223 -0.587 0 C-N-CA 121.414 -0.422 . . . . 25.0 112.833 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 63.8 mttt -125.97 145.93 50.08 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.142 0.496 . . . . 25.0 112.311 -172.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 99.6 m -79.65 135.66 36.62 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.895 -1.048 . . . . 25.0 111.046 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -114.78 137.33 52.06 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 105.822 -1.918 . . . . 25.0 105.822 171.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.6 p -60.45 -54.96 39.32 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 113.08 0.77 . . . . 25.0 113.08 -172.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 29.7 p30 -109.61 165.76 11.42 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 121.182 0.515 . . . . 25.0 110.576 166.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 65.1 tp -64.61 -24.16 67.5 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.15 0.5 . . . . 25.0 111.669 174.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.0 t -64.25 -45.4 88.31 Favored 'General case' 0 C--O 1.216 -0.686 0 O-C-N 121.754 -0.591 . . . . 25.0 110.826 178.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 46.0 m95 -65.63 -31.31 72.26 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 121.768 -0.582 . . . . 25.0 111.144 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -62.46 -44.86 95.4 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.917 -0.771 . . . . 25.0 108.917 174.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -65.18 -41.9 94.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.139 -0.482 . . . . 25.0 111.732 178.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -65.83 -30.86 71.55 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.633 0.254 . . . . 25.0 111.113 -178.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.95 -15.82 58.67 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.753 0.311 . . . . 25.0 111.17 177.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.66 15.92 80.03 Favored Glycine 0 C--O 1.231 -0.084 0 N-CA-C 114.775 0.67 . . . . 25.0 114.775 175.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.3 t -89.31 147.63 5.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 107.622 -1.251 . . . . 25.0 107.622 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.25 144.61 34.83 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 107.912 -2.075 . . . . 25.0 107.912 174.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 63.4 tp -70.31 142.36 52.24 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.348 -1.353 . . . . 25.0 107.348 176.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -122.92 -58.83 1.64 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.901 -0.319 . . . . 25.0 110.953 175.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 21.2 m-70 -112.01 153.77 26.33 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 122.351 -0.218 . . . . 25.0 111.584 176.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -95.2 145.92 24.7 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 103.582 -2.747 . . . . 25.0 103.582 167.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.02 168.21 40.46 Favored Glycine 0 N--CA 1.452 -0.27 0 N-CA-C 109.989 -1.244 . . . . 25.0 109.989 -175.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -80.14 159.23 26.11 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.397 -0.594 . . . . 25.0 109.397 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 27.7 p -142.17 167.42 22.16 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 122.921 0.488 . . . . 25.0 109.983 -177.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 62.8 tp . . . . . 0 C--O 1.244 0.781 0 N-CA-C 102.486 -3.153 . . . . 25.0 102.486 177.824 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 . . . . . 0 N--CA 1.496 1.836 0 CA-C-O 118.765 -0.636 . . . . 25.0 109.429 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.53 -39.7 70.57 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.567 0.622 . . . . 25.0 110.133 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -158.94 164.02 35.99 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 104.697 -2.334 . . . . 25.0 104.697 178.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.2 m -137.75 -34.4 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-O 121.205 0.526 . . . . 25.0 112.328 175.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 96.8 m -112.96 158.95 19.61 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 112.964 0.727 . . . . 25.0 112.964 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 20.3 p -89.77 156.16 18.7 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.153 -1.054 . . . . 25.0 108.153 172.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.9 p -102.94 7.25 39.24 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 123.264 1.507 . . . . 25.0 110.722 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -75.96 134.91 40.07 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 112.548 -2.115 . . . . 25.0 112.977 -177.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 54.3 t-105 -58.58 109.93 0.89 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.41 -1.33 . . . . 25.0 107.41 175.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -138.03 73.23 45.77 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 107.864 -1.161 . . . . 25.0 107.864 -176.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.04 134.43 36.92 Favored 'Trans proline' 0 CA--C 1.506 -0.886 0 C-N-CA 117.379 -1.281 . . . . 25.0 113.059 -173.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 m -140.33 159.52 25.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 106.012 -1.847 . . . . 25.0 106.012 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 35' ' ' HIS . 52.1 t -131.83 124.47 29.67 Favored 'General case' 0 C--O 1.246 0.91 0 CA-C-O 121.41 0.624 . . . . 25.0 109.715 -177.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -82.78 176.27 53.35 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 115.561 -0.745 . . . . 25.0 114.071 -175.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -67.9 -13.1 61.88 Favored 'General case' 0 C--O 1.216 -0.694 0 N-CA-C 112.186 0.439 . . . . 25.0 112.186 177.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.6 p-10 -82.77 0.84 41.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.363 -0.38 . . . . 25.0 111.043 175.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 76.88 16.94 80.34 Favored Glycine 0 C--O 1.225 -0.427 0 CA-C-O 119.565 -0.575 . . . . 25.0 114.106 178.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -115.8 143.86 44.81 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 118.028 0.914 . . . . 25.0 112.098 -176.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 91.1 m -84.97 132.97 34.28 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.241 -1.345 . . . . 25.0 110.659 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -114.93 138.56 50.68 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 106.745 -1.576 . . . . 25.0 106.745 174.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.3 p -62.52 -55.73 24.69 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 123.316 0.385 . . . . 25.0 111.889 -173.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 52.8 p30 -109.19 169.31 8.77 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-O 121.478 0.656 . . . . 25.0 111.386 166.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 45.5 tp -63.69 -23.7 67.48 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.765 -0.652 . . . . 25.0 111.283 172.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 31.1 t -61.12 -50.42 73.31 Favored 'General case' 0 C--O 1.22 -0.497 0 O-C-N 122.043 -0.411 . . . . 25.0 111.033 178.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 72.2 m95 -66.96 -28.72 68.51 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.209 -0.596 . . . . 25.0 111.492 -179.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -64.0 -45.72 87.74 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 108.886 -0.783 . . . . 25.0 108.886 174.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -65.6 -42.88 91.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.159 -0.473 . . . . 25.0 112.242 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -64.95 -31.84 73.26 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.745 0.307 . . . . 25.0 111.337 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.28 -13.36 59.95 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.659 0.266 . . . . 25.0 111.241 178.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.34 16.87 79.7 Favored Glycine 0 C--O 1.23 -0.144 0 N-CA-C 114.71 0.644 . . . . 25.0 114.71 175.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -88.52 140.81 15.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 108.42 -0.955 . . . . 25.0 108.42 -178.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.26 144.63 44.81 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 107.515 -2.234 . . . . 25.0 107.515 173.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 65.8 tp -72.24 145.38 47.98 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.208 -1.034 . . . . 25.0 108.208 177.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -129.98 -53.34 1.13 Allowed 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 113.107 0.78 . . . . 25.0 113.107 171.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.425 ' HB2' ' HB3' ' A' ' 13' ' ' CYS . 54.4 m-70 -112.13 143.47 43.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 118.154 0.434 . . . . 25.0 110.232 176.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.3 mp0 -85.79 145.11 27.38 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 102.072 -3.307 . . . . 25.0 102.072 166.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 93.03 176.07 40.9 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 109.711 -1.356 . . . . 25.0 109.711 -176.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.47 154.32 19.21 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.857 0.361 . . . . 25.0 111.654 -176.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 57.8 m -108.21 169.98 8.29 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 106.824 -1.547 . . . . 25.0 106.824 173.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 66.5 tp . . . . . 0 C--O 1.251 1.169 0 N-CA-C 104.555 -2.387 . . . . 25.0 104.555 176.024 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 110.293 -0.262 . . . . 25.0 110.293 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.36 -157.75 0.52 Allowed 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 102.561 -3.125 . . . . 25.0 102.561 -179.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.31 -76.38 0.07 Allowed 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 102.852 -3.018 . . . . 25.0 102.852 165.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.33 -48.27 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.69 0 N-CA-C 105.582 -2.007 . . . . 25.0 105.582 156.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 t -124.9 159.97 29.91 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.233 -1.349 . . . . 25.0 110.43 159.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.767 ' H ' ' HB2' ' A' ' 24' ' ' CYS . 16.6 p -95.9 155.96 16.53 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 100.853 -3.758 . . . . 25.0 100.853 159.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 42.2 p -102.65 5.06 38.88 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 123.432 1.587 . . . . 25.0 112.346 -179.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 31.4 mp0 -75.91 130.19 38.11 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 112.283 -2.235 . . . . 25.0 114.676 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 44.1 t-105 -69.2 104.84 2.3 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 105.007 -2.22 . . . . 25.0 105.007 171.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -137.9 73.73 45.72 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 108.012 -1.107 . . . . 25.0 108.012 -177.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -65.81 136.28 44.81 Favored 'Trans proline' 0 CA--C 1.512 -0.611 0 O-C-N 122.505 0.739 . . . . 25.0 112.948 -174.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.4 m -147.08 161.11 8.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 114.97 -1.014 . . . . 25.0 108.808 -177.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 9.0 t -120.82 124.69 45.68 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.086 -1.079 . . . . 25.0 108.086 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.95 167.82 44.38 Favored Glycine 0 C--O 1.225 -0.466 0 C-N-CA 120.75 -0.738 . . . . 25.0 111.841 -179.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 24.3 mtpp -66.81 -14.41 62.61 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 112.698 0.629 . . . . 25.0 112.698 178.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -82.24 3.35 27.79 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.695 0.76 . . . . 25.0 110.083 176.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.78 17.04 80.08 Favored Glycine 0 C--O 1.222 -0.644 0 O-C-N 121.502 -0.749 . . . . 25.0 112.658 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -105.55 135.59 46.67 Favored 'General case' 0 C--O 1.239 0.518 0 O-C-N 122.359 -0.494 . . . . 25.0 110.478 -177.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.6 m -87.58 128.91 35.26 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.634 -0.712 . . . . 25.0 110.578 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -114.83 137.16 52.29 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.939 -1.134 . . . . 25.0 107.939 176.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 93.7 p -71.83 -46.33 58.41 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.918 0.389 . . . . 25.0 111.467 -175.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -108.42 162.18 14.35 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 107.351 -1.351 . . . . 25.0 107.351 174.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 36.1 tp -68.52 -26.66 65.55 Favored 'General case' 0 C--O 1.212 -0.898 0 N-CA-C 107.94 -1.133 . . . . 25.0 107.94 173.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.767 ' HB2' ' H ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -52.39 -52.62 52.68 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 115.633 -0.712 . . . . 25.0 112.031 174.989 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 49.1 m95 -65.78 -34.24 77.73 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.539 -0.464 . . . . 25.0 110.541 -176.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.47 -45.67 86.37 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.0 0.429 . . . . 25.0 109.96 175.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -68.85 -34.51 75.59 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.342 0.497 . . . . 25.0 112.342 -177.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -79.13 -30.12 43.5 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 121.111 -0.235 . . . . 25.0 110.38 -177.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.2 -21.54 58.62 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.025 0.44 . . . . 25.0 109.952 175.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.84 15.86 80.0 Favored Glycine 0 C--O 1.228 -0.271 0 N-CA-C 114.561 0.584 . . . . 25.0 114.561 175.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.2 t -80.12 143.81 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 N-CA-C 108.036 -1.098 . . . . 25.0 108.036 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.37 152.57 52.73 Favored Glycine 0 C--N 1.316 -0.554 0 N-CA-C 108.092 -2.003 . . . . 25.0 108.092 173.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 57.4 tp -81.19 142.25 33.39 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.977 -0.749 . . . . 25.0 108.977 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -120.91 -58.71 1.79 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.72 0.295 . . . . 25.0 110.965 174.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 4.5 m170 -112.18 147.7 35.61 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 110.194 -0.298 . . . . 25.0 110.194 175.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -92.71 140.67 29.29 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 103.555 -2.757 . . . . 25.0 103.555 167.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.75 165.35 33.04 Favored Glycine 0 C--N 1.321 -0.278 0 N-CA-C 109.52 -1.432 . . . . 25.0 109.52 -174.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.54 160.46 30.88 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.296 -0.631 . . . . 25.0 109.296 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 28.1 p -142.68 173.04 11.89 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 106.875 -1.528 . . . . 25.0 106.875 179.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.0 pp . . . . . 0 C--O 1.243 0.712 0 N-CA-C 102.762 -3.051 . . . . 25.0 102.762 177.644 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 . . . . . 0 N--CA 1.495 1.78 0 CA-C-O 119.087 -0.482 . . . . 25.0 111.275 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.32 -31.85 71.71 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.739 0.781 . . . . 25.0 109.349 178.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -145.67 156.86 43.91 Favored 'General case' 0 C--O 1.245 0.836 0 N-CA-C 101.524 -3.51 . . . . 25.0 101.524 169.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 13.8 m -138.24 -34.97 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 113.085 0.772 . . . . 25.0 113.085 176.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 28.5 p -117.71 160.05 21.96 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.851 -0.613 . . . . 25.0 112.517 177.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.4 p -95.98 164.75 12.58 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 107.637 -1.246 . . . . 25.0 107.637 170.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.9 p -94.74 18.97 10.69 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.864 0.84 . . . . 25.0 112.016 -179.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -66.07 133.11 50.07 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.175 -0.92 . . . . 25.0 111.15 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.412 ' CE2' ' HD3' ' A' ' 11' ' ' PRO . 58.9 t-105 -58.98 108.98 0.74 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.267 -1.012 . . . . 25.0 108.267 177.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -138.03 73.11 45.99 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.333 -0.617 . . . . 25.0 109.333 -176.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.412 ' HD3' ' CE2' ' A' ' 9' ' ' TRP . 43.6 Cg_endo -66.35 134.97 37.97 Favored 'Trans proline' 0 CA--C 1.506 -0.918 0 C-N-CA 116.706 -1.729 . . . . 25.0 112.966 -174.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.2 m -141.57 163.81 19.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 106.259 -1.756 . . . . 25.0 106.259 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.408 ' HB3' ' HB2' ' A' ' 35' ' ' HIS . 48.8 t -129.88 128.85 43.05 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.749 -0.834 . . . . 25.0 108.749 -178.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.07 173.37 48.56 Favored Glycine 0 C--O 1.226 -0.369 0 C-N-CA 121.028 -0.606 . . . . 25.0 112.349 -178.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 17.7 mtpp -65.81 -12.13 51.76 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.213 1.19 . . . . 25.0 114.213 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -89.69 8.67 30.42 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.955 0.407 . . . . 25.0 110.093 174.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 78.64 2.74 85.96 Favored Glycine 0 C--O 1.22 -0.739 0 N-CA-C 114.784 0.673 . . . . 25.0 114.784 176.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.8 mmmt -96.65 138.83 33.62 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 118.11 0.955 . . . . 25.0 112.938 -176.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 37.2 m -82.09 132.61 35.25 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 113.907 -1.497 . . . . 25.0 111.697 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -114.96 137.14 52.34 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.105 -1.072 . . . . 25.0 108.105 173.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.7 m -58.83 -57.11 14.49 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.717 0.636 . . . . 25.0 112.717 -174.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 53.8 p30 -109.35 168.68 9.21 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 121.154 0.502 . . . . 25.0 110.608 165.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 41.7 tp -63.26 -22.29 66.78 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.913 -0.585 . . . . 25.0 111.332 172.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 5.7 t -61.82 -45.29 94.47 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 121.885 -0.509 . . . . 25.0 111.537 178.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 67.6 m95 -70.86 -30.4 66.78 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.303 -0.559 . . . . 25.0 110.816 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -62.67 -48.01 81.17 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 109.073 -0.714 . . . . 25.0 109.073 175.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -63.88 -42.59 97.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.846 -0.615 . . . . 25.0 112.076 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -66.46 -31.1 71.64 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 111.737 0.273 . . . . 25.0 111.737 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.67 -13.65 59.84 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.711 0.291 . . . . 25.0 111.11 178.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.97 14.44 82.2 Favored Glycine 0 CA--C 1.516 0.123 0 N-CA-C 114.778 0.671 . . . . 25.0 114.778 175.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.5 t -83.45 141.1 15.29 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.643 0 N-CA-C 107.907 -1.145 . . . . 25.0 107.907 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.53 144.89 47.93 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 107.307 -2.317 . . . . 25.0 107.307 172.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.8 tp -74.54 146.53 42.56 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.027 -1.101 . . . . 25.0 108.027 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -130.65 -59.19 1.02 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.167 0.508 . . . . 25.0 111.688 177.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.408 ' HB2' ' HB3' ' A' ' 13' ' ' CYS . 4.0 m170 -115.99 155.63 27.72 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.328 0.492 . . . . 25.0 112.328 -179.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -95.02 143.82 26.19 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 104.495 -2.409 . . . . 25.0 104.495 166.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.54 174.78 43.17 Favored Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 110.99 -0.844 . . . . 25.0 110.99 -177.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -77.77 159.72 28.85 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 113.861 1.059 . . . . 25.0 113.861 -177.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 34.4 m -123.61 173.4 8.1 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 104.719 -2.326 . . . . 25.0 104.719 170.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.6 mp . . . . . 0 C--O 1.247 0.953 0 N-CA-C 107.013 -1.476 . . . . 25.0 107.013 175.144 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 4.8 pm0 . . . . . 0 N--CA 1.497 1.904 0 CA-C-O 119.961 -0.066 . . . . 25.0 111.151 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.74 175.4 13.97 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 103.425 -2.806 . . . . 25.0 103.425 178.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.88 133.74 45.62 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.504 -1.665 . . . . 25.0 106.504 173.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.5 m -125.42 0.31 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 112.256 0.465 . . . . 25.0 112.256 -176.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 80.9 m -81.1 139.97 35.33 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 121.828 -0.545 . . . . 25.0 111.047 -176.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 36.6 p -95.95 168.01 10.89 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.112 -0.699 . . . . 25.0 109.112 177.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.3 p -89.58 24.92 2.14 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.389 0.614 . . . . 25.0 110.822 176.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -68.07 130.33 42.63 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.957 -0.565 . . . . 25.0 110.748 -178.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 64.2 t-105 -65.04 106.19 1.21 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.454 -0.943 . . . . 25.0 108.454 177.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -136.8 73.34 53.9 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 107.878 -1.156 . . . . 25.0 107.878 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -68.65 138.63 42.1 Favored 'Trans proline' 0 CA--C 1.506 -0.917 0 C-N-CA 117.372 -1.285 . . . . 25.0 113.556 -172.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.6 m -139.47 158.37 27.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 105.396 -2.076 . . . . 25.0 105.396 176.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 39.0 t -116.65 121.93 43.11 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.79 -1.189 . . . . 25.0 107.79 -179.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -77.66 169.22 54.66 Favored Glycine 0 C--O 1.227 -0.309 0 N-CA-C 110.763 -0.935 . . . . 25.0 110.763 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -66.24 -12.05 53.91 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 113.058 0.762 . . . . 25.0 113.058 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -78.83 0.48 26.94 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.823 0.345 . . . . 25.0 110.266 173.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.44 17.04 74.57 Favored Glycine 0 C--O 1.218 -0.873 0 CA-C-O 119.431 -0.649 . . . . 25.0 114.465 177.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.9 mmtt -122.2 147.72 45.84 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.041 0.92 . . . . 25.0 112.563 -175.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 85.4 m -79.1 136.61 37.2 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.337 -0.847 . . . . 25.0 112.147 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -114.86 137.04 52.43 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 105.487 -2.042 . . . . 25.0 105.487 170.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.9 p -59.82 -56.03 26.86 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 112.655 0.613 . . . . 25.0 112.655 -171.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 42.2 p30 -109.01 166.57 10.73 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 121.21 0.528 . . . . 25.0 110.418 166.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 63.6 tp -63.59 -25.12 68.09 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.188 0.518 . . . . 25.0 111.262 173.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 32.6 t -62.66 -46.48 87.98 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 121.889 -0.507 . . . . 25.0 111.207 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 54.7 m95 -67.19 -29.75 69.51 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 121.652 -0.655 . . . . 25.0 111.474 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -62.47 -45.64 92.11 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.642 -0.873 . . . . 25.0 108.642 174.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -63.4 -43.48 97.41 Favored 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 116.112 -0.494 . . . . 25.0 111.864 178.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 -68.3 -26.51 65.67 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.098 0.407 . . . . 25.0 112.098 -178.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.2 -14.88 58.8 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.586 0.231 . . . . 25.0 110.799 177.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.25 18.53 78.14 Favored Glycine 0 C--O 1.23 -0.12 0 N-CA-C 114.333 0.493 . . . . 25.0 114.333 175.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -95.64 142.77 13.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 107.781 -1.192 . . . . 25.0 107.781 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.2 155.63 53.51 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 108.102 -1.999 . . . . 25.0 108.102 172.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.8 tt -82.54 142.39 31.86 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.146 -1.057 . . . . 25.0 108.146 176.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -114.32 -58.81 2.1 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.624 -0.51 . . . . 25.0 109.624 174.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 3.5 m170 -111.82 157.72 20.24 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 110.222 -0.288 . . . . 25.0 110.222 176.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -96.23 148.43 22.73 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 101.738 -3.43 . . . . 25.0 101.738 161.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.1 165.82 39.22 Favored Glycine 0 C--N 1.32 -0.336 0 N-CA-C 110.085 -1.206 . . . . 25.0 110.085 -173.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -81.71 162.67 22.89 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.324 0.583 . . . . 25.0 112.203 -177.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 24.6 p -147.02 -174.75 4.58 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 106.213 -1.773 . . . . 25.0 106.213 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.5 tm? . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.143 -0.932 . . . . 25.0 109.442 179.756 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 119.284 -0.388 . . . . 25.0 110.148 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.47 -12.52 58.85 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.134 0.492 . . . . 25.0 110.575 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -72.11 100.56 2.56 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.998 -0.547 . . . . 25.0 110.301 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.5 m -106.78 0.35 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 108.274 -1.009 . . . . 25.0 108.274 177.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.2 p -81.48 159.79 24.12 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.697 -1.138 . . . . 25.0 110.933 -176.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 36.0 p -86.38 169.45 12.9 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.742 -0.663 . . . . 25.0 110.103 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.0 p -85.25 13.16 6.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 122.324 1.059 . . . . 25.0 112.569 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -63.2 130.12 43.2 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 113.762 -1.563 . . . . 25.0 110.462 176.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 53.2 t-105 -48.85 107.77 0.15 Allowed 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.727 -0.842 . . . . 25.0 108.727 176.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -137.74 73.77 46.68 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 107.187 -1.412 . . . . 25.0 107.187 -176.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -64.23 135.07 45.08 Favored 'Trans proline' 0 CA--C 1.506 -0.892 0 C-N-CA 118.049 -0.834 . . . . 25.0 113.27 -173.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.0 m -141.64 156.23 20.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 106.256 -1.757 . . . . 25.0 106.256 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.0 t -126.69 121.99 33.65 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.764 -0.828 . . . . 25.0 108.764 -177.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -78.69 176.76 54.33 Favored Glycine 0 C--O 1.226 -0.355 0 CA-C-N 115.929 -0.578 . . . . 25.0 112.833 -176.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -65.9 -21.54 66.45 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 122.582 -0.364 . . . . 25.0 111.552 178.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -75.23 -7.62 54.39 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.083 -0.508 . . . . 25.0 111.459 176.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.79 -7.66 73.08 Favored Glycine 0 C--O 1.224 -0.487 0 N-CA-C 111.483 -0.647 . . . . 25.0 111.483 -173.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -70.79 126.18 28.89 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 122.5 -0.412 . . . . 25.0 111.022 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.0 m -85.2 130.8 34.53 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.593 -0.731 . . . . 25.0 109.375 175.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -114.66 141.18 48.14 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.352 -0.981 . . . . 25.0 108.352 175.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.0 p -64.68 -57.89 7.78 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 112.682 0.623 . . . . 25.0 112.682 -174.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -109.27 166.37 10.92 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 121.452 0.644 . . . . 25.0 110.489 168.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 59.2 tp -62.16 -27.32 68.87 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.446 -0.797 . . . . 25.0 111.749 176.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 20.9 m -65.56 -40.42 92.8 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 121.73 -0.607 . . . . 25.0 111.734 -178.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -66.63 -34.77 78.61 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.387 -0.525 . . . . 25.0 110.62 176.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.64 -45.51 89.89 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.171 -0.677 . . . . 25.0 109.171 176.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -63.7 -43.41 96.67 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.315 0.487 . . . . 25.0 112.315 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -68.21 -29.37 68.2 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.48 0.178 . . . . 25.0 111.48 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.39 -16.45 57.63 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.691 0.281 . . . . 25.0 111.259 178.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.7 9.39 86.34 Favored Glycine 0 CA--C 1.518 0.24 0 N-CA-C 115.413 0.925 . . . . 25.0 115.413 176.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.5 t -78.92 138.91 19.24 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 N-CA-C 107.847 -1.168 . . . . 25.0 107.847 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.87 149.54 50.47 Favored Glycine 0 C--N 1.315 -0.61 0 N-CA-C 107.989 -2.044 . . . . 25.0 107.989 174.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 59.0 tp -74.03 145.58 44.41 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.062 -0.718 . . . . 25.0 109.062 178.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -125.09 -58.93 1.44 Allowed 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 121.147 -0.221 . . . . 25.0 110.438 172.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 26.8 m-70 -111.75 143.8 42.08 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.96 0.355 . . . . 25.0 111.96 176.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 33.0 mp0 -84.12 138.93 32.77 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 102.595 -3.113 . . . . 25.0 102.595 168.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.53 169.06 40.15 Favored Glycine 0 C--N 1.321 -0.276 0 N-CA-C 109.328 -1.509 . . . . 25.0 109.328 -174.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -83.33 160.6 21.64 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 122.668 -0.313 . . . . 25.0 111.32 -177.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 67.4 m -108.23 158.4 17.49 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 105.097 -2.186 . . . . 25.0 105.097 170.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 94.0 mt . . . . . 0 C--O 1.242 0.703 0 N-CA-C 104.78 -2.304 . . . . 25.0 104.78 179.411 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 22.2 pm0 . . . . . 0 N--CA 1.496 1.852 0 CA-C-O 119.29 -0.386 . . . . 25.0 110.197 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.87 41.49 3.15 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.167 0.508 . . . . 25.0 110.549 -177.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -139.3 138.27 36.57 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 106.527 -1.657 . . . . 25.0 106.527 178.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.17 -14.4 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 113.028 0.751 . . . . 25.0 113.028 -176.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 52.2 t -113.02 139.97 48.22 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 122.317 -0.24 . . . . 25.0 111.484 -177.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.0 p -95.97 155.85 16.58 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.05 -1.093 . . . . 25.0 108.05 171.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 36.1 p -102.84 10.07 38.59 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 122.845 1.307 . . . . 25.0 110.567 177.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -75.9 131.32 39.58 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 113.325 -1.761 . . . . 25.0 110.963 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 53.6 t-105 -59.02 108.62 0.7 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.108 -1.442 . . . . 25.0 107.108 173.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -137.72 73.41 47.55 Favored Pre-proline 0 C--N 1.322 -0.611 0 N-CA-C 107.682 -1.229 . . . . 25.0 107.682 -176.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.58 138.85 46.9 Favored 'Trans proline' 0 CA--C 1.507 -0.831 0 C-N-CA 117.228 -1.381 . . . . 25.0 112.524 -175.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.2 m -142.39 161.04 19.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 104.911 -2.255 . . . . 25.0 104.911 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -126.41 127.54 45.61 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.693 -0.854 . . . . 25.0 108.693 178.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -79.58 177.34 54.32 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 121.033 -0.604 . . . . 25.0 113.613 -176.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -71.16 -12.13 61.32 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 122.389 -0.477 . . . . 25.0 110.648 176.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 42.8 p-10 -82.77 -3.46 56.64 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.473 -0.785 . . . . 25.0 111.212 176.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 79.25 16.9 77.54 Favored Glycine 0 C--O 1.224 -0.501 0 C-N-CA 121.177 -0.535 . . . . 25.0 113.792 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.7 mmtp -110.31 141.38 43.4 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 118.047 0.924 . . . . 25.0 110.854 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.1 m -82.28 132.16 35.23 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.423 -0.955 . . . . 25.0 108.423 175.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -114.91 137.11 52.36 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 106.502 -1.666 . . . . 25.0 106.502 173.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.0 m -64.61 -55.8 17.96 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.577 0.584 . . . . 25.0 112.577 -173.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -113.77 158.72 20.59 Favored 'General case' 0 C--O 1.25 1.08 0 CA-C-O 121.216 0.531 . . . . 25.0 109.671 170.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 30.0 tp -57.35 -24.62 56.37 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.631 -0.713 . . . . 25.0 112.002 177.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.3 m -58.46 -42.95 88.6 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 121.951 -0.468 . . . . 25.0 112.178 177.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 40.1 m95 -73.81 -33.37 64.15 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.779 -0.452 . . . . 25.0 109.779 -177.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -61.45 -45.92 92.23 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.049 -0.723 . . . . 25.0 109.049 176.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -65.05 -41.15 95.42 Favored 'General case' 0 C--O 1.218 -0.569 0 CA-C-N 115.813 -0.631 . . . . 25.0 112.151 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -68.08 -30.79 70.06 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.906 0.336 . . . . 25.0 111.906 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.71 -14.76 59.92 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.899 0.38 . . . . 25.0 110.387 177.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.21 16.3 79.83 Favored Glycine 0 C--N 1.328 0.109 0 N-CA-C 114.149 0.42 . . . . 25.0 114.149 175.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -93.82 142.99 12.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 109.235 -0.654 . . . . 25.0 109.235 -178.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.12 152.36 49.91 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 108.43 -1.868 . . . . 25.0 108.43 171.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.1 tt -75.6 138.92 41.76 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.08 -1.081 . . . . 25.0 108.08 177.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -117.84 -50.24 2.5 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.564 0.221 . . . . 25.0 110.962 175.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 -112.01 151.97 28.69 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.873 -0.417 . . . . 25.0 109.873 175.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -94.5 146.42 24.11 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 102.895 -3.002 . . . . 25.0 102.895 166.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.97 170.14 46.83 Favored Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 110.201 -1.16 . . . . 25.0 110.201 -175.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -79.36 151.34 31.05 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.338 -0.986 . . . . 25.0 108.338 178.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.6 p -148.97 173.37 13.41 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.701 0.286 . . . . 25.0 111.088 -178.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.258 1.524 0 N-CA-C 102.902 -2.999 . . . . 25.0 102.902 174.182 . . . . . . . . 1 1 . 1 stop_ save_